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ABSTRACT 
Global surface waters are increasingly shown to be contaminated by anthropogenic chemical 
pollutants which, in turn exert potential lethal- and sub-lethal toxicity risks to the aquatic 
environment and humans. In particular, pollutants which are able to modulate endocrine system 
pathways, known as endocrine disrupting contaminants (EDCs) are of an emerging global 
concern. Treated wastewater discharge is a major contributing source of this pollution, with 
the recalcitrance and passage of various contaminants through wastewater treatment posing a 
risk to water security. This is highlighted as a critically important global challenge which need 
to be further addressed, especially for developing countries that are subjected to increased 
demands for clean water and sanitation services due to rapid population growth and 
urbanisation. Furthermore, routine monitoring and refinement of analytical methodologies for 
risk assessment are largely limited in the country, which points to the needed to assess the 
harmful impact of priority micro-pollutants in surface water systems. One of the aims of the 
present study was to assess the presence and fate of EDCs and other emerging contaminants 
(ECs) within a selection of South African wastewater treatment works (WWTWs) and 
associated environmental waters in order to refine the monitoring tools and methodology used 
for risk assessment approaches.  
Endocrine-disrupting activities generated by in vitro steroid hormone receptor binding assays, 
namely the yeast (anti)estrogen screen (YES/YAES), highlighted the complexity when dealing 
with environmental samples containing a mixture of analytes. Even though notable reductions 
of estrogenicity by the WWTWs were measured, some remaining loads in effluent receiving 
river waters remained above risk-based trigger values, therefore potentially compromising 
human- and aquatic health. Estimation of the potential toxic masking by analytes with anti-
estrogenic effect/activity highlighted further refinement that will be needed evaluating 
potential endocrine disrupting activity when applying bioassays for risk assessment. Both 
diurnal as well as seasonal variation in endocrine disrupting activities were recorded and 
discussed. Also, treated wastewater effluent served as a diluting medium to lower estrogenicity 
within recipient river waters at some study sites, and highlighted the contribution of alternative 
pollution sources that may significantly impact the quality of river systems.  
Although EDCs are mostly assumed to be associated with steroid hormones, in the present 
study I conducted scoping studies at selected WWTWs and showed the extent of regularly-
used pharmaceuticals & personal care products (PPCPs) and drugs of abuse (DOA) present 
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within wastewater and surface waters - having variable degradation profiles during wastewater 
treatment. In particular, ECs which were highlighted as priority micro-pollutants, such as anti-
epileptics, non-steroidal anti-inflammatory drugs (NSAIDs), opioids and anti-depressants 
showed moderate- to negative removal during wastewater treatment, even during advanced 
activated sludge treatment processes. Although all of these pollutants are known to undergo 
biological degradation, the present study recommended further refinement of current treatment 
processes to improve on the removal of such persistent ECs. The need to define the 
environmental impact of EC breakdown-products were also discussed, as their potential health 
risks are largely unknown.  
 
The dissertation also showed the value of urban water profiling to report on the use and abuse 
of licit and illicit DOA within communities connected to sewer networks at two study sites. 
Several prescription and over-the-counter (OTC) medications were detected within wastewater 
originating from domestic sewage, in particular opioids, an anaesthetic and anti-depressant 
drug – all of which are reported to be abused in South Africa, although limited statistics exist. 
For illicit DOA, the loads of cocaine, 3,4-methylenedioxymethamphetamine (MDMA), 
methamphetamine, heroin and the new psychoactive substance (NPS) mephedrone confirmed 
their consumption within the communities connected to the WWTWs, which were enriched by 
including the detection of their metabolic breakdown products, as well as enantiomeric 
profiling of the chiral drugs.  
 
The present study encapsulated the benefit of urban water profiling to address current- and 
emerging global challenges for environmental- and human sustainability. Incorporation of the 
research outputs from the current study during refinement of risk-based approaches in South 
Africa may greatly improve water reclamation and management strategies to ultimately 
safeguard this valuable commodity for driving community- and environmental resilience. 
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OPSOMMING 
Oppervlak water regoor die wêreld word toenemend besoedel deur menslike chemiese 
besoedelstowwe, wat verder getoon word om verskeie dodelike en sub-dodelike 
toksisteitsrisikos te veroorsaak in die akwatiese omgewing en mense. Besoedelstowwe wat in 
staat is om endokriene stelsels te belemmer, wat bekend staan as endokrien-versteurende 
verbindings (EVVs) is veral wêreldwyd van ‘n opkomende besorgdheid. ‘n Hoof bydraende 
bron van sulke besoedelstowwe is afkomstig van behandelde afvalwater wat na die omgewing 
lei, waar stowwe wat nie voldoende afgebreek word nie ‘n groot risiko vir water sekuriteit bied. 
Hierdie is ‘n krities-belangrike internasionale uitdaging wat verder aangespreek moet word, 
veral vir ontwikkelende lande wat onderworpe is aan verhoogde eise vir skoon water en 
sanitêre dienste as gevolg van vinnige bevolkingsgroei en verstedeliking. Roetiene monitering 
en verfyning van analitiese metodes om risikobepaling te doen is ook grootliks beperk in die 
land, wat dus die behoefde uitwys om die skadelike impak van prioriteit besoedelstowwe in 
oppervlakswaters te assesseer. Een doel van die studie was dus om die teenwoordigheid en lot 
van EVVs en ander opkomende kontaminante (OKs) te assesseer in verskeie Suid-Afrikaanse 
afvalwaterbehandelingswerke en die geaassosieerde omgewingswaters om ten einde die 
moniterinsinstrumente en metodes wat gebruik word vir risikobepaling te verfyn. 
 
Endokriene ontwrigsaktiwiteiete wat gemeet was deur ‘n in vitro steroïedhormoon 
reseptorbindingstoets genaamd die gis (anti)oestrogeen toets (YES/YAES) het die 
kompleksiteit beklemtoon wanneer omgewingsmonsters, wat ‘n mengsel van komponente 
besit, gehanteer word. Alhoewel 'n noemenswaardige vermindering van oestrogenisiteit 
gemeet was gedurende afvalwaterbehandeling het sommige oorblywende vragte in 
uitvloeiselwater bo risiko-gebaseerde snellerwaardes gebly, wat verwys word om potensieël 
die mens- en watergesondheid te beïnvloed. Bepaling van die potensiële toksiese maskering 
van anti-oestrogeniese effekte/aktiwiteite het die nood van verdere verfyning gemerk as sulke 
toetse gebruik word vir risikobepaling. Beide seisoenale, sowel as daaglikse variasies in 
endokriene ontwrigtingsaktiwiteite by die verskillende studie terreine was ook bespreek. Dit 
was ook gewys dat behandelde afvalwater soms dien as 'n verdunningsmiddel om 
oestrogenisiteit in ontvanklike rivierwater te verminder. Die bydrae van alternatiewe 
besoedelingbronne wat die kwaliteit van rivierstelsels aansienlik kan beïnvloed was ook 
uitgelig. 
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Alhoewel EVVs meestal geassosieer word met steroïed hormone het ek verder 
omvangsbepalingstudies by geselekteerde afvalwaterbehandelingswerke gedoen. Die omvang 
van gereeld-gebruikte farmaseutiese- en persoonlike versorgingsprodukte asook 
dwelmmiddels was aangetoon. Hierdie stowwe het baie variasie in hul afbrekingsprofiele 
gewys binne die verskeie afvalwaterbehandelingswerke. OKs wat veral uitgelig was as 
prioriteits kontaminante, insluitend anti-epileptiese stowwe, nie-steroïdale anti-
inflammatoriese middels (NSAIMs), opioïede en anti-depressante het matige- tot negatiewe 
verwydering getoon tydens afvalwaterbehandeling, selfs vir werke wat gevorderde 
geaktiveerde slykbehandeling prosesse gebruik. Alhoewel al hierdie besoedelstowwe bekend 
is dat hulle biologies afgebreek kan word, dui die studie daarop dat verdere verfyning van 
huidige behandelingsprosesse gedoen kan word om ten einde die behandeling van OKs te 
verbeter. Die behoefte om die omgewingsimpak van OK-afbreekprodukte te ondersoek was 
ook bespreek, aangesien hul potensiële gesondheidsrisiko's grootliks onbekend is. 
 
Die verhandeling het ook die waarde van stedelike waterprofiel studies gewys om te rapporteer 
op die gebruik en misbruik van beide wettige en onwettige dwelmmiddels binne gemeenskappe 
wat aan rioolsisteme verbind is in twee studie areas. Verskeie voorskrif- en oor-die-toonbank 
(ODT) medikasies was opgespoor in afvalwater wat afkomstig is van huishoudelike rioolwater, 
veral opioïede, 'n narkose- en anti-depressante middel – waar al hierdie stowwe uitgelig word 
vir hul misbruik in Suid Afrika, alhoewel beperkte statistieke bekombaar is. Die 
teenwoordigheid van die onwettige dwelmmiddels kokaïen, 3,4-metielendioxymetamfetamien 
(MDMA), metamfetamien, heroïen en die nuwe psigoaktiewe stof (NPS) mephedrone in 
afvalwater het die gebruik van hierdie dwelms in die gemeenskap bevestig, wat verder verryk 
was deur die teenwoordigheid van hul metaboliese afbreekprodukte, sowel as enantiomeriese 
profilering van die chirale middels te ondersoek. 
 
Die huidige studie het die samevattende voordele van stedelike waterprofiel studies uitgelig 
om huidige- en ontluikende globale uitdagings vir omgewings- en menslike volhoubaarheid 
aan te spreek. Deur die verfyning van risiko-gebaseerde benaderings te oorweeg wat uitgelig 
was in die huidige studie kan dus tot verbeterde waterherwinning en bestuurstrategieë lei om 
hierdie waardevolle kommoditeit te beskerm wat grootliks verantwoordelik is vir 
gemeenskaps- en omgewingsveerkragtigheid. 
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CHAPTER 1: GENERAL INTRODUCTION 
1.1. Rationale of the Thesis 
Safe- and clean freshwater resources have become a generally scarce commodity on a global 
scale due to increasing pressures associated with human population growth and related 
agricultural and industrial development, which contribute towards organic- and inorganic 
pollution. The contribution of treated- and/or untreated wastewater are of the utmost relevance 
as a primary pollution source, whereby a huge variety of pollutants are simultaneously 
discharged, often without necessarily being regulated or efficiently removed during treatment 
(Bolong et al., 2009; Petrie et al., 2014; Verlicchi et al., 2012). Despite the aim to treat 
wastewater to comply with national standards, the presence and fate of micro-pollutants that 
may exert toxic effects on ecosystems and human health are regularly overlooked – collectively 
known as ‘emerging contaminants’ (ECs). Such toxicity potentials are not restricted to 
compounds showing lethal toxicity (a conventional parameter for risk management), but also 
include chemical substances which can exert sub-lethal toxic effects by disrupting endocrine 
system pathways of wildlife and humans over extended periods of exposure at environmental 
concentrations – collectively known as endocrine-disrupting contaminants (EDCs). In 
developing countries such as South Africa, these problems are exacerbated by a combination 
of high population growth and urbanization rates. Little has been done to date to mandate the 
inclusion of priority ECs into water quality legislation, largely due to limited studies showing 
the extent to which various micro-pollutants may impact both short- and long-term health 
outcomes. For this reason, it is vital to assess the sources of recalcitrant ECs within 
environmental waters, such as discharge from wastewater treatment works (WWTWs). 
 
A WWTW may be seen as a series of interconnected ecosystems (modules) harbouring a 
diversity of microorganisms that are responsive to the varying abiotic conditions and the 
organic-rich influent wastewater medium. As a result, a vast array of metabolic processes will 
be at play for the biodegradation of organics. In WWTWs using activated sludge (AS) during 
secondary treatment, the increased contact to microbial aggregates and particulate matter 
facilitates sorption into the sludge, thereby lowering the loads within the aqueous phase which 
may then be subjected to further treatment. Such sorption is influenced by various factors, 
including the chemistry of the pollutant, redox conditions and other physical factors 
(temperature, pH, etc.) (Luo et al., 2014). For example, persistent compounds such as the anti-
epileptic drug carbamazepine and the non-steroidal anti-inflammatory drug diclofenac are 
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known to have weak partitioning into solid material (Baker and Kasprzyk-Hordern, 2011; 
Radjenović et al., 2009), and as an effect may pass untreated or only partially treated. On the 
other hand, pharmaceuticals such as the opioid drug tramadol and antidepressant venlafaxine 
have high tendencies to be absorbed within sludge (Baalbaki et al., 2017; Boix et al., 2016; 
Falås et al., 2016), although the recalcitrance of these compounds in treated effluent still remain 
a concern. Furthermore, compounds such as the plasticizer Bisphenol-A show rapid sorption 
and desorption kinetics in AS (Banihashemi and Droste, 2014), highlighting the potential of 
such compounds to rapidly dissolve back into newly-introduced wastewater. Predicting their 
environmental risk is further complicated by the large variety of enzymes produced by the 
heterogeneous microbial communities in the different components of WWTPs, which may 
favour different metabolic pathways leading towards transformation into stable by-products 
instead of complete mineralization. Clearly, improved risk assessment and management of 
water resources require a comprehensive understanding of the link between the fate of organic 
micro-pollutants during wastewater treatment and microbiological interactions that are 
responsible for their degradation. Relevant tests and analytical procedures, combined with 
novel approaches that are responsive to new challenges presented in various combinations, are 
essential for the development of such an expertise base.  
 
A promising approach for improved water management and risk strategies include the 
implementation of urban water profiling, also known as wastewater-based epidemiology 
(WBE; Castiglioni et al., 2016), which is increasingly also being adopted to estimate drug use 
and abuse through the detection of drug target residues (DTRs) in wastewater originating from 
communities connected to a sewer system network. As highlighted by the United Nations 
Office on Drugs and Crime (UNODC), the increase in substance abuse and distribution creates 
several pitfalls to sustainable social development, spanning from increased crime and health 
risks to higher rates of poverty and unemployment, especially in rural areas. Several social 
studies in South Africa have reported on the rising drug use problem in all parts of the country 
(Dada et al., 2017; Parry et al., 2017; Weich et al., 2017). There is also not sufficient 
information to accurately assess the extent of drug use and abuse within the country, especially 
for easily-obtainable prescription medications such as opiates and other new psychoactive 
substances (NPS). 
 
Stellenbosch University  https://scholar.sun.ac.za
 3 
 
1.2. Research Aims and Objectives  
The overall goal of the research was to apply wastewater profiling as a strategy for improved 
risk assessment concerning surface water pollution, with emphasis on the recalcitrance of 
priority ECs. The chapters are presented in the dissertation in a journal article style, with 
specific key outcomes addressed in each chapter through case/scoping studies conducted in 
two provinces of South Africa. The study sites included multiple wastewater treatment works 
(WWTWs) in Gauteng Province, and one WWTW in the Western Cape Province, as well as 
environmental waters up- and downstream from the WWTPs. The specific objectives were:   
• To compile a comprehensive literature overview to address the current knowledge regarding 
the presence of pharmaceuticals and personal care products (PPCPs) within South African 
surface waters, along with their associated risk to cause potential modulation of vertebrate 
endocrine systems – Chapter 2 
• To expand the knowledge base regarding the fate of endocrine-disrupting activities during 
wastewater treatment and refinement of a cost-effective bioassay using effect-based risk 
assessment approaches – Chapter 3 
• Monitoring of multiple DTRs to assess the fate of PPCPs and drugs of abuse (DOA) during 
wastewater treatment and within environmental surface waters, and to evaluated the result 
following conventional risk assessment approaches (ERA) and adverse outcome pathways 
(AOPs) – Chapter 4 and 5 
• To introduce urban water profiling through wastewater-based epidemiology (WBE) in an 
African case study - Chapter 6 
• To establish an analytical capacity to serve as a platform for multi-stakeholder partnerships 
between local- and international academic institutions and industry, which will set 
benchmarks for treatment plants’ efficiency, aimed at enhancing biodegradation of ECs.  
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CHAPTER 2: A REVIEW ON PHARMACEUTICAL AND PERSONAL CARE 
PRODUCTS (PPCPs) IN SOUTH AFRICAN SURFACE WATERS, THEIR 
ASSOCIATED ENDOCRINE-DISRUPTING EFFECTS AND 21ST CENTURY RISK 
ASSESSMENT 
Article: 
Archer, E., Wolfaardt, G. M., Van Wyk, J. H. 2017. Review: Pharmaceutical and personal care 
products (PPCPs) as endocrine disrupting contaminants (EDCs) in South African surface waters. 
Water SA. 43 (4), October 2017. 
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Abstract 
 
Globally, water resources are under constant threat of being polluted by a diverse range of man-
made chemicals, and South Africa is no exception. These contaminants can have detrimental 
effects on both human and wildlife health. It is increasingly evident that several chemicals may 
modulate endocrine system pathways in vertebrate species, and these are collectively referred 
to as endocrine disrupting contaminants (EDCs). Although the endocrine-disrupting effect of 
water pollutants has been mainly linked to agricultural pesticides and industrial effluents, other 
pollutants such as pharmaceuticals and personal care products (PPCPs) are largely unnoticed, 
but also pose a potentially significant threat. Here we present for the first time in a South 
African context, a summarised list of PPCPs and other EDCs detected to date within South 
African water systems, as well as their possible endocrine-disrupting effect in vitro and in vivo. 
This review addresses other factors which should be investigated in future studies, including 
endocrine disruption, PPCP metabolites, environmental toxicology, and antibiotic resistance. 
The challenges of removing EDCs and other pollutants at South African wastewater treatment 
works (WWTWs) are also highlighted. The need for focused research involving both in vitro 
and in vivo studies to detect PPCPs in water systems, and to delineate adverse outcome 
pathways (AOPs) of priority PPCPs to aid in environmental impact assessment (EIA), are 
discussed. 
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2.1. Introduction  
 
Fresh water is an essential resource for the survival of all life on earth. It is globally recognised 
that humans are creating great pressure on the quality of our water resources by means of 
anthropogenic (man-made) pollutants entering freshwater systems (WHO, 2012). The major 
sources of freshwater pollutants typically originate from industry, domestic practices, and/or 
agriculture (Genthe et al., 2013). These practices introduce either non-degradable and/or 
harmful chemicals into water systems, thereby creating health risks to both wildlife and 
humans. Reductions in fertility, increases in the incidence of several cancers, spontaneous 
abortions, and a range of in-utero physiological disorders and birth defects have been linked to 
contaminants found in freshwater (Robins et al., 2011; Soto and Sonnenschein, 2010).  
 
South Africa is a developing country, with a mid-year estimated population of 56.5 million 
people for 2017 (http://www.statssa.gov.za/). During the last formal 2011 census, the 
population was estimated at 51.8 million, of which 77.7% (40.3 million) are living in formal 
settlements, 7.9% (4.1 million) in traditional settlements, and 13.6% (7.1 million) in informal 
settlements (http://www.statssa.gov.za/). More recent statistics for 2016 showed an increase in 
formal housing (79.2%), and an increase in households having access to clean water supplies 
(from 70.9% in 2011 to 83.5% in 2016; http://www.statssa.gov.za/). These statistics therefore 
not only show the rapid increase in the country’s population, but also highlight the rapid rate 
of urbanisation within the country, both of which are directly associated with increased demand 
for water and sanitation services. 
 
Apart from the provision of clean water to the South African public, water treatment facilities 
are faced with increased pressures for the provision of improved sanitation services. Efficient 
operation of wastewater treatment works (WWTWs) is therefore important to remove 
pathogens and pollutants from surface waters, which might impact the health of both wildlife 
and human ecosystems. The performance of the WWTWs to remove pathogens and pollutants 
depends on several factors, such as the type of deployed treatment technologies, capacity, 
hydraulic retention time, as well as stakeholder requirements of the plant. However, the general 
target factor for all water treatment facilities is to improve on the quality of the water resource, 
and therefore ensure the health of the populations dependent on these resources. By extension, 
access to clean water supplies and proper sanitation services is therefore dependent on the 
performance of these facilities in order to adhere to water quality standards. As with many 
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countries worldwide, although most treatment processes are developed to successfully 
eliminate or lower the levels of pathogens and chemical pollutants to safe levels, this is not 
always the case in South African water treatment facilities. In a survey of 986 WWTWs in 
South Africa, it was shown that 50% of the plants are receiving less than 0.5 megalitres (ML) 
per day, 32% between 0.5 and 10 ML per day, and 17% more than 10 ML per day (Snyman et 
al., 2006). A suggested explanation for the occurrence of inefficient pathogen and micro-
pollutant removal is the inadequate human resources for maintenance and operation of the 
plants. To assess the South African situation, the South African Department of Water and 
Sanitation (DWS) launched a Green Drop (GD) certification programme in 2008, to evaluate 
the performance of the country’s wastewater works. This initiative was mandated to improve 
the quality of discharged effluent from wastewater treatment operations by awarding the 
operating bodies with a GD status if they comply with the DWS criteria for quality wastewater 
treatment (Ntombela et al., 2016). This initiative aimed to provide annual assessment reports 
on the operating efficiency of the plants, by awarding a cumulative risk rating (CRR) based on 
the design capacities (and hydraulic loading into receiving waters), operational flow relative to 
plant capacity, compliance/non-compliance of effluent quality being discharged into receiving 
waters, and compliance/non-compliance of technical skills utilised at the WWTWs (DWS, 
2012, 2013). In 2012, the GD report has shown that of the 831 WWTWs assessed nationwide, 
323 of these plants (39%) did not comply with the DWS standards, and 153 to 212 (18–26%) 
of all WWTWs received a critical and high-risk rating (Ntombela et al., 2016). Furthermore, 
some of the plants were reported to have unknown design capacities and/or not measure the 
plant influent at the required frequency, creating difficulties in reporting on the water quality 
these plants are treating. Although the 2013 GD report has shown an improvement in the 
overall CCRs of the assessed WWTWs for the 2012/13 year, it was still estimated that 49.6% 
of the WWTWs are still below 50% compliance (DWS, 2013). Furthermore, the DWS also 
awarded a Purple Drop status (critical state) to the 30.1% of the assessed WWTWs that 
achieved < 30% compliance (DWS, 2013). Taken from these reports, the high percentage of 
non-compliance with water quality and service delivery criteria therefore increases the risk for 
higher pathogen and harmful chemical loads in environmental waters. Although it is reported 
that the assessed WWTWs receiving a Purple Drop status in the 2013 GD report will be placed 
under regulatory surveillance (under the Water Services Act, Act 108 of 1997), the ongoing 
non-compliance of these treatment facilities creates great pressure on general surface water 
quality. This emphasizes the need to conduct environmental risk assessments (ERAs) to 
monitor both influents and effluents of water treatment facilities. Apart from the problem that 
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some WWTWs in South Africa do not comply with water quality standards and service 
delivery, another problem exists in that untreated river water is also not subjected to such water 
quality guideline initiatives, as this is not regarded as a drinking water resource in South Africa 
(Genthe et al., 2013). However, several rural communities depend on water taken directly from 
rivers for general daily activities, such as washing, cooking and consumption, as well as for 
agricultural purposes.  
 
Due to the complexity and sheer volume of pollutants potentially present in natural water 
systems, global regulating bodies, such as the United States Environmental Protection Agency 
(USEPA) and the World Health Organisation (WHO), have set out a framework to investigate 
and identify environmental pollutants in freshwater systems (USEPA, 1997; WHO, 2012). 
These approaches consist of four main steps to be followed when doing impact assessment of 
water pollutants: (i) identifying the hazard to the environment, (ii) conducting dose-response 
assessments, (iii) exposure assessment of the pollutants to non-target organisms, and (iv) 
implementing risk characterisation for possible pollutants entering freshwater ecosystems (Fig. 
2.1).  
 
 
Figure 2.1: Framework for the identification and regulation of environmental pollutants in freshwater 
systems, as set out by the United States Environmental Protection Agency 
 
By adhering to these approaches, the first line of investigation should include hazard 
identification of environmental pollutants entering freshwater systems. It is evident from 
literature that the identification of problematic areas in South Africa where water systems may 
be subjected to various pollutants coming from the abovementioned human sources 
(households, industry, and agriculture) is much needed. Also, water treatment facilities need to 
be a focus point for monitoring freshwater pollutants, especially in a developing country such 
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as South Africa, as these facilities can provide information regarding the origin of freshwater 
pollutants in areas of interest. In regard to the pollution of our natural water resources by human 
activities, some insight can be obtained by observing the wellbeing (health status) of wildlife 
populations within contaminated waters. Wildlife species inhabiting polluted freshwater 
supplies are in first-line contact with environmental pollutants and can provide useful 
information on the presence of pathogens in environmental waters and long-term exposure 
effects. Such sentinel species therefore serve as a valuable tool for hazard identification. 
 
2.2. Hazard Identification 
 
2.2.1. Endocrine disruptors and impacts on wildlife  
Several micro-pollutants, or emerging contaminants (ECs), found in environmental waters 
have been linked to potentially causing a large variety of health effects in both invertebrates 
and vertebrates (Bolong et al., 2009; Daughton and Ternes, 1999; Mckinlay et al., 2008). In 
particular, selected pollutants have been suggested to interact with endocrine system pathways 
of vertebrates, and are collectively referred to as endocrine-disrupting contaminants (EDCs). 
The USEPA defines an EDC as: ‘An exogenous agent that interferes with the synthesis, 
secretion, transport, binding, action, or elimination of natural hormones in the body that are 
responsible for the maintenance of homeostasis, reproduction, development, and/or behaviour’ 
(USEPA, 1997). Man-made compounds most frequently implicated as EDCs include 
pesticides, pharmaceuticals, personal care products, and industrial by-products. Classic 
examples of environmental endocrine disruption include studies showing the feminisation of 
male fish and widespread occurrence of anti-androgenic ligands within UK rivers which 
receive effluent from connected WWTWs (Liney et al., 2006; Jobling et al., 2009). Guillette 
and co-workers published a series of accounts confirming the disruption of the male 
reproductive system in juvenile male alligators in several lakes (especially Lake Apopka) 
situated within Florida, USA (Guillette et al., 1999, 1996). Reproductive deformities, ranging 
from reduced penis size to altered plasma testosterone (T) levels were associated with extensive 
agricultural use of the insecticide DDT and other persistent organic pollutants (POP) leading 
towards non-point source pollution in water systems flowing into the lakes (Guillette et al., 
1999, 1996). Along with the concerns about the general disruption of human reproductive 
systems leading to various detrimental effects such as ovarian cancer, breast cancer and 
declined sperm quality, international concerns were voiced regarding the potential subtle 
disruption of the endocrine systems of humans and wildlife during the organisational window 
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during development (Colborn et al., 1993). The documented reports on the occurrence of 
endocrine disruption within natural wildlife populations have raised international awareness of 
the harmful effects which man-made pollutants can exert on surface water quality for reuse. 
 
EDCs are known to modulate either one of the three major axes of the endocrine system, 
namely the hypothalamus-pituitary-gonad (HPG), hypothalamus-pituitary-thyroid (HPT), and 
hypothalamus-pituitary-adrenal (HPA) axes (Fig. 2.2). Within these pathways, several 
hormones, metabolic enzymes and receptors are responsible for the dispersal, activity and 
function of various physiological traits in vertebrates. Due to the vast cross-talk between 
endocrine system axes, disruption of a particular component within one endocrine axis may 
also cause modulation of other endocrine systems. It is therefore evident that a cocktail of 
EDCs present in the environment can have a range of negative effects on vertebrate health 
through modulating various endocrine system pathways. 
 
 
Figure 2.2: Basic representation of the three major endocrine system axes in humans mediated by 
hormonal signalling from the hypothalamus and anterior pituitary gland in the brain. TRH – 
thyrotropin-releasing hormone; CRH – corticotropin-releasing hormone; GnRH – gonadotropin-
releasing hormone; TSH – thyroid-stimulating hormone; ACTH – adrenocorticotropic hormone; LH – 
luteinising hormone; FSH – follicle-stimulating hormone. 
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Environmental contaminants causing disruption of the reproductive endocrine system have 
been the focus of many EDC studies around the world, including South Africa, where varying 
concentrations of contaminants having known estrogenic endocrine-disrupting effects have 
been found in surface waters (Aneck-Hahn et al., 2009; Barnhoorn et al., 2004; Bornman and 
Bouwman, 2012; Genthe et al., 2013). Such studies may only be the tip of the iceberg, as 
increasing number of ECs are shown to have endocrine-disrupting activities. Although termed 
‘emerging contaminants’, many of these contaminants have only recently been screened for 
their presence in the environment, despite being used for years; therefore, the full extent of 
their presence and associated risk is not fully understood.  
 
Studies on gonadal abnormalities in wildlife living within polluted water systems have been 
done in South Africa, similar to those done at Lake Apopka in the United States. The presence 
of intersex in Sharptooth Catfish (Clarias gariepinus) has been observed at two impoundments 
at the Rietvlei Nature Reserve in the Gauteng Province (Barnhoorn et al., 2004; Kruger et al., 
2013). Among the intersex fish, the presence of testicular oocytes was observed, in which the 
possible cause was linked to the presence of an industrial pollutant, p-nonylphenol (NP), in the 
water. The endocrine-disrupting activity of NP has been linked to its lipophilic properties and 
persistence in the environment (Folmar et al., 2002; Lech et al., 1996). Since the detection of 
endocrine disruption in freshwater fish, as well as the presence of POPs in the Rietvlei Nature 
Reserve, this area has been identified as a national priority area to monitor the presence of 
EDCs (Bornman and Bouwman, 2012). Further examples include populations of C. gariepinus 
in the Hartebeespoort Dam in the Gauteng province, where testicular abnormalities in male fish 
have been linked to the presence of POPs detected in the dam (Wagenaar et al., 2012). Intersex 
fish were also found in Mozambique Tilapia populations (Oreochromis mossambicus) at three 
impoundments in the Limpopo Province, which are also situated within an area that is 
intensively sprayed with DDT to combat malaria transmission (Barnhoorn et al., 2010). 
Sampling of O. mossambicus in the Loskop Dam (Mpumalanga province), which receives 
water from the Olifants River (a highly polluted river system), showed elevated plasma 
thyroxine (T3) hormone levels and enlarged thyroid gland follicles, indicating potential thyroid-
modulating EDCs in the water. In African Clawed Frog populations (Xenopus laevis), the 
presence of testicular ovarian follicles was observed in male frogs caught in the north-eastern 
region of South Africa, which are situated in areas of high agricultural pesticide usage (Du 
Preez et al., 2005). Male X. laevis frogs collected within impoundments in the Western Cape 
also situated near agricultural practices also showed modulation of testicular spermatogenic 
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development and altered plasma steroid- and thyroid hormone levels (Van Wyk et al., 2014). 
As these studies only aimed to link the presence of endocrine disruption in wildlife to pesticide 
contamination in water systems, the presence of other contaminants, such as pharmaceuticals 
and personal care products (PPCPs) or synthetic steroid hormones was most probably 
overlooked.  
 
Although the harmful effects of man-made pollutants on wildlife species are well documented 
(Aneck-Hahn et al., 2009; Barnhoorn et al., 2004; Kruger et al., 2013; Wagenaar et al., 2012), 
no national monitoring programmes or water quality guidelines have been implemented in 
South Africa to assess and monitor the occurrence and frequency of pollutants affecting 
endocrine pathways of non-target organisms (Jooste et al., 2008). The clinical implications of 
EDC contamination in surface waters have also received little attention in South Africa, and 
the importance of using sentinel species as bio-indicators of water pollution is regularly 
overlooked, especially by assessing the health of these organisms up- and downstream of water 
treatment processes.  
 
It is evident that most studies link the endocrine-disrupting effect observed in wildlife and 
water sources to the usage of agricultural pesticides. This assumption is supported by the fact 
that agriculture comprises a large percentage of a country’s gross produce, and therefore also 
utilises large quantities of available surface water. Because of the notable dependence of food 
production on pesticides, various point (identifiable) or non-point (diffuse) pollution sources 
for surface and groundwater are anticipated. However, the presence of PPCPs is regularly 
overlooked. These chemicals are used on a daily basis for improved healthcare, personal 
hygiene and/or as daily supplements. It can therefore only be assumed that the presence of 
PPCPs in environmental waters may contribute even more towards EDC pollution in 
freshwater resources than pesticides used in households or agriculture. Although it is globally 
recognised and recorded that several classes of PPCPs are present in environmental waters 
(Blair et al., 2015; Kasprzyk-Hordern et al., 2009a; Petrie et al., 2014), not many studies have 
been done on PPCP pollutants present in South African waters (especially PPCPs acting as 
EDCs), and this therefore needs to be addressed in future studies. 
 
2.3. Risk characterisation 
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2.3.1. Sources and emission routes of pharmaceuticals into the environment 
Pharmaceuticals can enter the environment by various routes, including wastewater/sewage 
effluents and sludge from water treatment facilities, improper disposal of unused 
pharmaceuticals, in faeces and urine from livestock feedlots, and from waste products in PPCP-
producing industries (GWRC, 2003). The two main sources of pharmaceuticals entering the 
environment are sewage from urbanised areas, ending up in sewage treatment works (STWs), 
and livestock feedlots using pharmaceuticals for growth promotion and disease control (Maletz 
et al., 2012). Through these pathways of exposure, several types of PPCPs (such as anti-
inflammatory drugs, antibiotics, anti-epileptics, anti-depressants, skin care products, 
disinfectants, etc.) eventually end up at water treatment facilities with the hope that these 
chemicals are effectively removed before being discharged into rivers and impoundments 
downstream. Although the amount of PPCP waste products from producers is relatively low 
(GWRC, 2003), several other industries, such as hospitals and clinics, can contribute greatly to 
the discharge of PPCPs through sewage and wastewater into the environment (Al Aukidy et 
al., 2014; Maletz et al., 2012). One way of estimating the levels of PPCPs in the environment 
is to gather information regarding the usage of PPCPs by the general public in the area of 
concern.  
 
2.3.2. Human pharmaceutical use in South Africa 
In South Africa, as with many developing countries, the information about the presence of 
pharmaceuticals in environmental and drinking waters is limited to a few studies. These studies 
have been restricted to certain regions in the country, without multiple studies confirming the 
occurrence of PPCPs in the same areas. A national survey of pharmaceutical compounds 
present in South African waters has therefore not yet been conducted. However, the limited 
amount of studies done on the presence of pharmaceuticals in environmental and drinking 
water provides a good indication on the type of compounds present in water bodies, and also 
gives an indication of priority PPCPs for future screening. 
 
Pharmaceutical usage may vary in the ratio of prescription and over-the-counter medication 
issued by the private vs. public health sectors. A study by Osunmakinde et al. (2013) listed 50 
of the most prescribed pharmaceuticals in both the public and private health sectors of South 
Africa. From these lists, the analgesic paracetamol (acetaminophen) is shown to be the most 
prescribed drug in both sectors. Other pharmaceutical compounds included in the list are 
antibiotics amoxicillin, ampicillin, ceftriaxone, chloramphenicol, trimethoprim and 
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sulfamethoxazole, the beta-blocker atenolol, and contraceptives containing levonorgestrel and 
the synthetic estrogen ethynyl-oestradiol (EE2) (Osunmakinde et al., 2013). In the private 
health sector, analgesics are the most prescribed, followed by antihistamines, bronchodilators, 
and antibiotics at second, third and fourth, respectively (Osunmakinde et al., 2013). In the 
public health sector, analgesics are also the most prescribed, followed by hypotensives, 
antiretrovirals (ARVs), and antibiotics at second, third and fourth, respectively (Osunmakinde 
et al., 2013). For both the public and private health sectors, it is shown that hypertension 
medication, analgesics, ARVs, antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), 
antidiabetics and antihistamines are the most common prescribed medications in South Africa. 
Therefore, it can be expected that water systems may contain a large amount of different types 
of pharmaceutical compounds in South Africa.  
 
2.3.3. Pharmaceuticals and steroid hormones detected in South African waters  
Initial detection studies of EDCs in South Africa consisted of steroid hormone detection 
(especially estrogens) in water systems (Table 2.1). This is due to the ubiquitous usage of 
synthetic estrogens as contraceptives and hormone replacement therapy (HRT) by a large 
percentage of the population. These hormones were shown to originate from human excretions 
and improper disposal of pharmaceuticals into sewage (Manickum et al., 2011; Manickum and 
John, 2014; Swart and Pool, 2007). However, it is increasingly becoming known that several 
types of PPCPs are also accumulating in water systems to the same extent as contraceptive 
medications. These compounds can serve as EDCs and are not completely removed during 
water treatment (Ncube et al., 2012). From these contaminants, pharmaceuticals stand out as 
one of the sources which might potentially cause endocrine-disrupting activities in non-target 
organisms. Although it has been globally recognised that pharmaceutical compounds do enter 
surface waters, the detection of PPCPs in water systems has only recently been done in the 
country (Table 2.1). To our knowledge, this summarised table is novel on both a local- and 
African scale by depicting the current knowledge and research to date regarding trace levels of 
PPCPs and hormones in South African surface waters. These detections provide valuable 
information regarding the presence of pharmaceutical drugs in South African waters. 
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Table 2.1: List of pharmaceuticals and steroid hormone concentrations (in µg.L-1) detected in South African WWTWs and surface waters 1 
Pharmaceutical group / Active Ingredient Concentration (µg.L-1)  Location (Province) Source Reference 
      
NSAIDs 
 
 
   
Acetaminophen  5.8 – 58.7  KwaZulu-Natal Surface water  Agunbiade and Moodley, 2014 
 5.8  KwaZulu-Natal WWTW influent Matongo et al., 2015 
 1.0 – 1.7  KwaZulu-Natal Surface water  Matongo et al., 2015 
 136.9 – 343.6  Gauteng WWTW influent Archer et al., 2017a 
 0.04 – 0.2  Gauteng WWTW effluent Archer et al., 2017a 
 0.02 – 0.2  Gauteng Surface water Archer et al., 2017a 
Aspirin 2.2 – 10.0  KwaZulu-Natal Surface water  Agunbiade and Moodley, 2014 
 13.7 - 25.4  KwaZulu-Natal Surface water  Agunbiade and Moodley, 2016 
Diclofenac 1.1 - 15.6  KwaZulu-Natal Surface water  Agunbiade and Moodley, 2014 
 222.7  KwaZulu-Natal WWTW influent Agunbiade and Moodley, 2016 
 123.7  KwaZulu-Natal WWTW effluent Agunbiade and Moodley, 2016 
 0.6 – 8.2  KwaZulu-Natal Surface water  Agunbiade and Moodley, 2016 
 2.7 – 5.6  Gauteng WWTW influent Archer et al., 2017a 
 2.2 – 2.5  Gauteng WWTW effluent Archer et al., 2017a 
 0.3 – 2.2  Gauteng Surface water Archer et al., 2017a 
Ibuprofen 0.8 – 18.9  KwaZulu-Natal Surface water  Agunbiade and Moodley, 2014 
 
39.8  Gauteng WWTW influent Amdany et al., 2014 
 
12.6  Gauteng WWTW effluent Amdany et al., 2014b 
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Table 2.1 (continued)      
      
 
111.9  Gauteng WWTW influent Amdany et al., 2014b 
 
24.6  Gauteng WWTW effluent Amdany et al., 2014b 
 0.02  Gauteng WWTW influent Osunmakinde et al., 2013 
 1.2  KwaZulu-Natal WWTW influent Agunbiade and Moodley, 2016 
 1.1  KwaZulu-Natal WWTW effluent Agunbiade and Moodley, 2016 
 0.4 – 0.7  KwaZulu-Natal Surface water  Agunbiade and Moodley, 2016 
 62.8  KwaZulu-Natal WWTW influent Matongo et al., 2015 
 58.7  KwaZulu-Natal WWTW effluent Matongo et al., 2015 
 0.5 – 8.5  KwaZulu-Natal Surface water Matongo et al., 2015 
 9.1 – 15.8  Gauteng WWTW influent Archer et al., 2017a 
 0.3 – 1.2   Gauteng WWTW effluent Archer et al., 2017a 
 0.1 – 0.6  Gauteng Surface water Archer et al., 2017a 
Ketoprofen 0.4 – 8.2  KwaZulu-Natal Surface water  Agunbiade and Moodley, 2014 
 1.1 – 2.0  KwaZulu-Natal Surface water  Madikizela et al., 2014 
 1.7 – 6.4  KwaZulu-Natal WWTW influent Madikizela et al., 2014 
 1.2 – 4.3  KwaZulu-Natal WWTW effluent Madikizela et al., 2014 
 0.02  Gauteng WWTW influent Osunmakinde et al., 2013 
 0.0001  Gauteng WWTW effluent Osunmakinde et al., 2013 
 3.2  KwaZulu-Natal WWTW influent Agunbiade and Moodley, 2016 
 0.4  KwaZulu-Natal WWTW effluent Agunbiade and Moodley, 2016 
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Table 2.1 (continued)      
      
 0.4 – 0.7  KwaZulu-Natal Surface water Agunbiade and Moodley, 2016 
 0.4 – 5.6   Gauteng WWTW influent Archer et al., 2017a 
 0.2 – 0.7  Gauteng WWTW effluent Archer et al., 2017a 
 0.01 – 0.8  Gauteng Surface water Archer et al., 2017a 
Naproxen 55.0  Gauteng WWTW influent Amdany et al., 2014b 
 
13.5   Gauteng WWTW effluent Amdany et al., 2014b 
 
52.3   Gauteng WWTW influent Amdany et al., 2014b 
 
20.4   Gauteng WWTW effluent Amdany et al., 2014b 
 2.9 – 5.5  Gauteng WWTW influent Archer et al., 2017a 
 1.8 – 2.9  Gauteng WWTW effluent Archer et al., 2017a 
 0.2 – 1.9  Gauteng Surface water Archer et al., 2017a 
Antibiotics/Biocides  
 
 
   
Ampicillin 2.5 – 14.5  KwaZulu-Natal River water Agunbiade and Moodley, 2014 
 6.6  KwaZulu-Natal WWTW influent Agunbiade and Moodley, 2016 
 8.9  KwaZulu-Natal WWTW effluent Agunbiade and Moodley, 2016 
 3.2 – 5.5  KwaZulu-Natal Surface water  Agunbiade and Moodley, 2016 
Chloramphenicol 0.5 – 10.7  KwaZulu-Natal Surface water  Agunbiade and Moodley, 2014 
Erythromycin 0.6 – 22.6  KwaZulu-Natal Surface water Agunbiade and Moodley, 2014 
 0.6  KwaZulu-Natal WWTW influent Matongo et al., 2015 
 0.2  KwaZulu-Natal WWTW effluent Matongo et al., 2015 
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Table 2.1 (continued)      
      
 0.1 – 0.2  KwaZulu-Natal Surface water Matongo et al., 2015 
Fluoroquinolones 0.09 – 0.1  Western Cape WWTW influent Hendricks and Pool, 2012 
 
0.07 – 0.09  Western Cape STW effluent Hendricks and Pool, 2012 
 0.7 – 16.9  KwaZulu-Natal Surface water  Agunbiade and Moodley, 2014 
 27.1  KwaZulu-Natal WWTW influent Agunbiade and Moodley, 2016 
 20.5  KwaZulu-Natal WWTW effluent Agunbiade and Moodley, 2016 
 2.4 – 14.3  KwaZulu-Natal Surface water Agunbiade and Moodley, 2016 
Nalidixic acid 1.7 – 30.8  KwaZulu-Natal Surface water Agunbiade and Moodley, 2014 
 29.9  KwaZulu-Natal WWTW influent Agunbiade and Moodley, 2016 
 25.2  KwaZulu-Natal WWTW effluent Agunbiade and Moodley, 2016 
 12.4 – 23.5  KwaZulu-Natal Surface water Agunbiade and Moodley, 2016 
Streptomycin 0.8 – 8.4  KwaZulu-Natal Surface water Agunbiade and Moodley, 2014 
Sulfamethoxazole 3.68  KwaZulu-Natal Surface water Agunbiade and Moodley, 2014 
 0.1 – 0.2  Western Cape WWTW influent Hendricks and Pool, 2012 
 
0.08 – 0.1  Western Cape STW effluent Hendricks and Pool, 2012 
 34.5  KwaZulu-Natal WWTW influent Matongo et al., 2015 
 1.2 – 5.3  KwaZulu-Natal Surface water Matongo et al., 2015 
 0.6 – 2.6  Gauteng WWTW influent Archer et al., 2017a 
 1.2 – 1.6  Gauteng WWTW effluent Archer et al., 2017a 
 0.6 – 1.4  Gauteng Surface water Archer et al., 2017a 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 20 
 
Table 2.1 (continued)      
      
Tetracycline 0.6 – 5.7  KwaZulu-Natal Surface water Agunbiade and Moodley, 2014 
Trimethoprim 0.3  KwaZulu-Natal Surface water Matongo et al., 2015 
 4.5 – 11.1  Gauteng WWTW influent Archer et al., 2017a 
 1.2 – 1.6  Gauteng WWTW effluent Archer et al., 2017a 
 0.3 – 1.1  Gauteng Surface water Archer et al., 2017a 
Tylosin 0.2 – 22.0  KwaZulu-Natal Surface water Agunbiade and Moodley, 2014 
      Biocide      
Triclosan 78.4   Gauteng WWTW influent Amdany et al., 2014b 
 10.7   Gauteng WWTW effluent Amdany et al., 2014b 
 127.7   Gauteng WWTW influent Amdany et al., 2014b 
 22.9   Gauteng WWTW effluent Amdany et al., 2014b 
 0.4 – 0.9  KwaZulu-Natal Surface water Madikizela et al., 2014 
 2.1 – 9.0  KwaZulu-Natal WWTW influent Madikizela et al., 2014 
 1.3 – 6.4  KwaZulu-Natal WWTW effluent Madikizela et al., 2014 
Beta-blockers      
Atenolol 1.0 – 39.1  KwaZulu-Natal Surface water Agunbiade and Moodley, 2014 
 1.6 – 2.5  Gauteng WWTW influent Archer et al., 2017a 
 0.4 – 0.7  Gauteng WWTW effluent Archer et al., 2017a 
 0.1 – 0.5  Gauteng Surface water Archer et al., 2017a 
Pindolol 0.03  Gauteng WWTW influent Osunmakinde et al., 2013 
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Table 2.1 (continued)      
      
 0.00003  Gauteng WWTW effluent Osunmakinde et al., 2013 
Anti-epileptics      
Carbamazepine 0.02 – 0.3  Free State Drinking water Patterton, 2013 
 0.01 – 0.02  KwaZulu-Natal Drinking water Patterton, 2013 
 0.01  Gauteng Drinking water Patterton, 2013 
 0.03 – 0.1  Gauteng Drinking water Patterton, 2013 
 0.01  Gauteng WWTW influent Osunmakinde et al., 2013 
 2.2  KwaZulu-Natal WWTW influent Matongo et al., 2015 
 0.9  KwaZulu-Natal WWTW effluent Matongo et al., 2015 
 0.1 – 3.2  KwaZulu-Natal Surface water Matongo et al., 2015 
 0.3 – 0.6  Gauteng WWTW influent Archer et al., 2017a 
 0.4  Gauteng WWTW effluent Archer et al., 2017a 
 0.2 – 0.3  Gauteng Surface water Archer et al., 2017a 
Anti-psychotic      
Clozapine 8.6  KwaZulu-Natal WWTW influent Matongo et al., 2015 
 9.6  KwaZulu-Natal WWTW effluent Matongo et al., 2015 
 2.2 – 8.9  KwaZulu-Natal Surface water Matongo et al., 2015 
Lipid regulators      
Bezafibrate 0.8 – 8.7  KwaZulu-Natal Surface water Agunbiade and Moodley, 2014 
 0.2  KwaZulu-Natal WWTW influent Agunbiade and Moodley, 2015 
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Table 2.1 (continued)      
      
 0.03  KwaZulu-Natal WWTW effluent Agunbiade and Moodley, 2016 
 0.003 – 0.2  KwaZulu-Natal Surface water Agunbiade and Moodley, 2016 
 1.4 – 3.0  Gauteng WWTW influent Archer et al., 2017a 
 0.3 – 0.7  Gauteng WWTW effluent Archer et al., 2017a 
 0.05 – 0.4  Gauteng Surface water Archer et al., 2017a 
Antivirals      
Ribavirin 0.02  Gauteng WWTW influent Osunmakinde et al., 2013 
 0.00004  Gauteng WWTW effluent Osunmakinde et al., 2013 
Famciclovir (Famvir) 0.02  Gauteng WWTW influent Osunmakinde et al., 2013 
 0.00006  Gauteng WWTW effluent Osunmakinde et al., 2013 
Tenofovir 0.25  Gauteng Surface water Wood et al., 2015 
 0.16 – 0.19  Free State  Surface water Wood et al., 2015 
Zalcitabine 0.07  Free State  Surface water Wood et al., 2015 
 0.03  Gauteng Surface water Wood et al., 2015 
 0.008  Gauteng Tap water Wood et al., 2015 
Lamivudine 0.09 – 0.24  Gauteng Surface water Wood et al., 2015 
Didanosine 0.05  Free State Surface water Wood et al., 2015 
Stavudine 0.41 – 0.78  Gauteng Surface water Wood et al., 2015 
Zidovudine 0.22 – 0.62  Gauteng Surface water Wood et al., 2015 
 0.45 – 0.97  Gauteng WWTW effluent Wood et al., 2015 
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Table 2.1 (continued)      
      
 0.05  Gauteng/Free State Surface water Wood et al., 2015 
 0.07  Gauteng Tap water Wood et al., 2015 
Nevirapine 0.24 – 1.48  Gauteng Surface water Wood et al., 2015 
Lopinavir 0.28 – 0.31  Gauteng Surface water Wood et al., 2015 
 0.13  Gauteng WWTW effluent Wood et al., 2015 
Human indicators      
Caffeine 4.5  KwaZulu-Natal WWTW influent Matongo et al., 2015 
 0.6  KwaZulu-Natal WWTW effluent Matongo et al., 2015 
 0.1 – 3.3  KwaZulu-Natal Surface water Matongo et al., 2015 
 5.1 – 1214.4  Gauteng WWTW influent Archer et al., 2017a 
 0.5 – 3.8  Gauteng WWTW effluent Archer et al., 2017a 
 0.6 – 6.6  Gauteng Surface water Archer et al., 2017a 
Steroid hormones 
 
 
   
Oestrone (E1) 0.001 – 0.03  KwaZulu-Natal WWTW downstream Manickum and John, 2014 
 0.01 – 0.02  Western Cape STW downstream Swart et al., 2011 
 
0.009 – 0.011  Western Cape STW efffluent Swart and Pool, 2007 
0.01  Western Cape STW efffluent Swart and Pool, 2007 
0.003 – 0.02  KwaZulu-Natal STW effluent Manickum et al., 2011 
 
0.01 – 0.35  KwaZulu-Natal WWTW influent Manickum and John, 2014 
 
0.003 – 0.08  KwaZulu-Natal WWTW effluent Manickum and John, 2014 
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Table 2.1 (continued)      
      
0.02 – 0.02  Western Cape STW influent Swart et al., 2011 
0.01 – 0.02  Western Cape STW downstream Swart et al., 2011 
 0.002 – 0.004  Gauteng Drinking water Van Zijl et al., 2017 
 0.0004 – 0.001  Western Cape Drinking water Van Zijl et al., 2017 
Oestradiol (E2) 0.001 – 0.03  KwaZulu-Natal WWTW upstream Manickum and John, 2014 
 0.002 – 0.07  KwaZulu-Natal WWTW downstream Manickum and John, 2014 
 
0.001  Western Cape STW effluent Swart and Pool, 2007 
0.005  Western Cape STW effluent Swart and Pool, 2007 
0.01 – 0.02  KwaZulu-Natal STW effluent Manickum et al., 2011 
0.02 – 0.20  KwaZulu-Natal WWTW influent Manickum and John, 2014 
0.004 – 0.11  KwaZulu-Natal WWTW effluent Manickum and John, 2014 
 0.001 – 0.03  Mpumalanga  Surface water Van Wyk et al., 2014 
 0.04 – 0.37  Gauteng Drinking water De Jager et al., 2013 
 0.05 – 0.37  Western Cape Drinking water De Jager et al., 2013 
 0.00003  Gauteng Drinking water Van Zijl et al., 2017 
 0.00002 – 0.00005  Western Cape Drinking water Van Zijl et al., 2017 
Ethynyl-oestradiol (EE2) 0.003  KwaZulu-Natal WWTW upstream Manickum and John, 2014 
 0.001 – 0.004  KwaZulu-Natal WWTW downstream Manickum and John, 2014 
 
0.01 – 0.095  KwaZulu-Natal WWTW influent Manickum and John, 2014 
0.001 – 0.008  KwaZulu-Natal WWTW effluent Manickum and John, 2014 
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Table 2.1 (continued)      
      
 0.001 – 0.01  Mpumalanga  Surface water Van Wyk et al., 2014 
 0.00002  Gauteng Drinking water Van Zijl et al., 2017 
Progesterone (P) 0.01  KwaZulu-Natal WWTW upstream Manickum and John, 2014 
 0.06  KwaZulu-Natal WWTW downstream Manickum and John, 2014 
 
0.16 – 0.90  KwaZulu-Natal WWTW influent Manickum and John, 2014 
0.03  KwaZulu-Natal WWTW effluent Manickum and John, 2014 
Testosterone  (T) 0.005 – 0.02  KwaZulu-Natal WWTW upstream Manickum and John, 2014 
 0.003 – 0.02  KwaZulu-Natal WWTW downstream Manickum and John, 2014 
 
0.12 – 0.64  KwaZulu-Natal WWTW influent Manickum and John, 2014 
0.03  KwaZulu-Natal WWTW effluent Manickum and John, 2014 
      
1 
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Although there has been limited information linking these contaminants to wildlife and human 
health disorders locally, the mechanism of physiological action is well established for all of 
these compounds. A worrying factor from these studies is that these contaminants are still being 
detected after wastewater treatment, as well as within environmental waters in rivers. Such 
trends of persistence of priority emerging contaminants after wastewater treatment are also 
recorded globally for PPCPs (Blair et al., 2015; Causanilles et al., 2017; Deo, 2014; Falås et 
al., 2016; Kasprzyk-Hordern et al., 2009a; Petrie et al., 2014). Contaminants which are not 
removed from water treatment processes are therefore destined to end up back in the 
environment (therefore affecting wildlife), or might possibly end up in drinking water (De 
Jager et al., 2013; Patterton, 2013). This emphasises the need to further conduct comprehensive 
monitoring studies in South African surface water systems to report on the fate of priority ECs 
to assist with environmental risk assessment.  
 
2.3.4. Environmental Risk Assessment (ERA) and Adverse Outcome Pathways (AOPs) 
Although the presence and recalcitrance of several PPCPs has already been demonstrated 
within surface water systems on a global scale, the implementation of such monitoring studies 
to predict environmental risk needs more scrutiny. Conventional methods for environmental 
risk assessment (ERA) are based on acute and/or chronic toxicity studies which assess toxicity 
towards the most sensitive organisms within ecosystems. These test organisms include several 
trophic levels, such as bacteria, algae, crustaceans, and vertebrate species. Acute toxicity data 
is based on short-term toxicity effects (< 24 h) which are expressed as EC50 (concentration 
which shows an effect in 50% of the experimental population) or LD50 (lethal dose at 50% of 
the experimental population), whereas chronic toxicity data are based on long-term toxicity 
effects (> 24 h) which are expressed as NOEC (concentration which shows no effect in the 
experimental population) or LOEC (lowest concentration which shows an effect in the 
experimental population). These toxicity endpoints are then corrected by an assessment factor 
to calculate the predicted no-effect concentration (PNEC) of the EC of interest. This PNEC is 
then compared to either predicted environmental concentrations (PEC) or measured 
environmental concentrations (MEC) of the EC to obtain a risk quotient (RQ). A RQ value 
calculated larger or equal to 1 then reflects the EC to be of environmental concern. Although 
such ERAs using RQ estimation for pollutants are valuable to assess toxicity risks in the 
environment, there are several limitations to this conventional calculation of ERA, namely: 
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 The relevance for selecting only specific test organisms to calculate PNEC in the 
environment is an underestimation of the total ecological impacts of the ECs 
 Using animal models is timely and not cost-effective to calculate risk for the vast majority 
of ECs on the market and in environmental waters 
 Ethical concerns using animal bio-indicators for toxicity testing 
 Sub-lethal and chronic (long-term; multigenerational) toxicity (such as endocrine 
disruption, behavioural effects and other physiological modulation) are not estimated 
 The prediction of environmental risk is also unknown for pollutants in highly complex 
chemical mixtures in the environment, which leads to the need to establish more defined 
ERAs which are not chemical-specific 
 
Due to these constraints that are shown for conventional ERA, it is necessary to construct more 
accurate and thorough models for risk assessment, constituting both lethal and sub-lethal 
toxicity. In vitro screening assays, molecular screening technologies and bioinformatics are 
just a few examples to be included in the decision-making process in predictive ecotoxicology. 
To add to the understanding of evolving 21st century toxicity testing and risk assessment, an 
adverse outcome pathway (AOP) framework has been proposed (Edwards et al., 2016; 
Villeneuve et al., 2014). This framework is structured upon existing knowledge based on the 
relationships between physiological pathways, spanning from molecular initiating events 
(MIEs), which in turn causes a perturbation in normal biological functioning, therefore 
impairing a sequence of measurable key events (KEs), ranging from cellular- to organism level 
(Edwards et al., 2016). Each KE is further linked with key event relationships (KERs) based 
on a weight-of-evidence approach. This downstream series of KEs are then coupled with a 
particular adverse outcome (AO) on a population level, which can be used for regulatory 
decision-making (Fig. 2.3). The AOP framework is well described by several authors (Edwards 
et al., 2016; Villeneuve et al., 2014), highlighting the advances made since its establishment 
by Ankley and colleagues (2010). Advancements of the AOP framework are still ongoing, 
which includes the broader AOP Knowledge Base (AOP-KB; https://aopkb.org/), containing 
the AOP Wiki (https://aopwiki.org/wiki/index.php/Main_Page). This initiative is led by several 
global regulating bodies, namely the USEPA, the Organisation for Economic Co-operation and 
Development (OECD), the European Commission Joint Research Centre (JRC), and the US 
Army Engineer Research and Development Centre (ERDC). 
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Figure 2.3: Basic representation of an adverse outcome pathway (AOP). A specific molecular 
initiating event (MIE) is linked to several key events (KE) by means of key event relationships 
(KERs) from a cellular to organism level, leading towards an adverse outcome (AO) observed within 
a population/community. Ultimately, several AOPs can be connected into an AOP network through 
several MIEs and KEs leading towards the same AO. Diagram based on the template from AOP-Wiki 
(https://aopwiki.org/wiki/index.php/Main_Page) 
 
Although the AOP framework is not considered to be part of risk assessment, nor constructed 
to show chemical-specific outcomes, it helps with the extrapolation of possible AOs which 
might occur when specific MIEs or KEs are altered. Moreover, this initiative can assist with 
the understanding of further downstream pathways which could be modulated when a specific 
KE is shown to be altered by micro-pollutants. Studies indicating the environmental risk caused 
by micro-pollutants is still lacking in South Africa. Incorporating ERAs and the AOP 
framework in a local context will aid in the re-establishment of the National Toxicity 
Monitoring Programme (NTMP), which is only concentrated on a few pollutants and does not 
address more recent ‘emerging contaminants’ such as PPCPs (Jooste, 2008). In order to 
contribute to a more thorough national programme, it is clear that more information is needed 
on the chronic, sub-lethal level of toxicity using wildlife species and several other bio-markers 
for more accurate ERA analysis. This can be achieved by adopting a tiered screening approach 
to quantify and organise/categorise both lethal and sub-lethal toxicity data on both in vitro and 
in vivo screening approaches. 
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2.3.5. Endocrine disruption of detected pharmaceutical contaminants 
Although studies indicating the monitoring of PPCPs within South African waters are on the 
increase (Table 2.1), there is still a lack of research effort towards correlating these levels of 
micro-pollutants with potential sub-lethal toxicological endpoints (such as endocrine 
disruption) for risk assessment. As discussed before, the potential for correlating MECs with 
known disruptions of KEs within an AOP framework can assist in demonstrating potential 
disruption of vertebrate endocrine systems, therefore serving as early-warning biomarkers of 
environmental health. Pollutants such as PPCPs are regularly shown to be present in water 
systems, either as their breakdown products, or to persist as their active ingredient, depending 
on several environmental factors and physiochemical properties of the compounds. 
Furthermore, several in vitro and in vivo toxicological studies have shown the potential of 
PPCPs to alter endocrine system pathways (Table 2.2), and many of these compounds have 
been detected within South African environmental waters and WWTW effluents (Table 2.1). 
Even more alarming, the levels of certain PPCPs detected within South African waters are well 
within, or close to, the levels reported to disrupt specific endocrine system pathways (as shown 
in Table 2.2). 
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Table 2.2: Endocrine-disrupting effects of commonly-detected and priority pharmaceuticals and personal care products (PPCPs), which are also referred to as 
key events (KEs) being disrupted within an adverse outcome pathway (AOP). Abbreviations: LOEC – Lowest Observed Effect Concentration for endocrine 
disruption in aquatic organisms; NSAIDs – non-steroidal anti-inflammatory drugs; SHBG – steroid hormone binding globulin; VTG – yolk precursor protein 
vitellogenin; CYP – cytochrome P450 enzyme; hAR – human androgen receptor; hER – human estrogen receptor; SAID – steroidal anti-inflammatory drug; T3 
– triiodothyrosine, T4 - thyroxine, mRNA – messenger ribonucleic acid 
Active 
ingredient 
Key event (KE) / endocrine disruption Assay / test species 
LOEC 
(µg.L-1) 
Reference 
     
Anti-epileptic 
Carbamazepine  Reduced steroid hormone levels, elevated 
SHBG levels in male and female patients 
Human patients - Herzog et al., 2005; 
Svalheim et al., 2009 
  Decrease 11-ketotestosterone levels in male 
fish 
Zebrafish (Danio rerio) 0.5 Galus et al., 2013 
     
NSAIDs 
Diclofenac  Elevated levels of the enzyme cytochrome 
P450 and VTG protein; estrogenic effects 
Japanese medaka (Oryzias latipes) 1.0 Hong et al., 2007 
 Decreased thyroid hormone levels in male and 
female patients 
Human patients - Bishnoi et al., 1994 
  Decreased thyroid hormone levels in fish Indian major carp (Cirrhinus mrigala) 1.0 Saravanan et al., 2014 
Ibuprofen  Increased VTG production in male fish Japanese medaka (Oryzias latipes) 1 000 Han et al., 2010 
 Reduced reproduction behaviour in fish Japanese medaka (Oryzias latipes) 10 Han et al., 2010 
 Increased estradiol hormone levels and 
aromatase enzyme activity; decreased 
testosterone hormone levels 
 Decreased egg fertilisation in fish. 
Human adenocarcinoma cell line (H295R) 
 
 
Florida flagfish (Jordanella floridae) 
2 000 
 
 
0.1 
Han et al., 2010 
 
 
Nesbitt et al., 2011 
 Disruption of thyroid hormone-mediated 
reprogramming in tadpoles 
North American bullfrog (Rana catesbeiana) 1.5 Veldhoen et al., 2014 
Naproxen  Decreased thyroid hormone levels in male and 
female patients 
Human patients - Bishnoi et al., 1994 
  Decreased egg fertilisation in fish Florida flagfish (Jordanella floridae) 0.1 Nesbitt et al., 2011 
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Table 2.2 (continued) 
 
Anti-depressant 
Fluoxetine  Increased uterine weight in female rats Wistar rats - Müller et al., 2012 
 Estrogenic response, proliferation of cells MCF-7 breast cancer cells - Müller et al., 2012 
 Upregulation of CYP11β2 gene expression Human adenocarcinoma cell line (H295R) - Gracia et al., 2007 
 Modulation of testicular structure, induced 
VTG production in male fish 
Fathead minnows (Pimephales promelas) 0.03 Schultz et al., 2011 
Biocides 
Triclosan  Decreased T4 hormone levels in female rats Long-Evans rats - Crofton et al., 2007 
 Increased VTG gene expression, decreased 
sperm counts in male fish 
Western Mosquitofish (Gambusia affinis) 101.3 Raut and Angus, 2010 
 Decreased T3 hormone levels and other 
thyroid-related gene expressions in tadpoles 
North American bullfrog (Rana catesbeiana) 0.03 Veldhoen et al., 2006 
 Increased hepatic VTG in male fish Japanese medaka (Oryzias latipes) 20.0 Ishibashi et al., 2004 
 Decreased hatchability and time of hatching of 
fertilised eggs in fish 
Japanese medaka (Oryzias latipes) 313.0 Ishibashi et al., 2004 
 Antagonist for steroid ER/AR-responsive gene 
expression 
Recombinant human ovarian cancer cells 
(BG1Luc4E2, ERα–positive), recombinant 
human cells (T47D-ARE) 
- Ahn et al., 2008 
 Enhance testosterone-dependent activation of 
AR-responsive gene expression 
MDA-kb2 breast cancer cell line - Christen et al., 2010 
Triclocarban  Induction of CYP2B6 and CYP1B1 mRNA 
expression; activate estrogen receptor target 
genes in female ovaries 
ERα positive MCF7 breast cancer cells, 
humanised UGT1 mice 
- Yueh et al., 2012 
 Enhance testosterone action through 
interaction with the AR 
Castrated male rats, cell-based human AR-
mediated bioassay 
- Chen et al., 2008 
 Agonist of ER/AR-responsive gene expression Recombinant human ovarian cancer cells 
(BG1Luc4E2, ERα–positive), recombinant 
human cells (T47D-ARE), MDA-kb2 breast 
cancer cell line 
- Ahn et al., 2008; 
Christen et al., 2010 
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Table 2.2 (continued) 
Antibiotics 
Amoxicillin  Upregulation of CYP19 and CYP17 gene 
expression and estradiol hormone levels 
Human adenocarcinoma cell line (H295R)  - Gracia et al., 2007 
Erythromycin  Upregulation of CYP11β2 gene expression 
and progesterone/estradiol hormone levels; 
downregulation of testosterone hormone 
levels. 
Human adenocarcinoma cell line (H295R) - Gracia et al., 2007 
Cephalexin  Upregulation of CYP19 gene expression; 
downregulation of testosterone hormone levels 
Human adenocarcinoma cell line (H295R) - Gracia et al., 2007 
Oxytetracycline  Upregulation of CYP19 and 3βHSD2 gene 
expression; increased estradiol hormone levels 
and aromatase enzyme activity 
Human adenocarcinoma cell line (H295R) - Gracia et al., 2007  
Ji et al., 2010 
Sulfathiazole 
 
 Upregulation of CYP17 and CYP19 gene 
expression 
 Increased estradiol hormone levels and 
aromatase enzyme activity, increased estradiol 
hormone levels in male fish 
Human adenocarcinoma cell line (H295R),  
 
Japanese medaka (Oryzias latipes) 
- Ji et al., 2010 
Doxycycline  Upregulation of CYP19 gene expression Human adenocarcinoma cell line (H295R) - Gracia et al., 2007 
Tylosin   Upregulation of CYP11β2 gene expression, 
downregulation of testosterone and estradiol 
hormone levels 
Human adenocarcinoma cell line (H295R) - Gracia et al., 2007 
SAID 
Dexamethasone  Upregulation of CYP11β2 gene expression, 
downregulation of testosterone hormone levels 
Human adenocarcinoma cell line (H295R) - Gracia et al., 2007 
Growth promoter 
Trenbolone  Upregulation of CYP19 gene expression, 
downregulation of testosterone hormone levels 
Human adenocarcinoma cell line (H295R) - Gracia et al., 2007 
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Table 2.2 (continued) 
     
Painkiller 
Acetaminophen  Upregulation of CYP11β2 gene expression 
and progesterone hormone levels 
Human adenocarcinoma cell line (H295R) - Gracia et al., 2007 
     
Bronchodilator 
Salbutamol  Upregulation of CYP17 gene expression, 
downregulation of estradiol hormone levels 
Human adenocarcinoma cell line (H295R) - Gracia et al., 2007 
     
Lipid regulator 
Bezafibrate  Decrease in plasma 11-ketotestosterone levels 
in fish 
Zebrafish (Danio rerio) - Velasco-Santamaría et 
al., 2011 
Clofibrate  Upregulation of CYP11β2 gene expression, 
downregulation of testosterone hormone levels 
Human adenocarcinoma cell line (H295R) - Gracia et al., 2007 
     
Preservatives 
Parabens  Estrogenic and anti-androgenic effects in vitro 
and in vivo 
Rat uterus receptor binding assay, MCF-7 
breast cancer cells, Transfected Chines hamster 
ovary (CHO-K1) cells, Recombinant yeast 
screens 
- Boberg et al., 2010 
 Hepatic necrosis, testicular fibrosis, induction 
of hepatic VTG in male fish 
Common carp (Cyprinus carpio) 840 Barse et al., 2010 
  Increase in plasma VTG concentrations, and 
increase in mRNA expression of VTG 
subtypes and estrogen receptor (ERα) in the 
liver of male fish 
Japanese medaka (Oryzias latipes) 9 900 Inui et al., 2003 
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Table 2.2 (continued) 
     
UV screens 
Benzophenones 
4-MBC  
OMC 
 Agonistic binding to the human estrogen 
receptor (hER), induced breast cancer cell 
proliferation, increased uterine weight female 
rats 
MCF-7 breast cancer cells and female Long-
Evans rats 
- Schlumpf et al., 2001 
 Increase in plasma VTG concentrations, and 
increase in mRNA expression of VTG 
subtypes and estrogen receptor (ERα) in the 
liver of male fish 
Japanese medaka (Oryzias latipes) 9 900 
 
Inui et al., 2003 
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It is apparent that several PPCPs can exert a range of MIEs and KEs according to the in vitro 
and in vivo studies shown in Table 2.2. The potential of these commonly-detected PPCPs in 
environmental waters to exert endocrine-disrupting activities therefore raise concerns for their 
impact upon environmental and human health. A further concern is that these compounds have 
been detected in broader environmental water systems, such as direct point sources of drinking 
water for human consumption. A study by Patterton and colleagues (2013) detected 
pharmaceutical compounds in drinking water from taps in Johannesburg (Gauteng Province) 
and Bloemfontein (Free State Province), South Africa. In particular, the anticonvulsant drug 
carbamazepine was detected in 63% of tap water tested in these regions (Table 2.1; Patterton, 
2013). Anticonvulsant drugs, such as carbamazepine, levetiracetam, lamotrigine and valproate, 
have been shown to cause several reproductive endocrine system side-effects in men and 
women suffering from epilepsy (Table 2.2; Rättyä et al., 2001; Svalheim et al., 2009; Harden 
et al., 2010), as well as in fish species exposed to carbamazepine (Galus et al., 2013). In men 
using levetiracetam and valproate as treatment, it has been shown that these drugs can lead to 
increased T and steroid hormone-binding globulin (SHBG) levels, which is responsible for the 
transport of steroid hormones in blood plasma (Rättyä et al., 2001; Harden et al., 2010). In the 
same studies, it was shown that men treated with carbamazepine also evidenced increased 
levels of SHBG, pituitary FSH and LH (Herzog et al., 2005; Svalheim et al., 2009). Therefore, 
it might be possible that anticonvulsant compounds found in drinking water resources can lead 
to altered steroidogenesis in men. Alternatively, carbamazepine treatment in women has been 
shown to lead to higher SHBP levels and lower levels of P and T steroid hormones (Löfgren et 
al., 2006; Svalheim et al., 2009). These endocrine-disrupting effects of anticonvulsant drugs 
were shown in wildlife as well, including modulation of steroidogenesis and ovarian 
malformations in ovarian follicular cells (Svalheim et al., 2009). 
 
Another group of pharmaceuticals that are frequently prescribed and also detected in South 
African waters are NSAIDs. A study by Amdany and colleagues (2014) detected varying levels 
of naproxen and ibuprofen in the influents and effluents of two WWTWs in the Gauteng 
province of South Africa (Table 2.1). These compounds have been shown to alter endocrine 
systems in non-target vertebrate species. In a full life-cycle study, exposing Japanese Medaka 
Fish (Oryzias latipes) to ibuprofen concentrations as low as 0.1 µg.L-1 resulted in delayed 
hatching success, while a concentration of 1 mg.L-1 resulted in increased blood plasma levels 
of the glycoprotein vitellogenin (VTG) (Table 2.2; Han et al., 2010). This protein molecule is 
the precursor for egg yolk, and has been validated as a biomarker to express estrogenic 
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endocrine disruption in egg-laying vertebrate species. In the same study, the exposure of 
ibuprofen to a human adrenocortical carcinoma cell line (H295R) resulted in an increase in E2 
hormone levels at concentrations of 2 and 20 mg.L-1, and also increased aromatase enzyme 
activity at concentrations of 0.2 and 2 mg.L-1 (Table 2.2; Han et al., 2010). Aromatase is the 
enzyme responsible for the metabolism of T to E2 in steroidogenic pathways. Apart from the 
possible gonadal endocrine-disrupting activity of ibuprofen, exposure of X. laevis larvae to 
concentrations ranging between 30.7 and 39.9 mg.L-1 leads to malformations in the 
development of these larvae, indicating teratogenic effects of ibuprofen as well (Richards and 
Cole, 2006). Another NSAID that has been investigated for its endocrine-disrupting effect is 
diclofenac. In South Africa, diclofenac has been detected in a KwaZulu-Natal Province river 
system at concentrations varying between 1.1 µg.L-1 and 15.6 µg.L-1 (Table 2.1; Agunbiade 
and Moodley, 2014). The exposure of X. laevis embryos to diclofenac has been shown to cause 
teratogenicity at a concentration of 4 mg.L-1 (Chae et al., 2015). Furthermore, diclofenac 
exposure in male O. latipes fish showed that concentrations as low as 1 µg.L-1 can increase the 
gene expression for VTG in the liver, thereby showing estrogenic effects (Hong et al., 2007). 
Furthermore, assessment of patients using diclofenac as an NSAID has shown a reduction in 
serum T3 levels (Table 2.2; Bishnoi et al., 1994), which is the more active thyroid hormone 
responsible for growth, development and metabolism in the body. The other NSAID that has 
also been found in South African waters, naproxen, has also been shown to cause a reduction 
in serum T3 levels in patients taking this medication (Bishnoi et al., 1994). However, according 
to our knowledge, little is known about the endocrine-disrupting activity of naproxen pollution 
into the environment, and the effects of this compound on non-target organisms. The dose-
dependent response of thyroid disruption by naproxen exposure still needs to be assessed in 
future studies. Although some of the endocrine-disrupting effects shown above may only occur 
at high levels of exposure to these NSAIDs, it is important to note that a mixture of different 
pharmaceuticals and other contaminants might accumulate in the water system. The presence 
of NSAIDs such as ibuprofen, naproxen and diclofenac may therefore contribute to endocrine 
disruption caused by other water pollutants as well. Furthermore, these compounds have been 
confirmed to be present in South African surface waters (Table 2.1), showing that they are not 
completely removed from the water system after treatment. The above-mentioned studies 
imply that NSAIDs, such as ibuprofen, naproxen and diclofenac, have the possibility to alter 
both gonadal and thyroid endocrine system pathways, and also possibly cause teratogenicity at 
environmentally relevant concentrations. 
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The PPCPs which are the most frequently detected in surface waters worldwide are antibiotics 
and biocides. Regularly-prescribed antibiotic pharmaceuticals, such as ampicillin, 
chloramphenicol, ciprofloxacin, erythromycin, nalidixic acid, streptomycin, sulfamethoxazole, 
tetracycline, and tylosin, have all been detected in South African river systems (Table 2.1; 
Agunbiade and Moodley, 2014). These compounds have all been shown to have endocrine-
disrupting effects. The semi-synthetic macrolide antibiotic tylosin, which is used in veterinary 
medicine, has been shown to increase the expression of the aldosteronogenic gene (CYP11β2), 
and decrease the production of T and E2 at a concentration of 3 mg.L
-1 in an H295R 
steroidogenic assay, showing that this chemical can serve as both an anti-estrogenic and anti-
androgenic EDC (Table 2; Gracia et al., 2007). In the same study, another macrolide antibiotic, 
erythromycin, showed an increase in the expression of CYP11β2 and a reduction in T 
production at a concentration of 3 mg.L-1, but caused increased production of E2 and P in the 
assay (Table 2.2; Gracia et al., 2007). Exposure of erythromycin in a recombinant yeast 
estrogen screen (YES) showed that this compound may be a minor mimic of E2 in binding to 
the estrogen receptor in a dose-dependent manner (Archer et al. unpublished). This shows that, 
although tylosin and erythromycin share the same macrolide ring in their chemical 
composition, the endocrine-disrupting effect differs between these two compounds, and 
therefore complicates environmental endocrine disruption studies if, for example, both these 
two types of chemicals are present in environmental samples. A study by Garcia and colleagues 
(2007) also showed that tetracyclines, exposed at a concentration of 81 µg.L-1 to H295R cells, 
can increase the expression of CYP19 enzymes and 3βHSD2 genes (Table 2), which are 
responsible for T-E2 metabolism and the production of P, respectively. Although these 
antibiotics were not detected in the range which showed endocrine system modulation in an in 
vitro assay, their effect on wildlife through long-term exposure within environmental waters is 
currently unknown. Furthermore, due to the extensive usage of antibiotics in both humans and 
livestock, the expected concentrations of these chemicals in the environment may be 
underestimated, and may also have a cumulative endocrine-disrupting effect in the water if 
they accumulate in mixtures with other pollutants. It is therefore evident that antibiotic 
chemical pollutants should receive high priority in environmental screening in water systems 
and water treatment facilities in South Africa. 
 
Apart from the regularly-prescribed antibiotic pharmaceuticals detected in environmental 
waters, it is shown that compounds in personal care products can also have endocrine-
disrupting properties. One of the most well documented compounds is the biocide triclosan 
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(TCS), which is used as a disinfectant in soaps, detergents, toothpastes, mouthwash, and more 
(Raut and Angus, 2010). This compound also shows a high partition coefficient (Kow) value 
(Log Kow 4.66; KOWWIN v. 1.67, EPI Suite), which indicates that TCS is highly lipid-soluble 
and does not readily dissolve in water. For this reason, TCS can be regarded as a POP, which 
can accumulate in the fat tissue of exposed organisms, and can also be transported in water 
bodies over great distances. This has been shown in a study demonstrating high levels of TCS 
in blood plasma (163 times more) and breast milk (12 times more) in pregnant women 
compared to unexposed individuals (Allmyr et al., 2006). Although the use of TCS has been 
phased out in several personal care products in developed countries, it is still found in South 
African consumer products, and therefore detected in surface waters (Amdany et al., 2014b; 
Madikizela et al., 2014). Amdany and colleagues (2014) showed varying levels of TCS in 
influents and effluents from two WWTWs in the Gauteng province of South Africa. These 
levels ranged from 78.4 to 127.7 µg.L-1 in influent samples, and 10.7 to 22.9 µg.L-1 in effluent 
samples (Amdany et al., 2014a). Although the concentrations of TCS are significantly reduced 
after water treatment, these levels are still high if sub-lethal effects are taken into account. 
Exposure of North American bullfrog tadpoles (Rana catesbeiana) to TCS showed that 
concentrations as low as 0.3 µg.L-1 can significantly lower tadpole body mass and decrease 
thyroid hormone receptor (TR) gene expression (Table 2.2; Veldhoen et al., 2006). Exposure 
of TCS at 20 µg.L-1 has also been shown to induce hepatic VTG levels in male Japanese 
Medaka (Oryzias latipes) (Table 2.2; Ishibashi et al., 2004). Exposure of mature male Western 
Mosquitofish (Gambusia affinis) to TCS at 101.3 µg.L-1 can cause decreased sperm counts, 
and also elevate VTG gene expression (Table 2.2; Raut and Angus, 2010). TCS exposure in 
MDA-kb2 breast cancer cells showed that a concentration of 289 µg.L-1 significantly induces 
cell proliferation, and a concentration as low as 290 ng.L-1 caused an elevated androgenic 
response when treated along with dihydrotestosterone (DHT), which is a more metabolically 
active androgen than testosterone (Table 2.2; Christin et al., 2012). These results show that 
TCS serves as an androgen agonist by binding to the androgen receptor in a human cell-based 
bioassay (Christin et al., 2012). These concentrations of endocrine disruption are either 
equivalent or lower than levels observed in South African waters (Table 2.1). Therefore, 
wildlife species living either upstream or downstream of WWTWs may be affected by levels 
of TCS in the environment. Bearing these studies in mind, it is possible that exposure to low 
concentrations of TCS over a long period of time (chronic exposure) may modulate both 
gonadal and thyroid endocrine systems in humans and other wildlife species at concentrations 
currently being detected in environmental waters.  
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Due to the regular detection and known endocrine-disrupting effect of TCS, it is also important 
to investigate other compounds found in personal care products and detected in South African 
waters. Based on chemical analyses and endocrine disruption studies done elsewhere in the 
world, it is evident that compounds used as preservatives, disinfectants and UV filters have not 
received much attention as priority environmental pollutants and EDCs in South Africa. 
Preservatives such as parabens (methylparaben, propylparaben, octylparaben), other biocides 
such as trichlorocarban (TCC), and UV filters in sunscreens (4-MBC, OMC) have all been 
shown to accumulate in wastewater systems and cause potential endocrine disruption. Several 
paraben compounds, as well as their metabolites, have been shown to have both estrogenic and 
anti-androgenic effects in vitro and in vivo (Table 2.2). These studies imply that contaminants 
such as parabens can affect multiple endocrine pathways, and are therefore of environmental 
concern. Biocides such as TCC are regularly included in several cosmetic and personal care 
products to deter microbial organisms. Although the endocrine disrupting effect of the biocide 
TCS has been well documented, and also found at high concentrations in the environment 
(Table 2.1, Halden and Paull, 2005), limited data are available on the endocrine-disrupting 
effect of TCC. Exposure to TTC in human cell-based bioassays, and exposure of rodents to 
TTC, indicated that the biocide does not have endocrine-disrupting activity on its own, but 
rather enhances the action and binding affinity of steroid hormones (Table 2.2) (Ahn et al., 
2008; Christen et al., 2010; Yueh et al., 2012). This shows a potentiating mechanism of 
endocrine disruption, as well as an alternative mode of endocrine disruption other than direct 
modulation of endocrine pathways. Several compounds used as UV filters in sunscreens, such 
as benzophenones, benzedrone (4-MBC), and octyl methoxycinnamate (OMC) have been 
shown to agonistically bind to the human estrogen receptor (hER) in human cell-based 
bioassays, and to increase VTG production in female rats and male fish species (Table 2.2). 
These compounds are therefore regarded as estrogenic contaminants, which might persist for 
long periods of time in the environment due to their low water solubility. The abovementioned 
compounds are all used as either ‘wash-off’ or ‘application’ personal care products. Therefore, 
it can be assumed that products containing biocides, UV screens, and preservatives will either 
be washed down in drain water, or will be absorbed through the skin after application. These 
compounds thus have multiple routes of exposure to either humans or other non-target 
organisms in water. Also, due to the fact that these chemicals are regularly used in personal 
care products, and the fact that these compounds have low solubility in water, their presence 
and persistence in the environment can be high. Paraben concentrations as high as 11 mg.L-1 
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have been detected in a UK river system, with concentrations as high as 30 mg.L-1 in 
wastewater influents (Kasprzyk-Hordern et al., 2009b). TCC concentrations of 6 µg.L-1 have 
been documented in a US river system (Halden and Paull, 2005). Environmental concentrations 
of UV filters as high as 13 mg.L-1 have been reported in wastewater influents (Kasprzyk-
Hordern et al., 2009b), with 6 mg.L-1 in wastewater effluents (Kasprzyk-Hordern et al., 2009b), 
266 ng.L-1 in swimming pools (Cuderman and Heath, 2007), and in seawater at concentrations 
of 3.3 µg.L-1 (Sánchez Rodríguez et al., 2015). These compounds have not been screened for 
their presence in South African water systems, which therefore highlights the importance of 
screening for these chemicals to evaluate their fate within water treatment facilities. 
 
2.4. Future perspectives 
 
Monitoring studies focusing on the presence and fate of EDCs and PPCPs in surface waters 
have been comprehensive internationally. However, based on the available information on 
South African toxicological studies, there are several aspects which still need to be addressed. 
Apart from conventional EDC investigations, there are also a large variety of other topics which 
need to be addressed. A few of these topics are mentioned below, and will provide a significant 
contribution towards the understanding of the fate and presence of chemical pathogens in 
environmental waters. Such interdisciplinary studies should receive high priority for future 
research, as they are all interlinked into the larger scope of environmental water pollution 
investigations in South Africa. 
 
2.4.1. Pharmaceutical metabolites and conjugates in WWTWs 
Most pharmaceutical detection studies concentrate on the detection of parent pharmaceutically 
active ingredients. However, it is known that some pharmaceutical compounds are rapidly 
metabolised in the body after consumption, resulting in their breakdown products being the 
predominant component of wastewater. Also, after their excretion and/or discharge into 
wastewater, some PPCPs may be further transformed through biotic (microbial metabolism) 
and/or abiotic (photodegradation, etc) factors which could affect the drug’s stability and fate. 
It is therefore possible that some toxicologically active compounds may be overlooked when 
screening for pharmaceutical residues in water bodies, due to the metabolic processing of the 
parent compound. For some pharmaceuticals, it is known that it is rather the major metabolite 
products from the parent compound which exert the physiological effect. For example, the 
analgesic compound tramadol will undergo hepatic metabolism by desmethylation to produce 
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the primary metabolite O-desmethyltramadol, which is a more potent and persistent opioid than 
tramadol itself. The anti-epileptic compound carbamazepine is also almost completely 
metabolised in the liver to produce the more potent carbamazepine-10,11-epoxide. These 
metabolites are then excreted at higher levels than the parent compounds. Regardless, the 
metabolites of pharmaceutical compounds are regularly ignored in environmental screening of 
water systems and need to be included in future studies. The environmental consequences of 
pharmaceutical metabolites in water systems may be even more detrimental than the presence 
of their parent compounds. Several metabolites of parent compounds of other types of 
environmental pollutants (mostly pesticides) have been shown to have more severe endocrine-
disrupting effects on non-target organisms than their parent compounds. For example, the 
dithiocarbamate fungicide mancozeb is shown to cause thyroid-modulating effects, but it is 
rather its metabolite, ethylene thiourea (ETU) which exerts this thyroid-modulating, and 
possible carcinogenic, activity (Opitz et al., 2006). The dicarboximide fungicide vinclozolin is 
also shown to be an anti-androgenic EDC, but it is rather its metabolites that have the greater 
half-lives and mobility in water necessary to cause endocrine-disrupting effects (Bayley et al., 
2003). Furthermore, metabolites from parent EDCs may modulate other endocrine system 
pathways as well, such as the organochloride insecticide DDT, which is a known oestogenic 
EDC, but its metabolite p,p’-dichlorodiphenyldichloroethylene (p,p’-DDE) is shown to rather 
have anti-androgenic activity (Mills et al., 2001). Also, although some breakdown products of 
EDCs may not have any endocrine-disrupting activity, these components might contribute 
towards an elevated pathogenic effect of another EDC (i.e. potentiating mixture interactions) 
in water bodies, as a large mixture of different EDCs might be present in water bodies. The 
potential of parent compounds and metabolites (breakdown products) having endocrine-
disrupting activities might therefore cause several toxicological mixture interactions in 
environmental waters (Hendricks and Pool, 2012). 
 
Apart from the potential of pharmaceutical metabolites to exert higher health impacts if they 
are present in the environment, the occurrence of negative mass balances for pharmaceuticals 
and their metabolites has also been detected at several WWTWs globally (Blair et al., 2015; 
Kasprzyk-Hordern et al., 2009b; Subedi and Kannan, 2014). This trend in negative mass 
balances is defined as higher concentrations of ECs being detected in WWTW effluents 
compared to raw wastewater entering the plant. One possibility is that the parent compounds 
of ECs are not detected within raw sewage, as the metabolite form of these compounds is more 
prevalent. It may be possible that these metabolites might then be re-transformed to their parent 
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compounds by the microbial communities present in the treatment plant, or by abiotic factors 
such as photolytic processes (Aris et al., 2014; Blair et al., 2015; Bonvin et al., 2012). This may 
therefore indicate that some compounds may bio-accumulate or transform within WWTWs, 
either through enzymatic metabolism or other abiotic pathways, and then be discharged into 
environmental waters. In particular, it is therefore important to further the knowledge regarding 
the metabolic capabilities of microbial communities to consume or transform xenobiotics in 
water treatment facilities.  
 
2.4.2. Mixture interactions of environmental pollutants 
It is recognised on a global scale that numerous xenobiotic chemicals accumulate in complex 
mixtures in the environment. Although the concentrations of pollutants range from mg.L-1 to 
ng.L-1, the chemical interaction between pollutants can be great (Carvalho et al., 2014). It is 
regularly found that chemical mixture studies do not always conform to conventional predicted 
ecotoxicological mixture interactions. These mixture interactions are largely dependent on the 
individual chemical’s general mode of action (MOA). The MOA of chemicals having gonadal 
endocrine-disrupting activities, for example, are grouped as being estrogenic, anti-estrogenic, 
androgenic, and anti-androgenic (Behrends et al., 2010). In ideal mixture interactions of 
environmental pollutants, it is generally assumed that compounds having the same MOA (e.g. 
estrogenic + estrogenic) will generate additive mixture interactions, meaning that the chemical 
mixture acts jointly to generate a larger physiological or toxicological response than their 
individual counterparts. This is generally known as the additivity null hypothesis (Christiansen 
et al., 2009). In contrast, chemicals having dissimilar MOAs (e.g. estrogenic + androgenic) are 
proposed to act independently from one another in regard to a measured physiological or 
toxicological endpoint. This is referred to as independent action (Christiansen et al., 2009). 
However, it is not as simple as grouping chemicals according to a general endocrine outcome. 
Chemicals having the same MOA (e.g. anti-estogenic) may have dissimilar mechanisms 
exerting the same MOA, for example, modulating steroid receptor binding or inhibiting 
steroidogenic enzyme functions. Both of these mechanisms have the same MOA, but act in a 
dissimilar manner, which can cause complex mixture interactions. This complexity in mixture 
interactions has been highlighted (Archer and Wyk, 2015; Kjaerstad et al., 2010). Therefore, 
recent mixture interaction studies refer not to the general outcome of the MOAs (estrogenic, 
androgenic, etc.), but rather to their mechanisms of action (steroid receptor 
agonism/antagonism, steroidogenesis inhibition/stimulation, enzyme inhibition/modulation). 
Bearing in mind that a vast majority of xenobiotic compounds from agriculture, industries and 
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domestic waste accumulate in water systems, it is expected that a large variety of compounds 
having both similar and dissimilar MOAs are present in the water matrix. This opens up the 
possibility of other ecotoxicological mixture interactions to occur, such as potentiation, 
synergism and antagonism. Furthermore, several compounds are known for having multiple 
MOAs for a large variety of physiological and toxicological endpoints, therefore creating 
further complications in mixture interaction studies. Regardless, from the retrospective 
information present to date, along with continuing research being done on this topic, the 
knowledge regarding mixture interactions of environmental pollutants is complex and needs to 
be addressed in future environmental studies.  
 
2.4.3. Antibiotic resistance  
Apart from the harmful endocrine-disrupting effects of several pharmaceutical contaminants 
in wildlife and human populations, the presence of pharmaceuticals, especially antibacterial 
agents, may influence the type and persistence of bacterial communities (harmless or 
pathogenic) in the environment and in societies. The most common types of water-related 
infectious diseases include gastroenteritis, amoebiasis, salmonellosis, dysentery, cholera, 
typhoid fever, hepatitis-A and diarrhoea, whereby the spread of such infected disease are 
associated with poor health and sanitation. 
 
Pathogenic bacteria are renowned for developing resistance to antimicrobial compounds (Levy, 
1998). Bacterial pathogens can come from several sources, depending on the type of species. 
Some strains are waterborne, coming from human and animal faecal matter (Gerba and Smith, 
2005). Other multidrug-resistant bacteria are known for their specific occurrence in hospitals. 
Due to the fact that most pathogenic bacteria are prone to infect immune-compromised 
individuals, these micro-organisms are not only responsible for their associated illnesses, but 
have also been shown to increase the death rates in patients with other communicable diseases 
(Levy et al., 1998). The control of pathogenic bacterial colonisation in public healthcare 
institutions, such as hospitals, is therefore vital to improve the health of the population. 
Resistance generated by pathogenic bacteria can also lead to insufficient response to 
antibacterial therapy, and to the implementation of further alternative drugs which might also 
eventually create resistance. In a South African study, Essack and colleagues (2005) identified 
24 pathogenic bacterial strains in 16 hospitals (2 tertiary, 9 regional and 5 district) in the 
KwaZulu-Natal province. Of the 1 270 bacterial isolates retrieved from patients at the different 
hospitals, 3% were sensitive to all 24 antibiotics tested, and 91% were resistant to multiple 
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antibiotics (Essack et al., 2005). However, less resistance was observed in isolates treated with 
cephalosporins and fluoroquinolones, which are regarded as ‘newly developed’ antibiotics. 
Fluoroquinolones have also been detected in a WWTW effluent in the Western Cape Province 
(Table 2.1; Hendricks and Pool, 2012) and, although this pharmaceutical has high sensitivity 
as an antibacterial treatment, its increased occurrence in water systems might also lead to 
bacterial adaptation and future resistance. 
 
With the known occurrence of pharmaceutical contaminants in water systems, it is also possible 
that the presence of low levels of these contaminants may improve the antibiotic resistance of 
undesired and/or pathogenic bacterial communities and/or influence the structure and 
occurrence of bacterial pathogens in the water system, therefore making it more difficult to 
eradicate these pathogens from the waters. These problems are the reason for increased 
pressure on water treatment facilities to remove both pathogens and toxins from the water 
system. Although water treatment facilities assure that bacterial pathogens are removed from 
the water, it is important to note that not all water treatment facilities operate at their expected 
levels (DWS, 2013). Although some WWTW facilities in South Africa comply with the 
recommended limits of physiochemical parameters in the effluent, they fail to adhere to other 
target standards (Odjadjare et al., 2012). A study by Odjadjare et al. (2012) detected several 
antibiotic-resistant Pseudomonas species in South African WWTW effluents. These strains did 
not only show resistance to antibiotics, but also to chemical treatments in the water treatment 
process, such as chlorination. It has also been noted that chlorination may increase the 
resistance of bacteria to the antibiotics ampicillin, cephalotin, sulfanilimide and tetracycline 
(Murray et al., 1984) through various potential mechanisms. Also, informal settlements 
situated above water treatment facilities might utilise water resources directly from the source, 
therefore prior to treatment. Although the levels of antibiotics in environmental waters might 
be below their concentrations to exert an antibiotic effect, these pollutants might serve as a 
‘primer’ for further anti-microbial resistance (AMR) development. Taking all these factors into 
consideration, the development of AMR needs to be investigated further, by incorporating the 
data generated from environmental pharmaceutical chemical analyses, to assess whether low 
concentrations of antibiotics detected in environmental waters might induce further antibiotic 
resistance in pathogenic bacteria. 
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2.4.4. Environmental biofilms (epilithon) as biomarkers of micro-pollutants  
In addition to the development of AMR in bacteria caused by selective evolutionary pressure 
(such as exposure to antibiotics), morphological and physical characteristics of microbial 
communities also play a role. It is known that microorganisms can adhere to solid surfaces 
where they deviate from their planktonic state, and grow and multiply to form biofilms. These 
biofilms typically constitute a community of multiple types of microorganisms, potentially 
including bacteria, fungi, and algae (Edwards and Kjellerup, 2013). The adherence of microbial 
communities to surfaces is assisted by the formation of extracellular polymeric substances 
(EPS) which keep the biofilm community intact. This facilitates a niche for the microorganisms 
to proliferate and colonise new surfaces by either single cell detachment, or multiple cell 
detachment, which is transported within the liquid environment (Ghadakpour et al., 2014). 
Biofilms may contain both harmless and pathogenic micro-organisms, and are challenging to 
eradicate in both the environment as well as WWTWs (Flemming et al., 2016). Therefore, 
pathogenic microbes may proliferate in the environment if favourable conditions are present 
for them to form biofilms, making them hard to remove at water treatment plants.  
 
Due to several obligate and opportunistic pathogens that have developed resistance to antibiotic 
chemicals, it is becoming even more important to prevent the formation of pathogenic biofilms 
in the environment. Such pathogenic microorganisms do not only proliferate in contaminated 
environmental waters, but can also spread to areas where humans are in direct contact with 
these pathogens. This has been highlighted by Hota et al. (2009), who investigated the 
incidence of 36 patients infected with a multidrug-resistant strain of P. aeruginosa in a 
Canadian hospital during 2004 and 2006. The research showed that a biofilm containing the 
pathogenic strain was lined around sink piping situated close to patient beds. Although the 
sinks were treated with antibacterial agents for disinfection, this did not inhibit the dispersal of 
the bacteria when accidental splashing from the sink occurred (Hota et al., 2009). Such 
incidences are very likely to occur in South African hospitals as well, as most public sector 
hospitals do not meet basic sanitation and hygiene requirements. The outbreak studied by Hota 
et al. (2009) highlights the importance of controlling and limiting the possible source points of 
adaptive pressure enabling these bacterial pathogens to develop resistance. If antibacterial 
pharmaceuticals are not effectively removed from drinking water supplies, these chemicals 
might accumulate and increase the antimicrobial resistance of pathogenic bacterial biofilms. 
Also, the continued usage of certain antibiotic compounds leads to the development of 
resistance by the pathogens against that specific compound, and therefore leads to the 
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development or usage of alternative antibiotic compound/s. These are, however, short-term and 
cyclic solutions, since they ultimately increase the suite of genetic adaptation mechanisms 
available to the microbial community. This is of particular concern in freshwater drinking 
sources, as it is found on a daily basis that more and more antibiotic pollutants are found in our 
freshwater systems, even after water treatment processes. 
 
Despite the detrimental effects of pathogenic biofilm communities, the presence of biofilms in 
environments is not always harmful. Biofilm communities can be found on streambed sediment 
surfaces in environmental waters, and are a critical element of the chemical and nutrient cycling 
in aquatic systems (Writer et al., 2011). Biofilms and microbial flocs are one of the primary 
means of carbon and nitrogen removal in wastewater treatment plants, responsible for 
facilitating clean water and preventing eutrophication of our water bodies (Sheng et al., 2010). 
Biofilms are also used for bioremediation and biotransformation of toxic compounds at water 
treatment facilities (see Edwards and Kjellerup, 2013 for a summary of biofilm-based treatment 
techniques). Therefore, biofilms may be used as a screening tool to investigate the 
accumulation and removal of harmful chemicals (including PPCPs and other EDCs) in surface 
waters. It is shown that steroid hormones and alkylphenols (such as NP) can partition very 
rapidly into the organic matter of biofilms (Writer et al., 2011). Biofilms can also contribute to 
the oxidation of organic material, such as converting E2 to E1 (Writer et al., 2011), thereby 
changing the chemical profiles in the water system. Thus, biofilms can serve as a bio-indicator 
of EDC presence in the environment, as organic compounds can be retained within the biofilm 
community and undergo transformation processes (Edwards and Kjellerup, 2013). However, 
other environmental factors may also influence the retention capacity of organic compounds in 
biofilms, such as temperature, light, competing carbon substrates and oxygen concentrations. 
Regardless, biofilm communities in environmental waters may serve as a valuable tool for EDC 
detection studies. Several aspects of biofilm interaction with environmental EDCs can be 
investigated in the future. Pharmaceuticals in environmental waters might exert pressure on the 
structure and composition (physical and community) of microbial biofilms in the environment, 
due to possible antimicrobial resistance or other chemical interactions with the microbial 
communities. This might have beneficial or detrimental effects on the fate and persistence of 
EDCs in the environment, as biofilms may assist in the bioaccumulation and/or biodegradation 
of organic pollutants, either making them less harmful or changing them into more biologically 
active metabolites. Thus, both antibiotics and broader pharmaceutical compounds will have a 
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modulating effect on the microbiological ecology of both wastewater treatment works and 
freshwater systems, as well as the endocrine-disrupting effects discussed above. 
 
2.4.5. A tiered approach to endocrine disruption of PPCPs of environmental concern 
Taking all environmental and socio-economic factors mentioned in the current review into 
consideration, as well as research to date on the accumulation of EDCs and other ECs in surface 
waters, and their implications towards the health of humans and wildlife (AMR and EDCs), it 
is important to implement a tiered approach towards identifying and categorising possible 
pathogens and routes of exposure in environmental and treated water systems.  
 
Several global regulatory bodies such as the Endocrine Disruptor Screening and Testing 
Advisory Committee (EDSTAC) managed by the USEPA, and a task force on Endocrine 
Disrupters Testing and Assessment (EDTA) by the OECD, have mandated the development 
and validation of testing (screening) methods for standardised assessments. The tiered 
approach suggested by USEPA was accepted globally and includes a battery of assays to screen 
or test for endocrine interactions and to identify and evaluate the potential of contaminants 
serving as EDCs (EDSTAC, 1998). First-tier assays were chosen to act as high-throughput 
screens to identify and prioritise ECs for second-tier testing, which aids in the understanding 
of the specific physiological MOA which are modulated by the EC of interest (EDSTAC, 
1998). Second-tier screens aim to evaluate the results obtained from the first-tier screens in 
multi-generational or long-term in vivo studies to gain further support for a compound or 
mixture of contaminants to serve as environmental EDCs (EDSTAC, 1998). First- and second-
tier screening can therefore provide biologically relevant information, which can be used to 
support ERAs and to establish AOPs for more detailed eco-toxicological assessment.  
 
2.5. Conclusions 
 
Based on the current status of micro-pollutant understanding and analyses described in this 
review, it is evident that there is a large source of information available which can aid in the 
prioritisation of emerging contaminants for environmental risk assessment. Several key points 
were discussed and should therefore receive priority in future studies to ensure sustainability 
of our freshwater resources, namely:  
 
 Further reports on the occurrences of PPCPs and their metabolites in surface waters 
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 Establishing the possible endocrine-disrupting effects of commonly-detected PPCPs and 
other micro-pollutants through a tiered eco-toxicological approach 
 Investigating the contribution of environmental micro-pollutants towards the global 
epidemic of AMR 
 Report on the effectiveness of WWTWs to remove priority micro-pollutants (such as 
EDCs), as well as biological pathogens 
 Raising public awareness of the consequences of liberal and irresponsible PPCP use and 
disposal 
 Establish and/or improve initiatives such as the National Toxicity Monitoring Programme 
(NTMP) to assist with environmental risk assessment through the use of AOP networks 
 Developing more effective water treatment technologies to eradicate persistent micro-
pollutants from the water system in order to deem the system safe for reuse 
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CHAPTER 3: SEASONAL AND DAILY VARIATIONS IN ESTROGENIC AND 
ANTI-ESTROGENIC ACTIVITY AT WASTEWATER TREATMENT WORKS AND 
RECEIVING WATERS: IMPLICATION FOR RELIABLE MONITORING 
Submitted to Water Science and Technology  
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Abstract 
 
The potential of natural- and man-made pollutants to modulate reproductive endocrine system 
pathways are well known. Natural/synthetic steroid hormones and many organic pollutants 
persisting through wastewater treatment works (WWTWs) are of particular concern for their 
endocrine-disrupting activities observed in receiving surface waters. Apart from the 
demonstrated presence of estrogen- and estrogen-mimicking compounds in surface waters, 
antagonistic (anti-estrogenic) responses originating from wastewater effluent are reported, but 
less known. Estrogenicity and anti-estrogenicity were assessed using recombinant yeast 
estrogen receptor binding assays (YES/YAES) at ten WWTWs and receiving rivers. Raw 
influent and treated effluent, as well as river water upstream and downstream of the various 
WWTWs were sampled for one week during two sampling campaigns within summer 2015/16 
and 2016/17 (December), and one sampling campaign during winter 2016 (June). Estrogenicity 
was notably reduced at most of the WWTWs. Estradiol-equivalent (EEQs) estimations in raw 
wastewater varied between 4.4 to 34.4 ng.L-1 during summer periods, and 6.6 to 31.5 ng.L-1 
during winter, whereas treated wastewater effluent varied between 0.3 to 6.9 ng.L-1 during 
summer and 0.2 to 4.9 ng.L-1 during winter. From these results, EEQs from several treated 
effluent and river water samples were above effect-based trigger values posing endocrine-
disruption risk for aquatic organisms and/or potential adverse health risks for humans. 
Furthermore, estrogenicity recorded in samples collected upstream from WWTW discharge 
also exceeded predicted no-effect concentrations (PNEC) and trigger values as shown for 
estradiol (E2), which highlights the impact of alternative pollution sources contributing towards 
endocrine disruption in the environment. The YAES showed variable tamoxifen-equivalent 
concentrations (TAM-EQ) in treated wastewater during two sampling campaigns, which varied 
between 3.7 to 78.7 μg.L-1 during winter 2016, and 0.7 to 10.0 μg.L-1 during summer 2016/17 
for selected WWTWs. The current study served as both scoping- and case study to highlight 
the variety of factors that will affect bioassay outcomes and conclusions drawn from the results 
for risk decision making. The experienced mismatch between estrogenic and anti-estrogenic 
activity suggested a potential masking effect WWTW effluents, which highlights the 
complexity of environmental monitoring of endocrine disruption in samples containing a large 
mixture of both estrogenic and anti-estrogenic properties.  
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3.1. Introduction 
 
Wastewater originating from domestic, industrial and agricultural practices are reported to 
create severe pressure on wastewater treatment works (WWTWs) to eliminate a large variety 
of organic micro-pollutants from the surface water system. However, several recalcitrant 
pollutants and their associated metabolites (breakdown products) are indeed not completely 
removed within treatment systems before discharged into recipient environmental waters, or 
re-used for potable- and/or non-potable purposes. Causes for of such incomplete removal 
include a variation of biotic- and abiotic factors, such as the physiochemical properties of the 
pollutants, the treatment technologies and capacity of the water works, environmental 
conditions (climate, pH, hydrology, geology, etc.), and the ratio of domestic and industrial 
contribution to the influent. These factors lead to the large variety in removal efficiencies of 
organic pollutant WWTWs, reported in studies around the globe (Bolong et al., 2009; Ort et 
al., 2010; Petrie et al., 2014). There is a continuous effort to advance water treatment 
technologies; concurrent development of analytical techniques with increasing sensitivity, 
coupled with expanding databases should offer new avenues to assess the efficiency of 
WWTWs to mitigate harmful discharge into environmental waters.  
 
Apart from the potential toxicological risk and lethal effects which organic pollutants may pose 
upon wildlife and human health, it has become evident that several micro-pollutants such as 
pharmaceuticals, consumer products, pesticides and industrial by-products are also able to 
interact with endocrine systems, in one way or another, at concentrations regularly detected in 
surface waters (Archer et al., 2017b; Mckinlay et al., 2008). In particular, compounds 
interfering with gonadal endocrine system pathways have been of interest in surface water 
monitoring studies during the past few decades (Barnhoorn et al., 2004; Gracia et al., 2007; 
Guillette et al., 1996; Mckinlay et al., 2008; Mills et al., 2001; Lӧfgren et al., 2006). The 
presence of these endocrine-disrupting contaminants (EDCs) in surface waters have been 
indirectly linked to various developmental- and reproductive disorders observed in wildlife. 
The fact that the endocrine system among vertebrates (including humans) is conserved, it has 
been proposed that similar long-term effects might be observed in humans sharing the same 
environment. Non-communicable diseases, such as infertility, in utero developmental 
disorders, compromised immune systems, and several cancer-types have been suggested to be 
linked to EDC exposures (Colborn et al., 1993). However, it remains difficult to extrapolate 
the possible effect which many untested environmental pollutants may have on wildlife and 
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humans, as these compounds do not impose an immediate- or acute toxic outcome. It appears 
possible that a mixture of organic compounds, as well as their breakdown products (or 
metabolites) in water bodies may yield several mixture interactions that are not yet fully 
understood. In vitro biomarker assays and in vivo bio-indicator organisms offer a valuable 
approach to assess the net endocrine-modulation effect or functionality of these compounds. 
Disadvantages associated with in vivo experimentation, such as logistics, cost and time, 
warrants the consideration of using in vitro bioassays to show potential risk prior to in vivo 
assessment. Although bioassays are widely applied to assist decision-making by weight-of-
evidence, the possibility of toxic masking within bioassay endpoints (leading to false negatives) 
may be a reality to be considered (König et al., 2017; Petrovic et al., 2004).  
 
This study was conducted in South Africa, a relatively arid country facing rapid urbanisation 
and population growth that outpace infrastructure development, thus offers a suitable proxy for 
other developing countries facing similar challenges. A consequence of such population 
dynamics are increased risk of surface water pollution due to insufficient sanitation services, 
along with a higher demand for treated water, food and health services – all being negatively 
impacted by pollution. For instance, the higher demand for food production leads towards an 
increased pesticide- and pharmaceutical use on crops and livestock, respectively, while the 
unhealthy living conditions in the rapidly growing informal or low-cost housing schemes 
further lead to an increased reliance on pharmaceuticals. Rapid population growth also directly 
leads towards an increased presence of natural steroid hormones within sewage. These factors, 
combined with the demonstrated recalcitrance of organic- and inorganic micro-pollutants place 
severe strain on WWTWs, especially in countries without sufficient financial resources to 
upgrade or expand existing systems.  
 
The aim of this study was to use an in vitro recombinant yeast receptor binding assay to assess 
the level and persistence of estrogenicity at several South African WWTWs that are compliant 
with the Department of Water and Sanitation (DWS) Green Drop accreditation 
(http://dwa.gov.za). The seasonal and daily variation of estrogenicity within WWTW influent 
and effluent, as well as the associated river waters upstream and downstream of the plants were 
compared and considered in the context of potential adverse health risks associated with the 
measured estrogenic concentrations. The influence of compounds which may antagonise 
estrogen-mediated receptor binding (anti-estrogens) in the bioassay used for the present study 
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was also investigated in order to further elaborate on the potential endocrine disrupting risk 
which treated wastewater may pose on surface waters spanning over multiple modes of action.  
 
3.2. Materials and Methods 
 
3.2.1. Study Site and Sampling Procedure 
The study site was situated in the East Rand district of the Gauteng Province, South Africa. 
This region of the country experience its rainfall during the summer period (December - 
February), whereas a colder but drier climate is experienced winter (June - August). Ten 
WWTWs were selected for the study, which vary in operating capacities, treatment processes 
and sources of the wastewater (Table 3.1). The ten WWTWs were all sampled during a summer 
(2015/16) and winter (2016) period for five consecutive days (Monday to Friday). Four 
WWTWs were then selected and further sampled during the following summer period 
(2016/17) for seven consecutive days (Monday to Sunday). No rainfall was recorded at any of 
the study sites during the summer 2015/16 and winter 2016 sampling campaigns, whereas high 
rainfall was recorded for the whole study region during summer 2016/17. For the summer 
2015/16 and winter 2016 sampling, grab samples (200 ml) were collected daily from both the 
influent (after grit screens) and effluent (after chlorination), acidified to pH 3 using 
Hydrochloric acid (HCl) and stored at 4⁰C. These daily samples were subsequently topped up 
until the final sampling day (Friday) when analyte extraction took place, giving a week-long 
composite sample for each WWTW. For the summer 2016/17 sampling, grab samples (200 ml) 
of both influent- and effluent wastewater were collected each morning, followed by immediate 
filtration and sample processing, giving a daily grab sample for each of the four WWTWs. For 
all the sampling campaigns (Dec 2015/16; 2016/17 and Jun 2016), grab samples of surface 
water (200 ml) in receiving rivers were also taken at locations upstream (50 m) and downstream 
(50 m) from the respective points of discharge of the WWTWs. Daily sampling was not 
possible due to logistical constrains. Therefore, samples were collected on a single day during 
the week, acidified (pH 3) using HCl and kept cold (± 4⁰C) during transportation and storage 
until analyte extraction.  
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Table 3.1: Information of the sample sites during the current study. 
 
Load 
(Domestic:Industrial) 
Capacity 
(ML/day) 
Treatment 
Population 
estimate # 
WWTW1 70:30 105.0 BF, AS, BNR (Bardenpho) 528 942 
WWTW2 60:40 55.0 AS (2-stage), BNR (Phostrip) 260 448 
WWTW3 100:0 0.4 AS 4 516 
WWTW4 100:0 16.0 BF, AS (BNR 3-stage) 23 273 
WWTW5 90:10 35.0 AS (Phoredox), chlor 275 929 
WWTW6 60:40  32.0 BF, chlor 229 674 
WWTW7 83:17 36.0 BF, AS, chlor 73 574 
WWTW8 96:4 83.0 BF (1-3), AS (Bardenpho), chlor, MP 330 473 
WWTW9 100:0 10.0 AS (BNR 3-stage), chlor 35 397 
WWTW10 96:4 155.0 BT, AS, chlor 1 092 297 
# based on chemical oxygen demand (COD) measurements generated from raw sewage influent from each WWTW 
BF – Biological filtration; AS – Activated sludge; BNR – Biological nutrient removal; BC – Biological clarification; chlor – 
Chlorination; MP – Maturation ponds; n.a. – not available 
 
3.2.2. Extraction Procedure 
Water samples were filtered using glass fibre filters (1.2μm pore size, Munktell) using a glass 
vacuum filtering system (Millipore) to get rid of solids in the samples. The filtrate was then 
extracted through solid-phase extraction (SPE) with Oasis HLB cartridges (6cc, 200 mg; 
Waters, Microsep, Johannesburg, South Africa). The cartridges were conditioned with 4 mL 
methanol, followed by 4 mL of ultrapure water (Millipore) and allowed to pass through the 
column by gravity. After conditioning, the water samples (200 mL) were passed through using 
a manifold (Supelco Visiprep) at a flow rate of 5 mL.min-1 and allowed to run dry for a 
minimum period of 30 minutes. The dried cartridges were eluted with 5 mL MeOH (HPLC-
grade; Sigma) by gravity and then dried under a gentle stream of nitrogen. The evaporated 
samples were then re-suspended in 400 µL MeOH, giving a 500x concentrated water sample. 
All samples were stored in 2 mL amber glass vials (CNW Technologies, Stargate Scientific) 
and stored at -20ºC until the bioassays were done. 
 
3.2.3. Yeast Estrogen Screen (YES) 
The yeast-based screen followed the protocol described by Sohoni and Sumpter (1998). 
Briefly, Saccharomyces cerevisiae transfected with the human oestrogen receptor (hER) gene 
and a plasmid containing an estrogen response element-linked lac-Z gene was used. Successful 
binding of ligands in the water samples (steroids and other EDCs) to the receptors in the yeast 
cells initiates the expression of the lac-Z reporter gene which encode for the enzyme β–
galactosidase in the assay. The β–galactosidase then metabolises chlorophenol red 
galactopyranoside (CPRG), which results in a colour change of the assay medium, indicating 
a dose-dependent activity of the ligands to bind to the estrogen receptor.  
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The assay medium was prepared as described by Sohoni and Sumpter (1998). The yeast were 
incubated in assay medium containing no CPRG for 48 hours under 26ºC on an orbital shaker. 
The concentrated wastewater extracts (500x) were serially diluted and 10 μL was spiked into 
the 96-well sterile flat-bottomed plates with low evaporation lids (Costar, 3370, Sigma). The 
previously incubated yeast culture was then included into new assay medium containing CPRG 
at a concentration of approximately 8x105 cells/mL. The seeded assay medium was then added 
at 200 μL/well into the assay plate to provide a final concentrations of the water extracts 
ranging from a 50x to a 1.56x. A concentration of 1x was depicted as an un-concentrated water 
sample. For the raw wastewater samples, serial dilutions of the samples were made with MeOH 
to obtain a concentration range of each sample ranging from 12.5x to 0.39x in the assay due to 
cytotoxicity observed in the 50x and 25x concentrated sample. For the final effluent and river 
water samples, serial dilutions of the samples were made with MeOH to obtain a concentration 
range of each sample ranging from 50x to 6.25x due to the lower observed estrogenicity in 
these samples compared to raw wastewater samples. All samples were analysed in triplicate in 
the same assay plate, and each assay was repeated twice. A standard curve for the steroid 
hormone 17β-estradiol (E2; CAS 50-28-2; Sigma) was included for each assay plate in 12 serial 
dilutions, ranging from 1.0 to 2700.0 ng.L-1. Blank wells were also included in each assay plate 
containing only assay medium and 10 μL of evaporated MeOH without any hormone spike or 
water sample extracts. The assay plates were then allowed to incubate on a shaker for 72 hours 
at 30ºC under dark conditions. 
 
3.2.4. Yeast anti-estrogen screen (YAES) 
The YAES was performed for the treated wastewater effluent samples during two sampling 
campaigns (winter 2016 and summer 2016/17) in the same manner as described for the YES, 
with minor modifications. Each well in the 96-well assay plate was spiked with a submaximal 
E2 concentration of 450 ng/L prior to addition of the concentrated water extracts (final 
concentration of 75x, 50x and 25x). Apart from an E2 standard curve as used in the YES, the 
YAES contained a positive control of the estrogen receptor antagonist tamoxifen (TAM; CAS 
10540-29-1; Sigma) in 12 serial dilutions (0.91 to 1857.6 mg.L-1 in the assay). The blank wells 
were separated into two sets; one set containing assay medium and yeast with a submaximal 
E2 spike (6 wells) and one set containing blank wells with only the assay medium and yeast (6 
wells). The assay plates were then allowed to incubate on a shaker for 72 hours at 30ºC under 
dark conditions. 
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3.2.5. Calculations 
Upon the 72 hours of incubation, the YES and YEAS assay plates were measured for colour 
change using a spectrophotometer. The absorbance was measured at 570 nm for colour change 
of CPRG caused by steroid hormone-mediated β–galactosidase production, and 620 nm for 
turbidity change and cytotoxicity. The turbidity change calculations (620 nm) were necessary 
to assess potential false negative- or positive results generated for the colour change 
calculations (570 nm), as a loss in turbidity (caused by cytotoxic analytes in the sample) leads 
to less viable yeast cells in the assay to produce β–galactosidase. The threshold for cytotoxicity 
in the samples were determined using equation 1. Samples which were below this threshold 
were excluded from further calculations. 
 
Cytotoxicity = Median Blank620nm – (3*stdev of Blank620nm)    [1] 
 
In order to correct for turbidity in the wells, a corrected absorbance (CA) was calculated for 
each sample in the assay using equation 2. This calculation compensated for background 
absorbance from the yeast suspension and allowed for more accurate measurement of the 
colour change in the assay medium. 
 
Corrected absorbance (CA) = (OD570nm – [OD620nm – Blank620nm])    [2] 
 
where OD570nm and OD620nm refers to the optical density of the sample measured at 570nm and 
620nm respectively, and Blank620nm refers to the median optical density measured for the blank 
wells in each assay plate at 620nm. Water samples were only considered for further analysis if 
the corrected absorbance was above a detection threshold using equation 3: 
 
Detection = Median blankCA + (3*stdev of BlankCA)      [3]  
 
For the YES, the CA of water samples above the detection threshold of the assay were then 
log-transformed and expressed as a percentage of the maximum log-absorbance value 
calculated in the E2 standard curve using equation 4: 
 
Log % max E2 (sample/standard curve) = (log-CAsample / log-CAE2 max) * 100  [4] 
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A non-linear calibration curve was then constructed for the E2 standard curve of each individual 
assay plate by plotting the calculated log % max E2 of the E2 dilution series against its known 
concentration (in ng.L-1). An E2-equivalent concentration (EEQ; ng/L) for each water sample 
was then calculated from the generated trend-line of the calibration curve, and corrected for 
their dilution factors to obtain a final EEQ concentration of each water sample (in ng.L-1). 
 
The calculated EEQ values were then used to estimate their mass loads within raw wastewater 
and treated effluent in order to compensate for the variation in flow rates of the various 
treatment plants between the daily and seasonal sampling campaigns using equation 5: 
 
Mass load (g.day-1) = EEQinf/eff * FRinf/eff * 1/1000      [5] 
 
where EEQinf/eff refers to the EEQ concentration (in ng.L
-1) of the samples in the YES for 
influent and effluent wastewater samples, and FRinf/eff refers to the flow rate (ML.day
-1) of the 
influent and effluent wastewater for each WWTW during the time period of the sampling 
campaigns. 
 
For estimation of the removal efficiency of estrogenicity at the WWTWs, removal (%) from 
each raw wastewater sample and the corresponding treated effluent sample was calculated 
using equation 6: 
 
Removal (%) = (MLinf - MLeff) / MLinf * 100      [6] 
 
where MLinf/eff refers to the mass loads (in g.day
-1) of the samples calculated from EQ. 5 for 
influent and effluent wastewater samples at the various WWTWs. 
 
For the YAES, the CA of the water extracts were compared with the CA measured for the blank 
wells containing the submaximal E2 spike in order to evaluate a percentage change of the 
sample extracts from the submaximal E2 spike. Samples which were above the E2 spike 
threshold (above 100%) were considered to have a masking effect of inert estrogenicity 
supressing the anti-estrogen response, whereas samples below the E2 spike threshold (below 
100%) were considered to contain analytes which significantly supress the binding of E2 to the 
hER in the assay, therefore showing an anti-estrogenic response. The samples that successfully 
supressed E2-mediated receptor binding were then considered for quantification of a 
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tamoxifen-equivalent concentration (TAM-EQ, μg.L-1) as calculated in a similar manner as 
calculated for the EEQ calculations in the YES. 
 
3.2.6. Statistical analysis 
All statistical analyses were performed using GraphPad Prism (v. 5.00). Variation between 
individual samples were assessed using an unpaired t-test. For the determination of significant 
variation between sampling days and study sites, a one-way analysis of variance (ANOVA) 
with a Tukey’s multiple comparisons post hoc test was performed. Significant variance was 
achieved with P < 0.05. 
 
3.3. Results and Discussion 
 
The results presented below relate to three interrelated themes, namely 1) the incidence of 
estrogenicity within raw wastewaters sourced from areas having heterogenous demographics, 
2) the transfer and fate of (anti)estrogenicity from treated wastewater to receiving surface 
waters, and 3) refining bioassay outcomes for risk assessment, with particular reference to 
effect-based trigger values and observed endocrine disrupting outcomes in sentinel aquatic 
organisms. The study highlights the complexity associated with interpreting bioassay 
outcomes, such as the YES, when multiple potential biotic- and abiotic factors may influence 
the results. In particular, the variation in climatic factors between seasons (rainfall, 
temperature, etc.), as well as WWTW having variable capacities, treatment technologies, 
sources of wastewater, and de novo / de facto population may all have a significant impact on 
the contribution of estrogenic EDCs within wastewater and their associated environmental 
waters. Furthermore, the complex composition of environmental samples containing both 
inorganic- and organic micro-pollutants poses challenges when endpoints such as total 
estrogenicity and anti-estrogenicity are assessed using a single bioassay, where masking of 
agonistic and antagonistic substances by one-another, as well as other complex chemical 
mixture interactions are proposed. In light of the global need to improve on the quality of 
surface water resources, as set out by the United Nations Sustainable Development Goals for 
2030, and the associated benefit of these goals towards human- and environmental resilience 
warrants the refinement of cost-effective bioassays such as the YES to improve on current risk 
assessment approaches.  
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3.3.1. Influent wastewater 
Raw influent wastewater showed varying levels of estrogenic activity during the various 
sampling campaigns, which ranged from 4.4 – 45.4 ng.L-1 EEQ during summer periods 
(2015/16 and 2016/17; APPENDIX Table A1 and A2) and 6.6 – 31.5 ng.L-1 EEQ during the 
winter 2016 sampling (APPENDIX Table A1). WWTW2, 7 and 10 showed the highest levels 
of estrogenicity during summer 2015/16 (APPENDIX Table A1), and WWTW1, 3 and 5 during 
winter 2016 (APPENDIX Table A2). However, by taking the variations of plant flow rates into 
consideration,  EEQ mass loads showed that WWTW1, 2, 8 and 10 had highest levels during 
summer 2015/16, compared to WWTW1, 2, 5 and 10 during winter 2016 (Fig. 3.1). As it is 
expected that the estrogenic response in the YES will most likely be from natural- and synthetic 
steroids (associated to domestic wastewater), the WWTWs which received the largest 
estrogenic loads were those that predominantly receives domestic sewage, apart from 
WWTW2, which receive wastewater from surrounding industries and also from a nearby 
airport.  
 
 
Figure 3.1: Mass load (g.day-1) of estrogen equivalent concentrations (EEQ) measured using the yeast 
estrogen screen (YES) for the various WWTWs during sampling campaigns in summer 2015/16 
(December) and winter 2016 (June). 
 
For the selected WWTWs screened during summer 2016/17, the EEQ estimations within raw 
wastewater did not differ significantly between sampling days for either WWTW2, 9 or 10 
(ANOVA, P > 0.05; APPENDIX Table A2). However, EEQ values for WWTW8 showed a 
significant variation in estrogenicity between sampling days (ANOVA, P < 0.05), with values 
on Tuesday and Wednesday being significantly lower than weekend samples (Tukey, P < 
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0.001). The variation in daily flow rates could also impact the variation of net estrogenicity 
between sampling days. For this reason, EEQ mass loads were instead used to compare 
between sampling days. For WWTW2, significant variation was only calculated between the 
Tuesday and Sunday sample (ANOVA, P = 0.033; Tukey, P < 0.05; Fig. 3.2; APPENDIX 
Table A3). For WWTW8, a significant increase in estrogenic loads were calculated over the 
weekend period (Friday to Sunday), as well for the following Monday (ANOVA, P < 0.0001; 
Tukey, P < 0.05; Figure 3.2; APPENDIX Table A3). For WWTW9, estrogenic loads decreased 
as the week continued, and increased significantly from Friday to the weekend period 
(ANOVA, P < 0.0001; Tukey, P < 0.05; Figure 3.2; APPENDIX Table A3). For WWTW10, 
the same trend was observed as for WWTW9, with a more pronounced decrease during the 
week, followed by an increase over the weekend period (ANOVA, P < 0.0001; Tukey, P < 
0.01; Figure 3.2; APPENDIX Table A3). Again, WWTW8, 9 and 10 almost exclusively 
receives domestic wastewater, whereas WWTW2 receives a large proportion of industrial 
wastewater (Table 3.1). Furthermore, the level of estimated EEQ mass loads calculated for 
these WWTWs (WWTW10 > WWTW8 > WWTW2 > WWTW9; Fig 3.2) were in association 
with each plant’s estimated population size (Table 3.1). These results further suggest that 
estrogenicity are predominantly influenced by the de facto and de novo population being served 
by the sewage plants. As shown by the current study, the daily variation for estrogenicity in 
raw wastewater do not follow the same trend for all WWTWs (Fig. 3.2), but highlight the fact 
that wastewater treatment monitoring for estrogenicity should not just be a periodic event, as 
significant variation in estrogenic compounds entering WWTWs may occur over time. 
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Figure 3.2: Daily variation in mass loads (g.day-1) of estrogen equivalent concentrations (EEQ) 
estimated for the various WWTWs during the summer 2016/17 sampling campaign (December).  
 
The two summer sampling campaigns (2015/16 and 2016/17) allowed for comparisons 
between similar seasons experiencing varying climatic events, such as rainfall. The EEQ mass 
loads in raw wastewater influent between the two sampling campaigns did not differ 
significantly for WWTW8 (t-test, p > 0.05), but were significantly different for WWTW2, 
WWTW9 and WWTW10 (t-test, p < 0.05; Table 3.2). Higher loads were estimated during 
summer 2015/16 for WWTW2 as opposed to higher loads which were recorded during summer 
2016/17 for WWTW 9 and WWTW10. To further demonstrate the complex nature of these 
analyses, it is worth to consider the high rainfall pattern which was experienced during summer 
2016/17 sampling, which subsequently led to higher flow rate operations from the WWTWs 
(APPENDIX Table A1). In particular, the flow rates for both raw influent and treated effluent 
at WWTW10 increased more than two fold (APPENDIX Table A1). Due to the large treatment 
capacity of WWTW10, raw wastewater destined for WWTW7 and WWTW8 are normally 
diverted to this plant during large runoff surges, such as rainfall events. The estimated EEQs 
(ng.L-1) in raw wastewater for this plant between the two summer sampling campaigns did not 
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differ significantly (t-test, p > 0.05; APPENDIX Table A1 & A2), whereas EEQ mass loads 
(g.day-1) increased by a factor of 2.1 from summer 2015/16 to summer 2016/17 (Table 3.2). As 
EEQ estimates were relatively similar between summer 2015/16 and 2016/17, the 2-fold 
increase in EEQ mass loads are merely due to a larger percentage of wastewater being treated, 
but not necessarily diluting the total estrogenic concentrations.  
 
Estimating the exact source of estrogenicity within environmental samples may prove difficult, 
which was the reason why chemical analysis of known estrogenic micro-pollutants were not 
considered during the present study. Several pesticides, pharmaceuticals, personal care 
products and industrial by-products have been established as estrogenic EDCs (Archer et al., 
2017b; Mckinlay et al., 2008). However, estrogenicity within waste- and surface waters are 
primarily attributed to the presence of synthetic- and natural estrogen hormones (Tanaka et al., 
2001), merely due to such steroid hormones being more potent ER agonists than the estrogen-
mimicking EDCs. For example, plastisizers such as bisphenol-A (BPA) are known to bind to 
the hER in a dose-dependent manner, although at far lower potencies than E2 and EE2 (Bistan 
et al., 2012). Regardless, this warrants the potential of such known estrogen agonists to exert 
an additive mixture effect towards a net estrogenic response in bioassays such as the YES. 
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Table 3.2: Mass loads (g.day-1) estimated using EEQ concentrations in the YES for both raw- and effluent wastewater samples at the various WWTWs. 
Site 
December 2015 (Summer) June 2016 (Winter) December 2016 (Summer) 
Influent Effluent Removal 
(%) 
Influent Effluent Removal 
(%) 
Influent Effluent Removal 
(%) 
WWTW1 1.54 ± 0.29 0.04 ± 0.02 97 2.66 ± 0.27 0.04 ± 0.001 98  -    -   - 
WWTW2 1.27 ± 0.06 0.01 ± 0.004 99 1.38 ± 0.07 0.05 ± 0.02 96 0.66 ± 0.1 0.07 ± 0.04 89 
WWTW3 0.02 ± 0.003 0.0004 ± 0.0001 98 0.03 ± 0.01 0.001 ± 0.0002 98  -    -   - 
WWTW4 0.12 ± 0.01  - 
 
- 0.13 ± 0.03  - 
 
-  -    -   - 
WWTW5 0.29 ± 0.07 0.03 ± 0.02 90 1.66 ± 0.37  - 
 
-  -    -   - 
WWTW6 0.18 ± 0.07 0.03 ± 0.01 83 0.23 ± 0.09 0.04 ± 0.01 83  -    -   - 
WWTW7 0.34 ± 0.12 0.003 ± 0.001 99 0.08 ± 0.03 0.002 ± 0.0001 98  -    -   - 
WWTW8 0.88 ± 0.27 0.23 ± 0.11 74 0.62 ± 0.19 0.41 ± 0.05 34 1.33 ± 0.3 0.18 ± 0.1 86 
WWTW9 0.11 ± 0.04 0.07 ± 0.04 36 0.29 ± 0.04 0.02 ± 0.005 93 0.50 ± 0.09 0.02 ± 0.01 96 
WWTW10 3.59 ± 0.57 0.21 ± 0.06 94 2.91 ± 0.51 0.15 ± 0.02 95 7.36 ± 1.69 0.37 ± 0.2 95 
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3.3.2. Treated Effluent  
EEQ estimations in treated wastewater effluents from the various WWTWs varied between 0.3 
to 6.9 ng.L-1 during summer 2015/16 (APPENDIX Table A1), 0.2 to 4.9 ng.L-1 during winter 
2016 (APPENDIX Table A1), and 0.2 to 3.0 ng.L-1 during summer 2016/17 (APPENDIX Table 
A2). Mass loads of the estimated EEQs, which compensated for flow variations between the 
WWTWs, ranged between 0.0004 to 0.23 g.day-1 during summer 2015/16, and 0.001 to 0.41 
g.day-1 during winter 2016 (Fig. 3.1; APPENDIX Table A3), and 0.01 to 0.58 g.day-1 during 
summer 2016/17 (Fig. 3.2; Table 3.2). The estimated EEQs from the current study correlates 
well to similar monitoring studies done elsewhere in the world. EEQs estimated in two 
Canadian WWTW effluents ranged from 1.0 – 24 ng/L (Arlos et al., 2018), 0.6-1.7 ng/L in 
WWTW effluent from the Netherlands (Avberšek et al., 2011), and 0.5-18 ng.L-1 in WWTW 
effluent from 75 European WWTWs (Jarošová et al., 2014b). Although high EEQs were 
estimated in the study by Jarošová et al. (2014b), it should be noted that final effluents of only 
two of the 75 WWTWs sampled showed EEQs above 10 ng.L-1, most ranging between 1 and 
4 ng.L-1 (Jarošová et al., 2014b).  
 
Some studies have aimed at correlating the concentrations of steroid hormones with observed 
EEQs generated from assays such as the YES. A study by Truter et al. (2016) compared levels 
of E2 and EE2 with estimated EEQ values using the YES. Within a particular surface water 
sampling site, concentrations of E2 ranged between 3.9 – 30.8 ng.L-1, for EE2 between 1.36 – 
10.83 ng.L-1, and for EEQ in the YES between 10.15 – 43.01 ng.L-1. From these results, the 
combined load of the major estrogen analytes (E2 and EE2) correlated well with the EEQs 
generated by the YES in the same samples. However, the same was not observed for 
comparisons between the concentrations of known steroid hormones and EEQ estimates in 
various WWTW effluents, in which the EEQs were much lower than the concentrations of the 
known estrogenic micro-pollutants (Aerni et al., 2004). The current study did not analyse the 
levels of steroid hormones. However, concentrations of E2 from WWTW effluents have been 
shown to range from 1 – 20 ng.L-1 in South African monitoring studies (Manickum et al., 2011; 
Swart and Pool, 2007). Although these maximum levels of E2 detected in WWTW influent and 
effluent are higher than shown for total estrogenicity in the current study (APPENDIX Tables 
A1 & A2), it should be noted that the current assay deals with a mixture of micro-pollutants in 
the water sample. Therefore, analytes that do not necessarily bind to steroid hormone receptors, 
but rather interfere with steroid receptor binding (such as anti-estrogens) may influence the 
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results from the assay (Gehrmann et al., 2016). For this reason, the presence of anti-
estrogenicity was measured in treated wastewater to verify such a possible masking effect. 
 
The estimated TAM-EQ concentrations ranged from 3.7 to 78.7 ug.L-1 in the treated 
wastewater from the ten WWTWs during the winter 2016 sampling campaign (APPENDIX 
Table A6), and 0.7 to 10.0 ug.L-1 for four WWTWs during the summer 2016/17 sampling 
campaign (APPENDIX Table A7). The results from the YAES indicated a possible masking 
effect by estrogenic compounds present in the water samples, whereby estrogenicity in the 
YAES decreased in the concentrated water extracts in a dose-dependent manner (APPENDIX 
Figs. A1 & A2). This is represented by a significant deviation above 100% of the E2 spike in 
the YAES for a 75x concentrated sample of WWTW2, 6, 9 and 10, whereby the deviation was 
less within a 50x and 25x concentrated sample respectively (APPENDIX Fig. A1). This may 
be attributed to the estrogenicity calculated for these WWTWs in the YES during the same 
sampling periods (APPENDIX Figs. A1 & A2). Higher estrogenicity was associated with lower 
anti-estrogenicity for most of the WWTW effluent samples (Fig. 3.3 & 3.4), as further pointed 
out in Appendix A.  
 
Pollutants contributing to anti-estrogenicity may vary between the locations of the WWTWs, 
which are influenced by e.g., the types of industry in the area, as well as different agricultural 
practices and types of crops necessitating different pesticide applications. Recalcitrant 
pollutants with the ability to antagonise ER binding may potentially persist throughout 
wastewater treatment processes. For example, the bisphenol antiseptic hexachlorophene 
(HCP), the synthetic vitamin menadione (K3) and the pesticide/disinfectant pentachlorophenol 
(PCP) have all shown affinity to antagonise ER binding and associated transcriptional activity 
by several in vitro assays (Jung et al., 2004). Anti-estrogenicity has also been identified for the 
fungicides propiconazole and myclobutanil, the herbicides dicamba, mecroprop, terbutryn, 
diuron and irgarol, and the neonicotinoid thiacloprid in a dose-dependent manner (Westlund 
and Yargeau, 2017). Fragrances such as tonalide and galaxolide, and UV filters such as BP3, 
4-MBC, octocrylene and EHMC are all known anti-estrogens, all with demonstrated 
recalcitrance to biodegradation (Hernandez Leal et al., 2010). Furthermore, degradation 
processes may create undesired by-products which may lead to anti-estrogenicity in treated 
wastewater. In particular, chlorination is known to increase anti-estrogenicity in wastewater by 
means of dissolved organic matter creating various disinfection by-products (Wu et al., 2009). 
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Focused studies at WWTWs that apply chlorination as final disinfection step prior to- and after 
the chlorination step should provide valuable information in this regard. 
 
 
Figure 3.3: Anti-estrogenicity calculated as tamoxifen-equivalent concentrations (1º y-axis; μg.L-1) for 
treated wastewater effluent at the various WWTWs during the winter 2016 sampling campaign (solid 
bar). The calculated EEQ concentrations (ng.L-1; 2º y-axis) are represented by the dashed bar for the 
same WWTWs. 
 
 
Figure 3.4: Anti-estrogenicity calculated 
as tamoxifen-equivalent concentrations 
(1º y-axis; μg.L-1) for treated wastewater 
effluent at the various WWTWs during the 
summer 2016 sampling campaign (solid 
bar). The calculated EEQ concentrations 
(ng.L-1; 2º y-axis) are represented by the 
dashed bar for the same WWTWs. 
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3.3.3. Removal of estrogenicity during wastewater treatment  
The EEQ mass load estimates (g.day-1) were considered as the most useful to show the removal 
of estrogenicity at the various WWTWs and between sampling campaigns, rather than using 
raw EEQ concentrations (ng.L-1). For example, EEQ estimations (ng.L-1) for raw- and treated 
effluent wastewater for WWTW9 showed a removal of 13% during the summer 2015/16, and 
a removal of 26% for WWTW8 during winter 2016 (APPENDIX Table A1). By rather using 
EEQ mass load estimations, removal was 36% for WWTW9 and 34% for WWTW8 
respectively (Table 3.2). EEQ loads showed moderate- to high removal in all the WWTWs 
during the sampling periods (APPENDIX Tables A1 & A2), with the exception of the 
previously mentioned WWTWs. In particular, WWTW8 showed moderate removal during 
summer 2015/16 and low removal during winter 2016 (APPENDIX Table A1), as well as 
variable removal between sampling days during summer 2016/17 (APPENDIX Table A2).  
 
It should be stated that the hydraulic retention time of the WWTWs were not included for 
removal calculations. Therefore, such removal estimations are also considered semi-
quantitative, as a raw influent- and treated effluent sample taken during the same day does not 
reflect the time taken for the treatment of the influent sample before its effluent product was 
analysed in parallel. Regardless, the removal estimates from the current study shows good 
agreement with similar studies using the YES (Murk et al., 2002), and for known estrogenic 
compounds during conventional wastewater treatment (Arlos et al., 2018; Avberšek et al., 
2011; Manickum and John, 2014). For example, concentrations of E2 has been estimated to 
range between 20 – 200 ng.L-1 in a WWTW influent situated in Kwazulu Natal, with effluent 
levels ranging from 4 – 110 ng.L-1 in the same plant (Manickum and John, 2014). Taken these 
upper and lower limits of detection, the removal may range between 45% and 80%. Although 
a moderate- to significant removal of estrogenic compounds during wastewater treatment are 
reported, the levels which will still be discharged into recipient waters may still pose an 
environmental risk or may add to the pollutants which are present within the surface water 
system.  
 
3.3.4. River water 
Although the source of estrogenicity in surface waters are often proposed to primarily originate 
from WWTW effluent discharge, the EEQ estimates for river water located upstream from 
seven of the 10 WWTWs showed higher levels than downstream water samples (APPENDIX 
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Table A1). This was particularly shown for WWTW9, where the average upstream EEQ value 
during winter 2016 sampling was 18.9 (±0.2) ng.L-1 as opposed to a calculated EEQ value of 
15.1 (± 0.9) ng.L-1 for the raw influent of the plant (APPENDIX Table A1). This river system 
has been reported to experience extreme pollution pressures, mainly form peri-urban 
communities located upstream from the WWTW, including direct sewage disposal into the 
river system. The river system associated with WWTW1 passes through informal settlements 
and industrial areas. The high loads of esterogenicity within upstream river waters samples are 
therefore indicative of alternative pollution sources. The river system associated with WWTW2 
serves as a main feed into a reservoir in a nature preserve, providing approximately 8% of the 
drinking water to a city with a population exceeding 2.1 million. This drinking water resource 
has been previously shown to be highly impacted by industrial pollutants and other known 
EDCs (Aneck-Hahn et al., 2009; Barnhoorn et al., 2015, 2004). Alarmingly, the estimated 
EEQs from the downstream river sample was higher than EEQs estimated for WWTW2 
effluent during the summer 2015/16 sampling campaign (APPENDIX Table A1). We 
previously reported similar results for this river, showing an extensive list of pharmaceuticals 
and personal care products at higher concentrations in downstream river water compared to 
treated wastewater discharge (Archer et al., 2017b). The same trend was shown in the current 
study for WWTW1, 3, 6, 7 and 9 during summer 2015/16, and WWTW1, 3, 6 and 9 during 
winter 2016 sampling.  
 
The YES received wide recognition as a bioassay to estimate net estrogenicity in surface 
waters, with estimated EEQ values ranging between 0.33-4.5 ng.L-1 in France (Cargouët et al., 
2004), up to 10 and 26.5 ng.L-1 in Belgium and the UK respectively (Matthiessen et al., 2006), 
0.4-6.3 ng.L-1 in South Korea (Ra et al., 2011), and 0.07-6.4 ng.L-1 in China (Jiang et al., 2012; 
Xiao et al., 2017). The higher levels of estrogenicity of the current study are in agreement with 
estimated EEQs in another South African river system receiving domestic wastewater 
discharge and surrounded by agriculture and mining activities, ranging between 10.2 ng.L-1 
during winter, 14.2 ng.L-1 during spring, and 43.0 ng.L-1 during summer (Truter et al., 2016). 
The reliance on these rivers for potable water at various scales – from small communities to 
large cities, highlights the need to establish the environmental risk through a refined weight-
of-evidence approach. 
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3.3.5. Risk assessment  
Despite the moderate- to efficient removal of estrogenicity by wastewater treatment (Table 
3.2), the measured EEQ values still pose a potential adverse health risk. As conventional risk 
assessment approaches are focussed on acute- or chronic toxicity endpoints, the use of 
predicted no-effect concentrations (PNEC) and no-observed effect concentrations (NOEC) are 
mostly incorporated to assess potential lethal toxicity in aquatic wildlife (Hernando et al., 
2006). However, such an approach is largely focussed on the toxicity of individual chemicals, 
and therefore does not consider the complex mixture interactions of environmental pollutants 
as a whole within a water system. The YES offers a viable option that indicate the net estrogenic 
potential of a water sample to modulate hormone receptor binding, with the estimated EEQs 
providing a semi-quantitative assessment of all compounds which may mimic an estrogenic 
response in a similar manner as E2. It is therefore possible to compare such EEQ values to other 
toxicological studies. For example, it has been shown that a concentration of 5 ng.L-1 E2 may 
induce the production of vitellogenin (VTG) in male fish (Brion et al., 2004). This protein is a 
precursor of egg yolk in oviparous animals, and is considered as an established biomarker of 
endocrine disruption, as its production is mediated by plasma steroid hormones (Aerni et al., 
2004). Any pollutant in the water samples which mimics an E2 mechanism of action (expressed 
as EEQs in the YES) may therefore create the same effect. As expected, nearly all of the EEQ 
estimates of raw influent WWTW samples were above the 5 ng.L-1 threshold (APPENDIX 
Tables A1 & A2), as several micro-pollutants are known to mimic an estrogen response similar 
to E2 (Archer et al., 2017c; Mckinlay et al., 2008). On the other hand, only one WWTW effluent 
sample showed an EEQ estimate above the 5 ng.L-1 threshold during the summer 2015/16 
sampling campaign (Fig. 5; APPENDIX Table A1), with both its river water samples located 
upstream and downstream of the discharge to also surpass this 5 ng.L-1 level during both the 
summer and winter sampling campaigns (Fig. 7; APPENDIX Table A1). Overall, the estimated 
river water EEQs showed more pronounced environmental risks than treated wastewater 
effluent, whereby EEQ estimates for up- and downstream river water at WWTW1 and 
WWTW9 exceeded, or were close to this threshold during summer 2015/16 and winter 2016 
(Fig. 3.7; APPENDIX Table A1). 
 
Apart from the observed estrogenic limit which shows a definite modulation of fish endocrine 
systems using an in vivo model, a predicted no-effect concentration (PNEC) of 2.0 ng.L-1 E2 
has also been established as a baseline limit which may modulate fish reproduction (Caldwell 
et al., 2012). The EEQ estimations for treated effluent samples showed that WWTW8 exceeded 
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this threshold during both the summer 2015/16 and winter 2016 sampling campaigns (Fig. 3.5; 
APPENDIX Table A1) and on one day during summer 2016/17 (Fig. 3.6; APPENDIX Table 
A2). Furthermore, only a single sampling day for treated effluent at WWTW2 and 10 showed 
EEQs above this threshold (Fig. 3.6; APPENDIX Table A2). For river water, upstream and/or 
downstream sampling locations from WWTW1, WWTW7 and WWTW9 were above this 
PNEC during summer 2015/16 and for WWTW1, WWTW8 and WWTW9 during winter 2016 
(Fig. 3.7; APPENDIX Table A1). Using such risk indicator concentrations for the YES 
therefore implicates whether further in vivo studies should proceed, as such studies are timely 
and costly, but still necessary to confirm areas under severe risk. On the other hand, effect-
based trigger values have also been proposed to serve as a marker for a potential risk of adverse 
health outcomes. An estimated E2 trigger value of 0.7 ng.L
-1 for drinking water standards have 
been proposed (Genthe et al., 2013), above which further monitoring should be considered to 
establish the identify and origin of the compounds. Jarosova et al (2014a) proposed a lower 
effect-based EEQ trigger value of 0.4 ng.L-1 for long-term exposure to effluent-impacted 
surface waters. Several WWTW effluent and river water samples from both the summer 
2015/16 and 2016/17, as well as the winter 2016 sampling campaigns were above these 
thresholds (Fig. 3.6, 3.7 & 3.8; APPENDIX Tables A1 & A2).  
 
It is clear from the current study that the interpreting bioassay outcomes, such as the YES, are 
complex, given the multiple biotic- and abiotic factors which may influence the results. In 
particular, the variation in climatic factors between seasons (rainfall, temperature, etc.), as well 
as WWTW having variable capacities, treatment technologies, sources of wastewater, and de 
novo / de facto population may all have a significant impact on the contribution of estrogenic 
EDCs within wastewater and their associated environmental waters. Furthermore, the complex 
composition of environmental samples containing both inorganic- and organic micro-
pollutants poses challenges when endpoints such as total estrogenicity and anti-estrogenicity 
are assessed using a single bioassay, where masking of agonistic and antagonistic substances 
by one-another, as well as other complex chemical mixture interactions are proposed. In light 
of the global need to improve on the quality of surface water resources, as set out by the United 
Nations Sustainable Development Goals for 2030 (UN-SDG), and the associated benefit of 
these goals towards addressing human- and environmental resilience warrants the refinement 
of cost-effective bioassays such as the YES to improve on current risk assessment approaches.   
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Figure 3.5: E2-equivalent concentrations (EEQ; ng.L-1) measured at the treated effluent samples from 
the 10 WWTWs during December 2015 (summer) and June 2016 (winter). * Concentration of E2 (5 
ng.L-1) showing increased VTG production in fish (Brion et al., 2004). ** Predicted no-effect 
concentration (PNEC, 2 ng.L-1) to modulate fish reproduction (Caldwell et al., 2012). *** Estimated 
trigger value (0.7 ng.L-1) for risk in drinking water (Genthe et al., 2013). **** EEQ trigger value (0.4 
ng.L-1) of effluent on long-term fish exposure (Jarošová et al., 2014a). 
 
 
Figure 3.6: Daily E2-equivalent concentrations (EEQ; ng.L-1) measured at the treated effluent samples 
from the four WWTWs during December 2016 (summer). * Predicted no-effect concentration (PNEC, 
2 ng.L-1) to modulate fish reproduction (Caldwell et al., 2012). ** Estimated trigger value (0.7 ng.L-1) 
for risk in drinking water (Genthe et al., 2013). *** EEQ trigger value (0.4 ng.L-1) of effluent on long-
term fish exposure (Jarošová et al., 2014a). 
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Figure 3.7: E2-equivalent concentrations (EEQ; ng.L-1) measured for river water samples located 
upstream and downstream of the WWTW discharges during December (summer 2015/16) and June 
(winter 2016). * Concentration of E2 (5 ng.L-1) showing increased VTG production in fish (Brion et al., 
2004). ** Predicted no-effect concentration (PNEC, 2 ng.L-1) to modulate fish reproduction (Caldwell 
et al., 2012). *** Estimated trigger value (0.7 ng.L-1) for risk in drinking water (Genthe et al., 2013). 
**** EEQ trigger value (0.4 ng.L-1) of estrogenicity on long-term fish exposure (Jarošová et al., 2014a). 
 
3.4. Conclusions 
 
The results presented here highlight the complex range of factors that may influence the fate 
of estrogenic EDCs during wastewater treatment, and the complexity when total estrogenicity 
and anti-estrogenicity are assessed using a single bioassay. The calculated EEQ and TAM-EQ 
values for total (anti)estrogenicity revealed by YES and YAES, respectively correlate well with 
existing literature and highlight the value of flow-proportional EEQ mass load estimations as 
an approach to compare WWTWs with variable treatment capacities. This offers a more refined 
estimation of removal estimations at WWTWs, and the subsequent potential negative impact 
caused by discharge. The yeast estrogen and anti-estrogen screens performed in this study 
further highlighted the complexity of environmental samples where a mixture of organic- and 
inorganic pollutants are present. The potential masking of both outcomes, however, should be 
considered when using such in vitro assays for risk decision making, as several mechanisms 
other than agonistic/antagonistic receptor binding may also influence the results. Regardless of 
whether environmental waters contain both estrogenic and anti-estrogenic analytes, the 
combined response generated from the YES and YAES still provide a semi-quantitative 
outcome, as these assays reflects a net (anti)estrogenic response.  
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Even though a notable reduction of estrogenicity by the WWTPs was measured, the effluent 
EEQs reported here remain a concern because of the risk for adverse outcomes to the aquatic 
environment and, by extension, humans’ health. Furthermore, despite the evidence implicating 
WWTPs as a major source for estrogenic endocrine disruption, our data suggest additional 
sources. In many parts of the developing world, alternative pollution sources include greywater 
from informal settlements and leakage from aging sewage systems, in addition to those also 
found in the developed world; amongst others, pesticide run-off. Clearly, the relative 
contribution of these alternative sources will show great regional variation, and with building 
evidence of the possible negative effect of other micro-pollutants not discussed here, including 
micro-plastics, it is imperative to further develop/refine techniques such as YES and YAES to 
become affordable tools to provide realistic indication of health risks, even in remote areas. 
This is especially relevant to the third UN-SDG for ‘Good Health and Well-Being’ calling for 
strengthened capacity for early warning and risk reduction – especially within developing 
countries. Reliable early detection of EDCs in water may indeed greatly facilitate improved 
universal healthcare through prevention rather than reactive treatment. 
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Abstract  
A large number of emerging contaminants (ECs) are known to persist in surface waters, and 
create pressure on wastewater treatment works (WWTW) for their effective removal. Although 
a large database for the levels of these pollutants in water systems exist globally, there is still 
a lack in the correlation of the levels of these pollutants with possible long-term adverse health 
effects in wildlife and humans, such as endocrine disruption. The current study detected a total 
of 55 ECs in WWTW influent surface water, 41 ECs in effluent, and 40 ECs in environmental 
waters located upstream and downstream of the plant. A list of ECs persisted through the 
WWTW process, with 28% of all detected ECs removed by less than 50%, and 18% of all ECs 
were removed by less than 25%. Negative mass balances of some pharmaceuticals and 
metabolites were observed within the WWTW, suggesting possible back-transformation of 
ECs during wastewater treatment. Three parent illicit drug compounds were detected within 
the influent of the WWTW, with concentrations ranging between 27.6-147.0 ng.L-1 for cocaine, 
35.6-120.6 ng.L-1 for mephedrone, and 270.9-450.2 ng.L-1 for methamphetamine. The related 
environmental risks are also discussed for some ECs, with particular reference to their ability 
to disrupt endocrine systems. The current study propose the potential of the pharmaceuticals 
carbamazepine, naproxen, diclofenac and ibuprofen to be regarded as priority ECs for 
environmental monitoring due to their regular detection and persistence in environmental 
waters and their possible contribution towards adverse health effects in humans and wildlife. 
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4.1. Introduction 
 
There is growing evidence that a variety of pharmaceuticals and personal care products 
(PPCPs) persist in natural freshwater resources (Blair et al., 2015; Kasprzyk-Hordern et al., 
2009b; Petrie et al., 2014). These organic pollutants are considered a part of emerging 
contaminants (ECs), which enter water systems from various sources, such as human excretion 
(sewage), wrongful disposal, leeching from landfill, drain water, or from industries. Even 
though it has been reported that these ECs are typically present at low environmental 
concentrations (ng.L-1 to µg.L-1 range), it is still unclear whether the levels of these compounds 
present in environmental waters can cause undesired physiological effects in wildlife and 
humans.  
 
Research has shown that several regularly-used PPCPs may mimic or alter different vertebrate 
endocrine system pathways, which are collectively referred to as endocrine-disrupting 
contaminants (EDCs) (Boberg et al., 2010; Schlumpf et al., 2001; Veldhoen et al., 2014). 
Several PPCPs have been shown to be persistent or pseudo-persistent during wastewater 
treatment, thereby posing potential risk when discharged in environmental waters (Al Aukidy 
et al., 2014; Kasprzyk-Hordern et al., 2009b; Petrie et al., 2014). The prioritisation of these 
ECs for risk assessment is difficult, because concentrations in environmental waters show huge 
variation (Matongo et al., 2015; Petrie et al., 2014), and their effects at sub-lethal 
concentrations are not yet well established. Studies reporting on the detection of PPCPs in 
South African water systems have increased in the past few years (Agunbiade and Moodley, 
2016, 2014; Amdany et al., 2014b; Madikizela et al., 2014; Matongo et al., 2015). These studies 
focussed on the detection of several classes of PPCPs and the plasticizer bisphenol-A, with 
concentrations regularly surpassing the µg.L-1 level in WWTW effluent and environmental 
waters. However, with the vast majority of ECs shown to be present in wastewater and 
environmental waters on a global scale, their fate and environmental effects within WWTWs 
and environmental waters are still poorly described.  
 
Apart from the ubiquitous detection of PPCPs in South African surface waters, the detection 
of illicit drugs and other drugs of abuse are poorly investigated. Although illicit drug usage is 
shown to be on the rise in South Africa (Dada et al., 2017), the sources of information for drug 
abuse in the country are largely limited to law enforcement and treatment centre data. However, 
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these sources may underestimate the extent of drug abuse. A promising approach to estimate 
illicit drug use include wastewater-based epidemiology (WBE), which estimates drug 
consumption through the detection of illicit drugs and their metabolites in wastewater (Baker 
et al., 2014; Castiglioni et al., 2016).  
 
The present study focused on the daily loads and fate of ECs and metabolites in the aqueous 
phase of a WWTW influent and effluent, as well as in surface waters in a river system located 
upstream and downstream of the plant. This study is a first to verify the detection and fate of a 
large list of PPCPs, metabolites, and illicit drugs at a South African WWTW. A further aim 
was to correlate the persistence of selected ECs detected during the study with data showing 
modulation of wildlife reproductive and thyroid systems, with reference to established adverse 
outcome pathway (AOP) frameworks.  
 
4.2. Materials and Methods 
 
4.2.1. Chemicals and Materials 
The study included the screening for 90 ECs including 38 deuterated internal standards for the 
method development. All the reference standards were supplied by the Department of 
Chemistry at the University of Bath (Bath, UK; see Petrie et al., 2016a for further details). All 
chemicals were prepared at either concentrations of 0.1 or 1 mg.mL-1 in the relevant solvents 
and stored in the dark at -20⁰C. All glassware were deactivated using dimethylchlorosilane 
(DMDCS) in toluene (5% v/v) to limit the sorption of basic chemicals to glass surfaces. Both 
the MeOH and toluene used for experimentation were obtained from Sigma-Aldrich (99%, 
HPLC grade). 
 
4.2.2. Study Site and Sampling Procedures 
The site of study was at a WWTW situated in the Gauteng Province of South Africa (Fig. 4.1; 
APPENDIX Fig. B1). Treated wastewater effluent is discharged into a nearby river, which 
joins other streams that eventually feeds into a major dam that supplies approximately 6% of 
the total municipal drinking water to the surrounding communities.  
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Figure 4.1: Location map of the WWTW, point of discharge into the receiving waters, and sampling 
locations upstream and downstream from the plant. 
 
Sampling was done over five consecutive days during the month of July 2015 (Monday to 
Friday). Influent and effluent samples were taken each day at 60 min intervals (100 mL.h-1) 
from the WWTW influent (after grit screens) and effluent (after chlorination), upon which a 
final composite sample (100 mL) was obtained for each sampling location per day. The influent 
and effluent samples were taken concurrently and not matched to the hydraulic retention time 
of the WWTW. Grab samples of river surface water (100 mL) were taken at a location upstream 
(100 m) and downstream (3.5 km from the point of discharge) of the WWTW (Fig. 4.1). All 
samples were transported on ice from the sampling sites to the laboratory and were kept cold 
(± 4 ⁰C) and in the dark until analyte extraction, which was done within a maximum time of 
10 hours. 
 
4.2.3. Extraction Procedure 
The collected water samples were adjusted to a pH of 7 (± 0.2) and filtered using 0.45µm pore 
size PTFE filters prior to solid-phase extraction (SPE). Each 100 mL water sample from the 
various locations were split into two 50 mL samples to allow for duplicate extraction of each 
locality and between each day of sampling. Each sample included 50 ng of each of the 
deuterated PPCP internal standard and was mixed well before extraction. The water samples 
were extracted using Oasis® HLB (3cc, 60 mg) SPE cartridges (Waters; Microsep, 
Stellenbosch University  https://scholar.sun.ac.za
 80 
 
Johannesburg, South Africa). The cartridges were conditioned with 2 mL methanol, followed 
by 2 mL of ultrapure water (Millipore) at a flow rate of 1 mL min-1. After conditioning, the 
water samples (50 mL) were passed through the SPE cartridges at a flowrate of 5 mL.min-1 and 
allowed to run dry for a minimum period of 15 min. The dried cartridges were kept frozen (-
20⁰C) until all sampling were completed, from which the cartridges were then sent to the 
University of Bath (United Kingdom) for chemical analysis within 10 days of extraction. Each 
cartridge was individually wrapped with foil and placed frozen in a polystyrene pack lined with 
ice packs. Upon arrival at the University of Bath, the cartridges were dried and eluted with 4 
mL MeOH using a manifold at a flow rate of 1 mL.min-1. The extracts were dried under a 
gentle stream of nitrogen using a TurboVap evaporator (Caliper, UK, 40⁰C, N2, <5psi) and the 
evaporated samples were re-suspended in 500 µL of a H2O:MeOH (80:20) solvent, giving a 
100x concentrated sample, and transferred to polypropylene MS vials (Waters, Manchester, 
UK) for chromatography.  
 
4.2.4. Liquid Chromatography – Mass Spectrometry  
A Waters Acquity UPLC system coupled to a Xevo Triple Quadrupole Mass Spectrometer 
(UPLC/TQD-MS; Waters, Manchester, UK) was used following the method described by 
Petrie et al. (2016). Two separate chromatography methods were used for the quantification of 
acidic and basic compounds, as further described in Appendix B (Figure B2). In essence, both 
methods used a reversed-phase BEH C18 column (150 x 1.0 mm, particle size – 1.7 µm; 
Waters, Manchester, UK) coupled with a 0.2 µm (2.1 mm) in-line column filter. Mobile phase 
flow rates and injection volumes were maintained at 0.04 mL.min-1 and 15 µL respectively for 
both methods. Argon was used as the collision gas, and nitrogen as the desolvation and 
nebulising gas. Solvent blanks containing H2O:MeOH (80:20) were inserted after each ten 
samples, and two solvent blanks after quality control (QC) samples of the internal standards. 
The corrected recoveries of the analysed compounds are shown in Appendix B (Table B1). 
 
4.2.5. Calculations 
The mass loads of the target analytes in the aqueous phase at both the influent and effluent of 
the WWTW during the sampling period (g.day-1) were determined using Equation 1: 
 
Mass Load (g.day-1) = (Inf or Eff) * FR * 1/1000     [Eq. 1] 
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Where Inf and Eff refers to the concentration (in ng.L-1) of the analytes detected at the influent 
and effluent wastewater samples, and FR refers to the mean flow rate of the plant (ML.day-1) 
during each sampling day. The ability of the WWTW to remove the detected compounds in the 
aqueous phase were determined by calculating the percentage removal efficiency (RE %) 
between influent and effluent wastewater during the sampling period using Equation 2:  
 
RE (%) = ((Inf - Eff) / Inf) * 100       [Eq. 2] 
 
Where Inf refers to the mass loads (g.day-1) of the analytes detected at the influent sample site 
of the plant, and Eff refers to the mass loads (g.day-1) of the analytes detected at the effluent 
sample site of the plant. 
 
4.2.6. Statistical analysis 
Statistical analyses were performed using Statistica (version 13.0). Concentrations of the ECs 
detected at the WWTW influent and effluent, as well as water samples located upstream and 
downstream of the plant during the sampling period were compared using a repeated measure 
mixed-model ANOVA with the sampling day as a random factor. Significant differences were 
recorded as p < 0.05. 
 
4.3. Results and Discussion  
 
4.3.1. Analysis of WWTW samples 
A total of 55 ECs were detected in wastewater influent, and 41 ECs in effluent samples, which 
represented 19 classes of PPCPs, human indicators, illicit drugs and metabolites (Fig. 4.2; 
APPENDIX Table B2). The human indicators contained chemicals which are associated with 
endogenous products of human metabolism or which are used for population equivalent 
estimates. Although flow data (ML.day-1) from each day was incorporated to calculate the mass 
loads of the ECs within the WWTW during the sampling period, the variation in the mass loads 
of the ECs between sampling days may be attributed to several factors, such as the variation in 
the daily human usage of these compounds, pollution events from surface water sources leading 
towards the plant, the retention time of wastewater within the plant, or the overall performance 
of the treatment processes within the sampling period. 
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Figure 4.2: Mass loads (g.day-1) for the detected compounds at the WWTW during the sampling period. Values are expressed on a logarithmic scale. The 
standard deviations shows variation between sampling days. NSAIDs: non-steroidal anti-inflammatory drugs, EPH/pEPH: ephedrine/pseudoephedrine, dh-
hCBZ: 10,11-dihydro-10-hydroxycarbamazepine, CBZ-ep: carbamazepine-10,11-epoxide, DMX: 1,7-dimethylxantine, NDT: N-desmethyltramadol, ODT: O-
desmethyltramadol, DMV; desmethylvenlafaxine. * Mass load of acetaminophen = 10530 (± 3216) g.day-1. 
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The WWTW sampled in the current study showed varying removal efficiencies of the detected 
ECs (APPENDIX Table B3) and conforms to similar removal data of PPCPs reported in other 
studies (Verlicchi et al., 2012; Bahlmann et al., 2014; Petrie et al., 2014 & 2016). By comparing 
the average mass loads of the ECs at the influent and effluent, it was calculated that 28% of all 
detected ECs were removed by less than 50%, and 18% of all ECs were removed by less than 
25% (Fig. 4.3). A significant increase in final effluent concentration of the pharmaceutical 
metabolite desmethylvenlafaxine (DMV; from venlafaxine; p = 0.039), were measured 
compared to influent wastewater (negative mass balance). Also, a significant average negative 
mass balance was observed for the antibiotic azithromycin (p = 0.001; Fig. 4.3). Negative mass 
balances were also calculated based on the average mass load concentrations for the 
pharmaceutical metabolites 10,11-dihydro-10-hydroxycarbamazepine and O-
desmethyltramadol, as well as the parent compound tramadol (Fig. 3). However, statistical 
analysis deemed these negative mass balances non-significant due to the variation between 
sampling days (p>0.05).
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Figure 4.3: Removal efficiencies (%) of the detected compounds at the WWTW during the sampling period. Standard deviations indicate variation in between 
sampling days. NSAIDs: non-steroidal anti-inflammatory drugs, EPH/pEPH: ephedrine/pseudoephedrine, dh-hCBZ: 10,11-dihydro-10-hydroxycarbamazepine, 
CBZ-ep: carbamazepine-10,11-epoxide, DMX: 1,7-dimethylxantine, NDT: N-desmethyltramadol, ODT: O-desmethyltramadol, DMV; desmethylvenlafaxine. 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 85 
 
Two potential explanations for the occurrence of negative mass balances for ECs in WWTWs 
have been postulated, namely: i) persistent ECs accumulate in aggregates, leading to 
subsequent dissolution through biotic or abiotic processes, and/or ii), metabolites and/or 
conjugate forms of ECs are not detected at the WWTW influent and are subsequently back-
transformed or de-conjugated into parent compounds through either biotic or abiotic processes 
within the WWTW (Blair et al., 2015; Verlicchi et al., 2012). For example, conjugate forms of 
ethynyl-estradiol (EE2), carbamazepine and diclofenac have been shown to be de-conjugated 
by bacterial cultures (Aris et al., 2014; Lee et al., 2012; Vieno et al., 2007), while metabolites 
of the antibiotic sulfamethoxazole were shown to be transformed to its parent compound by 
photolytic processes (Bonvin et al., 2012). Although not all metabolites and conjugate forms 
of ECs can be regarded to be easily transformed within wastewater, it is possible that the 
perceived recalcitrance of some compounds in the current study at the WWTW (such as 
carbamazepine, tramadol, sulfamethoxazole and NSAIDs) may partly be caused by a 
combination of biotic and/or abiotic events leading towards the transformation of parent 
compounds and their metabolites.  
 
The recalcitrance of certain ECs (such as tramadol) is well-known. Tramadol, is rapidly 
metabolised in the liver by desmethylation enzymatic activities encoded by the Cytochrome 
P450 gene (CYP2D6), which give rise to its two primary metabolites O-desmethyltramadol 
(ODT) and N-desmethyltramadol (NDT) (Ardakani and Rouini, 2007). Only 10-30% of the 
parent tramadol is excreted in sewage, and hence, a large amount of the primary or secondary 
metabolites will also be prevalent in wastewater (Ardakani and Rouini, 2007). It is also 
noteworthy to mention that levels of the enzyme CYP2D6 may vary significantly between 
human individuals and sex. Taken that the WWTW screened during the current study receives 
wastewater from public, domestic and industrial sources, the daily levels of ECs (such as 
tramadol and its primary metabolites) in wastewater may vary greatly according to the de facto 
population contributing sewage of the WWTW. Partition coefficients for tramadol (log Kow 
3.01) and its metabolites ODT and NDT (log Kow 2.45; EPI Suite v4.11, KOWWIN, v1.68 
estimate) are indicative of a moderate tendency towards sorption onto organic constituents 
within soil, sediment and/or sludge. Such association with microbial aggregates and solids may 
protect these compounds from degradation until release. Floc breakup in the sludge and other 
forms of decay may then lead to association-disassociation events that may explain the large 
variation in metabolite levels.  
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Apart from the possible transformation of parent and/or metabolite ECs in wastewater, a 
number of factors could also potentially contribute to the attenuation and biodegradation of 
ECs in WWTWs. These include climatic conditions, physiochemical properties of the ECs, the 
hydrological retention time of the WWTW, and the microbial activity within the plant during 
the sampling period. The latter will include the properties of the extracellular polymeric 
substances (EPS) produced by microbial biofilms to absorb organic and inorganic pollutants 
(Petrie et al., 2014; Writer et al., 2011). It is possible that, unless some of these ECs are 
fortuitously co-metabolized, the energy that can be gained by microorganisms via degrading 
them at the low, environmentally relevant concentrations would not warrant the energy input 
required for enzyme production for further biodegradation. Furthermore, it was shown that 
environmentally relevant concentrations of the antibiotics phenazone, amoxicillin, and 
erythromycin can affect the initial adhesion of bacteria onto surfaces (Schreiber and Szewzyk, 
2008), and that a specialist degradative strain of yeast had a lesser habitat range than non-
degradative strains in soil (Barratt et al., 2003). Admittedly speculative, it is possible that such 
a shift, together with the availability of labile nutrients at relatively high concentrations may 
favour generalists to dominate the microbial community at the expense of specialist degraders, 
causing ECs to pass through unaltered.  
 
4.3.2. Detection of illicit drugs at the WWTW 
During the current study, eight ECs classified as illicit drugs, their metabolites, and a drug 
precursor were identified in raw wastewater (Fig. 4.2). An increase in the loads of breakdown 
products and precursors of amphetamine-type stimulants (ATS) were observed at the WWTW 
(pseudoephedrine > norephedrine > amphetamine > methamphetamine) (Fig. 4.2). The new 
psychoactive substance (NPS) mephedrone was detected only at influent samples, ranging from 
36 – 121 ng.L-1 and calculated at an average load of 3.1 g.day-1 during the sampling period. 
Similar to the ATS drugs, higher levels in the breakdown products of cocaine was observed in 
the wastewater influent (benzoylecgonine > cocaethylene > cocaine) (Fig. 4.2). The drug-
precursor and nasal decongestant, (pseudo)ephedrine, was detected at an average concentration 
of 6321 ng.L-1 (269.4 g.day-1) (APPENDIX Table B3). Norephedrine was detected at an 
average concentration of 1519 ng.L-1 (65.1 g.day-1). In comparison, the levels of ephedrine and 
norephedrine ranged between 8.7 – 1979.5 ng.L-1 (median load of 16.5 g.day-1) and 15.0 – 99.9 
ng.L-1 respectively at the influent of six WWTWs in the UK (Baker and Kasprzyk-Hordern, 
2013). These levels were noticeably lower than reported in the current study. Although 
(pseudo)ephedrine is generally used as an over-the-counter nasal decongestant, a report by the 
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South African Department of Social Development mentioned that South Africa is one of the 
largest importers of (pseudo)ephedrine in the world (CDA, https://www.cda.gov.za), which 
explains the high levels of the compound detected in the current study.  
 
 It is worthy to mention that the sources of ATS drugs in surface waters might vary. 
Methamphetamine is shown to be metabolised to amphetamine by de-methylation enzymes 
from the CYP2D6 gene (De La Torre et al., 1991), whereas amphetamine is also an active 
ingredient in medication for the treatment of attention deficit hyperactivity disorder (ADHD). 
Therefore, the presence of certain compounds could not be attributed to a specific source of 
exposure or drug abuse. The levels detected for methamphetamine (271-450 ng.L-1; 15.2 g.day-
1), cocaethylene (186-225 ng.L-1; 8.8 g.day-1), and (pseudo)ephedrine (283-16640 ng.L-1; 269.4 
g.day-1) in the WWTW influent (APPENDIX Tables B2 & B3) were detected at much higher 
levels than reported for UK WWTWs (Petrie et al., 2014). The current study therefore 
highlights the usage of sewage samples to indicate the trends of drug abuse within a 
community, and may therefore serve as a valuable tool in epidemiological studies. 
 
4.3.3. ECs in Environmental Waters 
A total of 40 ECs were detected in surface waters located upstream and downstream of the 
plant during the sampling period (Table 4.1). The levels of diclofenac, ibubrofen, ketoprofen, 
sulfamethoxazole, and bezafibrate were also analysed in other South African surface waters, 
and were detected at higher concentrations than in the current study (Agunbiade and Moodley, 
2016). However, the average concentrations of the measured ECs in surface water during the 
current study showed that 30 of the 40 detected ECs (75%) were higher than reported in UK 
surface waters (Petrie et al., 2016a, 2014). Although methylparaben, bisphenol-A, nicotine, 
cotinine, caffeine, and 1,7-dimethylxantine were removed with moderate to high efficiency by 
the WWTW (Fig. 4.2), the average concentrations of these compounds were calculated to be 
higher in downstream samples compared to the WWTW effluent (APPENDIX Table B2). 
However, only the levels of nicotine were found to be significantly higher in downstream 
samples compared to WWTW effluent samples during the sampling period (p < 0.05), mainly 
due to large variations of the other EC levels during the sampling period and also due to 
composite samples which were taken at the WWTW effluent and grab samples taken at the 
downstream site. In contrast, by comparing the average levels of ECs at the upstream and 
downstream sampling sites, it was shown that 26 out of the 40 detected ECs in surface waters 
(65%) were found to be two-fold or higher in downstream samples, with codeine detected 
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higher than 10 fold (Table 4.1). The concentrations of ECs in surface waters are known to not 
only fluctuate on a seasonal or daily basis, but also in distance from the plant (Vieno et al., 
2005). The higher levels of some PPCPs detected at downstream samples may therefore largely 
be attributed to the distance between the WWTW effluent and downstream sampling points 
(3500 m from the point of discharge), and fluctuations in the concentrations of the detected 
compounds between sampling days could also be attributed to variations in river water flow 
rates between sampling days.   
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Table 4.1: Mean concentrations (ng.L-1) of detected PPCPs, metabolites, illicit drugs and human indicator compounds at sampling localities located upstream 
and downstream of the WWTW. Standard deviation indicate variation between sampling days for the compounds. Abbreviations: NSAIDs: non-steroidal anti-
inflammatory drugs, EPH/pEPH: ephedrine/pseudoephedrine, dh-10-hCBZ: 10,11-dihydro-10-hydroxycarbamazepine, CBZ-ep: carbamazepine-10,11-
epoxide, DMX: 1,7-dimethylxantine, NDT: N-desmethyltramadol, ODT: O-desmethyltramadol. 
  Upstream Downstream       Upstream Downstream   
  Average Stdev Average Stdev Fold change   Average Stdev Average Stdev Fold change 
Parabens       Anti-epileptic      
Methylparaben 58.7 29.2 146.1 107.3 2.5  Carbamazepine 157.1 11.5 279.5 24.1 1.8 
Propylparaben 31.8 17.4 136.7 76.8 4.3  CBZ-ep 398.8 27.9 752.2 69.4 1.9 
       dh-hCBZ 22.7 1.58 56.9 8.9 2.5 
UV filters             
Benzophenone-3 56.2 1.7 64.3 6.0 1.1  Diabetes      
Benzophenone-4 441.1 23.8 1076.5 389.6 2.4  Gliclazide 43.2 2.4 53.9 22.3 1.3 
       Metformin 73.3 7.2 174.6 81.7 2.4 
Plasticizer             
Bisphenol-A 239.0 72.1 396.4 208.1 1.7  Hypertensions      
       Irbesartan 311.1 28.7 554.4 120.0 1.8 
Antibiotics       Valsartan 263.7 24.6 924.7 50.2 3.5 
Azithromycin 24.6 0 6.4 3.4 0.3        
Clarithromycin 76.2 13.4 235.5 66.1 3.1  Anti-depressants      
Sulfamethoxazole 757.4 83.2 1013.2 294.2 1.3  Fluoxetine 34.4 22.1 109.2 125.6 3.2 
Sulfasalazine 37.6 3.4 53.0 13.0 1.4  Venlafaxine 35.4 3.7 94.6 19.6 2.7 
Trimethoprim 383.0 42.2 898.7 303.0 2.4  Desmethylvenlafaxine 50.0 7.5 174.9 53.8 3.5 
             
NSAIDs       Analgaesics      
Acetaminophen 20.8 4.5 63.7 76.1 3.1  Codeine 11.3 6.7 128.9 65.4 11.5 
Diclofenac 467.4 176.2 1461.5 508.7 3.1  Tramadol 97.7 11.2 299.9 73.2 3.1 
Ibuprofen 153.3 39.5 312.1 204.6 2.0  NDT 16.0 9.9 74.0 8.1 4.6 
Ketoprofen 642.2 0 330.3 319.0 0.5  ODT 207.6 32.2 577.3 149.8 2.8 
Naproxen 224.3 31.1 1112.8 518.3 5.0        
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Table 4.1 (continued)             
             
Lipid regulators       Drug precursor      
Atorvostatin 74.0 5.2 150.6 55.7 2.0  Eph/pEPH 38.8 8.0 80.4 28.4 2.1 
Bezafibrate 54.9 8.3 234.4 116.8 4.3        
       Stimulants      
Antihistamine       Amphetamine 27.1 22.6 37.0 22.6 1.4 
Fexofenadine 368.4 36.7 887.0 172.0 2.4        
       Human indicators      
X-ray contrast media       Nicotine 154.3 78.7 245.5 67.6 1.6 
Iopromide 265.8 11 598.3 235.4 2.3  Cotinine 25.5 3.3 31.7 11.7 1.2 
       Caffeine 812.2 146.3 2077.5 259.7 2.6 
Beta-blockers       DMX 479.4 357.6 957.6 728.6 2.0 
Atenolol 156.2 34.43 272.0 154.6 1.7        
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The fact that human indicator compounds (such as nicotine) were detected at higher average 
levels in the downstream samples relative to the WWTW effluent samples (Table S2) indicates 
human activities further downstream from the WWTW, which could have re-introduced some 
ECs (such as methylparaben, codeine and bisphenol-A) back into the water system after the 
levels of the pollutants were lowered at the plant. The direct discharge and/or illegal dumping 
of sewage and other waste products may have been a contributing factor to these observations. 
This might also explain the high fold-increase in codeine further downstream of the plant 
(Table 1), which is regarded as the most abused over-the-counter drug in the country. However, 
the difference in mode of sampling should also be pointed out; composite samples were taken 
at the WWTW, whereas grab samples were taken for the river water, which should be corrected 
in future studies. Some industrial (such as a brick manufactory) and agricultural practices 
(poultry and other livestock) are present between the point of discharge of the WWTW and the 
downstream sample taken in the study. The presence of PPCPs and some metabolites point to 
other waste sources and human activities further downstream from the WWTW. 
 
4.3.4. Environmental risk of the detected pollutants  
The demonstrated presence of a vast mixture of ECs in WWTW effluent and river water in the 
current study emphasises the need to consider potential associated environmental risks. 
Conventional methods for environmental risk assessment (ERA) includes acute- and/or chronic 
toxicity data based on the most sensitive organism or combination of organisms within a given 
ecosystem to determine a predicted no-effect concentration (PNEC) of an environmental 
pollutant. This value is then compared to predicted- or measured environmental concentrations 
(PEC or MEC respectively) to obtain a risk quotient (RQ) of the EC of interest. An RQ value 
exceeding 1.0 is then regarded as an environmental risk. Table B4 in appendix B reports on 
RQs determined for some ECs which were detected in WWTW effluent and river water during 
the current study. The MECs show that 5 out of the 41 detected ECs in WWTW effluent, and 
4 of the 40 detected ECs in environmental surface waters posed an environmental risk (RQ > 
1; APPENDIX Table B4). These ECs included diclofenac, sulfamethoxazole, clarithromycin, 
codeine, and nicotine, with clarithromycin only showing an environmental risk for WWTW 
effluent water (RQ > 1), although still of environmental relevance (RQ = 0.8; Table S4).  
 
Although conventional ERA is valuable to show toxicity risks of ECs found in environmental 
waters, a few limitations exist. These models only consider lethal toxicity on an in vivo level 
as a risk endpoint and hence, the consequences of pollutants triggering sub-lethal toxicity on 
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physiological pathways (from molecular to cellular level) are highly underestimated. The 
possibility of PPCPs to modulate molecular and/or cellular pathways (such as those involved 
in endocrine system function) at concentrations well below lethal toxicity therefore makes such 
outcomes more ecologically relevant for risk assessment. To assist with the understanding of 
toxicity mechanisms leading towards an observed adverse outcome on a population level, an 
adverse outcome pathway (AOP) framework has been proposed (Ankley et al., 2010). This 
conceptual framework is aimed towards using existing toxicological knowledge to establish a 
relationship between biological events on cellular- to organism level (termed key events, KEs) 
through key event relationships (KERs), which is initiated by a molecular initiating event 
(MIE) (Margiotta-Casaluci et al., 2016; Villeneuve et al., 2014). The KERs are dependent on 
a weigh-of-evidence approach to show the relationship between established KEs. The 
downstream KEs through biological complexity subsequently lead towards an observed 
adverse outcome (AO) which can be used for environmental regulatory decision-making 
(Ankley et al., 2010). Although the AOP framework is not directly constructed to be chemical 
specific, nor to serve as a risk assessment tool, the correlation of established AOP networks to 
EC monitoring studies (such as the current study) can therefore show the possibility of ECs in 
environmental waters to modulate certain MIEs or KEs. As a result, RQ values can be 
generated for certain MIEs and KEs (RQMIE/RQKE) in a similar way as conventional ERA.  
Such risk predictions can therefore serve as early warning systems to prioritise ECs for their 
potential to contribute towards possible detrimental health effects in the environment. 
 
Several studies have suggested that organic pollutants can modulate endocrine system 
pathways of vertebrate species at low concentrations which are regularly detected in the 
environment. In vitro studies have shown, for example, that the plasticizers bisphenol-A, 
disinfection products (such as parabens), and UV filters can induce MIEs such as agonistic 
binding to the human estrogen receptor (hER), which has further been shown to lead towards 
the proliferation of breast cancer cells (Boberg et al., 2010; Schlumpf et al., 2001). Exposure 
of fish to paraben and UV filter compounds have been reported to induce MIEs and KEs such 
as increased expression of mRNA transcripts of the estrogen receptor-α (ERα) and protein 
vitellogenin (VTG) in the liver of male fish, which can be linked to further downstream KEs 
such as increased levels of plasma VTG in the body (Barse et al., 2010; Inui et al., 2003). The 
protein VTG is a precursor of egg yolk in oviparous animals, and serves as a common 
biomarker to show estrogenic endocrine disruption in aquatic organisms due to its direct KERs 
with circulating androgen- and estrogen hormone levels (Jones et al., 2000)(AOP-Wiki, KE219 
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& KE285). The relevant MIEs and KERs leading towards increased VTG production has been 
well documented to be directly linked with KEs on organismal level such as fecundity and 
spawning, which can eventually have an effect on population trajectories (AOP-Wiki, AOP25). 
Although it has been shown in the current study that parabens and UV filters are effectively- 
to moderately removed in the WWTW (Fig. 4.2), methylparaben, benzophenone-4, and 
benzophenone-3 were still detected in river water downstream of the plant (Table 4.1), albeit 
well-below reported levels to modulate KEs as shown in laboratory studies (Barse et al., 2010; 
Inui et al., 2003) (RQKE << 1; APPENDIX Table B4).  
 
Exposure of other pharmaceuticals, such as the NSAIDs diclofenac and ibuprofen have also 
been shown to modulate KEs such as elevated plasma estradiol levels and induction of VTG in 
male fish, either through upregulation of upstream MIEs (such as increased aromatase activity) 
or other molecular targets (APPENDIX Table B4). Although the concentrations to modulate 
these observed estrogenic endpoints are higher than the environmental concentrations for 
ibuprofen in the current study, the concentration of diclofenac in WWTW effluent and river 
water samples regularly exceeded the 1000 ng.L-1 value previously reported to modulate VTG 
production in fish (Hong et al., 2007; RQKE > 1; APPENDIX Table B4). Although an increase 
in VTG production has been shown for diclofenac at 1000 ng.L-1, Gröner and colleagues (2017) 
mentioned that such a concentration, however, does not impair population-relevant endpoints 
such as survival and hatching success. On the contrary, both ibuprofen and naproxen have been 
reported to cause decreased egg fertilisation in fish at a concentration of 100 ng.L-1 (Nesbitt et 
al., 2011), which therefore reflects upon modulation of an established KE of fecundity and 
spawning (AOP-Wiki, KE78). The concentrations of ibuprofen and naproxen within WWTW 
effluent and river water during the current study were well above the threshold to potentially 
modulate such a KE (RQKE > 1; APPENDIX Table B5), and therefore indicates a potential 
environmental risk to impair fecundity and spawning, which can ultimately lead to a decline in 
fish populations (AOP-Wiki, AO360). Whether the concentrations of these NSAIDs is 
sufficient to induce further downstream KEs, or can be extrapolated to other vertebrate species 
need further investigation.  
 
Apart from NSAIDs showing reproductive endocrine disruption in aquatic organisms, in vivo 
exposure of 500 ng.L-1 carbamazepine in water has been shown to cause significant reduction 
in plasma 11-ketotestosterone (11-KT) concentrations in male fish (Galus et al., 2013b), of 
which the upstream MIE causing this endpoint is still unknown. 11-KT is the primary teleost 
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androgen necessary for normal reproductive functioning, and hence, also influence the 
reproductive success of fish populations. The average concentration of carbamazepine in the 
WWTW effluent of the current study was close to the 500 ng.L-1 threshold which can cause 
such a reduction in fish steroid hormone levels (APPENDIX Table B4). Although the 
modulation of circulating 11-KT is not shown to lead towards altered estradiol hormone 
synthesis through aromatase enzyme activities (such as the case with circulating testosterone 
levels), the modulation of circulating 11-KT levels in fish can still be regarded as a potential 
KE to lead towards reproductive dysfunction in male fish. Furthermore, no studies have been 
conducted to report on the potential endocrine disrupting effect of the primary metabolites of 
carbamazepine, which was shown to be detected at higher concentrations within WWTW 
effluent and river water (Fig. 4.3; Table 4.1), and removed to a lower extent in the WWTW 
(Fig. 4.2).  We therefore propose that this compound and its metabolites need further 
monitoring for its potential to cause detrimental effects in aquatic vertebrates, especially due 
to its demonstrated recalcitrance and potential to modulate androgen-controlled endocrine 
pathways. 
 
Apart from the potential of ECs to modulate reproductive endocrine system pathways, studies 
showing modulation of the thyroid endocrine system have also been reported. Exposure of the 
NSAID ibuprofen to tadpoles of the American bullfrog (Rana catesbeiana) at concentrations 
ranging from 1500 – 15 000 ng.L-1 have been shown to potentiate triiodothyronine (T3)-induced 
mRNA transcription of thyroid hormone receptors (Veldhoen et al., 2014). In the same study, 
exposure to ibuprofen alone resulted in increased mRNA transcripts for enzymes such as 
thyroxine 5-deiodinase (dio3) in a tail fin tissue assay, which is necessary to regulate thyroid 
hormone homeostasis (Veldhoen et al., 2014). Although the levels of ibuprofen observed in the 
present study was below these concentrations in both the WWTW effluent and river water, the 
levels of other NSAIDs, such as naproxen (average concentration of 2296 ng.L-1 in WWTW 
effluent; APPENDIX Table B2) and diclofenac (average concentration of 2326 ng.L-1 in 
WWTW effluent; APPENDIX Table B2), fell within the concentration range to possibly alter 
such MIEs, given that these NSAIDs yield the same mechanism of endocrine disruption as 
ibuprofen. It has been shown that diclofenac (but not naproxen) can antagonistically bind to 
the thyroid hormone receptor-ß (thrß) in a human reporter assay, and also inhibit T3-induced 
vasodilation of rat mesenteric arteries (Zloh et al., 2016). Also, it is important to note that cross-
talk between endocrine system pathways exist. For example, Nelson and Habibi (2016) 
demonstrated an increased production of VTG and upregulation of ERα following a treatment 
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of T3 in female goldfish (Carassius auratus). Therefore, the potential of NSAIDs to alter both 
thyroid- and gonadal endocrine system pathways can be linked to several KEs and KERs, given 
that the concentrations and bioaccumulation of these pollutants are sufficient within the 
organisms to exert such effects. However, relatively little has been done to assess the impact 
of NSAIDs on whole-life cycles within aquatic organisms, and should receive more attention 
in future studies, especially due to their ease of purchase, their regular usage, and moderate 
persistence in the aqueous phase at WWTWs as shown in the current study.  These results 
therefore indicate the importance to regard NSAIDs as priority environmental EDCs in future 
studies.  
 
Another complication which arise in establishing ECs as an environmental risk is the complex 
range of interactions that are found in environmental waters. Several ECs generally accumulate 
in complex mixtures of varying concentrations (including other types of organic and inorganic 
pollutants), in which the modulating effects of such mixtures may differ from observed effects 
of the individual pollutants. For example, a study by Galus and colleagues (2013a) showed a 
mixture of environmentally relevant concentrations of acetaminophen, carbamazepine, 
gemfibrozil, and venlafaxine (500 ng.L-1 for each compound) significantly altered embryo 
production, oocyte development, and fecundity in female zebrafish (Danio rerio), while the 
individual compounds exposed to the fish species at the same concentrations did not yield the 
same results (Galus et al., 2013b). Although investigations of PPCP mixture effects generate a 
more ecologically relevant scenario, it is more feasible to identify the KEs and KERs which 
are modulated by individual compounds, which may ultimately lead to a better understanding 
of the health risks in environmental waters. The fact that some ECs in the current study showed 
low removal from the WWTW, as well as the possibility to cause adverse effects on vertebrate 
endocrine system pathways (such as carbamazepine, UV filters, plasticizers, parabens and 
NSAIDs) highlights the importance to further monitor these priority ECs to limit their impact 
on both the aquatic ecosystem and contamination to drinking water resources. 
 
4.4. Conclusions 
 
The current study aimed to provide a link between the monitoring of ECs in WWTWs and 
environmental waters with possible adverse health consequences in wildlife. Although most 
ECs were shown to be notably reduced in WWTW effluent, some persisted, and were even 
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detected at higher concentrations in effluent (as shown for some pharmaceutical metabolites 
and parent compounds). It is therefore important to report on the fate of both parent ECs as 
well as their metabolites and/or conjugate forms in surface waters to elucidate the possible 
negative mass balances observed in WWTWs and recalcitrance of pollutants in environmental 
waters. Drawing definite conclusions regarding the health impact which these pollutants may 
cause when entering environmental waters is no simple task, considering that these pollutants 
are present in complex mixtures with varying physiochemical properties, as well as their 
varying affinities to modulate a range of molecular and cellular pathways in wildlife species. 
It is therefore clear that there is a need for more eco-toxicological assessment on the sub-lethal 
effects of ECs and polluted water systems into identifying MIEs, KEs and KERs which certain 
ECs can modulate to advance current risk assessment approaches.  
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CHAPTER 5: ENANTIOMERIC PROFILING AND THE FATE OF DRUGS OF 
ABUSE (DOA) DURING WASTEWATER TREATMENT AND WITHIN 
ENVIRONMENTAL WATERS 
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 Abstract 
 
Contamination of surface waters with organic micro-pollutants is a growing concern. In 
particular, the persistence of pharmaceuticals that result in their passage through wastewater 
treatment works (WWTWs) before being discharged into environmental waters or reused for 
non-potable purposes pose a severe threat to global freshwater security. There are numerous 
reports on the recalcitrance of several emerging contaminants (ECs) during wastewater 
treatment, including contaminants which show high tendencies to be absorbed into solid 
particulate matter, therefore posing an environmental risk. The current study included a 
weeklong monitoring campaign at two South African WWTWs. Influent, treated effluent, as 
well as the liquid- and solid phase of return activated sludge (RAS) and environmental surface 
waters sampled upstream and downstream of the plants were screened for the presence of drugs 
of abuse (DOA), known recalcitrant pharmaceuticals, and their associated metabolites. Most 
compounds analysed for were removed with high efficiency at both treatment plants, with the 
exception of the opioid drug tramadol (TRAM), the anti-depressant venlafaxine (VEN), their 
metabolites, as well as the anaesthetic drug ketamine. Methamphetamine (METH) was shown 
to be enriched with the R-enantiomer in wastewater effluent due to stereoselective 
biodegradation favouring the S-enantiomer. The DOA TRAM, codeine, morphine, VEN and 
S-(+)-METH were detected in environmental waters not necessarily associated with 
wastewater discharge, suggesting alternative pollution sources. The study highlights the impact 
of recalcitrant micro-pollutants on environmental and human health, and point to the need for 
expanded monitoring to trace the origin of ECs in environmental waters, especially for rural 
and peri-urban areas which are not connected to the sewage system.  
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5.1. Introduction 
 
Contamination of surface waters by organic micro-pollutants is globally shown as a growing 
concern, with treated wastewater discharge being considered a major source. Bioprocesses, 
including activated sludge (AS) employed in wastewater treatment play an important part in 
reducing the organic load discharged to surface waters. However, conventional wastewater 
treatment works (WWTW) have been shown to be inefficient to eradicate a number of 
recalcitrant ECs (Petrie et al., 2014; Yang et al., 2017). This is partly the result of rapid 
urbanisation and population increase pushing facilities beyond their design capacity, as well as 
increased loads of pharmaceuticals, personal care products, pesticides and industrial by-
products being directly discharged and/or excreted in surface waters and sewage respectively. 
These ECs are therefore considered pseudo-persistent due to their regular occurrence within 
wastewater influent due to their partial degradation, as well as their continued release into 
receiving waters (Evans and Kasprzyk-Hordern, 2014), from which the environmental risk 
assessment are largely  limited.  
 
Removal efficiency of EC’s during wastewater treatment depends on several factors, such as 
their physio-chemical properties, the treatment process and associated residence time, as well 
as the source input of the pollutants (domestic/industrial). Compared to removal of parent 
compounds, the presence and fate of their breakdown products received less attention. For 
pharmaceuticals, several studies suggested a negative mass balance of some compounds, by 
which a larger concentration will be detected in the treated effluent compared to influent 
samples (Archer and Wyk, 2015; Baalbaki et al., 2017; Blair et al., 2015; Subedi and Kannan, 
2014). Furthermore, compared to the aqueous phase, the sorption onto suspended particulate 
matter such as AS has received less attention (Boix et al., 2016). While the increased contact 
time with microbial aggregates in activated sludge processes generally enhance removal 
efficiency (Kasprzyk-Hordern and Baker, 2012a), the recalcitrance of pharmaceuticals such as 
the opioid drug tramadol (TRAM) and antidepressant drug venlafaxine (VEN) has been 
ascribed for their tendency to be absorbed into solid particulate matter (SPM) during the AS 
treatment process (Baalbaki et al., 2017; Boix et al., 2016; Gasser et al., 2012). Re-circulation 
of AS (through return activated sludge; RAS) allows for floc maturity, as well as increased 
contact time to SPM. Compounds showing attenuation onto SPM, but not necessarily degraded 
may therefore ultimately be desorbed into the aqueous phase of treated wastewater or be 
discharged in waste sludge that are regularly destined for the use of agricultural fertilisers.  
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As the list of ECs being detected in surface waters are ever-increasing, it is vital to prioritise 
their monitoring following a weigh-of-evidence (WOE) approach to promote improved risk 
assessment. This warrants frequent assessment of their presence/concentrations in surface 
waters, establishing their fate throughout wastewater treatment, delineating the mechanisms 
for their persistence, as well as their potential risk to cause adverse health effects in both 
wildlife and potentially - humans.  
 
Several prescription- and over-the-counter (OTC) medications such as the opioids TRAM and 
codeine are addictive. Along with the known abuse of illicit drugs, the rise in both licit- and 
illicit drugs of abuse (DOA) is an ongoing concern globally. Furthermore, substance abuse data 
is limited for developing countries, whereby most information are largely generated from abuse 
treatment centres (Dada et al., 2017). This may lead to a significant underestimation of 
substance abuse, as only a limited number of abusers will admit to their drug use or be willing 
to be admitted for rehabilitation. For this reason, a wastewater-based epidemiology (WBE) 
approach, based on water profiling of defined sewage-collections systems, has been proposed 
to assist with drug use estimates in a region (Castiglioni et al., 2016; Castrignanò et al., 2016; 
Causanilles et al., 2017). 
 
The current study focussed on the fate of several licit and illicit drugs of abuse (DOA) and 
known recalcitrant pharmaceuticals during wastewater treatment and associated environmental 
waters, followed by conventional risk assessment approaches for the study sites. The 
attenuation of ECs within return activated sludge (RAS) was also investigated to assess the 
partitioning of recalcitrant compounds into the solid vs. the aqueous phases, in search for 
explanations for their persistence during passage through treatment plants.  
 
5.2. Materials and Methods 
 
5.2.1. Sampling locations 
Two WWTWs were selected for a consecutive 7-day sampling campaign during the study: 
WWTW1 is located in the Northern interior (Gauteng Province), and WWTW2 located near 
the coastline in the Western Cape Province of South Africa (Fig. 5.1). The information for the 
plants are shown in Table 5.1. WWTW1 is situated 3 km from a lifestyle estate and 4 km from 
the nearest populated area, whereas WWTW2 is situated within a close proximity of a 
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populated area. For WWTW1 the total treated effluent is directly discharged into the receiving 
river system after disinfection, whereas WWTW2 diverts its treated effluent into either 
maturation ponds or the receiving river system after chemical disinfection. 
 
 
Figure 5.1: Map showing the sampling locations of WWTW 1 (Gauteng Province) and 
WWTW 2 (Western Cape Province). 
 
Table 5.1: Plant information of the two WWTWs during the study. 
 Capacity 
(ML.day-1) 
Domestic: 
Industrial 
HRTa 
(hours) 
Population Estimateb 
WWTW1 63.0 60:40 24 200 000 
WWTW2 105.0 80:20 24 470 000 
a Hydraulic retention time (in hours) of wastewater within the treatment process. 
b de facto population estimate for 2017 based on projected census data from the last formal census in 2011. 
 
5.2.2. Chemicals and consumables 
The study included the multi-residue quantification for a selected list of DOA using analytical 
methods described elsewhere (Castrignanò et al., 2016). The following internal standards were 
included in the water samples to enable quantification: cocaine-d3, benzoylecgonine-d8, 
amphetamine-d5, methamphetamine-d5, mephedrone-d3, MDA-d5, MDMA-d5, cotinine-d3, 
EDDP-d3, heroin-d9, codeine-d6, oxycodone-d6, hydrocodone-d6, methadone-d9, ketamine-
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d4, norketamine-d4 and 1S,2R-(+)-ephedrine-d3. Hyper-grade methanol (MeOH, 98%) and 
ultra-pure water (Millipore) were used for cleaning glassware and for solid phase extraction. 
All glassware were deactivated using 5% dimethyldichlorosilane (DMDCS) in toluene, 
followed by two wash steps in toluene and three wash steps in MeOH. 
 
5.2.3. Sample collection and preparation 
Sampling was done in 7 consecutive days at the WWTWs, which included samples from the 
raw sewage after grit screens, final effluent after chlorination, return activated sludge (RAS), 
and river water collected upstream and downstream from the plants. For WWTW2, the 
downstream sampling point was located 3.5 km from the point of discharge due to 
inaccessibility closer to the point of discharge. Time-proportional composite samples (100 ml) 
was taken every 10 minutes from raw sewage and final effluent, and then combined to obtain 
a 24 hour sample of the treatment steps. Grab samples (250 ml) were taken for the RAS and 
river water samples. The samples were kept cold during sampling and transport to the 
laboratory, from which further sample filtration and extraction were completed immediately. 
The samples were filtered using 0.7 µm GF/F filters using a vacuum manifold, except for the 
RAS samples.  
 
The focus of this report is on analyses performed on liquid samples. RAS samples were 
centrifuged, from which the supernatant was collected to separate the liquid phase of the RAS 
(RASliquid), and the centrifuged pellet was placed into a glass jar for lyophilisation to obtain the 
solid phase of the RAS samples (RASsolid) for follow-op work. The freeze-dried RASsolid was 
subjected to a standard protocol of microwave-assisted extraction (MAE) (Evans et al., 2015), 
with slight modifications. Briefly, a 0.25 g dried sludge sample were spiked with the internal 
standard mixture (5 µl of a 1 µg.ml-1 concentration) and left for 30 mins. The samples were 
then suspended in 30 ml of a 50:50 mixture of MeOH and ultrapure water. The suspension was 
transferred to the MAE tubes and extracted using a Mars5 MAE machine (CEM Corporation). 
The temperature was allowed to increase over 9 minutes, and held at 121⁰C for 30 minutes. 
The samples were then allowed to cool down to room temperature and then filtered through 
GF/F filters (Whatmann). The filtered samples were diluted in 270 ml ultrapure water to obtain 
a concentration of MeOH less than 5%, followed by solid phase extraction (SPE).  
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5.2.4. Solid phase extraction (SPE)  
All aqueous samples were extracted using Oasis® HLB cartridges (Waters; 3cc, 60 mg), and 
Oasis® MAX cartridges (Waters; 3cc, 60 mg) for the RASsolid samples using the following 
protocol: The Oasis® HLB cartridges were conditioned with 2 ml MeOH, followed by 2 mL of 
ultrapure water, and the Oasis® MAX cartridges with 4 mL MeOH and 4 mL ultrapure water, 
where the solvents were allowed to pass by gravity. Each sample was then divided into 
duplicates, which included a 50 mL sample for raw sewage, final effluent, and RASliquid, 100 
mL for river water upstream and downstream, and 300 mL for the RASsolid. The extraction was 
carried out using a vacuum manifold (Supelco Visiprep). The samples were allowed to pass 
through the cartridges at a rate of 6 mL.min-1 and allowed to run dry for at least 30 minutes. 
The dried cartridges were then transported refrigerated for elution and analysis. Upon arrival, 
the cartridges were eluted with 4 mL MeOH into 5 mL salinized glass vials and dried under a 
gentle stream of nitrogen (5-10 psi, 40⁰C) using a TurboVap evaporator (Caliper, UK). The 
dried samples were then reconstituted in 0.5 mL of the mobile phase used during LC/MS (1 
mM ammonium acetate:methanol, 85:15, v/v), where after the suspended samples were 
vortexed and filtered through 0.2 µm PTFE filters (Whatman, Puradisc, 13 mm) using 3 mL 
syringes. The filtered samples were then placed in polypropylene plastic vials fitted with pre-
slit PTFE/Silicone septa (Waters, UK) for chemical analysis.  
 
5.2.5. Chiral liquid chromatography coupled with tandem mass spectrometry 
The method parameters and conditions used are described elsewhere (Castrignanò et al., 2016) 
(APPENDIX C, Table C1). Briefly, the analytes in the processed samples were separated using 
a Waters ACQUITY UPLC® system (Waters, Manchester, UK) equipped with a 
CHIRALPAK® CBH HPLC column, 5 µm particle size, L × I.D. 10 cm × 2.0 mm (Chiral 
Technologies, France) and a Chiral-CBH guard column 10 × 2.0 mm, 5  µm particle size (Chiral 
Technologies, France). The ACQUITY UPLCTM autosampler was kept at 4⁰C, and the column 
temperature was set at 25⁰C. All samples were injected at 20 µL. The mobile phase (1 mM 
ammonium acetate / methanol, 85:15, v/v) was injected at 0.1 ml.min-1 under isocratic 
conditions. The separated analytes were quantified using a triple quadrupole mass spectrometer 
(Xevo TQD, Waters, Manchester, UK) with an electrospray ionisation (ESI) source, which was 
managed in the multiple reaction monitoring (MRM) mode. Two- to three MRM transitions 
were created for each compound, which assisted with confirmation and quantification. Spiked 
quality control (QC) standards containing the deuterated and non-deuterated analytes were 
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incorporated throughout the analytical procedure. The quality and quantification of the analytes 
in the samples were determined using the method detection limits (MDL) and method 
quantification limits (MQL) as set out in Castrignanó et al. (2016), as well as quality control 
criteria according to the European Commission Council Directive 2002/657/EC (European 
Commission, 2002). 
 
5.2.6. Calculations 
For each target analyte within raw wastewater and final effluent, a mass load (g.day-1) was 
calculated to compensate for the variation in daily WWTW flow rates at the sewage inlet 
(influent) and outlet (effluent). This was achieved by multiplying the estimated concentration 
of the compounds (ng.l-1) generated during LC-MS with the daily flow rate measurement 
(Ml.day-1) at the WWTW influent or effluent. This estimate was then used to calculate the 
removal of the analytes during wastewater treatment. For removal estimates, the following 
equation was used: 
Removal (%) = [(MLinfluent – MLeffluent)/MLinfluent]*100     
 
where MLinfluent and MLeffluent refers to the daily mass load (in g.day
-1) measured for each analyte 
within raw wastewater and treated effluent. For each removal estimation, the hydraulic 
retention time (HRT) was considered. Both WWTWs are recorded to have a HRT of 24 hours 
(Table 5.1), which led to removal estimates using the ML of influent wastewater for the one 
day (for example Monday) and the ML of the effluent wastewater recorded for the next day 
(for example Tuesday). 
 
The enantiomeric fraction (EF) for the chiral drugs was calculated to assess whether the chiral 
drugs are present in a racemic mixture or rather enantiomerically enriched within the various 
water matrices. This was achieved using the following equation: 
 
 
 
5.3. Results and Discussion 
 
Enantiomeric Fraction 
(EF) = 
(+) 
[(+) + (-)] [E1 + E2] 
E1 
or 
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5.3.1. Wastewater  
A total of 38 DTRs, including illicit stimulants and hallucinogens, precursor drugs, opioids, 
antidepressants, anaesthetics, and four human chemical markers were screened for in the 
aqueous phase of wastewater. In total, 31 of the target compounds were quantified within raw 
wastewater at WWTW1 (APPENDIX, Table C1), and 35 of the compounds at WWTW2 
(APPENDIX, Table C2). These results confirm the use of illicit drugs, as well as other OTCs 
and prescription DOA by the surrounding population. An extensive discussion on the 
estimation of illicit drug use estimates will be shown in Chapter 6 using a wastewater-based 
epidemiology (WBE) approach (Castiglioni et al., 2016). Overall, the majority of the DTRs 
were detected at higher concentrations in WWTW2, largely due to its wastewater source having 
a larger proportion of domestic sewage, as well as its larger holding capacity and estimated 
population being 1.7-fold and 2.4-fold higher respectively than recorded for WWTW1 (Table 
5.1).  
 
Mass load ratios of cocaine (COC) compared to its primary metabolite, benzoylecgonine 
(BEG), in raw wastewater ranged from 1.8 - 4.0 BEG/COC at WWTW1, and 1.9 - 3.8 
BEG/COC at WWTW2. These ratios suggest that a large proportion of COC is present within 
sewage in its un-metabolised form, suggesting possible disposal rather than consumption 
(BEG/COC < 5)(Karolak et al., 2010). However, the overall higher loads of BEG compared to 
COC in the raw samples does indeed confirm hepatic metabolism of the drug, thereby 
confirming its consumption within the domestic community connected to the sewage system. 
The enantiomeric signature of methamphetamine (METH) in raw wastewater suggests an illicit 
origin (Castrignanò et al., 2017b; Xu et al., 2017), as all raw wastewater samples were 
predominantly enriched with the S-enantiomer (APPENDIX, Table C1 and C2). The new 
psychoactive substance (NPS) mephedrone was detected only in raw wastewater from 
WWTW2 (APPENDIX, Table C2). Although data showing mephedrone abuse in the country 
is limited, the current study suggest its use within the community connected to WWTW2, 
which is known for high rates of substance abuse (Dada et al., 2017). The same was shown for 
MDMA, whereby the loads were more predominant at WWTW2 (APPENDIX, Table C2), but 
suggest that this drug is only used as a secondary DOA on a recreational basis. Heroin, which 
is classified as one of the primary DOA in South Africa (Dada et al., 2017), was not detected 
at any raw or treated effluent samples during the current study, largely due to its low stability 
leading to rapid metabolism after administration and within wastewater. However, a minor, yet 
exclusive metabolite of heroin, O-6-monoacetylmorphine (O-6-MAM) was detected in raw 
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influent of WWTW2 only, confirming the presence of heroin use within the communities 
served by WWTW2. Ketamine, which is mostly used as a veterinary anaesthetic but also a licit 
DOA, was detected in raw wastewater at loads ranging from 0.1 to 17.2 g.day-1 at WWTW1 
(APPENDIX, Table C3), and 0.4 to 1.4 g.day-1 at WWTW2 (APPENDIX, Table C4). Although 
it is reported that the metabolite norketamine would rather be excreted during its consumption, 
the current study only detected ketamine. This result is in agreement with similar studies 
(Bijlsma et al., 2016; Castiglioni et al., 2015), which point to the need for further refinement 
of ketamine’s excretion profile in sewage in order to estimate its abuse.  
 
All of the illicit compounds and their associated metabolites were removed with high efficiency 
at both WWTWs (Fig. 5.2A). Both WWTWs utilise advanced AS process for improved 
biological nutrient removal (BNR), which is known to cause a higher rate of stereoselective 
reduction of chiral drugs compared to other types of treatment systems (Kasprzyk-Hordern and 
Baker, 2012a). Removal estimates for (±)-METH was shown to be stereo-selective at both 
WWTWs, whereby R-(-)-METH was less removed than S-(+)-METH (Fig. 5.2A). This has 
been proven both on micro- and macroscale biodegradation studies, confirming an enrichment 
of R-(-)-METH during biological treatment (Bagnall et al., 2013; Xu et al., 2017). The same 
was shown for MDMA, whereby R-(-)-MDMA was enriched in treated wastewater effluent at 
WWTW2 and therefore, less effectively removed during treatment (Fig. 5.2A). This result has 
been confirmed in microcosm studies where stereoselective biodegradation was shown to 
favour the degradation of the S-enantiomer (Evans et al., 2016). The reason why removal of 
MDMA did not show the same trend for WWTW1 can be ascribed by the limited number of 
detections within raw- and treated effluent wastewater during the sampling campaign 
(APPENDIX, Table C1). In addition, AS may also provide biological catalysts which may 
cause chiral inversion. This has been shown for some chiral compounds (Hashim and Khan, 
2011; Neirinckx et al., 2011; Reist et al., 1998), but not for the drugs detected during the current 
study. Ketamine showed moderate- to negative removal during WWTW treatment at both study 
sites (Fig. 5.2B), which is in agreement with other studies (Baker and Kasprzyk-Hordern, 2011) 
and warrants this compound as a priority EC to assess its potential risk environmental risk. 
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Figure 5.2: Removal (%) of illicit drugs (A) and other drugs of abuse and human indicators (B) during 
wastewater treatment. Error bars represent the lowest- and highest recorded removal for each compound 
during sampling. nd – not determined. 
 
For the prescription and OTC drugs (including ketamine), distinctions could not be made 
between their general use apart from their potential abuse within the communities due to the 
unavailability of a unified pharmacological prescription database for the country (currently 
divided into the public- and private health sector). Regardless of this, influent wastewater 
samples revealed high concentrations of the opiates codeine and morphine up to μg.L-1 levels 
(APPENDIX, Table C1 and C2). Codeine concentrations in raw influent wastewater for 
WWTW1 ranged between 1 712.2 and 2 619.5 ng.L-1 (APPENDIX, Table C1), and for 
WWTW2 between 1 663.2 and 20 567.7 ng.L-1 (APPENDIX, Table C2) compared to measured 
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codeine concentrations at a maximum concentration of 5 200 ng.L-1 in other parts of the world 
(summarised in Thai et al., 2016). These results highlight the extent of codeine use and potential 
abuse within the current study areas. Attempts to estimate codeine abuse through wastewater-
based epidemiology (WBE) have proven troublesome, as unified and/or refined excretion- and 
stability correction factors are lacking for the drug, as well as the inability to distinguish from 
its therapeutic use (at least for the current study).  
 
Establishing the source of opiates and their metabolites are complex for urban water profiling, 
as these drugs are metabolised into one another (Fig. 5.3), whereby the metabolites are also 
used for prescription medications. For example, heroin administration will predominantly be 
excreted as morphine in the body, whereas morphine may also be derived from the metabolism 
of codeine or through administration of itself (Fig. 5.3). Morphine concentrations in raw 
influent wastewater for WWTW1 ranged between 291.8 and 407.2 ng.L-1 (APPENDIX, Table 
C1), and for WWTW2 between 761.1 and 9 379.7 ng.L-1 (APPENDIX, Table C2), which once 
again, are high compared to similar case studies around the world (Baker et al., 2014; 
Castrignanò et al., 2016; Causanilles et al., 2017). Furthermore, during wastewater treatment, 
hydrocodone was detected in treated effluent wastewater, but not in raw influent at both 
WWTWs (APPENDIX, Table C5 and C6). Although hydrocodone serves as an active 
ingredient for some pharmaceutical prescriptions, the current findings suggest that this 
compound was rather derived from codeine metabolism driven by microbial bio-degradation 
within WWTW processes. For example, enzyme isolates from environmental bacterial strains, 
such as morphinone reductase isolated from Pseudomonas putida, has been described to result 
in the conversion of morphine and codeine to hydromorphone and hydrocodone respectively 
(French and Bruce, 1994), whereby such organisms are able to utilise these compounds as a 
sole nutrient source. Furthermore, high codeine degradation is proposed to be driven by 
ammonia-oxidising bacteria under anaerobic conditions (Falås et al., 2016). Within the aqueous 
phase of RAS samples in the current study, the concentrations of hydrocodone were higher 
than for codeine, ranging from 40.8 to 60.2 ng.L-1 at WWTW1 and from 89.7 to 318.2 ng.L-1 
at WWTW2, as opposed to average concentrations of codeine calculated at 2.8-274.6 ng.L-1 
and 6.6-15.1 ng.L-1 at WWTW1 and WWTW2 respectively (APPENDIX, Tables C9 and C10). 
The single high concentration for codeine on the Sunday sample at WWTW1 was just after the 
plant experienced a treatment downtime on the Saturday (further discussed below), which is 
therefore proposed to have led to inefficient degradation of codeine (APPENDIX, Table C9). 
Interestingly, the concentration of hydrocodone was not lower during the same day as expected. 
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It should be highlighted that the concentrations of codeine within raw sewage was also at its 
highest for the Sunday sample (APPENDIX, Table C1), which suggest that the degradation of 
codeine and eventual formation of hydrocodone are influenced by ‘fresh’ compounds entering 
the plant, as well as low levels of codeine being re-circulated during AS treatment (from RAS). 
Regardless of the various metabolic pathways which opiates may follow, both parent- and their 
respective metabolites were removed with high efficiency at both WWTWs (Fig. 5.2B). It 
should be noted, however, that such removal estimations are based on the comparisons of the 
drug levels in raw- and treated wastewater effluent, whereby the risk of the residual load after 
treatment should still be determined. More discussion on this will follow in the risk assessment 
section below. 
 
 
Figure 5.3: Metabolic pathways for the three main opiates and oxycodone and the associated enzymes 
driving their metabolism in humans. CYP – cytochrome-P450. 
 
The two pharmaceutical compounds which ranged from moderate- to negative removal during 
the current study include the opioid drug TRAM, the anti-depressant drug VEN and their 
primary metabolites (Fig. 5.2B). TRAM and its primary metabolite, O-desmethyltramadol (O-
DMT) were moderately removed at WWTW1, whereas the removal at WWTW2 for TRAM 
was stereo-selective, but generated the same removal profile for O-DMT between the study 
sites (Fig. 5.2B). VEN showed an overall negative mass balance during treatment at WWTW1, 
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whereas its metabolite, desmethylvenlafaxine (DMV) was moderately removed (Fig. 5.2B). 
Removal of VEN and DMV at WWTW2 showed an opposite result, whereby VEN removal 
was slightly negative- to low, and DMV was negatively removed on average during the 
sampling campaign (Fig. 5.2B). Negative removal has been largely attributed to two 
contributing factors; 1) the high tendency of both compounds to sorb onto particulate matter, 
from which desorption into the aqueous phase may occur periodically during primary 
clarification, and 2) biological de-conjugation or re-methylation processes during wastewater 
treatment, leading towards a build-up of the parent compound at the treated effluent (Blair et 
al., 2015; Subedi and Kannan, 2014). The current study further suggests that such recalcitrant 
compounds which are known to have a strong association with solids are constantly 
recirculated within RAS, from which desorption from the solid matrix and increased contact 
time with anaerobic digestion may largely contribute towards its pseudo-persistence 
throughout sampling days. 
 
Both TRAM and VEN undergo desmethylation metabolism into their primary metabolites, 
which are shown to be predominantly driven by anaerobic digestion, and not aerobic, in AS 
treatment (Baalbaki et al., 2017; Falås et al., 2016; Gasser et al., 2012; Kasprzyk-Hordern and 
Baker, 2012a). However, significant degradation under anaerobic conditions mostly require 
long residence times (14 days), which are not necessarily feasible for WWTW treatment. The 
average negative removal of VEN during WWTW1 treatment may well be due to a difference 
in sludge maturity and residence times. Also, a municipal power outage (which will be further 
discussed later) could also have impacted the overall performance of the plant. As de-
methylation does in fact lead to the degradation of VEN, it may inversely lead to the build-up 
of DMV during treatment, which is shown by the negative mass balances of DMV estimated 
for WWTW2 (Fig. 1B). However, as both VEN and TRAM remain within the wastewater 
treatment system (within RAS), their pseudo-persistence may compromise daily estimations of 
removal. Enantiomeric profiling of VEN and DMV within the aqueous phase of RAS showed 
a racemic mixture for VEN (average EF = 0.5 ±0.02; Fig. 5.4C & D), and slight 
stereoselectivity for DMV (average EF = 0.6 ±0.01; Fig. 5.4C & D) at both WWTWs. On 
average, the concentrations of a racemic mixture of DMV compared to VEN were 3.9 times 
more in RASliquid samples for WWTW1 and 4.2 times more for WWTW2. In raw wastewater 
samples, DMV/VEN ratios were 8.3 and 3.0 for WWTW1 and WWTW2 respectively, 
suggesting further desmethylation metabolic processes during AS treatment for WWTW2, but 
rather high possible de-methylation processes within sewage prior to treatment at WWTW1 
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(in-sewer degradation). This is supported by the fact that a racemic DMV concentration were 
similar between raw influent and RASliquid samples for WWTW1, but rather 1.8 times higher 
in RASliquid samples than raw influent wastewater for WWTW2. These results imply that 
although recalcitrant compounds such as VEN and its metabolite are returned into the treatment 
steps (hence increasing residence time for their removal), their continued persistence and 
regular input into raw sewage will compromise the removal during the overall treatment 
process.  
 
 
Figure 5.4: Concentrations (ng.L-1) and enantiomeric fractions (EF) of venlafaxine (A & B), 
desmethylvenlafaxine (DMV; C & D) and tramadol (E & F) within the aqueous phase of return 
activated sludge (RAS). 
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It should be noted that the treatment performance of WWTW1 were compromised during the 
weekend period of the current sampling campaign. A clear spike in the loads of BEG, S-(+)-
METH, ephedrines, codeine, caffeine, 1,7-dimethylxanthine and cotinine were observed on the 
Sunday in the treated wastewater effluent (APPENDIX, Table C5 and C7) - all compounds 
which are known to be effectively degraded during AS treatment. During the Saturday, the 
plant experienced a municipal power outage, which led to a downtime in the treatment 
modules. The flow from the effluent discharge was still maintained, which led to a sampling 
day whereby wastewater were not treated before discharged into the recipient river system. 
Interestingly, the loads of O-DMT and DMV were significantly lower during Saturday and 
Sunday in treated effluent compared to the other sampling days, but not for the parent TRAM 
and VEN (Fig. 5.5). This may suggest a decrease in desmethylation metabolic activities during 
treatment downtime, leading to reduced degradation of TRAM and VEN into their primary 
metabolites. On the other hand, both TRAM and VEN are known to have high sorption affinity 
to solids (Baalbaki et al., 2017; Boix et al., 2016). As a consequence of the treatment module 
downtime, the solid particulate matter (SPM) within AS treatment settled down, which may 
have retained these compounds; explaining why they were not detected at higher 
concentrations in treated effluent. Overall, the concentrations in treated effluent from WWTW1 
were 347.0 – 687.5 ng.L-1 for TRAM, 157.1 – 905.1 ng.L-1 for O-DMT, 78.2 – 148.9 ng.L-1 
for VEN, and 167.4 – 691.0 ng.L-1 for DMV (APPENDIX, Table C5). For WWTW2, 
concentrations in treated effluent were 1155.5 – 1514.0 ng.L-1 for TRAM, 1141.0 – 1949.5 
ng.L-1 for O-DMT, 159.0 – 206.9 ng.L-1 for VEN, and 513.1 – 955.2 ng.L-1 for DMV 
(APPENDIX, Table C6). The chiral signature for TRAM and VEN were both racemic for 
influent and effluent samples at the WWTWs (Fig. 5.5), which suggest no enantio-selective 
degradation during treatment. The EF for DMV also did not differ between influent and effluent 
samples for both study sites (Fig. 5.5). However, the chiral signature for DMV showed slight 
stereo-selectivity, with EFs of 0.62 (±0.01) and 0.64 (± 0.01) in influent and effluent samples 
respectively at WWTW1, and 0.63 (±0.02) and 0.61 (± 0.02) in influent and effluent samples 
respectively for WWTW2 (Fig. 5.5). This suggest that DMV degradation is also not enantio-
selective during wastewater treatment, but rather emphasise the need to establish its enantio-
selective toxicity for refined risk assessment purposes.  
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Figure 5.5: Mass loads (g.day-1) and enantiomeric fractions (EF) of venlafaxine, desmethylvenlafaxine (DMV) and tramadol within raw influent- and treated 
effluent wastewater samples from the two study sites.
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5.3.2. River water 
Compounds removed with high efficiency at WWTW1 and thus discharged at low 
concentrations from treated wastewater, such as the human markers caffeine, nicotine and their 
metabolites, were overall detected at higher concentrations in downstream samples during the 
sampling period (APPENDIX, Table C12). This was especially true for samples collected on 
Monday, with a clear spike in the concentrations of COC, BEG, S-(+)-METH, ephedrines, 
codeine, caffeine, 1,7-dimethylxanthine, and cotinine compared to the rest of the sampling days 
(APPENDIX, Table C12). This result is in accordance to the observed spike in the same 
compounds within treated effluent wastewater on the previous day (Sunday) (APPENDIX, 
Table C5 & C7). Even though the downstream sample was taken 3.5 km from the point of 
discharge (Fig. 5.1), it is possible that the pollutant load originated from this WWTW discharge 
event. However, the average concentrations of S-(+)-METH in effluent wastewater was 
calculated at 27.5 ng.L-1 in comparison to 29.0 ng.L-1 for the downstream samples, which were 
not significantly different. Assuming the high loads in treated effluent was a result for the loads 
on the following day in the downstream sample, the fold change in S-(+)-METH were still 1.2 
(higher in downstream). It is therefore unlikely that the discharge from wastewater would still 
have resulted in the high loads of S-(+)-METH at least in the downstream sample, taken the 
long distance between the sampling points (Fig. 5.1), as well as the known stereo-selective 
biodegradation of S-(+)-METH over R-(-)-METH (Bagnall et al., 2013). The average 
concentration of S-(+)-METH during the sampling campaign was further shown to be 18 times 
higher in the downstream samples than upstream river water (Table 5.2), from which S-(+)-
METH was removed with relatively high efficiency during wastewater treatment (Fig. 5.2A). 
As this compound is known to be the primary enantiomer of illicit drug use, the current results 
suggest that this compound is either excreted or directly disposed from an additional source 
downstream from the WWTW. Interestingly, the same result of higher DTRs in downstream 
than treated effluent discharge was shown in a similar sampling campaign done at the WWTW 
during 2015 (Archer et al., 2017b), when the WWTW did not experience any treatment failures. 
Overall, 25 of the 38 target compounds screened for during the current study were detected in 
river water associated with WWTW1, whereby 23 of the compounds were detected at 
concentrations two-fold and higher in downstream samples (Table 5.2). 
 
For river water samples associated with WWTW2, the opposite was observed than for the 
WWTW1 study site, whereby the concentrations of the analytes for upstream river water 
samples were higher than downstream water samples (Table 5.2). It is worth to mention that 
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the plant discharges a large percentage of its treated effluent into maturation ponds for reuse 
due to the ongoing droughts in the region, although the ratio of treated wastewater discharge 
into maturations ponds compared to river discharge could not be verified. The distance between 
upstream- and downstream sampling sites at WWTW2 was much shorter than for WWTW1 
(300m as opposed to 4km), thus less time for degradation of the target analytes between these 
two sampling points. Regardless, the compounds which were detected at higher concentrations 
in downstream than upstream samples were R-(-)-METH, R-(-)-MDMA, VEN and DMV 
(Table 5.2), which were also reported to be less removed during wastewater treatment (Fig. 
5.2). In particular, METH and MDMA were the two chiral drugs that were shown to undergo 
stereoselective degradation during wastewater treatment, leading to an enrichment of the R-
enantiomers in treated wastewater. As opposed to these recalcitrant compounds, TRAM and 
O-DMT, which also showed low- to moderate removal during wastewater treatment were not 
detected at higher concentrations in downstream samples (Table 5.2), which may suggest other 
contributing factors that may lead to their sorption onto sediment rather than persisting in the 
aqueous phase of environmental waters (although the same would have been assumed for VEN 
and DMV). Another interesting observation was the detection of the minor metabolite of 
heroin, O-6-MAM, during two sampling days in upstream water, along with concentrations of 
S-(+)-METH which were higher than the concentrations measured for treated sewage effluent 
(APPENDIX, Table C13). Therefore, similar to the results observed for river water associated 
with WWTW1, the higher concentrations of most target analytes within upstream samples from 
WWTW2 suggests alternative pollution or possible dumping of sewage into the river system, 
as this river system passes directly through both formal- and informal domestic housing.  
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Table 5.2: Concentrations (ng.L-1) of the DOA within river water located upstream and downstream from WWTW1 and WWTW2.  
Chemical 
River associated with WWTW1 River associated with WWTW2 
Upstream Downstream Fold 
Change* 
Upstream Downstream Fold 
Change* Average Min - Max Average Min - Max Average Min - Max Average Min - Max 
Illicit drugs                   
Cocaine ND 5.2    - 1.0 0.6 - 1.6 0.8 0.4 - 2.1 0.8 
Benzoylecgonine 3.3 2.7 - 3.7 10.7 5.4 - 34.9 3.2 20.6 14.2 - 28.7 20.1 13.2 - 31.0 1.0 
R-(-)-methamphetamine 4.8 3.2 - 5.8 20.0 10.7 - 33.1 4.2 14.1 6.1 - 25.9 18.5 9.6 - 28.3 1.3 
S-(+)-methamphetamine 1.6 0.8 - 5.0 29.0 1.7 - 178.8 18.1 218.7 137.9 - 465.2 113.3 73.5 - 206.1 0.5 
Methamphetamine-rac 6.3 4.2 - 10.8 49.0 12.4 - 210.5 7.8 232.7 144.2 - 491.1 131.8 81.3 - 234.4 0.6 
R-(-)-MDMA ND ND - 0.7 0.4 - 1.2 2.1 0.7 - 4.6 3.0 
S-(+)-MDMA ND ND - 0.3 0.2 - 0.4 ND - 
MDMA-rac - - - 0.9 0.6 - 1.5 - - 
Precursors                   
1S,2R-(+)-ephedrine 0.6 0.7 - 1.1 1.8 1.2 - 3.1 3.0 ND ND - 
1R,2S-(-)-ephedrine/1R,2R-(-)-
pseudoephedrine 
19.4 16.9 - 22.9 42.6 20.1 - 142.6 
2.2 
28.8 26.2 - 35.9 30.9 24.3 - 35.1 
1.0 
1S,2S-(+)-pseudoephedrine 3.9 3.1 - 5.6 19.2 5.3 - 46.2 4.9 12.5 9.2 - 20.1 13.1 11.6 - 14.4 1.0 
E1-Norephedrine ND 3.1 1.9 - 5.4 - ND 1.7 0.7 - 2.4 - 
E2-Norephedrine ND  ND   - ND  ND   - 
Opioids          
O-6-MAM ND ND - 14.6 11.7 - 17.5 ND - 
Morphine ND ND - 64.1 54.8 - 80.0 30.2 19.5 - 55.1 0.5 
Codeine 5.6 4.1 - 9.4 50.3 4.3 - 217.5 9.0 42.1 29.4 - 51.4 27.6 16.3 - 35.8 0.7 
Hydrocodone 4.7 4.3 - 5.2 ND - 16.6 13.7 - 18.6 ND - 
E1-tramadol 37.6 21.3 - 54.3 128.1 55.6 - 196.2 3.4 1137.2 881.4 - 1458.9 705.7 494.7 - 974.8 0.6 
E2-tramadol 30.8 15.3 - 44.6 98.6 38.6 - 149.3 3.2 829.8 594.0 - 1076.7 505.1 368.5 - 647.5 0.6 
Tramadol-rac 68.4 36.6 - 98.9 226.7 94.2 - 345.5 3.3 1967.0 1475.4 - 2535.6 1210.7 863.2 - 1622.3 0.6 
O-DMT 61.1 51.9 - 73.2 257.3 62.9 - 410.1 4.2 2573.5 2221.5 - 2824.7 1753.7 1394.4 - 2100.6 0.7 
Anti-depressants                   
E1-venlafaxine 6.2 2.5 - 8.9 27.9 14.4 - 47.9 4.5 35.0 24.7 - 46.8 61.1 37.2 - 104.5 1.7 
E2-venlafaxine 5.6 2.5 - 7.8 21.7 10.9 - 37.2 3.9 41.1 31.4 - 54.6 49.4 26.9 - 83.4 1.2 
Venlafaxine-rac 11.8 5.0 - 16.7 49.6 25.3 - 85.1 4.2 76.1 56.1 - 101.4 110.6 64.1 - 187.9 1.5 
E1-DMV 36.5 12.1 - 52.2 107.4 24.0 - 187.3 2.9 227.5 110.9 - 347.8 256.2 153.8 - 423.4 1.1 
E2-DMV 24.2 9.0 - 34.4 64.1 14.8 - 106.2 2.6 108.7 48.3 - 173.0 135.2 84.3 - 241.0 1.2 
DMV-rac 60.7 21.1 - 85.7 171.5 39.5 - 293.5 2.8 336.1 159.2 - 506.9 391.3 238.1 - 664.4 1.2 
Anaesthetics                   
Ketamine 2.3 1.6 - 2.9 13.5 3.8 - 28.3 5.9 7.8 6.6 - 9.1 5.9 3.9 - 7.9 0.8 
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Table 5.2 (continued)                   
Human markers                   
Caffeine 541.2 104.4 - 1100.0 3289.0 113.0 - 21130.9 6.1 2293.7 1313.4 - 4316.1 1105.6 187.3 - 1894.4 0.5 
1.7-DMX 592.5 165.1 - 1298.5 3632.3 216.5 - 21464.9 6.1 9654.9 4196.1 - 15027.0 4089.8 1308.5 - 6130.5 0.4 
Nicotine 139.1 16.6 - 312.4 241.4 60.1 - 438.2 1.7 1645.9 553.3 - 4332.2 1956.4 280.6 - 7007.5 1.2 
Cotinine 28.6 14.8 - 48.5 71.6 24.0 - 268.4 2.5 293.2 169.6 - 473.4 156.2 46.3 - 297.3 0.5 
*Differences in the average concentrations of the analytes between upstream and downstream samples. Fold change > 1 = higher concentration in downstream water.  
Abbreviations: O-6-MAM, O-6-monoacetylmorphine; O-DMT, O-desmethyltramadol; DMV, desmethylvenlafaxine; 1,7-DMX, 1,7-dimethylxanthine; ND, not detected
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5.3.3. Risk assessment 1 
The formulation to conduct conventional risk assessment has been previously discussed (see 2 
Chapter 4). Based on the generated risk quotients (RQs), a RQ < 0.1 was considered low risk, 3 
between 0.1 and 1.0 a medium risk, and above 1.0 as a high risk (Hernando et al., 2006). These 4 
RQs were determined using predicted no-effect concentrations (PNECs) generated from 5 
literature showing lethal toxicity for the most sensitive test species (either algae, cladocerans 6 
or fish) (Bergmann et al., 2011; Deo, 2014; Mendoza et al., 2014; Minguez et al., 2016). From 7 
the assessed target analytes during the current study, the compounds which showed the most 8 
pronounced lethal toxicity risk were TRAM, codeine and nicotine, having high RQs for both 9 
treated wastewater effluent and river water at both study sites (Table 5.3). For VEN, a medium 10 
risk was calculated for the surface waters and treated effluent wastewater from both study sites, 11 
whereas the other analytes were considered a low risk for lethal toxicity endpoints (Table 5.3). 12 
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Table 5.3: Environmental risk screening based on acute predicted no-effect concentration (PNEC) toxicity data on the most sensitive evaluated test species in 
literature (algae, cladocerans or fish). Risk quotients (RQ) were measured for the minimum and maximum measured environmental concentration (MEC; 
ng.L-1; range, min and max) determined for each analyte within WWTW effluent (eff) and surrounding environmental waters (rw).  
* Low risk, ** median risk, *** high risk based on RQ values (Hernando et al., 2006) 
# Average measured concentration of the compounds in river water samples (upstream and downstream from the WWTW) 
Compound 
PNEC 
(ng/L) 
Reference 
WWTW1 WWTW2 
MECeff 
(ng/L) 
RQeff 
MECrw 
(ng/L)# 
RQrw 
MECeff 
(ng/L) 
RQeff 
MECrw 
(ng/L)# 
RQrw 
Tramadol 320.0 Bergmann et al., 2011 
511.7 
(341.6-714.8) 
1.1-2.2 
*** 
147.6 
(36.6-345.5) 
0.1-1.1 
** - *** 
1308.8 
(1142.8-1646.4) 
3.6-5.1 
*** 
1588.9 
(863.2-2535.6) 
2.7-7.9 
*** 
Methamphetamine 1970.0 Mendoza et al., 2014 
66.4 
(28.7-212.2) 
<0.1 
* 
27.7 
(4.2-210.5) 
<0.1 
* 
143.7 
(118.3-182.5) 
<0.1 
* 
182.2 
(81.3-491.1) 
<0.1 
* 
Venlafaxine 322.0 Minguez et al., 2016 
108.1 
(78.2-148.9) 
0.2-0.5 
** 
30.7 
(5.0-85.1) 
<0.1-0.2 
* - ** 
191.3 
(182.4-206.9) 
0.6 
** 
93.3 
(56.1-187.9) 
0.2-0.6 
** 
Ketamine 720.0 ECOSAR 
23.9 
(6.0-63.6) 
<0.1 
* 
7.9 
(1.6-28.3) 
<0.1 
* 
3.7 
(2.1-6.0) 
<0.1 
* 
6.8 
(3.9-9.1) 
<0.1 
* 
Morphine 93.0 Mendoza et al., 2014 - - - - 0.1 
<0.1 
* 
47.1 
(19.5-80.0) 
0.2-0.9 
** 
Cocaine 2280.0 Mendoza et al., 2014 0.6 
<0.1 
* 
5.4 
<0.1 
* 
1.1 
(0.6-2.7) 
<0.1 
* 
0.9 
(0.4-2.1) 
<0.1 
* 
Benzoylecgonine 4900.0 ECOSAR 
19.0 
(9.0-54.0) 
<0.1 
* 
7.6 
(2.7-34.9) 
<0.1 
* 
40.1 
(27.7-57.8) 
<0.1 
* 
20.4 
(13.2-31.0) 
<0.1 
* 
Codeine 60.0 ECOSAR 
61.4 
(8.4-150.6) 
0.1-2.5 
** - *** 
30.0 
(4.1-217.5) 
0.1-3.6 
** - *** 
53.6 
(14.3-96.3) 
0.2-1.6 
** - *** 
34.8 
(16.3-51.4) 
0.3-0.9 
** 
Nicotine 14.0 Bergmann et al., 2011 
340.1 
(73.3-715.3) 
5.2-51.1 
*** 
190.2 
(16.6-438.2) 
1.2-31.3 
*** 
932.5 
(246.5-1759.5) 
17.6-125.7 
*** 
1801.2 
(280.6-7007.5) 
20.0-500.5 
*** 
MDMA 216.0 Mendoza et al., 2014 0.3 
<0.1 
* 
- - 
5.8 
(2.8-11.0) 
<0.1 
* 
1.5 
(0.6-4.6) 
<0.1 
* 
Caffeine 490 000.0 Deo, 2014 
3837.2 
(96.0-
23732.5) 
<0.1 
* 
1915.1 
(104.4-21330.9) 
<0.1 
* 
393.4 
(171.0-864.4) 
<0.1 
* 
1699.7 
(187.3-4316.1) 
<0.1 
* 
Cotinine 520 000.0 Deo, 2014 
92.5 
(27.6-331.0) 
<0.1 
* 
50.1 
(14.8-268.4) 
<0.1 
* 
56.5 
(27.5-104.3) 
<0.1 
* 
224.7 
(46.3-473.4) 
<0.1 
* 
Ephedrine 3620.0 Mendoza et al., 2014 
41.8 
4.2-217.5) 
<0.1 
* 
14.6 
(0.7-142.6) 
<0.1 
* 
40.3 
(11.1-63.8) 
<0.1 
* 
21.3 
(9.2-35.9) 
<0.1 
* 
O-6-MAM 1340.0 Mendoza et al., 2014 - - - - - - 
14.6 
(11.7-17.5) 
<0.1 
* 
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Apart from reports showing lethal toxicity risks, the potential of the target analytes to exert sub-
lethal adverse health effects are discussed below. These outcomes are more representative on 
the potential long-term health effects of the pollutants through continued daily exposure rather 
than sporadic events which may lead to acute and/or chronic lethal toxicity. As an effect sub-
lethal toxicity endpoints are also more useful to represent toxicity for higher vertebrates other 
than using invertebrate and/or microbial test organisms. 
 
Toxicity of illicit drugs 
Illicit substances are not generally regarded as priority ECs for risk assessment. However, some 
studies included cocaine (COC) in toxicological studies. COC concentrations as low as 40 ng.L-
1 showed a significant decrease in lysosomal stability and increased DNA damage in hemocytes 
of the Zebra mussel, Dreissena polymorpha (Binelli et al., 2012). Furthermore, higher 
concentrations during the same study (220 and 10 000 ng.L-1) led to a further increase in 
cytotoxicity and genotoxicity. During the current study, no wastewater effluent or 
environmental surface water samples reached these concentrations for possible toxicity. It 
should be noted that only a portion of consumed COC will be excreted unmetabolised in sewage 
(1-9%), while the majority will be found as primary metabolites such as BEG (Baselt, 2004). 
BEG was frequently detected above 40 ng.L-1 in wastewater effluent from both study sites (up 
to 57.5 ng.L-1; Table 3). Similar to the study for COC, BEG at concentrations of 500 ng.L-1 
showed an increase in oxidative stress, as well as increased cytotoxicity of hemocytes in D. 
polymorpha (Parolini et al., 2013). More recently, BEG exposure as low as 11.5 ng.L-1 showed 
DNA damage and slight oxidative stress in Zebrafish embryos (Danio rerio), as well as other 
cyto-genotoxic endpoints at concentrations of 115 ng.L-1 (Parolini et al., 2017). Furthermore, 
the authors concluded that BEG pose a higher cyto-genotoxicity risk than COC in their 
combined analysis with the D. rerio embryos. Even though the information is still relatively 
limited, there is thus increasing evidence that metabolic breakdown products have significant 
adverse health effects apart from their parent counterparts, emphasising the need to also include 
them for risk assessment.  
 
The modulation of neuroendocrine system has also been reported for laboratory animals and 
aquatic vertebrates. Exposure of methamphetamine to rats under laboratory conditions resulted 
in increased corticosterone release, as well as decreased dopamine levels in the brain of exposed 
animals compared to controls (Herring et al., 2010).  Methamphetamine has further been shown 
to induce mating behaviour in male sailfin molly fish (Poecilia latipinna), from which such 
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elevated sexual behaviour was attributed to the modulation of monoamine levels in the brain 
and disruption of other dopaminergic pathways (Ghazilou and Ghazilou, 2011). The influence 
of monoamines to control gonadotropin release in the vertebrate brain are well known (Waye 
& Trudeau, 2011). As an effect, the modulation of neurotransmitter release (including 
monoamines) through environmental exposure of psychoactive stimulants such as 
methamphetamine may not only affect physiological pathways associated with cognitive 
function and behaviour, but also potentially modulate the early onset of the control in gonadal 
endocrine system pathways.  
 
Toxicity of Opioids 
Although conventional risk assessment shows a low environmental risk for morphine, based on 
lethal toxicity endpoints (Table 5.3), sub-lethal toxicity endpoints have been ascribed for 
morphine exposure. A strong association with observed endocrine modulations in laboratory 
animals and humans have been drawn following opioid administration, especially for morphine 
(Vuong et al., 2010). In particular, morphine exposure to female rats caused a polycystic 
morphology of ovaries, decreased intact brain neurons (Karimi et al., 2017), as well as other 
undesired endocrine system modulations, including altered growth- and thyroid-stimulating 
hormone levels, and decreased steroid hormone levels (Vuong et al., 2010). Even though 
endocrine-disrupting endpoints on aquatic wildlife have received little attention, the potential 
genotoxicity which could be caused by opioids should also not be ignored. For example, 
morphine exposure in mice has been linked to increased incidence of micro-nucleated bone 
marrow erythrocytes in a dose-dependent manner (Puli and Patil, 2007). From these results, the 
potential of opiates, such as morphine, to modulate endocrine systems and to cause genotoxicity 
in exposed aquatic surface waters should receive priority. Taken that metabolism of codeine 
and heroin use also lead to the formation of morphine and its derivatives highlights the need for 
combined mixture risk assessment, as the combination of these opiates may have synergistic, 
potentiating or additive mixture interactions. This warrants the need to include these 
compounds as priority ECs for risk assessment monitoring, especially due to their regular 
detection within surface waters as highlighted within the current study. Apart from their 
potential adverse risks to wildlife and human health exposed to contaminated surface waters, 
the abuse of these substances in communities are also of a socio-economic concern. In 
particular, the abuse of common over-the-counter (OTC) medications, such as codeine, are 
globally well reported to be on the rise, with South Africa being no exception (Parry et al., 
2017). However, substance abuse data is limited to treatment centre data in the country, which 
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may be subjective. Therefore, the use of urban water profiling may well assist with opioid use 
estimations, given that more sufficient prescription databases become available for the country.  
 
The widespread use of TRAM for pain relief, as well as its reported abuse necessitates the 
continued monitoring for its presence and fate in surface waters. TRAM has also been 
associated with variable toxicological risks to aquatic ecosystems. Acute exposure to Danio 
rerio eggs at a concentration of 10 μg.L-1 has been shown to cause hatching retardation, but 
with no mortality (Sehonova et al., 2016). Chronic exposure (21 days) of common carp 
(Cyprinus carpio) larvae to TRAM at 10 μg.L-1 lead to a retardation in total body length 
development (Sehonova et al., 2016). The authors concluded that the lowest-observed effect 
concentration (LOEC) of 10 μg.L-1 can significantly influence development of fish during early 
ontogeny (Sehonova et al., 2016). However, monitoring studies have shown that this compound 
is not detected at such high concentrations in environmental surface waters, including the 
current study. Although TRAM itself does not lead to significant high levels in surface waters 
to affect aquatic vertebrate development, as shown by Sehonova and colleagues (2016), it 
should also be pointed out that its primary metabolites are also regularly detected in wastewater 
effluent and surface waters. It is still unclear though, whether these metabolites may pose an 
additive toxicological effect with its parent counterpart. However, it is reported that O-DMT 
has higher affinity for opiate receptors than TRAM itself (de Jongh et al., 2012), making this a 
much more potent EC than the parent compound. The recalcitrance of TRAM and O-DMT 
during wastewater treatment, consequently leading to their pseudo-persistence in discharged 
effluent, warrants the need for future investigation into the possible mixture interaction of such 
a chemical with other recalcitrant pollutants with similar physiological modes of action for 
aquatic wildlife.  
 
Concerning human health risks, a study by de Jongh and colleagues (2012) aimed at 
establishing a provisional drinking water guideline value (pGLV) for a combined mixture of 
TRAM and O-DMT by considering daily therapeutic doses, acceptable daily intake (ADI) 
and/or tolerable daily intake (TDI) estimations. The authors concluded that a threshold of 6 
μg.L-1 should be considered for a combined parent/metabolite risk for human health. During 
the current study, the highest combined TRAM/O-DMT concentrations were 1.35 and 3.46 
μg.L-1 in treated wastewater effluent from WWTW1 and WWTW2 respectively, whereas 
highest concentrations in river water was recorded at 0.76 and 5.3 μg.L-1 at the respected study 
sites. This implicates that river water from at least one study site were close to this threshold to 
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potentially impact human health. As with the opiates, the risk of TRAM has not only been 
associated with aquatic toxicology, but is also highlighted as a licit DOA. Urban water profiling 
for TRAM will therefore not only provide further information to show the extent of drug abuse 
within communities associated with the sewage network, but also for source tracking to show 
alternative pollution other than wastewater discharge due to its recalcitrance within surface 
waters. 
 
Toxicity of venlafaxine 
Studies showing potential sub-lethal toxicity of VEN in aquatic vertebrates generated much 
lower effect-concentrations than reported for TRAM. Chronic exposure of VEN to male fathead 
minnows (Pimephales promelas) at a concentration of 305 ng.L-1 has been shown to result in 
40% mortality of the test organisms (Schultz et al., 2011). Exposure of VEN to rainbow trout 
(Oncorhynchus mykiss) at a concentration as low as 260 ng.L-1 led to a significant reduction in 
the dopamine metabolism within the brain, whereas a concentration of 1 020 ng.L-1 significantly 
modulate brain neuroendocrine pathways (Melnyk-Lamont et al., 2014). In Danio rerio, VEN 
exposure of 500 ng.L-1 showed a reduction in plasma estradiol (E2) concentrations in female 
fish and a reduction in plasma 11-ketotestosterone concentrations in male fish (Galus et al., 
2013b). These results highlight the possibility of VEN to not only modulate neuroendocrine 
responses in aquatic species at environmentally relevant concentrations, but also pose a risk 
towards the modulation of reproductive endocrine systems. Such adverse health risks may be 
extrapolated to higher vertebrates, including humans, subjected to chronic exposure to water 
resources containing low levels of the drug, as VEN may bio-accumulate within tissues. During 
the current study, daily detected concentrations for a racemic mixture of venlafaxine within 
both upstream and downstream water samples ranged between 5.0 to 85.1 ng.L-1 at WWTW1, 
and 56.1 to 187.9 ng.L-1 at WWTW2 (Table 5.3). These concentrations are well below the lethal 
toxicity levels of 305 ng.L-1 for P. promelas, but still close to reported levels studied by Melnyk-
Lamont and colleagues (2014) to modulate the levels of monoamine neurotransmitters in other 
fish species.  
 
Considering that metabolism of VEN leads to the formation of a pharmacologically active 
metabolite (DMV), it would be feasible to consider DMV for risk assessment as well. Also, 
DMV showed a slight enrichment of one enantiomer in its chiral signature in treated wastewater 
(EF = 0.61 – 0.64 ±0.02) and environmental waters (EF = 0.61 – 0.67 ±0.02) at both study sites, 
which warrants the need to establish its enantio-specific toxicity on aquatic wildlife and/or 
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human health. However, such toxicity data are highly limited for most chiral compounds, 
although such stereo-specific toxicities are known for other anti-depressants such as fluoxetine 
(Evans et al., 2017). An additional consideration is the potential added mixture effect that VEN 
and DMV may have on aquatic- and human health, as DMV was shown to be present at higher 
concentrations in surface waters compared to VEN (Table 5.3). Global monitoring studies have 
shown a similar result in that DMV are present more than two-fold in surface waters compared 
to VEN (Evans et al., 2017). During the current study, concentrations of a racemic mixture of 
DMV ranged between 21.1 to 293.5 ng.L-1 at WWTW1, and 159.2 to 664.4 ng.L-1 at WWTW2 
(Table 5.3). These levels are close to- or within the reported lethal toxicity levels shown for 
VEN, and also within the range showing neuroendocrine and steroidogenesis modulation in 
fish. The toxicity of DMV has not been established in a similar manner than for its parent 
compound in vertebrates. However, given the fact that several pharmaceutical metabolites are 
primarily responsible for the desired physiological effect, the presence of both pharmaceutical 
parent compounds and metabolites in surface water systems should be considered for risk 
assessment approaches (de Jongh et al., 2012). As for TRAM risk assessment for human health, 
estimated pGLV for a VEN and DMV mixture was calculated at 19 μg.L-1 (de Jongh et al., 
2012). However, this value is much higher than any combined concentrations for either treated 
effluent- or surface waters at both study sites, which implicates a low risk for human health. 
 
5.4. Conclusions 
 
The current study included a multi-disciplinary approach through environmental micro-
pollutant monitoring by investigating 1) the presence and fate of organic micro-pollutants 
during wastewater treatment, 2) the impact of RAS on the recalcitrance of priority ECs, 3) urban 
water profiling to show the use of licit- and illicit DOA within communities, and 4) evaluating 
the lethal- and sub-lethal health risks associated with the detected DTRs. The results 
demonstrate the recalcitrance of ECs (such as VEN and TRAM), even with the use of advanced 
AS processes for wastewater treatment. Although effective removal was reported for most of 
the target analytes, enantiomeric profiling showed stereoselective degradation of some 
compounds during wastewater treatment. Although the physiological potency of most chiral 
drugs are shown to be stereo-specific, their associated toxicity risks still need to be evaluated 
in future studies to establish whether the residual enantiomers pose a significant environmental 
risk. Also, the results further highlighted the need for the monitoring of metabolic by-products, 
as removal of parent compounds does not necessarily imply that their potential environmental 
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risks are completely mitigated. The lack in sufficient risk assessment parameters for 
pharmaceutical breakdown products should therefore receive more attention in the future.  
 
As the database and knowledge of ECs within surface waters are growing on global scale, it 
would appear inevitable that the discharge of priority ECs would be incorporated into 
legislation or at least refined for risk assessment guidelines and/or directives due to increasing 
information regarding their pronounced risks on wildlife and human health. Although such 
legislation will be more likely for developed- than developing countries, the influence on more 
strict export quality standards, for example in agricultural produce, will also greatly impact 
international trade for developing countries if reclaimed water and digested sludge are used for 
irrigation and fertilisation purposes. 
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CHAPTER 6: WASTEWATER-BASED EPIDEMIOLOGY (WBE) AND 
ENANTIOMERIC PROFILING OF ILLICIT DRUGS OF ABUSE (DOA) IN SOUTH 
AFRICAN WASTEWATER: APPLICATION IN AN AFRICAN CONTEXT 
 
Article: 
Archer, E., Castrignanó, E., Kasprzyk-Hordern, B., Wolfaardt, G. M. (2018) Wastewater-
Based Epidemiology and Enantiomeric Profiling for Drugs of Abuse in South African 
Wastewaters. Science of the Total Environment. 625, 792-800. 
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 Abstract 
 
The current study is aimed to introduce a wastewater-based epidemiology (WBE) approach for 
the first time on the African continent where substance abuse data is limited. The study included 
the quantification of several drugs of abuse (DOA) in raw wastewater samples. Quantification 
of urinary metabolites as drug target residues (DTR), as well as enantiomeric profiling of chiral 
DOA were performed to distinguish between consumption and direct disposal into sewage. 
Monitoring campaigns were undertaken at two South African wastewater treatment works 
(WWTWs) located within two provinces of the country. The presence of non-racemic 3,4-
methylenedioxymethamphetamine (MDMA) and methamphetamine, as well as the metabolite 
of cocaine, benzoylecgonine (BEG), confirmed their consumption within the areas investigated. 
Enantiomeric profiling further pointed to the abuse of methamphetamine as the primary DOA 
with use estimates calculated between 181.9 and 1184.8 mg.day-1.1000 inhabitants-1. 
Population-normalised mass loads for MDMA and cocaine confirmed their status as secondary 
DOA within the study sites. Use estimates for the new psychoactive substance (NPS) 
mephedrone were performed for one WWTW. The minor metabolite of heroin, O-6-
monoacetylmorphine (O-6-MAM), was also detected at one WWTW and served as a qualitative 
indicator for heroin abuse within the area. These findings provide a novel comparison of the 
WBE approach in a developing-country with other global studies, with the aim to strengthen 
this approach as a tool to inform drug prevention strategies in countries where substance abuse 
data is limited due to financial constraints and lack of government structures to facilitate 
conventional monitoring.  
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6.1. Introduction 
Drug use and abuse have notable socio-economic consequences that globally impede 
sustainable development amongst communities (UNODC, 2016). Such drugs of abuse (DOA) 
are not only limited to illicit substances, but also include prescription and over-the-counter 
(OTC) medications, which have the potential to cause addiction through their designed 
physiological mechanisms of action. However, the methods to collate information on drug use 
are largely limited to substance abuse treatment centres and law enforcement reports, which 
may lead to inaccurate or underestimations of drug abuse. Wastewater-based epidemiology 
(WBE) has shown great promise to assist with such constraints by providing a near-real time 
profile of substance abuse (Castiglioni et al., 2016).  
 
As with any consumed product, DOAs are excreted in sewage either as its parent form, or as 
primary and secondary metabolites, depending on their metabolic pathways in the body. These 
substances are then transported through the connected sewage network to wastewater treatment 
works (WWTWs). Apart from their role in the degradation of a large variety of organic 
pollutants, WWTWs may thus also serve as composite sampling sites for the chemical profiling 
of wastewater as a non-intrusive tool to estimate drug use and abuse within the communities 
connected to the sewer system (Castiglioni et al., 2014; Daughton, 2001). However, several 
discrepancies to this approach have been discussed (Castiglioni et al., 2016), which include the 
fate of the parent drug in wastewater, as well as the distinction between drug consumption and 
direct disposal into the recipient waters (Kasprzyk-Hordern and Baker, 2012a). For this reason, 
the inclusion of metabolic breakdown products as drug target residues (DTR) were proposed to 
address this limitation by serving as more stable DTRs for consumption estimates, as well as 
confirming whether the drug has undergone metabolic breakdown due to consumption (Petrie 
et al., 2016b).  
 
Apart from the benefits of establishing  DOA metabolite loads in wastewater, the enantiomeric 
profiling of chiral DOA may also be used to distinguish between direct disposal, consumption, 
and manufacturing (Camacho-muñoz et al., 2016; Emke et al., 2014; Kasprzyk-Hordern and 
Baker, 2012a, 2012b; Petrie et al., 2016b). Some DOA, such as 3,4-
methylenedioxymethamphetamine (MDMA) and mephedrone are manufactured in their 
racemic form, from which the enantiomers will follow different metabolic pathways and 
excretion patterns within the body, which leads to a non-racemic mixture in sewage 
(Castrignanò et al., 2017a/2017b; Kasprzyk-Hordern and Baker, 2012a). Therefore, if the 
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enantiomeric composition of the drug is racemic in the wastewater sample, it might indicate 
direct disposal of the drug rather than its consumption (Emke et al., 2014). In contrast, the 
manufacturing of some chiral illicit drugs, such as methamphetamine, is primarily 
enantioselective (Castrignanò et al., 2017b; Xu et al., 2017), as the potency and desired 
physiological effects differ between the chiral isoforms. For methamphetamine, the S-
enantiomer is the predominant form to represent an illicit origin, which has also been confirmed 
during WBE (Castrignanò et al., 2017b; Xu et al., 2017). However, it has been reported that 
both enantiomers may also be associated with illicit methamphetamine use, depending on the 
method of synthesis and trafficking. For example, a racemic mixture of methamphetamine was 
detected in Norwegian wastewater samples in contrast to other European countries where 
wastewater was predominantly enriched with the S-enantiomer (Castrignanò et al., 2017b). The 
authors highlighted that this occurrence was due to the known differences in manufacturing and 
trafficking of the drug between countries. Establishing the enantiomeric signature of chiral 
DOA in wastewater therefore provide an added value to WBE for improved drug enforcement 
strategies, substance abuse estimates, and information to social services.  
 
WBE has been applied in many countries to date (Castiglioni et al., 2014; Devault et al., 2017; 
Emke et al., 2014; Evans et al., 2016; Lai et al., 2017; Ort et al., 2014; Petrie et al., 2016b; 
Subedi and Kannan, 2014; Xu et al., 2017). Ironically, the value of implementing such an 
overarching approach to monitor drug abuse in African countries are lacking, where it may 
arguably provide an effective means to fill a void left by a chronic shortages in funding and 
human capacity. Given the current state of substance abuse within developing countries, as well 
as limited drug use statistics, assessment tools such as WBE are needed to assist with future 
drug use prevention strategies. Recent reports have highlighted an increase in the abuse of illicit 
drugs in South Africa (Dada et al., 2017; USDS, 2017), with these substances shown to be 
present in wastewater (Archer et al., 2017b). The aim of the current study was therefore (i) to 
monitor the loads of common illicit drugs (cocaine, methamphetamine, MDMA and heroin), as 
well as the new psychoactive substance (NPS) mephedrone at two South African WWTWs in 
order to estimate the drug use patterns within communities serviced by the sewage systems, (ii) 
to lay a foundation for local drug monitoring programmes and (iii) to adopt this approach that 
should facilitate a common ‘language’ with nascent programmes in developed countries.  
 
6.2. Materials and Methods 
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6.2.1. Sampling locations 
Two WWTWs were selected for a consecutive 7-day sampling campaign during 2017 (Fig. 
6.1). WWTW1 is Gauteng Province serving one city in the East Rand district adjacent to the 
city of Johannesburg, and WWTW2 located in the Western Cape Province of South Africa 
serving several suburbs around the city of Cape Town (Fig. 6.1). The information for the plants 
are shown in the supplementary information (APPENDIX, Table D1). The current de facto 
population estimate (PE) for the WWTWs were estimated from population growth projections 
since the last national census campaign in 2011, which resulted in a PE of 200 000 for WWTW1 
and 470 000 for WWTW2. 
 
 
Figure 6.1: Map showing the sampling locations of WWTW 1 (Gauteng Province) and WWTW 2 
(Western Cape Province). 
 
6.2.2. Chemicals and consumables 
The study included the multi-residue quantification for 16 DTRs (cocaine, benzoylecgonine, 
cocaethylene, (±)-amphetamine, (±)-methamphetamine, (±)-mephedrone, (±)-ephedrine, (±)-
pseudoephedrine, norephedrine, (±)-MDMA, (±)-HMMA, (±)-HMA, heroin, O-6-
monoacetylmorphine, morphine and normorphine) using analytical methods described 
elsewhere (Castrignanò et al., 2016), which is summarised in the supplementary information 
(Fig. S1). The following internal standards were included in the water samples to assist with 
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quantification: cocaine-d3, benzoylecgonine-d8, cocaethylene-d3, amphetamine-d5, 
methamphetamine-d5, mephedrone-d3, MDMA-d5, heroin-d9, 1S,2R-(+)-ephedrine-d3, 
morphine-d6 and PCP-d5. Methanol (MeOH, HPLC-grade; Sigma) and ultra-pure water 
(Millipore) were used for cleaning glassware and for solid phase extraction (SPE). All 
glassware were deactivated using 5% dimethyldichlorosilane (DMDCS) in toluene, followed 
by two wash steps in toluene, and three wash steps in MeOH. Acetonitrile, DMDCS, MeOH 
and ammonium acetate were all purchased from Sigma-Aldrich. 
 
6.2.3. Sample collection and preparation  
Raw wastewater samples from the two study sites were taken over a period of seven consecutive 
days during the month of March 2017. Briefly, composite samples (100 ml every 10 mins) were 
taken over a 24 hour period (9am to 9am) using a time-and-volume-proportional composite 
sampler (Aquacell, Aquamatic Ltd, UK) at the raw sewage inlet after the grit screens. The 
samples were kept cold during sampling and transportation to the laboratory, from which 
sample filtration and extraction were completed upon arrival. Duplicate raw wastewater 
samples (50 mL each) from each sampling locality and day were filtered using 0.7 µm glass 
microfiber filters (grade GF/F; Whatman®, Sigma-Aldrich) using a vacuum manifold, whereby 
all aqueous samples were extracted using Oasis HLB cartridges (3cc, 60 mg). The cartridges 
were conditioned with 2 ml MeOH, followed by 2 mL of ultrapure water. The samples were 
then allowed to pass through the cartridges at a rate of 6 mL.min-1, washed with 3 mL ultrapure 
water, and allowed to run dry for at least 30 minutes. The dried cartridges were frozen and then 
transported on ice to the University of Bath (UK) for elution and analysis. Upon arrival, the 
cartridges were eluted with 4 mL MeOH into 5 mL silanized glass tubes and dried under a 
gentle stream of nitrogen (5-10 psi, 40⁰C) using a TurboVap evaporator (Caliper, UK). A 
mixture of the ISs were added to each dried sample and reconstituted in 0.5 mL of the mobile 
phase used for chiral LC-MS/MS analysis (1 mM ammonium acetate:methanol, 85:15, v/v) to 
give a 100x concentrated sample containing a final concentration of 1μg.L-1 IS mix per 50 mL 
water sample. The suspended samples were filtered through 0.2 µm PTFE filters (Whatman®, 
Puradisc, 13 mm) and placed in polypropylene plastic vials bonded with a pre-slit 
PTFE/Silicone septa (Waters, UK).  
 
6.2.4. Chiral liquid chromatography coupled with tandem mass spectrometry 
A chiral method for the detection of a list of chiral and achiral DOA was used as developed by 
Castrignanò et al. (2016). Briefly, the analytes in the processed samples were separated using a 
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Waters ACQUITY UPLC® system (Waters, Manchester, UK) equipped with a CHIRALPAK® 
CBH HPLC column (5 µm particle size, L × I.D. 10 cm × 2.0 mm; Chiral Technologies, France) 
and a Chiral-CBH guard column (10 × 2.0 mm, 5 µm particle size; Chiral Technologies, 
France). The ACQUITY UPLCTM autosampler was kept at 4⁰C, and the column temperature 
was set at 25⁰C. All samples were injected at 20 µL. The flow rate of the mobile phase was set 
at 0.1 ml.min-1 under isocratic conditions. The separated analytes were identified and quantified 
using a triple quadrupole mass spectrometer (Xevo TQD, Waters, Manchester, UK), equipped 
with an electrospray ionisation (ESI) source, which was managed in the multiple reaction 
monitoring (MRM) mode. Quality controls (QC) spiked with standards and deuterated 
compounds were added throughout the run of the batch for ensuring good instrumental 
performance. The quality and quantification of the analytes in the measured samples followed 
the criteria set by the European Commission Council Directive 2002/657/EC (European 
Commission, 2002). 
 
6.2.5. Daily loads and drug use estimate calculations 
In order to normalise for the variation in daily wastewater flow rates of the plants, the daily 
mass loads of the target analytes (g.day-1) at each WWTW were calculated by multiplying the 
measured concentration of the DTR from LC-MS/MS analysis (in ng.L-1) in the wastewater 
samples with the flow volume (L.day-1) of wastewater entering the plant over 24 hrs. 
Population-normalised drug loads (mg.day-1.1000 inhabitants-1) of the selected target analytes 
were then calculated using equation 1: 
 
 
 
where Loadinf refers to the calculated mass loads (g.day
-1) of the DTRs, CF refers to the 
correction factor calculated by dividing the most recent excretion rates of each DTR by the 
molar mass ratios between the parent drug and DTR (Table S2), and Pop. refers to the 
population estimate (de facto number of individuals) for each WWTW (Table S1).  
 
In order to distinguish between the illicit or pharmaceutical origin of the chiral drugs, or to 
assist with distinction between direct disposal and consumption of the DTRs within the study 
Population-normalised drug loads 
(mg.day
-1
.1000 inhabitants-1) 
= 
Loadinf (g.day
-1
) * CF * 1x106 
Pop. 
Eq. 1 
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areas, the enantiomeric fraction (EF) of the selected chiral compounds in wastewater were 
calculated using equation 2: 
 
 
 
where (+) and (-) are referred to the concentrations (ng.L-1) of the enantiomers in wastewater 
influent or E1 and E2 as the mass load concentrations (g.day-1) of the first- and second eluted 
enantiomer respectively. An EF equal to 1 or 0 represents an enantiomerically pure substance, 
whereas an EF equal to 0.5 represents a racemic mixture of the drug.  
Enantiomeric Fraction 
(EF) = 
(+) 
[(+) + (-)] [E1 + E2] 
E1 
or Eq. 2 
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6.3. Results and Discussion 
 
The concentrations (ng.L-1) of the DOA that were quantified in this study can be found in the 
supplementary information (Table S3 and S4), from which the calculations for mass loads 
(g.day-1; Table S5 and S6) and population-normalised mass loads (mg.day-1.1000 inhabitants-1; 
Table 1) were done. 
 
6.3.1. Cocaine 
The mass loads calculated for cocaine in the aqueous phase of raw wastewater showed a slight 
increase during the weekend period (Saturday and Sunday) for WWTW2, but not WWTW1 
(Fig. 6.2; APPENDIX, Table D5 & D6). However, both the metabolites of cocaine, 
benzoylecgonine (BEG) and cocaethylene (CE) showed a significant increase in their loads 
within raw wastewater during the weekend period for both WWTWs (ANOVA, P < 0.05; Fig. 
6.2; APPENDIX, Table D5 & D6). This can be attributed to the known recreational use of this 
drug. BEG loads ranged from 5.59 to 17.26 g.day-1 at WWTW1 (Fig. 6.2; APPENDIX, Table 
D5), and between 33.59 to 76.98 g.day-1 at WWTW2 (Fig. 6.2; APPENDIX, Table D6), 
whereas cocaine loads ranged between 2.12 and 7.23 g.day-1 at WWTW1 (Fig. 6.2; 
APPENDIX, Table D5), and between 8.84 to 39.97 g.day-1 at WWTW2 (Fig. 6.2; APPENDIX, 
Table D6). The observed higher mass loads for BEG compared to cocaine in raw wastewater 
samples therefore assumes its consumption rather than direct disposal into wastewater. For 
WWTW1, the cocaine/BEG ratio varied between 0.2 and 0.6 (median 0.3), and for WWTW2 
varied between 0.3 and 0.5 (median 0.4), which is below the suggested cut-off ratio of 0.75 that 
is indicative of human consumption (Van Nuijs et al., 2009). However, these ratios were higher 
than suggested in a more recent study to assume in vivo cocaine metabolism, which was set at 
0.1 or lower (Castiglioni et al., 2011). This may then suggest some direct disposal of the drug 
or possibly other factors affecting these ratios, such as the route of administration of street drugs 
containing cocaine and co-administration with other substances.   
 
The detection of CE in wastewater highlights a few considerations which should be addressed 
when WBE is applied for cocaine consumption estimates. This metabolite is formed when 
cocaine is co-administered with alcohol, which is shown to lead towards a decrease in hepatic 
metabolism of the parent drug (Parker and Laizure, 2010). It has been shown that the percentage 
of excretion products during co-administration of cocaine and alcohol over a 24 hour period 
was 4.6% for cocaine, 21.1% for BEG and 0.7% for CE (De La Torre et al., 1991). Although 
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only eight subjects for the study were used, these excretion values are much different from case 
studies where cocaine was administered alone (Khan and Nicell, 2011). Although cocaine is 
shown to be less stable in wastewater than BEG (Castiglioni et al., 2016), the increased levels 
of the parent drug can therefore not be considered to be a sole result of direct disposal, but may 
also be as a result of co-administration with alcohol. Co-administration of cocaine with alcohol 
may thus supress hepatic metabolism to BEG and instead cause increased excretion of the 
parent drug. This implies that re-adjustment of the correction factors should be considered in 
future studies that will include refinement of parent/metabolite ratios in order to compensate 
for simultaneous alcohol intake by users.   
 
 
Figure 6.2: Daily mass loads (g.day-1) estimated for cocaine, BEG (1º y-axis) and cocaethylene (2º y-
axis) within raw wastewater entering WWTW1 and WWTW2. 
 
Average population-normalised mass loads for cocaine (using BEG) for WWTW1 was 
estimated at 155.8 mg.day-1.1000 inhabitants-1 during weekdays (Monday to Friday), and 263.8 
mg.day-1.1000 inhabitants-1 over the weekend (Saturday and Sunday) (Table 6.1). For 
WWTW2, mean consumption of cocaine during the week was estimated at 342.0 mg.day-1.1000 
inhabitants-1 and 533.0 mg.day-1.1000 inhabitants-1 over the weekend (Table 6.1). Although it 
is reported that cocaine is considered as a secondary DOA in South Africa (Dada et al., 2017), 
the use estimates fell within the range of cocaine consumption estimated at several European 
cities during a 2016 monitoring campaign (Table 6.1), but were lower than estimates in South 
American studies and some European countries such as Belgium and England (EMCDDA, 
2016; APPENDIX, Table D7).  
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6.3.2. MDMA 
The loads of MDMA in South African wastewater have not been reported previously. As with 
cocaine, this drug is normally shown to be used for recreational purposes and is reported to be 
a secondary DOA in the country according to substance abuse treatment data (Dada et al., 
2017). During the current sampling campaign, mass loads of ±-MDMA ranged between 0.10 to 
0.23 g.day-1 at WWTW1 (Fig. 6.3; APPENDIX, Table D5), and between 0.94 to 6.52 g.day-1 at 
WWTW2 (Fig. 6.3; APPENDIX, Table D6). This estimate is low compared to similar studies 
done for European cities (Baker et al., 2014; EMCDDA, 2016), which highlights its status as a 
secondary DOA in the country. Regardless of the low mass loads detected in the current study, 
a significant increase in MDMA loads in raw wastewater for both WWTWs on the Sunday was 
observed compared to the rest of the sampling days (ANOVA, P < 0.05; Fig. 6.3; APPENDIX, 
Table D5 & D6), confirming its recreational use. The consumption of MDMA was further 
confirmed by the presence of the metabolite 4-hydroxy-3-methoxymethamphetamine (HMMA) 
within raw wastewater at both WWTWs, with ±-HMMA loads varying from 0.25 to 0.42 g.day-
1 at WWTW1 (APPENDIX, Table D5), and 0.72 to 2.49 g.day-1 at WWTW2 (APPENDIX, 
Table D6). Another metabolite of MDMA, namely 4-hydroxy-3-methoxyamphetamine 
(HMA), was not detected at any of the sampling sites during the current study. The use of 
HMMA as DTR has also been recently proposed (Castrignanò et al., 2017b), as it is indicative 
of consumed MDMA rather than possible direct disposal into wastewater.  
 
Both MDMA and HMMA are chiral, with conventional methods for clandestine manufacturing 
producing racemic MDMA (Castiglioni et al., 2016). Therefore, a racemic mixture of MDMA 
in a sample indicates direct disposal (EF = 0.5), where an EF lower than 0.5 will indicate its 
consumption due to the drug’s stereoselective metabolism in the body (Emke et al., 2014; Petrie 
et al., 2016b). In the current study, average EF values for MDMA in raw wastewater samples 
were 0.36 (± 0.09) for WWTW1, and 0.33 (± 0.05) for WWTW2, which indicates a clear 
enrichment of R-(-)-MDMA at both WWTWs. This finding conforms to similar studies 
showing an enrichment of R-(-)-MDMA in wastewater (Castrignanò et al., 2016; Emke et al., 
2014; Kasprzyk-Hordern et al., 2010). Other potential factors leading towards a shift in EFs 
also need further investigation, such as biological processes in wastewater (in-sewer 
degradation) which may favour the degradation of S-(+)-MDMA, leading to a further 
enrichment of R-(-)-MDMA in the water sample (Evans et al., 2016, 2015). Nevertheless, 
enantiomeric profiling of both MDMA and HMMA has been shown to further confirm 
consumption rather than disposal. It has been proposed that if MDMA is found to be enriched 
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with R-(-)-MDMA (as with the current study), an enrichment of S-(+)-HMMA will further 
verify consumption of the drug (Castrignanò et al., 2017b). A similar trend was found for 
WWTW2, as the enantiomeric signature of HMMA showed an average EF value above 0.5, 
indicating an enrichment of  S-(+)-HMMA (APPENDIX, Table D6). A similar trend was not 
detected in WWTW1, which may be attributed to lower loads of parent MDMA in the raw 
wastewater samples (Fig. 6.3; APPENDIX, Table D5) and may therefore merely reflect a lower 
use of the drug within the communities. 
 
Population-normalised MDMA load estimates ranged between 2.2 and 4.9 mg.day-1.1000 
inhabitants-1 at WWTW1 (Table 6.1), and 9.0 to 61.6 mg.day-1.1000 inhabitants-1 at WWTW2 
(Table 6.1). The highest consumption estimate for WWTW1 (5.0 mg.day-1.1000 inh-1, Table 
6.1) was similar to monitoring campaigns in Italy, Spain and Finland, whereas the highest 
consumption estimate for WWTW2 (61.6 mg.day-1.1000 inhabitants-1, Table 1) was similar to 
monitoring campaigns in the United Kingdom and Switzerland (EMCDDA, 2016). Recent 
statistics on drug use and abuse in South Africa show that although MDMA abuse are reported, 
the true extent of its abuse in the country is largely unknown (Dada et al., 2017). Again, most 
statistics are limited to individuals being treated for drug use, and therefore does not reflect on 
the total number of drug users in an area, especially for such a recreational substance. The 
current study demonstrated the presence of both MDMA and its metabolite in wastewater, thus 
expanding the scope of investigation beyond individuals that received treatment.  
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Figure 6.3: Daily mass loads (g.day-1) estimated for MDMA and HMMA within raw wastewater 
entering WWTW1 and WWTW2. EF = Enantiomeric fraction. 
 
6.3.3. Amphetamine and methamphetamine  
Mass loads of methamphetamine calculated is the current study were the highest when 
compared to other detected illicit drugs (APPENDIX, Table D5 & D6), highlighting its use as 
a primary abused substance in the study areas. The chiral signature for methamphetamine 
showed, almost exclusively, the presence of S-(+)-methamphetamine at both WWTWs (EF 0.8 
– 1.0; Fig. 6.4), which is similar to monitoring studies in Europe (Castrignanò et al., 2017b; 
Evans et al., 2016) and China (Xu et al., 2017). At WWTW1, mass loads varied between 2.90 
to 6.30 g.day-1 for R-(-)-methamphetamine, and 12.92 to 40.01 g.day-1 for S-(+)-
methamphetamine (APPENDIX, Table D5). At WWTW2, mass loads were higher for both 
enantiomers, which varied between 7.77 to 11.94 g.day-1 for R-(-)-methamphetamine, and 
130.17 to 229.07 g.day-1 for S-(+)-methamphetamine (APPENDIX, Table D6). The mass loads 
for the racemic methamphetamine mixture also increased significantly during the weekend 
period at WWTW2 (ANOVA, P < 0.05; Fig. 4), which is not surprizing, as this plant is located 
in an area where adolescent and recreational use of the drug is high (Asante and Lentoor, 2017; 
Pluddemann et al., 2010).  
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Clandestine manufacturing of illicit methamphetamine usually aims at the synthesis of the S-
enantiomer due to its more desired physiological effect over the R-enantiomer (Xu et al., 2017).  
The chiral signature for methamphetamine during the current study therefore suggests an illicit 
origin rather than a resultant breakdown from licit pharmaceuticals, given the history of high 
methamphetamine abuse in the country (Arfer et al., 2017; Asante and Lentoor, 2017; Dada et 
al., 2017; Pluddemann et al., 2010). Although R-(-)-methamphetamine loads were lower than 
S-(+)-methamphetamine in raw wastewater for both WWTWs, the loads were not negligible 
and could possibly have been derived from licit pharmaceuticals, for example Parkinson’s 
disease treatments containing selegiline. However, a lack of national prescription data limits 
the possible profiling to distinguish between the licit- or illicit origin of the R-enantiomer. In 
contrast, no enantiomeric study has been conducted in the country to verify the chiral signature 
and purity of ‘street’ methamphetamine, which are largely synthesised using ephedrine 
precursors and may yield variable enantiomerically pure drugs between various clandestine 
laboratories and/or imported drugs. For this reason, the racemic loads of methamphetamine 
were still deemed feasible to be used for consumption estimates. The population-normalised 
methamphetamine loads ranged from 181.9 to 532.5 mg.day-1.1000 inhabitants-1 at WWTW1, 
and 675.0 to 1184.8 mg.day-1.1000 inhabitants-1 at WWTW2 (Table 6.1). These estimates 
correlate well with reports in other countries where high methamphetamine use is reported, 
such as Slovakia and the Czech Republic (EMCDDA, 2016), China (Xu et al., 2017), Australia 
(Thai et al., 2016) and New Zealand (Lai et al., 2017) and highlights the need for further 
profiling to more accurately estimate its consumption and manufacturing within the country. 
 
For amphetamine, it has been highlighted that the presence of the drug in wastewater cannot 
solely be ascribed to abuse, nor can it be pinpointed to originate from a single source. 
Amphetamine may originate from several prescription medications, which may either include 
the S- and/or R-enantiomer or a mixture thereof. In South Africa, amphetamine-type stimulants 
(ATS) are registered to be used in several prescription medications, including attention-deficit 
hyperactivity disorder (ADHD) medications, non-steroidal anti-inflammatory drugs (NSAIDs), 
Parkinson’s disease treatment, and appetite suppressants. However, prescription data in the 
country is not available, along with few reports on the abuse of ATS medications. In the current 
study, amphetamine was detected exclusively as S-(+)-amphetamine in raw sewage (EF = 1), 
which ranged between 0.71 to 1.04 g.day-1 at WWTW1 (Fig. 6.4; APPENDIX, Table D5), and 
4.17 to 9.15 g.day-1 at WWTW2 (Fig. 6.4; APPENDIX, Table D6). This finding differs from 
monitoring studies where amphetamine in raw wastewater was rather detected to be enriched 
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with R-(-)-amphetamine, which was concluded to have originated from the use of amphetamine 
itself rather than as a breakdown product form other compounds (Kasprzyk-Hordern and Baker, 
2012a, 2012b). In contrast, other studies have also detected an enrichment of S-(+)-
amphetamine in raw sewage (Evans et al., 2016; Xu et al., 2017). Several factors led to the 
conclusion that the presence of S-(+)-amphetamine in the wastewater samples analysed during 
the current study were derived from the reduction of methamphetamine rather than 
amphetamine use. First, the use and abuse of amphetamine itself may be low in the country due 
to access to other more easily-available illicit substances. Second, given the more rapid 
metabolism of S-(+)-amphetamine over R-(-)-amphetamine during human metabolism and in 
wastewater (Kasprzyk-Hordern and Baker, 2012a), it would be assumed that raw wastewater 
samples would have at least contained traces of R-(-)-amphetamine, or mostly be enriched with 
this more stable enantiomer. Third, the breakdown of S-(+)-methamphetamine will exclusively 
lead to the formation of S-(+)-amphetamine (Bagnall et al., 2013). The higher load of S-(+)-
methamphetamine in wastewater (EF = 0.9 ±0.1) at both study sites may therefore lead to a 
higher fraction of breakdown of the S-enantiomer than the R-enantiomer. The low levels of R-
(-)-methamphetamine in wastewater then simply leads to a lower fraction of R-(-)-
amphetamine, which was below detection.    
 
 
Figure 6.4: Daily mass loads (g.day-1) methamphetamine and S-(+)-amphetamine in raw wastewater 
entering WWTW1 and WWTW2. EF = Enantiomeric fraction. 
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Due to the probable origin of S-(+)-amphetamine coming from S-(+)-methamphetamine 
degradation during the current study, the distinction between methamphetamine consumption 
and disposal were assessed by considering the amphetamine and methamphetamine load ratios 
of the S-enantiomers (AMP/METH). Estimated AMP/METH ratios in urine samples of abusers 
show considerable variation ranging from 0.025 to 0.208, depending on the post-dose time of 
sampling and the amount of the consumed dose (Valentine et al., 1995; Xu et al., 2017). The 
AMP/METH ratios for influent wastewater during the current study were estimated at 0.041 (± 
0.02) for WWTW1, and 0.038 (± 0.005) for WWTW2, which are also within the range that was 
reported in several Chinese wastewater influents (0.017-0.076) where the S-enantiomer for both 
analytes was predominantly or exclusively detected (Xu et al., 2017). Dumping rather than 
consumption of methamphetamine would be sporadic and therefore yield spikes in 
methamphetamine between sampling days, along with a clear shift in AMP/METH ratios 
compared to the other sampling days. For WWTW2, no such trends were observed during the 
study. However, the clear spike in methamphetamine loads on the Thursday and Sunday 
samples at WWTW1 (Fig. 4) also resulted in AMP/METH ratios of 0.02 compared to an 
average AMP/METH ratio of 0.05 (± 0.01) if these sampling days were excluded. This also 
conforms to a similar finding by Xu et al. (2017), where an AMP/METH ratio of 0.017 was 
considered as a dumping event due to this value which deviated significantly from other 
wastewater samples. The two sampling days during the current study thus suggest possible 
discharge of methamphetamine during manufacturing operations or attempted seizures rather 
than consumption, but further suggest an overall consumption of the drug rather than disposal 
at the two sampling sites. 
 
6.3.4. Drug precursors 
The loads of ephedrine, pseudoephedrine and the metabolite norephedrine were investigated 
due to their possible association with methamphetamine use and manufacturing. The production 
of methamphetamine from phenyl-2-propanone (P2P) are less common in Africa, where the 
conventional use of ephedrine precursors are reported to be common practice (USDS, 2017). 
Due to ephedrine having two chiral centres, four isomers can be established. Both 1R,2S-(-)-
ephedrine and 1S,2S-(+)-pseudoephedrine are known to be used in clandestine manufacturing 
of methamphetamine using the Nagai method, which exclusively generates S-(+)-
methamphetamine (Xu et al., 2017). However, as several OTC medications also contain 
ephedrine diastereomers, along with unknown prescription data for the country, the use of 
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ephedrine for clandestine manufacturing could not be distinguished from its medicinal use. This 
constraint may be addressed by screening for additional compounds used during clandestine 
manufacturing in future sampling campaigns. The chiral LC-MS method used for the current 
study did not allow for the distinction between 1R,2S-(-)-ephedrine and 1R,2R-(-)-
pseudoephedrine, and hence is reported as a combined load. Mass loads of 1R,2S-(-)-
ephedrine/1R,2R-(-)-pseudoephedrine were calculated to range from 41.52 to 95.18 g.day-1 at 
WWTW1 (APPENDIX, Table D5), and 22.47 to 32.74 g.day-1 at WWTW2 (APPENDIX, Table 
D6), whereas 1S,2S-(+)-pseudoephedrine loads ranged from 40.61 to 68.78 g.day-1 at WWTW1 
(APPENDIX, Table D5), and 35.29 to 60.32 g.day-1 at WWTW2 (APPENDIX, Table D6). 
From these estimations, the loads of 1S,2S-(+)-pseudoephedrine are similar for both sites, 
whereas loads for 1R,2S-(-)-ephedrine/1R,2R-(-)-pseudoephedrine were higher at WWTW1 
than WWTW2. Norephedrine is proposed to form through several sources, such as 
demethylation of ephedrine and/or pseudoephedrine, but also from methamphetamine and other 
OTC medications. During the current study, mass loads of E1/E2-norephedrine were calculated 
to range between 5.89 and 8.34 g.day-1 at WWTW1 (APPENDIX, Table D5), and between 2.03 
to 6.37 g.day-1 at WWTW2 (APPENDIX, Table D6). Average EF values were 0.39 (± 0.02) for 
WWTW1, and 0.33 (± 0.07) for WWTW2. The higher load in norephedrine at WWTW1 than 
WWTW2 shows a similar trend as for ephedrine loads at the two WWTWs, suggesting that the 
source of norephedrine is most likely from ephedrine/pseudoephedrine metabolism rather than 
from other sources. 
 
Although methamphetamine abuse is shown to predominate in the region where WWTW2 is 
situated (Dada et al., 2017), manufacturing is presumed to be higher in the province where 
WWTW1 is situated (USDS, 2017). The mass load estimates for ephedrine partly support this 
hypothesis (APPENDIX, Table D5 and D6). The combined average loads of ephedrines were 
114.5 (± 27.4) g.day-1 at WWTW1, and 78.5 (± 11.8) g.day-1 at WWTW2, whereas the 
methamphetamine loads were significantly higher at WWTW2 than WWTW1. Interestingly, a 
clear spike in 1R,2S-(-)-ephedrine/1R,2R-(-)-pseudoephedrine loads was detected for the 
Thursday samples at WWTW1 (APPENDIX, Table D5), which correlates to the clear spike 
shown for S-(+)-methamphetamine loads on the same day as well (Fig. 6.4; APPENDIX, Table 
D5). Additionally, a clear spike in hydro-chemical parameters (COD, PO4, NH3, suspended 
solids and conductivity), as well as a spike in mass loads of caffeine were also measured for the 
Thursday samples at WWTW1 (data not shown). This may suggest an alternative discharge 
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event during this day or even an alternative source of sewage effluent being discharged into the 
WWTW inlet as previously recorded for this WWTW.  
 
6.3.5. Mephedrone  
The NPS drug mephedrone was only detected in raw wastewater for WWTW2, with only two 
days of quantitative data on the Friday and Sunday sampling days (APPENDIX, Table D6). 
Mass loads of ±-mephedrone during these two sampling days ranged between 3.80 and 5.58 
g.day-1 for Friday and Sunday respectively (APPENDIX, Table D6). No clear trend in 
weekday/weekend use could be seen for this drug as shown for the recreational drugs cocaine 
and MDMA, suggesting low use of this drug within the study area. As for MDMA, mephedrone 
is also generally manufactured as a racemic mixture (EMCDDA, 2011). Therefore, a non-
racemic mixture in wastewater will further point to its consumption. Enantiomeric fractions for 
both sampling days revealed a racemic mixture (EF = 0.52 ±0.01), which contradicts studies 
showing an enrichment of R-(+)-mephedrone in wastewater (Castrignanò et al., 2017a, 2016). 
Although mephedrone is listed as an illegal substance in South Africa, its abuse is also poorly 
reported. Mephedrone was also detected in South Africa, in a WWTW monitoring campaign 
during 2015. No chiral signature of mephedrone was determined then (Archer et al., 2017a). 
These findings indicate its possible use in the country, although lower compared to other DOA. 
Population-normalised mephedrone loads were estimated to range between 7.6 to 10.4 mg.day-
1.1000 inhabitants-1 (Table 6.1). This estimate is still close to a UK study where population-
normalised mass loads were shown to range between 7.6 and 26.3 mg.day-1.1000 inhabitants-1 
during a 2014 sampling campaign, but lower than estimates during the following year, ranging 
from 14.9 to 47.7 mg.day-1.1000 inhabitants-1 (Castrignanò et al., 2017a). The current results 
suggest low use of this drug in the study area, but still confirm its presence in wastewater. For 
this reason, only semi-quantitative consumption estimates were suggested for the present study. 
More sensitive analytical methods will be required to verify actual mephedrone use in the 
country. 
 
6.3.6. Heroin  
Heroin is considered the most commonly-abused opioid in South Africa, with its abuse has 
increased more than 10-fold between 1997 and 2011 in the province where WWTW2 is 
situated (Weich et al., 2017), where it is often used in combination with other drugs such as 
low-grade cannabis and cocaine (Weich et al., 2008). As a consequence, heroin is typically 
smoked rather than conventional intravenous route of administration - also reported in 
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Colombia (Bijlsma et al., 2016). Despite its popularity as a primary DOA in South Africa, 
heroin was not detected at any of the WWTWs during the current study (APPENDIX, Table 
D5 and D6), which has been largely attributed to its low recovery and stability during sample 
preparation (Baker and Kasprzyk-Hordern, 2011), as well as its low excretion and rapid 
metabolism in the body after consumption (Castiglioni et al., 2016). WBE thus offer an 
accurate estimation of heroin consumption, as its metabolism in the body predominantly lead 
to the formation of morphine, which then undergo further metabolism into its conjugated form 
and nor-morphine. During the current study, morphine was detected in raw wastewater, 
ranging from 12.56 to 20.93 g.day-1 at WWTW1 (APPENDIX, Table D5), and 54.03 to 769.13 
g.day-1 at WWTW2 (APPENDIX, Table D6), whereas nor-morphine loads ranged from 4.62 
to 7.89 g.day-1 at WWTW1 (APPENDIX, Table D5), and 10.71 to 14.60 g.day-1 at WWTW2 
(APPENDIX, Table D6). Both morphine and nor-morphine mass loads were similar 
throughout the sampling period at WWTW1 (APPENDIX, Table D5), whereas morphine loads 
at WWTW2 were much higher during the week than for the weekend period (APPENDIX, 
Table D6). Apart from the detection of morphine and its metabolite within the wastewater 
samples, a minor metabolite of heroin, O-6-monoacetylmorphine (O-6-MAM), was also 
detected at WWTW2, with loads ranging from 2.09 to 5.54 g.day-1 (APPENDIX, Table D6). 
The detection of this metabolite confirms the use of heroin within the region, as this metabolite 
is formed exclusively from heroin consumption. However, population-normalised mass loads 
for heroin consumption could not be calculated, as O-6-MAM is a minor, relatively unstable 
metabolite, which can lead to underestimation (Castiglioni et al., 2016).  
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Table 6.1: Drug use estimates (mg.day-1.1000 inhabitants-1; ±stdev) of selected illicit drugs at WWTW1 and WWTW2 based on the detected loads of parent- 
and metabolite compounds in raw wastewater. 
WWTW1 
Drug DTR Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Cocaine BEG 156.4 ± 5.1 178.4 ± 77.5 184.9 ± 7.9 158.9 ± 8.0 100.6 ± 3.5 310.7 ± 28.7 216.9 ± 3.2 
MDMA MDMA 2.2 ± 0.2 2.6 ± 0.2 -   -   -   -   4.9 ± 0.7 
 HMMA 6.2 ± 1.5 -   -   -   7.7 ± 0.5 -   10.4 ± 0.3 
Methamphetamine Methamphetamine 319.4 ± 38.1 287.5 ± 37.7 181.9 ± 31.3 433.1 ± 10.9 245.2 ± 8.9 284.7 ± 21.5 532.5 ± 28.6 
Mephedrone Mephedrone -   -   -   -   -   -   -   
WWTW2 
Drug DTR Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Cocaine BEG 435.6 ± 54.3 333.1 ± 6.7 305.1 ± 13.4 257.3 ± 0.6 378.7 ± 0.1 476.3 ± 15.9 589.6 ± 27.5 
MDMA MDMA 36.7 ± 0.04 15.2 ± 0.6 15.3 ± 1.1 9.0 ± 0.1 13.1 ± 1.7 33.1 ± 0.7 61.6 ± 0.7 
 HMMA 19.9 ± 1.2 15.0 ± 2.3 8.3 ± 0.9 7.9 ± 0.6 7.7 ± 0.1 8.5 ± 0.3 26.6 ± 1.4 
Methamphetamine Methamphetamine 975.0 ± 5.4 948.4 ± 45.4 781.5 ± 52.9 675.0 ± 20.5 825.6 ± 22.6 1100.3 ± 93.4 1184.8 ± 13.5 
Mephedrone Mephedrone 1.6 ± 0.6 4.3 ± 0.7 1.7 ± 0.1 -   7.6 ± 0.3 2.6 ± 0.2 10.4 ± 0.9 
EMCDDA-SCORE 2016* 
Cocaine 113.8 (Munich, GER), 138.4 (Oslo, NOR), 169.6 (Paris, FRA), 390.4 (Bristol, UK), 409.6 (Antwerp, BEL), 484.7 (Geneva, SWI), 699.1 (Barcelona, SPA) 
Methamphetamine 58.3 (Oslo, NOR), 83.4 (Helsinki, FIN), 89.5 (Espoo, FIN), 136.7 (Dresden, GER), 261.9 (Budweis, CR), 310.2 (Piestany, SLO), 671.8 (Bratislava, SLO) 
MDMA 2.5 (Athens, GRE), 4.5 (Milan, ITA), 10.8 (Porto, POR), 17.2 (Paris, FRA), 34.2 (Helsinki, FIN), 51.2 (Bristol, UK), 59.3 (Zurich, SWI) 
* Examples of daily means of population-normalised mass loads estimated for several European cities as reported by the EMCDDA-SCORE initiative for 2016. A more 
detailed list can be found in the supplementary information (Table S7).
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 147 
 
6.4. Conclusions 
Methamphetamine was confirmed to be the primary DOA detected within the raw sewage, with 
enantiomeric profiling (EF > 0.5) confirming an enrichment of S-(+)-methamphetamine and 
suggesting an illicit origin of the drug. Similarly, quantification of the loads and enantiomeric 
profile of MDMA, and subsequent enantiomeric profiling of the metabolite HMMA point to 
consumption over direct disposal of the drug in the study areas. Cocaine use estimates was 
comparable to some use estimates in European countries. Although BEG was predominantly 
detected in both WWTWs, the cocaine/BEG ratios suggest possible direct discharge of the drug 
in wastewater. Mephedrone was also detected at one WWTW where substance abuse is of a 
growing concern.  
 
Finally, the results highlight the under-estimation of drug use when substance abuse treatment 
data is exclusively considered, as this data only represent a fraction of people admitting to their 
drug abuse. Further refinement of PEs for WBE should consider the demographic age of active 
substance abusers, as conventional PE may not be a true reflection of inhabitants contributing 
to substance abuse within a region. Also, more distinction need to be placed between the de 
facto and de novo population contributing waste to the WWTW, as the use of recreational 
drugs, for example cocaine, MDMA and mephedrone, may not reflect on the actual population 
connected to the sewer system. This will include the advances of using chemical markers (e.g. 
cotinine, caffeine) for population estimates. However, more studies are needed to refine 
statistical data on caffeine and tobacco use within South African communities in order to use 
such markers to generate sufficient estimations. We encourage the use of WBE to serve as a 
supplement to drug use statistics in a country where substance abuse data is limited, with the 
aim to extend this approach to other African countries.  
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CHAPTER 7: GENERAL CONCLUSIONS  
It is evident that a daunting task lies ahead concerning the quality of surface waters on a global 
scale. This is emphasized by the increased knowledge regarding possible health effects of a 
growing list of emerging contaminants (ECs) being detected in surface waters. Most 
anthropogenic substances are perceived needed to sustain human development, support 
industry and enhance agricultural output. However, it is vital to regulate their exposure to 
surface waters in order to decrease their negative impacts on the aquatic environment. This will 
consequently lead to innovative approaches to manage potential environmental health risks, 
which inevitably reflects back to community resilience. 
 
At the forefront of the need to limit human impact on the environment shared by wildlife lies 
the sufficient treatment of wastewater and the need for increased restoration of surface water 
resources. From the scoping studies presented in this dissertation, it must be emphasised that 
prioritisation of micro-pollutants will be dependent on the specific problem that need to be 
addressed, being for general water quality legislation, antimicrobial resistance (AMR) 
development, or to report on the occurrence of long-term adverse health outcomes associated 
with endocrine disruption. Although current legislation does not mandate the regulation of ECs, 
this should change in the near future. Furthermore, it became clear that the understanding of 
both biotic- and abiotic degradation of emerging micro-pollutants during wastewater treatment 
processes need further scrutiny, especially in view of incomplete degradation of compounds in 
WWTPs that are indeed biodegradable in microcosm studies. Furthermore, the impact of 
additional pollution sources on surface water quality, other than WWTW discharge, need more 
investigation. This will include more refined sampling and analytical approaches to identify 
such ‘non-WWTW pollution hotspots’. This is especially important for developing countries 
undergoing rapid urbanisation, industrialization and agricultural growth, where current 
infrastructure does not facilitate increased water provision, sanitation or recycling services. 
 
The databases compiled in Chapter 2 summarized the current knowledge concerning a vast 
quantity of ECs (known- or suggested to occur) in South African surface waters, along with a 
reflection of their potential negative impacts on aquatic ecosystems and human health. The 
literature review showed that several compounds regularly detected in surface waters may 
indeed be capable of causing various adverse health effects, considering the potential mixture 
interactions of these substances in the contaminated waters. More refined research should 
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therefore focus on prioritising these contaminants on a weight-of-evidence and outcome-
specific approach, by considering their persistence in surface waters, as well as their lethal- 
and/or sub-lethal health effects. The development and implementation of a routine first-tier risk 
assessment approach is therefore needed for a developing country where data are limited, 
which therefore require the use of sensitive- and cost-effective bioassays to address specific 
molecular- and/or key-event outcomes leading to adverse health effects. 
 
The use of the in vitro estrogen receptor binding assays (YES/YAES) in Chapter 3 screened 
for pollutants in surface waters which interfere with steroid hormone receptor binding 
(estrogenic and anti-estrogenic activities). The results highlighted the challenges faced when 
multiple risk-based outcomes are addressed, as well as the need for continuous risk assessment 
among study sites. In particular, the impact of climatic conditions, such as rainfall, as well as 
other seasonal and diurnal changes in both biotic- and abiotic conditions warrants further 
investigation, which are highly site-specific. Even though the WWTWs that were used for the 
present case studies showed compliance with current South African water treatment standards, 
additional parameters, including the fate of EDCs and other ECs within treatment discharges 
and recipient surface waters need further scrutiny for their inclusion in water quality legislation. 
The presence of anti-estrogenic activity in treated wastewater effluent also warrants further 
investigation, as the anthropogenic origin of compounds which exert this endocrine-disrupting 
response and their fate during wastewater treatment are less known. Also, the high microbial 
metabolic activities associated with wastewater treatment processes, as well as final 
disinfection steps, such as chlorination and UV treatment, may potentiate the loads of anti-
estrogenicity in treated wastewater, which further impacts other endocrine system outcomes 
through toxic masking. However, the YES bioassay screened for the collective endocrine-
disrupting effect in water bodies without the need to establish the micro-pollutant chemistry of 
the sample. As an effect, net-estrogenicity in the water samples (calculated in EEQs) which 
were recorded above effect-based trigger values points to focus areas where further risk 
assessment should be conducted. In particular, estrogenicity in river waters not necessarily 
associated with WWTW discharge were shown surpass these trigger values, showing the need 
to monitor further upstream as well. This increased health risk reported for environmental 
waters further highlighted the need to include analytical chemistry to identify potential EDCs 
and persistent substances. In particular, establishing the presence and fate of metabolic by-
products during wastewater treatment need further attention, as their eco-toxicological impact 
are less known compared to their parent counterparts. 
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The monitoring studies reported on in Chapters 4 and 5 included the detection and 
quantification of various pharmaceuticals and personal care products (PPCPs) as well as drugs 
of abuse (DOA) in WWTWs utilising activated sludge treatment processes. In agreement with 
literature, these studies revealed a range of low- to high removal rates of various pollutants, but 
also confirmed negative mass balances of some compounds (higher loads in treated effluent 
than raw influent). From the list of PPCPs selected for the scoping study reported in Chapter 
4, the compounds which stood out for both their persistence and potential adverse health risks 
were the antibiotics azithromycin, clarithromycin and sulfamethoxazole, the non-steroidal anti-
inflammatory drugs, diclofenac and naproxen, the antidepressant, venlafaxine and its primary 
metabolite, the anti-epileptic drug, carbamazepine and its metabolites, as well as the opioid 
drug, tramadol and its metabolites. The persistence of these highlighted antibiotics raises 
concern regarding their potentiating effect on multi-drug AMR development. The other classes 
of pharmaceuticals were further shown to potentially modulate endocrine system pathways 
through various molecular- and cellular pathways. The association of compounds such as 
venlafaxine and tramadol within solid particulate matter during activated sludge treatment 
processes were further highlighted in Chapter 5 to contribute to their recalcitrance in WWTWs. 
Longer retention time associated with the matured activated sludge (RAS) process did not 
necessarily lead to improved removal of these compounds and their metabolites. Although 
these compounds were degraded to some extent, the loads of their metabolic by-products in 
treated wastewater effluent also need routine monitoring, as the toxicological mixture 
interactions between parent drugs and metabolites are still elusive. Also, the novelty in 
establishing enantio-selective degradation profiles of chiral pharmaceuticals and illicit 
substances for risk assessment were outlined. Although it is known that various chiral 
pharmaceuticals have variable potencies on a pharmacological level, their stereo-selective 
toxicities on the aquatic environment and human health are hardly investigated. Future 
considerations will therefore be to enrich the database of enantio-specific toxicities of chiral 
drugs which are shown to persist during wastewater treatment in order to improve on the value 
of chiral profiling for risk assessment purposes.  
 
The study during Chapter 6 introduced wastewater-based epidemiology (WBE) for the first 
time in an African country. This approach showed promise to serve as an additional approach 
for substance abuse estimates in a country with limited drug use statistics. Detections and 
quantification of the illicit substances benzoylecgonine (for cocaine), MDMA, 
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methamphetamine, O-6-MAM (for heroin) and mephedrone in raw wastewater samples 
highlighted the extent of their abuse in the study areas. In particular, use estimates for 
methamphetamine were calculated to be high, even compared to other countries worldwide. 
The detection of the metabolic breakdown products and the enantiomeric profiling of the chiral 
illicit drugs was further shown to refine such consumption estimates. The results presented in 
this chapter emphasised the need to extend such an approach to other African countries by also 
addressing the estimation of licit pharmaceutical abuse. However, the study was limited to 
inadequate prescription data of licit DOA such as codeine, morphine and tramadol to draw 
adequate conclusions whether these substances are indeed misused. Future refinement may also 
include to establish the age demographics of particular abused substances in study areas in 
order to lower underestimations in drug use estimates. The inclusion of communities which are 
not directly connected to sewer systems also need attention, as these sources may indirectly 
contribute towards the sewage load at WWTWs trough septic tank sewage disposal. The latter 
is of particular importance in developing countries where substance abuse is of an ongoing 
concern in informal- and peri-urban settlements.  
 
Another consideration for future sampling strategies include the consideration of an extended 
sampling period and a fractionated sampling approach as mentioned by others (Baalbaki et al., 
2016; Ort et al., 2010). As highlighted by Ort and colleagues (2010), several experimental and 
analytical uncertainties arise during wastewater sampling. Such uncertainties are attributed to 
several variable factors which may influence micro-pollutant distributions within sewage 
systems, including, but not limited to, diurnal variations in the flow parameters of influent- and 
effluent wastewater, the source distribution of wastewater (domestic/industrial), amount of 
‘flushing events’, and residence time distributions (RTD) of treatment units (Baalbaki et al., 
2016; Ort et al., 2010). Taking these considerations into account may further refine the 
investigation on the fate of emerging contaminants during wastewater treatment, which further 
include the analysis of analyte concentrations within solid particulate matter (SPM) of 
receiving wastewater and especially accounting for RTDs of treatment units for more accurate 
removal estimates. The results reported in Chapter 5 further highlighted the influence of return 
activated sludge (RAS) which may contribute towards elongated retention of pollutants during 
the activated sludge maturation process, and therefore may also impact removal estimates. 
During the course of the experimental chapters for the current dissertation, a series of sampling 
methodologies were used, ranging from single grab sampling of river water, to high interval, 
time-proportional composite samples for wastewater influent and effluent. It is indeed 
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acknowledged that removal estimates from the various chapters would have benefitted by 
considering SPM concentrations and the influence of wastewater treatment RTDs, and should 
therefore receive priority for future sampling campaigns.  
 
Scientific significance of the thesis 
With freshwater resources being a valuable- and scarce commodity, the impact of pollution 
raise several socio-economic concerns, such as affecting human health and increasing 
environmental risk by limiting access to reliable and safe water resources. The use of urban 
water profiling for risk assessment and drug-use estimation addresses several global socio-
economic challenges, as outlined by the United Nations Sustainable Development Goals (SDG) 
for 2030 (http://www.un.org), in particular, the target set out by SDG-12 (Responsible 
Consumption and Production): 
 
 “By 2020, achieve the environmentally sound management of chemicals and all wastes 
throughout their life cycle, in accordance with agreed international frameworks, and 
significantly reduce their release to air, water and soil in order to minimize their adverse 
impacts on human health and the environment” – United Nations Sustainable Development Goals for 
2030 
 
Other targets set out by SDG-3 (Good Health and Well-being) and SDG-6 (Clean Water and 
Sanitation) can therefore be considered as the foundation which largely contribute towards 
environmental- and community resilience. Risk management and WBE approaches should be 
further refined to address other key global challenges, such as the development of antimicrobial 
resistance (AMR), which are of an emerging global concern.  
 
From a local perspective, the present study showed alignment with the South African 
Government National Development Plan (NDP) for 2030 by addressing specific targets, such 
as (1) 'conducting research on critical issues affecting long-term development', and (2) 
addressing 'interventions to ensure environmental sustainability and resilience to future 
shocks'. International research has highlighted the possible risk of in utero exposure to 
contaminants, therefore placing emphasis on current issues associated with water pollutants 
that translate into possible health consequences over generations. Especially in a country such 
as South Africa, where rapid population growth and urbanisation leads to an increased demand 
for potable water, numerous communities still rely on environmental surface waters as a 
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drinking water source. Advancing the knowledge and education on the possible health 
consequences associated with freshwater pollutants will contribute to enhanced community 
resilience. A further alignment with the NDP include the issue to 'reduce crime by 
strengthening criminal justice and improving community environments', whereby WBE may 
provide an innovative approach to estimate substance abuse and their manufacturing in 
countries where statistics are largely limited. The study further showed alignment with the 
Department of Science and Technology's (DST) Ten-Year Innovation Plan, especially Grand 
Challenge #4 regarding water scarcity. Although the extent of water pollution is evident in 
South African surface waters, the risks associated with these emerging contaminants need to 
be clearly defined, especially in view of chronic water scarcity that leads to increased reliance 
on water reuse. This requires improved monitoring and risk assessment approaches, which will 
support wastewater management, advance treatment and reuse initiatives, and ultimately lead 
to improved access to clean and safe water and sanitation services as set out by the DST Grand 
Challenge #5. 
 
In summary, the research described here (1) refined approaches and considerations to use cost-
effective bioassays for risk assessment, (2) identified emerging micro-pollutants and their 
associated by-products that should receive priority based on their associated risk, and (3) 
highlighted other socio-economic challenges such as substance abuse. These case studies may 
prove valuable for decision-making in water quality management by identifying their 
associated risk to cause adverse human- and environmental health consequences. By 
investigating the fate of these priority micro-pollutants in conventional WWTWs may provide 
a valuable database for the industry on the decision-making to improve current wastewater 
treatment infrastructure. This is of particular importance to provide safe reusable water supplies 
to communities and industry – relieving the pressure for access to a commodity which is 
already almost 100% allocated, with no surplus to accommodate the projected rates of 
population growth and urbanization. 
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APPENDIX A: SUPPLEMENTARY INFORMATION FOR CHAPTER 3 
Seasonal and daily variations in estrogenic and anti-estrogenic activity at wastewater 
treatment works and receiving waters: Implication for reliable monitoring 
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Table A1: E2-equivalent concentrations (EEQs; ng.L
-1 ±stdev) measured within the various water matrices from the WWTWs and environmental waters during 
summer (December 2015) and winter (June 2016). 
Site 
Summer  Winter  
Influent Effluent 
Removal 
(%) 
Upstream Downstream Influent Effluent 
Removal 
(%) 
Upstream Downstream 
WWTW1 16.8 ± 4.1**** 0.4 ± 0.2* 98 11.8 ± 2.3**** 6.5 ± 1.2**** 30.1 ± 4.9
**** 0.5 ± 0.01* 99 6.3  ± 0.2**** 1.9   ± 0.01** 
WWTW2 34.1 ± 0.4**** 0.3 ± 0.1 99 0.2   ± 0.1 0.8 ± 0.4** 23.5 ± 2.1
**** 0.9 ± 0.3** 96 0.2  ± 0.03 0.2   ± 0.01 
WWTW3 14.9 ± 3.4**** 0.4 ± 0.1* 97 1.3   ± 0.7** 0.8 ± 0.3** 31.5 ± 2.8
**** 0.5 ± 0.01 98 - 0.6   ± 0.01* 
WWTW4 11.8 ± 1.3**** - - 1.5   ± 0.5** 0.3 ± 0.1 13.5 ± 0.1
**** - - 0.8  ± 0.06** - 
WWTW5 4.4   ± 1.1*** 0.7 ± 0.4** 84 - 0.4 ± 0.2* 29.4 ± 5.4
**** 1.4 ± 0.03** 95 - 0.6   ± 0.1* 
WWTW6 5.3   ± 2.2**** 0.9 ± 0.3** 84 - 1.3 ± 0.8* 7.0 ± 1.6
**** 1.4 ± 0.04** 81 0.3   ± 0.02 1.6   ± 0.1** 
WWTW7 29.4 ± 6.3**** 0.3 ± 0.1 99 2.5   ± 0.9*** 0.5 ± 0.3* 11.4 ± 2.0
**** 0.2 ± 0.01 98 - - 
WWTW8 8.8   ± 2.7**** 2.6 ± 1.3*** 70 1.2   ± 0.5** 0.5 ± 0.1* 6.6   ± 0.7
**** 4.9 ± 0.2*** 26 - 5.0   ± 0.1**** 
WWTW9 7.8   ± 2.5**** 6.9 ± 0.3**** 13 7.5   ± 0.2**** 9.5 ± 0.7**** 15.1 ± 0.9
**** 1.3 ± 0.03** 91 18.9 ± 0.2**** 11.3 ± 1.9**** 
WWTW10 22.8 ± 4.9**** 1.1 ± 0.04** 95 0.6   ± 0.3* 0.4 ± 0.1* 15.3 ± 3.8
**** 0.9 ± 0.03** 94 1.2   ± 0.01** 0.6   ± 0.06* 
* EEQ trigger value (0.4 ng.L-1) of effluent estrogenicity on long-term fish exposure (Jarošová et al., 2014a). 
** Estimated trigger value (0.7 ng.L-1) for E2 in humans (Genthe et al., 2013) 
***  Predicted no-effect concentration (PNEC, 2 ng.L-1) for E2 to modulate fish reproduction (Caldwell et al., 2012) 
**** Concentration of E2 (5 ng.L-1) showing increased VTG production in adult male zebrafish (Brion et al., 2004) 
 
Additional remarks on river water 
Estimated EEQs for upstream river samples ranged from 0.2 – 11.8 ng.L-1 during summer 2015/16,  and 0.2 – 18.9 ng.L-1 during winter 2016, whereas estimated 
EEQs for downstream river samples ranged from 0.3 – 6.5 ng.L-1 and 0.2 – 11.3 ng.L-1 during summer 2015/16 and winter 2016 respectively (Table S1). Four 
upstream water sample locations were significantly higher than their associated downstream locations during both summer 2015/16 and winter 2016 (ANOVA, 
P < 0.05; Table S1). Furthermore, the average EEQ value for the water samples collected upstream from WWTW9 during the winter sampling was measured at 
18.9 ng.L-1, which was at an even higher concentration than estimated for the raw influent of the plant (Table S1). 
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Table A2: Daily variation in E2-equivalent concentrations (EEQs; ng.L-1) using the yeast estrogen screen (YES) for the various WWTWs December 2016 (summer). 
Day 
WWTW2 WWTW8 WWTW9 WWTW10 
Influent Effluent Removal Influent Effluent Removal Influent Effluent Removal Influent Effluent Removal 
Monday 15.7 ± 1.6**** 1.1 ± 0.3** 93 14.3 ± 2.3**** 1.3 ± 0.6** 91 28.9 ± 4.0**** 0.9 ±0.4** 97 21.0 ± 2.6**** 1.5 ± 0.4** 95 
Tuesday 13.9 ± 4.3****  2.6 ± 0.3*** 81 6.9 ± 0.9**** 1.5 ± 0.3** 78 27.9 ± 3.3**** 1.7 ±0.2** 94 45.4 ± 3.0**** 0.5 ± 0.3* 99 
Wednesday 13.5 ± 0.9**** 1.6 ± 0.4** 88 8.2 ± 1.1**** 1.6 ± 0.3** 80 27.7 ± 2.8**** 1.9 ±0.4** 93 22.3 ± 3.2**** 1.1 ± 0.2** 95 
Thursday - 1.2 ± 0.3** - 9.2 ± 2.6**** 3.0 ± 0.9*** 67 23.8 ± 1.2**** 1.2 ±0.3** 94 22.1 ± 3.9**** 1.3 ± 0.1** 99 
Friday 10.8 ± 2.2**** 0.7 ± 0.1**  94 12.7 ± 0.8**** 1.0 ± 0.2** 92 21.7 ± 3.3**** 1.5 ±0.01* 92 21.2 ± 4.8**** - - 
Saturday 14.3 ± 1.5**** 1.4 ± 0.2** 90 13.0 ± 3.3**** 1.5 ± 0.4** 88 25.4 ± 2.5**** 0.6 ±0.2* 98 21.2 ± 6.4**** 1.8 ± 0.2** 99 
Sunday 10.6 ± 3.6**** 0.8 ± 0.3** 93 15.1 ± 3.4**** 1.5 ± 0.8** 90 24.7 ± 11.9**** 0.4 ±0.1* 98 24.4 ± 2.5**** 2.1 ± 0.7*** 99 
Average 13.1 ± 2.0**** 1.3 ± 0.6** 90 11.3 ± 3.2**** 1.6 ±0.6** 84 26.8 ± 3.5**** 0.7 ±0.6* 97 25.4 ±8.9**** 1.4 ± 0.4** 98 
* EEQ trigger value (0.4 ng.L-1) of effluent estrogenicity on long-term fish exposure (Jarošová et al., 2014) 
** Estimated trigger value (0.7 ng.L-1) for E2 in humans (Genthe et al., 2013) 
*** Predicted no-effect concentration (PNEC, 2 ng.L-1) for E2 to modulate fish reproduction (Caldwell et al., 2012) 
**** Concentration of E2 (5 ng.L-1) showing increased VTG production in adult male zebrafish (Brion et al., 2004) 
 
 
Table A3: Mass loads (g.day-1) estimated using EEQ concentrations in the YES for both raw- and effluent wastewater samples at the various WWTWs during the December 
2016 sampling campaign. 
Day 
WWTW2 WWTW8 WWTW9 WWTW10 
Influent Effluent 
Removal 
(%) 
Influent Effluent 
Removal 
(%) 
Influent Effluent 
Removal 
(%) 
Influent Effluent 
Removal 
(%) 
Monday 0.72 ± 0.07 0.05 ± 0.03 93 1.64 ± 0.26 0.14 ± 0.07 92 0.58 ± 0.08 0.02 ± 0.01 97 8.81 ± 1.08 0.58 ± 0.28 93 
Tuesday 0.77 ± 0.24 0.14 ± 0.02 82 0.92 ± 0.11 0.19 ± 0.04 79 0.52 ± 0.08 0.03 ± 0.004 94 9.38 ± 1.10 0.17 ± 0.05 98 
Wednesday 0.71 ± 0.05 0.08 ± 0.02 89 1.10 ± 0.15 0.20 ± 0.03 82 0.49 ± 0.05 0.03 ± 0.01 94 8.32 ± 1.18 0.39 ± 0.06 95 
Thursday  -  0.06 ± 0.02 - 1.07 ± 0.31 0.32 ± 0.10 70 0.42 ± 0.02 0.02 ± 0.005 96 6.84 ± 1.21 0.37 ± 0.15 95 
Friday 0.68 ± 0.09 0.04 ± 0.01 94 1.40 ± 0.09 0.10 ± 0.02 93 0.37 ± 0.06 0.02 ± 0.001 94 4.58 ± 1.01  -  - 
Saturday 0.59 ± 0.05 0.05 ± 0.01 91 1.49 ± 0.38 0.16 ± 0.04 89 0.50 ± 0.05 0.01 ± 0.003 98 5.96 ± 1.80 0.48 ± 0.06 92 
Sunday 0.49 ± 0.17 0.04 ± 0.01 93 1.70 ± 0.38 0.16 ± 0.08 91 0.62 ± 0.14 0.01 ± 0.002 99 7.62 ± 0.77 0.62 ± 0.21 92 
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Table A4: Hydrochemical parameters and flow rates measured for selected WWTWs during the December 2016 (summer) sampling campaign. 
Table A5: Hydrochemical parameters and flow rates measured for selected WWTWs during the December 2016 (summer) sampling campaign. 
WWTW # 
Hydrochemical parameters Tuesday Wednesday Thursday Friday Saturday Sunday Monday 
06/12/2016 07/12/2016 08/12/2016 09/12/2016 10/12/2016 11/12/2016 12/12/2016 
WWTW2 COD (mg/L) 711.0 786.0 621.0 890.0 529.0 634.0 916.0 
 NH3 (mg/L) 6.4 15.0 13.6 14.7 16.2 13.2 12.6 
 Flowraw (ML/day) 55.5 53.0 54.1 59.9 41.6 45.6 46.0 
 Floweffluent (ML/day) 52.8 50.4 51.4 56.9 39.5 43.3 43.7 
WWTW8 COD (mg/L) 323.0 450.0 969.0 187.0 276.0 231.0 350.0 
 NH3 (mg/L) 15.6 15.5 17.8 21.8 24.6 26.7 21.3 
 Flowraw (ML/day) 133.4 133.6 116.9 110.4 114.8 112.6 115.2 
 Floweffluent (ML/day) 123.4 123.6 108.2 102.1 106.2 104.1 106.9 
WWTW9 COD (mg/L) 282.0 361.0 485.0 303.0 178.0 269.0 157.0 
 NH3 (mg/L) 28.5 17.1 17.2 17.2 21.1 31.5 24.1 
 Flowraw (ML/day) 19.9 17.7 17.5 17.1 19.8 19.2 20.2 
 Floweffluent (ML/day) 17.3 15.4 15.2 14.9 17.3 16.8 17.5 
WWTW10 COD (mg/L) 576.0 362.0 1121.0 718.0 674.0 461.0 481.0 
 NH3 (mg/L) 24.3 13.3 17.3 20.0 25.1 21.4 21.2 
 Flowraw (ML/day) 370.1 373.1 308.7 210.6 281.9 311.7 419.6 
 Floweffluent (ML/day) 342.3 345.1 285.6 194.8 260.8 288.3 388.1 
 
WWTW # Capacity 
December 2015 June 2016 December 2016 Pop. Eq. COD Pop. Eq.  
NH3 
COD 
(mg/L) 
NH3 
(mg/L) 
FRraw 
(ML/day) 
FReffluent 
(ML/day) 
COD 
(mg/L) 
NH3 
(mg/L) 
FRraw 
(ML/day) 
FReffluent 
(ML/day) 
COD 
(mg/L) 
NH3 
(mg/L) 
FRraw 
(ML/day) 
FReffluent 
(ML/day) 
WWTW1 105.0 1092.1 39.2 92.6 86.7 619.7 39.2 83.4 78.1 583.7 39.2 87.7 82.1 528942 499144 
WWTW2 55.0 797.6 29.7 37.1 35.2 559.0 17.4 59.4 56.3 726.7 13.1 50.8 48.3 260448 135241 
WWTW3 0.4 693.9 41.8 1.1 1.0 348.1 36.5 1.2 1.1 - - - - 4516 6297 
WWTW4 16.0 340.4 16.7 10.0 9.3 287.3 27.9 8.8 8.1 - - - - 23273 30265 
WWTW5 35.0 455.7 17.6 66.1 44.8 605.3 18.6 66.8 - - - - - 275929 174313 
WWTW6 32.0 995.0 5.9 33.3 33.3 819.9 22.0 31.8 31.9 - - - - 229674 65284 
WWTW7 36.0 973.4 25.8 13.1 12.9 738.7 20.4 8.3 8.6 - - - - 73574 37392 
WWTW8 83.0 480.6 31.2 100.2 92.6 334.4 24.9 94.3 87.2 398.0 20.5 119.6 110.6 330473 380454 
WWTW9 10.0 324.9 18.4 14.3 10.0 187.4 16.5 19.3 18.0 290.7 22.4 18.8 16.3 35397 48160 
WWTW10 155.0 714.7 30.5 158.2 146.3 583.6 23.3 187.4 176.9 627.6 20.4 325.1 300.7 1092297 763990 
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Figure A1: Deviation (%) from the submaximal E2 spike in the YAES for treated wastewater effluent 
samples from the various WWTWs during the winter 2016 sampling campaign. 
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Figure A2: Daily variation in the 
deviation (%) from the submaximal 
E2 spike in the YAES for treated 
wastewater effluent samples from 
the various WWTWs during the 
summer 2016 sampling campaign. 
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Table A6: Tamoxifen-equivalent concentrations (TAM-EQ; μg.L-1) estimated for treated effluent 
water samples from the various WWTWs during the winter 2016 sampling campaign. 
Site TAM-EQ (ug.L-1) 
WWTW1 22.5 ± 4.6 
WWTW2 6.5 ± 1.2 
WWTW3 3.7 ± 3.6 
WWTW4 78.7 ± 17.9 
WWTW5 28.0 ± 4.6 
WWTW6 5.6 ± 1.2 
WWTW7 12.0 ± 9.2 
WWTW8  -  
WWTW9 10.7 ± 1.5 
WWTW10 36.9 ± 14.8 
 
 
Table A7: Daily variation in tamoxifen-equivalent concentrations (TAM-EQ; μg.L-1) estimated for 
treated effluent water samples from selected WWTWs during the summer 2016 sampling campaign. 
Sampling day WWTW1 WWTW2 WWTW8 WWTW9 WWTW10 
Monday  -  1.4 ± 0.6  -  3.0 ± 0.3 1.3 ± 0.3 
Tuesday  -  1.0 ± 0.2  -   -  2.2 ± 1.3 
Wednesday 3.8 ± 2.2 1.3 ± 0.2  -  2.2 ± 0.7  -  
Thursday  -  4.8 ± 2.6  -  1.6 ± 0.7 5.4 ± 2.0 
Friday 2.3 ± 1.3 10.0 ± 3.0  -  2.9 ± 0.7 2.2 ± 0.7 
Saturday 2.2 ± 0.6 1.9 ± 0.4  -  2.0 ± 0.6 2.4 ± 0.7 
Sunday 0.7 ± 0.3  -   -   -   -  
Average 2.3  1.3 3.4 ± 3.5  -  2.3 ± 0.6 2.7 ± 1.6 
 
Additional remarks on anti-estrogenicity 
High estrogenicity was shown for WWTW8 during the same sampling period where the YAES 
showed cytotoxicity within the assay (Fig. 3). On the other hand, estrogenicity at WWTW4 
was below detection in the YES, but showed the highest anti-estrogenicity from all WWTW 
samples in the YAES (Fig. 3). During the summer 2016/17 sampling campaign, WWTW2, 9 
and 10 showed an observable lower concentration of EEQs during certain sampling days, 
whereas TAM-EQ concentrations were shown to be higher, and vice versa (Fig. 4). However, 
not all the results showed such a trend. For example, similar EEQ values were recorded for 
WWTW5 and WWTW6 during the winter 2016 sampling campaign, but TAM-EQ 
concentrations differed significantly between these two sampling sites (t-test, p < 0.05; Fig. 4). 
These two plants have similar treatment capacity, but different treatment processes (Table 1), 
with WWTW5 primarily receiving domestic sewage, and WWTW6 receiving wastewater from 
both domestic sewage and industry (including mining wastewater). Although WWTW5 and 
WWTW6 showed the same level of estrogenicity in treated effluent samples, a dose-dependent 
deviation above 100% of the E2 spike was not observed for WWTW5 in the YAES, as was the 
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case for WWTW6, which may be explained by the higher concentrations of anti-estrogenicity 
calculated for WWTW5 compared to WWTW6, resulting in less masking. The presence of 
higher anti-estrogenicity at WWTW5 may therefore be due to analytes originating from 
domestic sewage rather than industrical by-products. On the other hand, the different treatment 
technologies being utilised by the plants may degrade or possibly create anti-estrogenicity 
differently than for estrogenic compounds, or may contain different composition of estrogenic- 
and anti-estrogenic compounds in their wastewater. 
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APPENDIX B: SUPPLEMENTARY INFORMATION FOR CHAPTER 4 
The fate of pharmaceuticals and personal care products (PPCPs), endocrine disrupting 
contaminants (EDCs), metabolites and illicit drugs in a WWTW and environmental 
waters 
 
Figure B1: Liquid chromatography-Mass spectrometry (UPLC/TQD-MS) methods for acidic and 
basic compound detection. 
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Table B1: List of corrected recoveries of target ECs within WWTW influent/effluent and river water 1 
upstream and downstream samples. 2 
Chemical Class Chemical 
Corrected recovery (%) 
WWTW River water 
Effluent Influent Upstream Downstream 
UV filters 
 
 
Benzophenone-1 45.7 39.3 63.4 64.5 
Benzophenone-3 164.6 41.9 92.7 98.3 
Benzophenone-4 145.7 121.9 136.2 128.1 
Parabens 
 
 
 
Methylparaben 97.1 83.9 94.2 93.5 
Ethylparaben 62.8 50.6 56.9 60.6 
Propylparaben 106.1 83.7 149.1 170.7 
Butylparaben 95.1 81.8 135.6 156.9 
Plasticizer Bisphenol-A 119.5 87.7 125.8 119.0 
Antibiotics 
 
 
 
 
Sulfasalazine 118.9 177.6 165.5 140.1 
Clarithromycin 158.2 56.2 97.6 104.8 
Azithromycin 51.3 30.6 59.6 76.5 
Trimethoprim 158.2 165.2 149.3 164.1 
Sulfamethoxazole 135.4 130.7 107.0 110.0 
H2 receptor agonists 
Ranitidine 66.5 57.3 63.7 68.7 
Cimetidine 73.7 93.8 117.8 119.5 
NSAIDs 
Ketoprofen 107.6 113.7 108.5 110.8 
Ibuprofen 87.1 81.9 110.4 110.3 
Naproxen 85.5 86.8 101.9 103.6 
Diclofenac 191.8 208.7 190.9 176.5 
Acetaminophen 120.7 122.6 104.8 103.2 
Lipid regulators 
Bezafibrate 90.4 95.2 102.6 106.5 
Atorvastatin 229.4 270.2 159.2 116.8 
Anti-depressants 
Venlafaxine 71.1 50.5 85.2 76.5 
Desmethylvenlafaxine 88.0 88.5 107.1 101.9 
Fluoxetine 107.5 108.3 117.1 120.7 
Desmethylcitalopram 95.6 114.4 88.2 79.6 
Antihistamines Fexofenadine 66.1 73.7 61.1 47.4 
Anti-cancer Azathioprine 145.8 165.3 104.1 104.1 
Anti-epileptic 
Carbamazepine 95.5 100.6 99.0 100.2 
Carbamazepine10,11-epoxide 128.9 139.2 126.8 135.2 
10,11-Dihydro-10-hydroxycarbamazepine 131.9 154.3 115.8 124.1 
Diabetes 
Metformin 113.6 122.6 123.0 118.1 
Gliclazide 125.5 56.5 101.5 93.7 
Hypertension 
Valsartan 185.0 195.6 165.7 145.1 
Irbesartan 143.6 137.9 195.4 203.0 
Lisinopril 67.0 47.9 39.4 37.1 
X-ray contrast media Iopromide 137.8 147.0 167.6 174.5 
Beta-blocker Atenolol 91.7 86.8 97.4 102.4 
Analgaesics 
Morphine 91.4 111.3 104.6 102.3 
Normorphine 94.6 106.5 93.5 94.6 
Codeine 100.6 80.0 103.7 98.0 
Tramadol 83.5 83.6 100.2 94.1 
N-desmethyltramadol 67.6 67.0 74.8 74.9 
O-desmethyltramadol 101.2 118.1 104.4 99.4 
Drug precursor  Ephedrine/pseudoephedrine 69.0 60.9 77.5 87.0 
Stimulants 
Amphetamine 106.1 103.3 101.1 106.3 
Methamphetamine 98.1 107.8 93.4 92.2 
Cocaine 102.8 101.8 100.9 102.0 
Benzoylecgonine 121.6 116.9 112.8 119.9 
Cocaethylene 101.8 103.8 103.6 101.4 
Mephedrone 99.9 103.3 105.3 99.9 
Human indicators 
Creatinine 67.3 82.2 71.0 66.8 
Nicotine 80.2 108.3 77.6 82.4 
Caffeine 132.0 124.4 92.7 90.3 
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Cotinine 98.9 83.1 100.7 100.5 
1,7 dimethylxantine 122.2 114.6 67.3 60.7 
1 
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Table B2: Quantitative concentrations (ng.L-1) of the detected ECs in samples obtained from influent and effluent WWTW, and river water samples located upstream 
and downstream of the plant. Abbreviations: BEG – benzoylecgonine; DMX - 1,7-dimethylxantine; NDT – N-desmethyltramadol; ODT – O-desmethyltramadol; CBZ-
ep – carbamazepine epoxide;  dh-h-CBZ – 10,11-dihydro-10-hydroxycarbamazepine; DMV – desmethylvenlafaxine; dm-citalopram – desmethylcitalopram;  METH – 
methamphetamine; PSE/EPH – (pseudo)ephedrine; SMX - sulfamethoxazole. 
 
Concentration (ng.L-1, ± stdev) 
06/07/2015 (Monday) 07/07/2015 (Tuesday) 08/07/2015 (Wednesday) 09/07/2015 (Thursday) 10/07/2015 (Friday) 
US Inf. Eff. DS US Inf. Eff. DS US Inf. Eff. DS US Inf. Eff. DS US Inf. Eff. DS 
Chemicals in ESI- mode 
Atorvostatin 82 ±0.4 278 ±8.6 206 ±13.4 76 ±4.4 77 ±0.7 570 ±5.3 175 ±4.7 146 ±4.9 71 ±0.4 635 ±3.2 184 ±1.6 152 ±13.2 70 ±0.1 447 ±8.6 233 ±6.6 233 ±8.5 71 ±0.8 1101 ±12.3 252 ±4.9 146 ±1.8 
Benzophenone
-1 - 4552 ±2909.2 - - - 172 ±2.1 - - - 67 ±4.9 - - - 183 ±1.7 - - - 121 ±1.7 - - 
Benzophenone
-4 443 ±8.5 9085 ±49.5 2869 ±9.5 498 ±1.4 411 ±2.6 7280 ±70.7 2549 ±3.1 1584 ±0.9 448 ±7.4 7505 ±233.4 1978 ±3.3 1022 ±5.2 475 ±4.2 9710 ±70.7 1961 ±5.3 1184 ±7.8 429 ±0.6 9440 ±113.1 1904 ±4.4 1094 ±8.6 
Bezafibrate 46 ±1.3 1611 ±3.6 540 ±12.0 133 ±8.6 47 ±3.3 1952 ±5.6 664 ±3.7 427 ±2.5 56 ±4.9 1403 ±8.6 463 ±6.2 249 ±0.1 66 ±5.0 2998 ±10.3 405 ±2.1 206 ±1.1 59 ±0.9 1999 ±5.7 317 ±5.2 157 ±0.4 
Bisphenol A 167 ±0.1 944 ±39.5 301 ±0.8 614 ±95.5 
360 
±184.9 4043 ±273.9 223 ±7.4 616 ±452.3 213 ±3.1 1567 ±23.8 148 ±0.6 167 ±42.4 233 ±41.9 1640 ±121.1 225 ±0.6 338 ±18.9 223 ±8.7 1742 ±7.6 337 ±67.5 247 ±39.6 
Butylparaben - - - - - - - - - 39 ±2.3 - - - 165 ±1.6 - - - 173 ±4.5 - - 
Diclofenac 280 ±6.1 5579 ±231.5 2525 ±3.1 758 ±58.9 
647 
±388.3 4130 ±314.8 2285 ±4.3 
2182 
±233.3 354 ±4.9 2734 ±9.5 2152 ±2.0 
1570 
±161.6 393 ±0.1 2910 ±1.3 2283 ±8.8 1424 ±9.5 663 ±1.6 5647 ±0.5 
2385 
±106.1 1374 ±83.5 
Ethylparaben - 885 ±5.9 - - - 4649 ±9.3 - - - 1983 ±7.9 - - - 3279 ±17.1 - - - 2291 ±14.6 - - 
Fexofenadine 413 ±3.4 - 1384 ±2.1 591 ±14.9 347 ±2.5 0.8 ±1.1 
1198 
±10.4 1025 ±3.4 351 ±1.3 4114 ±63.2 1314 ±7.3 959 ±11.7 402 ±8.1 156 ±220.4 1216 ±3.1 891 ±6.8 330 ±5.4 3331 ±28.7 1613 ±6.9 968 ±0.8 
Ibuprofen 129 ±3.8 15780 ±410.1 1151 ±1.8 233 ±2.0 175 ±0.4 9055 ±7.1 1031 ±3.0 608 ±1.6 213 ±1.6 10865 ±431.3 444 ±4.8 145 ±0.7 125 ±1.5 14810 ±155.6 375 ±4.3 436 ±3.5 125 ±0.6 15250 ±240.4 304 ±0.5 138 ±1.5 
Irbesartan 305 ±4.1 1224 ±6.8 872 ±7.4 489 ±2.3 347 ±98.3 1133 ±2.2 908 ±2.8 759 ±45.8 273 ±2.8 897 ±1.6 772 ±3.5 563 ±2.2 299 ±10.7 1333 ±9.3 737 ±4.5 498 ±3.1 332 ±3.5 837 ±2.3 823 ±28.7 463 ±4.2 
Ketoprofen - 353 ±19.1 296 ±4.9 12 ±16.8 - 353 ±4.5 244 ±3.9 - - 500 ±6.9 394 ±3.4 341 ±1.5 - 1490 ±2.9 435 ±2.7 205 ±5.5 642 ±1.9 5586 ±4.1 665 ±4.5 764 ±2.9 
Methylparaben 26 ±0.3 6110 ±551.5 44 ±2.5 61 ±0.4 38 ±9.8 
30050 
±480.8 46 ±4.5 41 ±0.9 65 ±1.3 14455 ±49.5 132 ±48.9 117 ±49.7 102 ±0.2 12030 ±806.1 252 ±4.0 295 ±20.5 62 ±3.2 12800 ±961.7 76 ±10.7 216 ±18.0 
Naproxen 209 ±2.1 3675 ±21.2 2882 ±0.3 471 ±9.1 184 ±0.8 2925 ±21.2 2799 ±8.4 1899 ±64.9 
221 
±10.1 3205 ±21.2 2058 ±2.7 1070 ±10.7 243 ±4.9 5455 ±21.2 1993 ±7.3 1199 ±2.2 265 ±2.3 5295 ±49.5 1751 ±12.9 924 ±3.7 
Propylparaben - - - - 14 ±19.4 
10950 
±509.1 - - 21 ±0.2 15830 ±56.6 72 ±49.9 96 ±64.6 51 ±9.1 2835 ±162.6 144 ±19.9 225 ±13.9 41 ±51.1 1305 ±431.3 22 ±27.4 89 ±0.7 
Sulfasalazine 38 ±1.9 3330 ±0.0 163 ±1.4 36 ±1.8 43 ±11.5 3330 ±14.1 131 ±16.2 44 ±5.2 37 ±3.0 3335 ±7.1 67 ±15.2 67 ±23.7 35 ±1.8 3350 ±14.1 122 ±3.6 63 ±37.9 35 ±0.5 3440 ±99.0 79 ±22.5 55 ±28.9 
Valsartan 233 ±5.7 19660 ±919.2 2692 ±4.0 674 ±6.5 253 ±7.7 
17535 
±728.3 2834 ±3.0 1768 ±2.5 300 ±6.2 15620 ±452.6 1630 ±3.4 605 ±5.8 264 ±0.2 17510 ±664.7 1338 ±3.1 1020 ±6.9 269 ±2.1 17825 ±558.6 1131 ±4.7 556 ±0.8 
Chemicals in ESI+ mode 
Acetaminophe
n - 
232760 
±11229 61 ±5.4 27 ±4.0 24 ±2.4 
282675 
±8619 44 ±8.7 39 ±3.6 26 ±0.6 343620 ±25343 41 ±4.1 26 ±10.0 17 ±3.0 228893 ±15737 216 ±23.7 200 ±11.6 17 ±2.6 136887 ±680 123 ±10.8 27 ±1.6 
Amphetamine 18 ±0.3 1110 ±290.1 60 ±0.1 76 ±8.1 20 ±3.0 2591 ±332.6 184 ±2.5 38 ±4.8 67 ±2.3 535 ±74.2 94 ±2.4 29 ±6.7 17 ±2.8 760 ±61.2 73 ±2.7 21 ±2.0 14 ±0.1 256 ±12.0 54 ±5.8 22 ±2.8 
Atenolol 202 ±0.5 2541 ±13.1 392 ±26.0 193 ±10.0 158 ±15.5 1593 ±18.1 712 ±70.5 544 ±6.1 161 ±5.1 1745 ±18.6 537 ±17.8 241 ±22.6 155 ±7.9 1839 ±110.4 457 ±19.9 216 ±11.2 105 ±2.1 1627 ±101.5 364 ±12.1 166 ±1.4 
Azathioprine - 89 ±2.2 - - - 65 ±2.4 - - - 57 ±7.4 - - - 83 ±3.8 - - - 65 ±0.9 - - 
Azithromycin - 32 ±2.8 157 ±12.1 3 ±1.0 - 23 ±1.8 173 ±3.5 7 ±2.5 25 ±0.6 139 ±15.6 213 ±7.2 11 ±1.8 - 65 ±4.5 178 ±1.5 5 ±1.1 - 45 ±3.3 138 ±24.5 - 
Benzophenone
-3 54 ±0.5 173 ±9.3 79 ±0.2 58 ±1.8 55 ±0.4 211 ±3.7 75 ±3.5 62 ±6.4 57 ±0.1 103 ±8.1 87 ±9.5 60 ±5.9 59 ±0.5 137 ±1.3 77 ±3.3 71 ±3.8 56 ±1.3 63 ±4.1 76 ±6.7 70 ±5.2 
BEG - 514   ±0.9 7 ±0.8 - - 478 ±10.8 - - - 298 ±8.7 - - - 276 ±12.2 - - - 380 ±29.4 - - 
Carbamazepin
e 172 ±8.3 403 ±6.2 426 ±20.2 241 ±23.3 153 ±10.3 459 ±9.5 411 ±18.3 304 ±14.9 152 ±3.1 332 ±7.7 390 ±13.9 281 ±16.8 165 ±4.8 458 ±20.0 422 ±14.5 294 ±6.2 144 ±7.0 610 ±24.8 414 ±3.5 277 ±5.7 
CBZ-ep 421 ±3.3 1119 ±26.2 
1239 
±20.0 647 ±37.4 367 ±24.7 1183 ±44.3 1363 ±1.8 834 ±40.0 
398 
±11.6 1094 ±60.7 1159 ±9.6 733 ±26.5 432 ±10.1 1666 ±82.4 1235 ±4.2 765 ±21.4 376 ±8.9 1269 ±12.2 1184 ±30.6 783 ±20.9 
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1 
Caffeine 
573 
±171.6 15125 ±559.3 799 ±60.9 
1039 
±77.8 
784 
±117.9 5094 ±61.9 470 ±22.8 356 ±62.1 
950 
±77.9 
347155 
±30568.0 718 ±97.5 787 ±268.6 862 ±97.7 
1214375 
±21291.0 
3824 
±102.9 6646 ±122.1 
891 
±257.6 
389460 
±29090.0 2557 ±26.1 1559 ±41.3 
Cimetidine - 731 ±3.8 - - - 499 ±2.3 - - - 1337 ±86.3 - - - 454 ±23.5 - - - 1378 ±8.1 - - 
Clarithromycin 91 ±0.5 491 ±6.3 488 ±0.2 126 ±3.0 59 ±4.1 497 ±12.9 516 ±5.9 265 ±2.0 87 ±2.5 1541 ±2.4 603 ±0.4 235 ±5.0 67 ±4.7 953 ±2.1 495 ±5.7 250 ±2.7 78 ±0.2 260 ±39.9 579 ±0.1 302 ±8.2 
Cocaethylene - 225.5 ±4.5 - - - 186.0 ±39.1 - - - - - - - - - - - - - - 
Cocaine - 28 ±0.1 - - - 147 ±31.0 - - - 125 ±4.4 - - - 97 ±8.8 - - - 40 ±2.1 - - 
Codeine 1 ±0.4 1550 ±2.1 516 ±6.2 34 ±3.3 - 1011 ±4.8 401 ±3.0 216 ±1.8 15 ±2.8 1737 ±4.5 289 ±6.9 138 ±3.0 15 ±3.8 947 ±45.9 286 ±15.2 144 ±4.0 13 ±1.2 1070 ±22.1 235 ±4.1 112 ±1.1 
Cotinine 21 ±0.9 4892 ±3.8 32 ±0.1 35 ±0.0 23 ±1.3 3333 ±21.6 25 ±0.9 17 ±0.4 27 ±0.9 4493 ±19.2 23 ±0.9 23 ±4.2 27 ±2.6 4147 ±13.9 25 ±2.0 36 ±0.3 29 ±6.0 4266 ±0.8 35 ±2.2 47 ±1.8 
Creatinine - 2849 ±33.2 - - - 2939 ±9.5 - - - - - - - 4900 ±339.4 - - - 12625 ±374.8 - - 
dh-h-CBZ 23 ±2.5 33 ±0.5 110 ±1.7 41 ±5.6 21 ±1.6 55 ±3.6 110 ±2.1 62 ±2.0 21 ±1.0 42 ±3.7 99 ±3.5 60 ±2.5 24 ±1.0 137 ±1.6 103 ±0.8 61 ±3.0 24 ±1.5 196 ±4.8 98 ±4.5 60 ±0.2 
dm-citalopram - - 6 ±0.4 - - - 1 ±1.6 - - - 11 ±5.4 - - - 3 ±0.3 - - - 6 ±0.1 - 
DMX 262 ±96.0 237345 22 ±31.5 
471 
±551.8 24 ±33.2 163613 - 216 ±305.1 
901 
±37.5 16765 
716 
±1012.8 630 ±426.9 
452 
±579.0 110975 3705 
1641 
±1879.1 
759 
±962.0 147445 1216 
1830 
±2260.5 
DMV 60 ±0.9 - 297 ±11.0 80 ±6.9 43 ±9.7 171 ±21.9 287 ±10.0 191 ±6.4 44 ±1.6 206 ±2.0 317 ±3.7 192 ±13.8 56 ±4.1 245 ±15.1 337 ±1.3 200 ±18.4 47 ±1.3 323 ±43.6 334 ±1.8 212 ±15.9 
Gliclazide 46 ±0.3 671 ±219.1 79 ±2.3 19 ±26.7 43 ±1.1 169 ±2.5 58 ±1.3 60 ±8.8 41 ±0.4 258 ±34.9 48 ±0.8 47 ±1.1 41 ±0.1 304 ±0.5 68 ±5.6 75 ±4.4 45 ±0.6 135 ±7.1 71 ±1.3 69 ±2.7 
Iopromide 271 ±4.4 386 ±3.5 944 ±3.5 256 ±3.4 247 ±7.2 622 ±18.2 
1218 
±37.4 808 ±10.5 265 ±5.5 1029 ±23.2 1049 ±44.5 484 ±14.8 275 ±3.1 2762 ±232.6 1113 ±15.5 814 ±4.1 271 ±4.2 1172 ±56.8 978 ±100.9 629 ±24.4 
Lisinopril - - - - - - - - - 196 ±5.2 - - - 200 ±1.6 - - - - - - 
Mephedrone - - - - - - - - - 56 ±12.8 - - - 121 ±0.7 - - - 36 ±0.5 - - 
Metformin 75 ±0.1 9228 ±280.0 499 ±7.8 126 ±0.9 67 ±0.6 4799 ±122.9 566 ±30.6 316 ±43.1 78 ±0.6 3585 ±89.0 378 ±13.1 160 ±0.9 81 ±0.4 4723 ±14.1 295 ±37.2 161 ±0.9 65 ±0.9 4740 ±7.0 167 ±1.9 111 ±1.0 
METH - 450   ±6.7 0.2 ±0.3 - - 420 ±42.9 25 ±1.5 25 ±1.6 - 271 ±40.2 13 ±1.6 - - 315 ±15.1 4    ±1.8 - - 316 ±27.4 3 ±1.3 - 
Morphine - 687 ±30.6 - - - 414 ±5.4 - - - 391 ±4.4 - - - 474 ±40.8 - - - 457 ±25.2 - - 
NDT 7 ±1.3 - 111 ±1.8 65 ±5.1 8 ±0.6 145 ±12.9 95 ±5.7 69 ±4.2 29 ±4.8 149 ±11.9 121 ±10.0 84 ±21.1 24 ±12.4 - 115 ±3.0 72 ±8.3 12 ±5.8 33 ±2.8 126 ±0.4 81 ±2.8 
Nicotine 95 ±4.9 4874 ±95.0 182 ±1.3 268 ±1.9 108 ±21.5 
11866 
±138.5 175 ±4.7 182 ±0.2 
239 
±23.9 11866 ±141.4 174 ±4.8 232 ±4.5 241 ±38.0 10365 ±35.4 217 ±2.8 350 ±3.0 89 ±16.8 8625 ±190.9 169 ±7.3 195 ±6.4 
Norephedrine - 2914 ±890.7 - - - 1950 ±265.7 - - - 1107 ±357.7 - - - 852 ±20.8 - - - 772 ±34.1 - - 
Normorphine - - - - - 111 ±6.6 - - - 144 ±65.5 - - - 128 ±12.6 - - - 185 ±8.6 - - 
ODT 199 ±9.8 - 
1469 
±57.8 319 ±26.3 182 ±16.5 214 ±303.0 
1330 
±71.6 691 ±47.7 
254 
±10.0 1283 ±33.16 1139 ±33.3 594 ±54.2 227 ±10.0 - 1136 ±16.0 671 ±29.3 177 ±16.3 - 1056 ±55.1 612 ±14.1 
PSE/EPH 35 ±3.7 4885 ±77.8 177 ±3.6 61 ±1.5 30 ±4.6 4080 ±70.7 167 ±7.9 85 ±5.9 44 ±2.1 5720 ±254.6 109 ±0.7 43 ±8.6 50 ±1.8 - 113 ±14.9 102 ±1.5 36 ±3.8 16640 ±2152 138 ±7.8 111 ±5.6 
Ranitidine - 240 ±16.2 - - - 143 ±0.7 - - - 50 ±19.7 - - - 52 ±12.8 - - - 103 ±18.0 - - 
SMX 859 ±7.3 2589 ±3.2 
1560 
±18.6 711 ±6.3 749 ±29.7 554 ±16.5 1229 ±2.1 1283 ±69.7 
745 
±15.4 1339 ±6.0 1473 ±81.9 1351 ±43.1 801 ±56.9 806 ±4.8 1289 ±0.1 962 ±35.9 634 ±19.4 2521 ±46.1 1173 ±42.4 758 ±19.4 
Tramadol 101 ±2.3 - 549 ±0.9 169 ±0.8 87 ±5.2 480 ±0.6 495 ±4.0 337 ±0.4 92 ±3.1 411 ±4.4 514 ±4.6 324 ±0.1 116 ±1.2 503 ±4.5 514 ±43.5 332 ±3.2 94 ±0.1 493 ±9.6 540 ±18.5 337 ±0.9 
Trimethoprim 410 ±0.3 6249 ±34.8 1490 ±6.0 381 ±10.0 318 ±20.6 
11136 
±981.5 1117 ±4.0 879 ±1.8 419 ±4.1 7250 ±53.0 1446 ±11.2 1045 ±60.8 404 ±9.9 4537 ±296.4 1501 ±7.3 1067 ±31.5 363 ±3.7 4502 ±908.1 1676 ±24.1 1121 ±24.4 
Venlafaxine 34 ±0.4 - 148 ±5.3 60 ±3.2 36 ±2.2 461 ±22.0 126 ±1.0 102 ±0.6 34 ±1.3 335 ±21.2 143 ±3.2 107 ±4.7 42 ±0.0 270 ±0.0 140 ±4.5 101 ±6.3 32 ±1.1 275 ±21.2 155 ±3.6 104 ±0.0 
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Table B3: Average mass loads (g.day-1) determined for the ECs at influent and final effluent water in 1 
the WWTW. 2 
Chemical Class Compound Name 
Mass Load (g.day-1, av. ± stdev) Removal 
(%) Influent Effluent 
UV Filters Benzophenone-1 43.3 ±83.7 - 100 
 
Benzophenone-3 5.9 ±2.5 3.2 ±0.2 46 
 
Benzophenone-4 370.4 ±52.1 92.0 ±17.3 75 
Parabens Methylparaben 650.8 ±389.8 4.5 ±3.7 99 
 Ethylparaben 113.3 ±62.8 - 100 
 Propylparaben 331.2 ±289.8 3.3 ±2.6 99 
 Butylparaben 5.4 ±3.3 - 100 
Plastisizer Bisphenol A 85.8 ±52.1 10.1 ±3.0 88 
Antibiotics Azithromycin 2.6 ±2.0 7.0 ±1.1 -170 
 
Sulfasalazine 144.4 ±3.6 4.6 ±1.6 97 
 
Clarithromycin 32.2 ±21.6 21.9 ±1.9 32 
 
Sulfamethoxazole 66.7 ±40.0 54.9 ±6.2 18 
 Sulfasalazine 144.4 ±3.6 4.6 ±1.6 97 
 
Trimethoprim 289.6 ±118.1 59.1 ±8.2 80 
Hypertensions Irbesartan 46.8 ±9.9 33.6 ±2.8 28 
 Lisinopril 8.6 ±0.4 - 100 
 
Valsartan 758.4 ±63.3 78.6 ±32.0 90 
H2 receptor agonists Cimetidine 37.6 ±18.7 - 100 
 Ranitidine 5.0 ±3.3 - 100 
NSAIDs Ibuprofen 565.8 ±130.1 27.0 ±16.1 95 
 Ketoprofen 71.1 ±95.7 16.6 ±6.6 77 
 
Naproxen 177.3 ±53.3 93.8 ±20.7 47 
 
Diclofenac 180.2 ±58.3 95.1 ±5.6 47 
 
Acetaminophen 10530.2 ±3216.0 4.0 ±3.2 100 
Lipid Regulators Bezafibrate 86.1 ±28.6 19.5 ±5.4 77 
 
Atorvostatin 26.0 ±13.0 8.6 ±1.4 67 
Diabetes Metformin 232.6 ±92.0 15.6 ±6.5 93 
 
Gliclazide 13.2 ±9.0 2.6 ±0.5 80 
Beta-blockers Atenolol 80.3 ±16.2 20.1 ±5.8 75 
X-ray contrast media Iopromide 51.9 ±41.8 43.4 ±5.1 16 
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Anti-depressants & 
metabolites Venlafaxine 14.5 ±3.8 5.8 ±0.4 60 
 
Desmethylvenlafaxine 10.2 ±2.8 12.9 ±1.0 -26 
 Fluoxetine - 1.1 ±0.9 - 
 Desmethylcitalopram - 0.2 ±0.1 - 
Anti-epileptics & 
metabolites Carbamazepine 19.5 ±4.4 16.9 ±0.8 13 
 
10,11-dihydro-10-
hydroxycarbamazepine 4.0 ±3.1 4.2 ±0.3 -6 
 
Carbamazepine-10,11-
epoxide 54.6 ±11.4 50.5 ±3.9 7 
Antihistamine Fexofenadine 107.5 ±88.5 54.9 ±6.2 49 
Anti-cancer Azathioprine 3.1 ±0.6 -  100 
Analgaesics & 
metabolites Tramadol 15.7 ±9.3 21.3 ±0.8 -36 
 
N-desmethyltramadol 4.7 ±2.8 4.6 ±0.5 1 
 
O-desmethyltramadol 21.1 ±28.9 50.1 ±6.8 -58 
 
EDDP 0.6 ±0.0 0.6 ±0.0 5 
 
Codeine 54.1 ±14.3 14.1 ±4.5 74 
 Morphine 20.8 ±5.0 0.2 ± - 99 
 Normorphine 6.1 ±1.3 - 100 
Drug precursor 
Stimulants & metabolites 
(Pseudo)ephedrine 269.4 ±260.9 5.7 ±1.2 98 
Amphetamine 45.4 ±39.9 3.8 ±2.2 92 
Cocaine 3.8 ±2.3 0.4 ±0.0 90 
Benzoylecgonine 16.7 ±4.5 0.3 ± - 98 
Cocaethylene 8.8 ±1.1 - 100 
Methamphetamine 15.2 ±3.3 0.4 ±0.4 98 
Norephedrine 65.1 ±38.5 - 100 
Mephedrone 3.1 ±2.0 - 100 
Human indicators & 
metabolites Cotinine 181.6 ±22.9 1.1 ±0.2 99 
 
Nicotine 410.2 ±127.5 7.5 ±1.0 98 
 
1,7-dimethylxantine 5818.9 ±3420.3 48.7 ±63.2 99 
 
Caffeine 17224.1 ±21941.2 69.1 ±61.7 100 
 Creatinine 251.1 ±196.2 - 100 
 1 
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 1 
Figure B2: Percentage change of the detected ECs between final effluent water samples and river 2 
samples located downstream of the plant. Standard deviation shows variation between sampling days. 3 
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Table B4: Environmental risk calculation of the detected ECs based on conventional environmental risk assessment (ERA) and modulation of molecular 1 
initiating events (MIEs) and key events (KEs). Abbreviations: MEC – measured environmental concentration (based on concentrations in the current study); 2 
PNEC – predicted no-effect concentration (acute or chronic lethal toxicity outcomes); RQ – risk quotient (MEC.PNEC-1 or MEC.AOP conc.-1). An RQ > 1 is 3 
indicated in bold and reflects that the EC is of environmental concern. # Concentration of river water is a combination of both upstream and downstream water 4 
samples. 5 
 MEC (ug.L-1) Environmental Risk Assessment (ERA)  Molecular Initiating Events (MIEs) and Key Events (KEs) 
Compound Effluent River 
Water# 
PNEC 
(µg.L-1) 
Reference RQeff RQrw  Event  Conc. 
(µg.L-1) 
Reference RQeff 
 
RQrw 
Diclofenac 2.31 0.96 0.10 Bergmann et 
al., 2011 
23.1 10.0  Increased VTG gene 
expression in fish (MIE) 
1.0 Hong et al., 2007; 
Gröner et al., 2017 
2.31 0.96 
        Decreased thyroid hormone 
levels in fish (KE) 
1.0 Saravanan et al., 
2014 
2.31 0.96 
Ibuprofen 0.66 0.23 7.10 Carlsson et 
al., 2006a 
0.13 0.04  Lower thyroid-mediated 
mRNA transcripts in 
tadpoles (MIE) 
1.5 Veldhoen et al., 
2014 
0.44 0.15 
        Decreased egg fertilisation 
in fish (KE) 
0.1 Nesbitt, 2011 6.60 2.30 
Naproxen 2.30 0.67 3.30 Bergmann et 
al., 2011 
0.7 0.2  Decreased egg fertilisation 
in fish (KE) 
0.1 Nesbitt, 2011 23.0 6.7 
Carbamazepine 0.41 0.22 2.50 Ferrari et al., 
2003 
0.16 0.09  Lower keto-testosterone 
hormone levels in fish (KE) 
0.5 Galus et al., 2013 0.82 0.4 
Azithromycin 0.17 0.015 4.80 Bergmann et 
al., 2011 
0.04 0.003       
Iopromide  1.06 0.43 6800.0 Bergmann et 
al., 2011 
0.001 0.001       
Sulfamethoxazole 1.34 0.89 0.59 Bergmann et 
al., 2011 
2.27 1.51  Induction of VTG in fish 1000.0 Kang et al., 2006 0.001 0.001 
Acetaminophen 0.10 0.04 0.24 Bergmann et 
al., 2011 
0.42 0.17       
Clarithromycin 0.54 0.16 0.2 Bergmann et 
al., 2011 
2.7 0.8       
Irbesartan 0.82 0.43 100.0 Minguez et 
al.,2016 
0.01 0.004       
Valsartan 1.93 0.59 100.0 Minguez et 
al.,2016 
0.02 0.006       
Ketoprofen 0.41 0.39 3.10 Bergmann et 
al., 2011 
0.13 0.13       
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Bezafibrate 0.48 0.14 1.20 Bergmann et 
al., 2011 
0.4 0.12       
Tramadol 0.52 0.20 0.96 ECOSAR 0.54 0.21       
Venlafaxine 0.14 0.07 47.60 Minguez et 
al.,2016 
0.003 0.001       
Methamphetamine 0.009 - 2.30 ECOSAR 0.004 -       
Morphine   32.0 ECOSAR         
Cocaine 0.009 - 4.90 ECOSAR 0.002 -       
Benzoylecgonine   4.90 ECOSAR         
Codeine 0.35 0.08 0.06 ECOSAR 5.83 1.33       
Benzophenone* 1.16 0.41 6.00 ECOSAR 0.19 0.07       
Methylparaben 0.11 0.11 11.2 Carlsson et 
al., 2006b 
0.01 0.01  Increase VTG and lower 
GSI in fish 
8400.0 Barse et al., 2010 0.001 0.001 
Propylparaben 0.08 0.08      Increased VTG in fish 9.0 Scott, 2014 0.009 0.009 
Chloramphenicol   0.019 Bergmann et 
al., 2011 
        
Amphetamine 0.09 0.03 0.98 Bergmann et 
al., 2011 
0.09 0.03       
Bisphenol A 0.25 0.32 1.0 ECOSAR 0.25 0.32  Induction of VTG in fish 10.0 Villeneuve et al., 
2011 
0.03 0.03 
Atenolol 0.49 0.21 100.0 Minguez et 
al.,2016 
0.005 0.002       
Trimethoprim 1.45 0.64 20.0 Bergmann et 
al., 2011 
0.07 0.03       
Nicotine 0.18 0.20 0.014 Bergmann et 
al., 2011 
12.86 14.29       
1 
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APPENDIX C: SUPPLEMENTARY INFORMATION FOR CHAPTER 5 
Enantiomeric profiling and fate for drugs of abuse (DOA) during activated sludge 
treatment and environmental waters 
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Table C1: Concentrations (ng.L-1) calculated from Influent wastewater at WWTW1 over a 7-day period. 
Compound 
Concentration (ng.L-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 52.4 ± 3.1 60.8 ± 7.7 40.9 ± 6.1 91.3 ± 3.9 52.4 ± 0.1 145.1 ± 14.8 58.6 ± 2.5 
Benzoylecgonine 169.1 ± 5.5 197.6 ± 8.3 197.5 ± 8.5 162.3 ± 8.2 129.8 ± 4.5 346.3 ± 32.0 233.1 ± 3.5 
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine 20.2 ± 1.3 15.6 ± 5.8 15.5 ± 9.0 13.1 ± 3.5 18.8 ± 5.4 20.7 ± 5.4 17.0 ± 2.7 
R-(-)-methamphetamine 96.1 ± 11.0 69.1 ± 11.1 55.7 ± 8.8 83.0 ± 5.3 78.5 ± 1.3 102.7 ± 2.4 121.8 ± 9.2 
S-(+)-methamphetamine 444.2 ± 53.4 429.3 ± 54.2 248.5 ± 43.6 609.4 ± 12.2 417.0 ± 16.7 394.0 ± 35.1 773.9 ± 38.9 
R-(+)-mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-ephedrine/1R,2R-(-
)-pseudoephedrine 
1208.1 ± 28.1 965.8 ± 0.7 1472.6 ± 23.6 1749.9 ± 34.3 964.6 ± 12.1 1134.6 ± 97.3 1252.1 ± 106.4 
1S,2S-(+)-pseudoephedrine 1299.7 ± 4.7 822.1 ± 9.6 864.9 ± 0.2 1264.5 ± 3.8 943.5 ± 47.1 961.6 ± 79.4 893.7 ± 15.5 
E1-norephedrine 61.4 ± 3.4 47.4 ± 1.0 44.2 ± 4.0 55.2 ± 1.6 58.1 ± 0.6 55.5 ± 9.6 59.1 ± 0.2 
E2-norephedrine 100.8 ± 3.6 78.6 ± 1.5 69.1 ± 1.0 79.6 ± 1.5 81.8 ± 0.3 82.4 ± 2.7 94.5 ± 3.4 
Hallucinogens                      
R-(-)-MDMA 1.9 ± 0.1 1.7 ± 0.3 ND   ND   ND   ND   2.5 ± 0.2 
S-(+)-MDMA ND   0.7 ± 0.1 ND   ND   ND   ND   1.9 ± 0.4 
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA 4.9 ± 1.1 ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   7.2 ± 0.4 ND   8.0 ± 0.2 
Opioids                      
Codeine 1712.2 ± 40.3 1796.8 ± 115.3 1372.4 ± 8.5 1866.0 ± 74.6 1857.0 ± 145.6 1925.6 ± 9.8 2619.5 ± 233.7 
Dihydrocodeine 7.7 ± 0.7 10.4 ± 0.3 6.2 ± 1.1 10.3 ± 0.1 9.1 ± 0.5 13.7 ± 1.4 10.0 ± 1.3 
Hydrocodone ND   ND   ND   ND   ND   ND   ND   
Oxycodone 6.8 ± 0.6 ND   ND   4.2 ± 0.8 3.4 ± 0.7 3.2 ± 0.2 3.3 ± 0.8 
Morphine 407.2 ± 6.7 355.4 ± 41.1 328.9 ± 6.3 326.6 ± 10.3 291.8 ± 31.8 380.0 ± 6.9 400.8 ± 30.8 
Normorphine 150.2 ± 24.2 157.2 ± 5.7 88.9 ± 0.02 103.3 ± 8.0 105.8 ± 12.6 143.6 ± 21.4 127.3 ± 10.6 
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   ND   ND   ND   ND   ND   
E1-tramadol 459.9 ± 8.7 414.2 ± 38.2 143.5 ± 111.7 476.6 ± 26.6 593.4 ± 36.7 478.9 ± 15.8 577.7 ± 3.2 
E2-tramadol 364.5 ± 8.8 380.8 ± 4.4 357.2 ± 29.1 422.6 ± 19.0 460.8 ± 23.1 353.8 ± 9.9 507.9 ± 30.1 
O-desmethyltramadol 920.1 ± 7.2 907.4 ± 62.1 742.2 ± 17.3 768.6 ± 47.3 820.4 ± 48.6 880.2 ± 84.8 1122.3 ± 34.6 
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Methadone ND   ND   ND   ND   ND   ND   ND   
EDDP ND   ND   ND   ND   ND   ND   ND   
Antidepressants                      
E1-venlafaxine 75.8 ± 5.2 67.4 ± 7.6 31.4 ± 4.2 44.1 ± 3.9 26.4 ± 5.1 65.1 ± 0.8 42.1 ± 2.7 
E2-venlafaxine 75.1 ± 10.3 62.3 ± 5.2 27.3 ± 0.7 40.6 ± 3.4 26.9 ± 6.2 62.6 ± 0.4 36.3 ± 4.5 
E1-desmethylvenlafaxine 435.3 ± 61.3 348.3 ± 43.4 342.9 ± 70.7 406.6 ± 5.4 531.5 ± 17.2 460.4 ± 6.2 497.7 ± 27.0 
E2-desmethylvenlafaxine 276.0 ± 2.4 204.4 ± 14.9 206.5 ± 34.4 267.9 ± 6.9 334.4 ± 19.9 260.3 ± 25.4 285.1 ± 33.9 
Anaesthetics                      
Ketamine 4.7 ± 1.4 ND   1.9 ± 0.1 3.9 ± 1.6 399.0 ± 19.9 12.7 ± 1.0 5.5 ± 0.5 
Human biomarkers                      
Caffeine 231174.9 ± 3546.8 443400.9 ± 14578.8 230741.3 ± 6176.1 458704.1 ± 7592.3 270872.9 ± 13534.5 265864.3 ± 15780.7 133546.0 ± 2057.9 
1,7-dimethylxanthine 208044.4 ± 373.6 155020.9 ± 605.5 139927.1 ± 5497.6 106914.6 ± 2428.0 114163.6 ± 16617.6 162228.5 ± 15890.6 123071.2 ± 10808.4 
Nicotine 35442.8 ± 150.6 40987.4 ± 2713.4 20884.2 ± 1620.5 19262.9 ± 311.0 16939.7 ± 1187.7 26721.1 ± 2678.3 13423.7 ± 277.3 
Cotinine 3876.0 ± 57.2 3773.9 ± 112.6 3418.7 ± 123.8 3177.5 ± 51.4 3265.0 ± 80.4 3480.9 ± 251.0 3556.1 ± 54.7 
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Table C2: Concentrations (ng.L-1) calculated from Influent wastewater at WWTW2 over a 7-day period. 
Compound 
Concentration (ng.L-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 308.3 ± 7.6 217.3 ± 5.2 195.2 ± 12.4 107.8 ± 3.6 323.1 ± 1.3 349.7 ± 26.3 563.0 ± 3.3 
Benzoylecgonine 693.5 ± 86.5 517.7 ± 10.4 485.8 ± 21.3 409.6 ± 0.9 588.5 ± 0.1 840.2 ± 28.0 1084.2 ± 50.5 
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine 97.3 ± 0.6 90.5 ± 2.1 50.9 ± 6.6 62.1 ± 3.8 79.2 ± 0.1 100.6 ± 6.3 128.9 ± 11.1 
R-(-)-methamphetamine 112.1 ± 6.8 135.2 ± 3.8 119.3 ± 1.4 94.7 ± 4.5 118.7 ± 3.9 161.3 ± 19.1 183.5 ± 2.3 
S-(+)-methamphetamine 2317.6 ± 6.6 2171.9 ± 106.6 1828.3 ± 133.2 1587.4 ± 46.6 1889.8 ± 51.2 2877.1 ± 238.7 3226.4 ± 36.5 
R-(+)-mephedrone ND   2.0 ± 1.0 1.6 ± 0.1 ND   3.5 ± 0.1 1.6 ± 0.01 6.4 ± 0.4 
S-(-)-mephedrone 1.4 ± 0.5 2.0 ± 0.3 ND   ND   3.4 ± 0.3 1.1 ± 0.2 5.7 ± 1.5 
Precursors                      
1S,2R-(+)-ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-ephedrine/1R,2R-(-
)-pseudoephedrine 
374.1 ± 22.8 384.3 ± 14.7 274.1 ± 2.4 362.9 ± 14.1 373.6 ± 1.8 415.2 ± 4.9 461.1 ± 25.0 
1S,2S-(+)-pseudoephedrine 664.5 ± 38.0 718.1 ± 7.0 430.4 ± 8.8 501.0 ± 33.7 628.0 ± 27.9 580.0 ± 3.6 742.2 ± 5.1 
E1-norephedrine 25.1 ± 1.7 27.7 ± 4.3 5.7 ± 0.4 26.6 ± 14.6 18.0 ± 0.1 16.7 ± 3.7 22.2 ± 1.2 
E2-norephedrine 41.5 ± 0.5 48.1 ± 1.5 19.1 ± 0.6 29.7 ± 2.2 44.6 ± 1.3 39.7 ± 0.3 46.9 ± 1.1 
Hallucinogens                      
R-(-)-MDMA 34.5 ± 0.1 13.8 ± 0.2 13.5 ± 1.0 7.6 ± 0.1 10.0 ± 1.4 28.0 ± 0.4 57.5 ± 1.1 
S-(+)-MDMA 12.8 ± 0.1 5.4 ± 0.6 6.2 ± 0.4 3.9 ± 0.2 6.4 ± 0.6 19.3 ± 0.6 34.4 ± 0.02 
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA 10.7 ± 0.5 7.3 ± 1.8 ND   ND   ND   10.8 ± 0.4 16.0 ± 0.9 
S-(+)-HMMA 12.1 ± 0.9 9.5 ± 0.8 9.5 ± 1.0 9.1 ± 0.7 8.6 ± 0.1 ND   19.2 ± 0.9 
Opioids                      
Codeine 11527.4 ± 1184.3 9856.0 ± 632.5 10426.3 ± 244.9 20567.7 ± 213.5 10402.5 ± 86.9 1987.8 ± 100.0 1663.2 ± 88.7 
Dihydrocodeine 59.7 ± 1.0 30.4 ± 3.4 33.9 ± 2.2 24.7 ± 2.1 17.5 ± 0.4 10.6 ± 4.9 10.5 ± 2.2 
Hydrocodone ND   ND   ND   ND   ND   ND   ND   
Oxycodone ND   ND   ND   ND   ND   4.8 ± 1.8 6.6 ± 1.2 
Morphine 9379.7 ± 1078.0 3585.8 ± 422.8 4002.8 ± 123.0 4528.2 ± 3.8 3757.4 ± 83.2 927.5 ± 193.0 761.0 ± 10.1 
Normorphine ND   173.8 ± 39.5 ND   131.8 ± 3.4 139.4 ± 25.5 ND   152.3 ± 26.3 
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   29.9 ± 4.5 34.1 ± 8.8 66.0 ± 3.7 28.2 ± 0.1 29.3 ± 3.2 
E1-tramadol 756.0 ± 39.6 732.1 ± 7.1 763.6 ± 4.8 695.1 ± 25.8 682.8 ± 27.5 768.6 ± 71.3 950.5 ± 15.7 
E2-tramadol 694.5 ± 19.3 732.6 ± 25.3 645.7 ± 38.2 679.8 ± 27.8 651.8 ± 0.2 788.9 ± 32.6 870.4 ± 6.5 
O-desmethyltramadol 2129.2 ± 180.1 2135.5 ± 204.3 2147.2 ± 229.7 2382.4 ± 5.9 2011.6 ± 28.2 1901.9 ± 58.5 2073.8 ± 77.7 
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Methadone ND   ND   ND   ND   ND   ND   ND   
EDDP 2.8 ± 0.8 ND   4.6 ± 1.1 0.6 ± 0.04 2.4 ± 0.1 2.9 ± 0.4 2.9 ± 0.2 
Antidepressants                      
E1-venlafaxine 127.3 ± 1.8 102.7 ± 1.4 105.1 ± 2.2 82.7 ± 3.5 77.0 ± 3.1 88.1 ± 6.2 114.7 ± 2.4 
E2-venlafaxine 132.7 ± 8.0 109.2 ± 0.7 104.7 ± 3.0 85.6 ± 1.5 83.4 ± 5.4 95.6 ± 3.5 114.1 ± 2.3 
E1-desmethylvenlafaxine 386.0 ± 17.8 380.5 ± 1.0 413.7 ± 72.5 384.0 ± 10.0 274.9 ± 21.7 329.4 ± 21.5 424.9 ± 1.2 
E2-desmethylvenlafaxine 211.4 ± 4.9 219.1 ± 2.5 226.2 ± 2.6 200.4 ± 8.6 162.5 ± 8.8 223.2 ± 27.6 251.0 ± 18.3 
Anaesthetics                      
Ketamine 4.9 ± 0.6 17.1 ± 2.9 ND   5.5 ± 1.2 5.5 ± 0.3 ND   ND   
Human biomarkers                      
Caffeine 104776.3 ± 7150.1 89854.1 ± 1409.1 8717.4 ± 6253.5 90543.8 ± 34.4 93770.0 ± 3717.6 66837.7 ± 2029.0 54565.1 ± 846.4 
1,7-dimethylxanthine 316160.1 ± 37977.5 271209.5 ± 3961.2 203751.1 ± 21425.9 178205.7 ± 26396.4 255945.2 ± 337.1 256005.4 ± 247.9 217148.0 ± 10490.7 
Nicotine 90513.1 ± 4649.8 66786.7 ± 251.4 90344.6 ± 3118.0 64497.6 ± 2072.2 74124.6 ± 1890.5 82624.5 ± 9212.2 66578.1 ± 2832.6 
Cotinine 5523.0 ± 298.5 4762.3 ± 2.4 4503.2 ± 89.8 4038.7 ± 83.1 5097.3 ± 139.1 5666.8 ± 108.5 5654.2 ± 0.8 
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Table C3: Mass loads (g.day-1) calculated from Influent wastewater at WWTW1 over a 7-day period. 
Compound 
Mass Load (g.day-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 2.7 ± 0.2 3.0 ± 0.4 2.1 ± 0.3 5.0 ± 0.2 2.3 ± 0.01 7.2 ± 0.7 3.0 ± 0.1 
Benzoylecgonine 8.7 ± 0.3 9.9 ± 0.4 10.3 ± 0.4 8.8 ± 0.4 5.6 ± 0.2 17.3 ± 1.6 12.0 ± 0.2 
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine 1.0 ± 0.1 0.8 ± 0.3 0.8 ± 0.5 0.7 ± 0.2 0.8 ± 0.2 1.0 ± 0.3 0.9 ± 0.1 
R-(-)-methamphetamine 11.4 ± 1.3 8.0 ± 1.3 6.7 ± 1.1 10.4 ± 0.7 7.8 ± 0.1 11.8 ± 0.3 14.5 ± 1.1 
S-(+)-methamphetamine 54.8 ± 6.6 51.7 ± 6.5 31.0 ± 5.4 79.6 ± 1.6 43.1 ± 1.7 47.1 ± 4.2 96.0 ± 4.8 
R-(+)-mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-ephedrine/1R,2R-(-)-pseudoephedrine 62.1 ± 1.4 48.4 ± 0.03 76.6 ± 1.2 95.2 ± 1.9 41.5 ± 0.5 56.5 ± 4.9 64.7 ± 5.5 
1S,2S-(+)-pseudoephedrine 66.8 ± 0.2 41.2 ± 0.5 45.0 ± 0.01 68.8 ± 0.2 40.6 ± 2.0 47.9 ± 4.0 46.2 ± 0.8 
E1-norephedrine 3.2 ± 0.2 2.4 ± 0.05 2.3 ± 0.2 3.0 ± 0.1 2.5 ± 0.03 2.8 ± 0.5 3.1 ± 0.01 
E2-norephedrine 5.2 ± 0.2 3.9 ± 0.1 3.6 ± 0.1 4.3 ± 0.1 3.5 ± 0.01 4.1 ± 0.1 4.9 ± 0.2 
Hallucinogens                      
R-(-)-MDMA 0.1 ± 0.01 0.1 ± 0.01 ND   ND   ND   ND   0.1 ± 0.01 
S-(+)-MDMA ND   0.04 ± 0.005 ND   ND   ND   ND   0.1 ± 0.02 
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA 0.2 ± 0.1 ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   0.3 ± 0.02 ND   0.4 ± 0.01 
Opioids                      
Codeine 88.0 ± 2.1 90.1 ± 5.8 71.4 ± 0.4 101.5 ± 4.1 79.9 ± 6.3 96.0 ± 0.5 135.4 ± 12.1 
Dihydrocodeine 0.4 ± 0.03 0.5 ± 0.01 0.3 ± 0.1 0.6 ± 0.01 0.4 ± 0.02 0.7 ± 0.1 0.5 ± 0.1 
Hydrocodone ND   ND   ND   ND   ND   ND   ND   
Oxycodone 0.3 ± 0.03 ND   ND   0.2 ± 0.05 0.1 ± 0.03 0.2 ± 0.01 0.2 ± 0.04 
Morphine 20.9 ± 0.3 17.8 ± 2.1 17.1 ± 0.3 17.8 ± 0.6 12.6 ± 1.4 18.9 ± 0.3 20.7 ± 1.6 
Normorphine 7.7 ± 1.2 7.9 ± 0.3 4.6 ± 0.001 5.6 ± 0.4 4.6 ± 0.5 7.2 ± 1.1 6.6 ± 0.5 
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   ND   ND   ND   ND   ND   
E1-tramadol 23.6 ± 0.4 20.8 ± 1.9 21.5 ± 5.8 25.9 ± 1.4 25.5 ± 1.6 23.9 ± 0.8 29.9 ± 0.2 
E2-tramadol 18.7 ± 0.5 19.1 ± 0.2 18.6 ± 1.5 23.0 ± 1.0 19.8 ± 1.0 17.6 ± 0.5 26.3 ± 1.6 
O-desmethyltramadol 47.3 ± 0.4 45.5 ± 3.1 38.6 ± 0.9 41.8 ± 2.6 35.3 ± 2.1 43.9 ± 4.2 58.0 ± 1.8 
Methadone ND   ND   ND   ND   ND   ND   ND   
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EDDP ND   ND   ND   ND   ND   ND   ND   
Antidepressants                      
E1-venlafaxine 3.9 ± 0.3 3.4 ± 0.4 1.6 ± 0.2 2.4 ± 0.2 1.1 ± 0.2 3.2 ± 0.04 2.2 ± 0.1 
E2-venlafaxine 3.9 ± 0.5 3.1 ± 0.3 1.4 ± 0.04 2.2 ± 0.2 1.2 ± 0.3 3.1 ± 0.02 1.9 ± 0.2 
E1-desmethylvenlafaxine 22.4 ± 3.2 17.5 ± 2.2 17.8 ± 3.7 22.1 ± 0.3 22.9 ± 0.7 22.9 ± 0.3 25.7 ± 1.4 
E2-desmethylvenlafaxine 14.2 ± 0.1 10.3 ± 0.7 10.7 ± 1.8 14.6 ± 0.4 14.4 ± 0.9 13.0 ± 1.3 14.7 ± 1.8 
Anaesthetics                      
Ketamine 0.2 ± 0.1 ND   0.1 ± 0.004 0.2 ± 0.1 17.2 ± 0.9 0.6 ± 0.05 0.3 ± 0.03 
Human biomarkers                      
Caffeine 11882.4 ± 182.3 22241.0 ± 731.3 11998.5 ± 321.2 24948.9 ± 412.9 11658.4 ± 582.5 13250.7 ± 786.5 6904.3 ± 106.4 
1,7-dimethylxanthine 10693.5 ± 19.2 7775.8 ± 30.4 7276.2 ± 285.9 5815.1 ± 132.1 4913.6 ± 715.2 8085.5 ± 792.0 6362.8 ± 558.8 
Nicotine 1821.8 ± 7.7 2055.9 ± 136.1 1086.0 ± 84.3 1047.7 ± 16.9 729.1 ± 51.1 1331.8 ± 133.5 694.0 ± 14.3 
Cotinine 199.2 ± 2.9 189.3 ± 5.6 177.8 ± 6.4 172.8 ± 2.8 140.5 ± 3.5 173.5 ± 12.5 183.8 ± 2.8 
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Table C4: Mass loads (g.day-1) calculated from Influent wastewater at WWTW2 over a 7-day period. 
Compound 
Mass Load (g.day-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 25.3 ± 0.6 18.3 ± 0.4 16.0 ± 1.0 8.8 ± 0.3 27.1 ± 0.1 25.9 ± 1.9 40.0 ± 0.2 
Benzoylecgonine 56.9 ± 7.1 43.5 ± 0.9 39.8 ± 1.7 33.6 ± 0.1 49.4 ± 0.01 62.2 ± 2.1 77.0 ± 3.6 
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine 8.0 ± 0.05 7.6 ± 0.2 4.2 ± 0.5 5.1 ± 0.3 6.7 ± 0.01 7.4 ± 0.5 9.2 ± 0.8 
R-(-)-methamphetamine 21.1 ± 1.3 26.1 ± 0.7 25 ± 0.3 17.9 ± 0.8 22.9 ± 0.8 27.5 ± 3.2 30.0 ± 0.4 
S-(+)-methamphetamine 456.1 ± 1.3 437.9 ± 21.5 359.8 ± 26.2 312.4 ± 9.2 381.0 ± 10.3 511.0 ± 42.4 549.8 ± 6.2 
R-(+)-mephedrone ND   1.1 ± 0.5 0.9 ± 0.04 ND   1.9 ± 0.03 0.8 ± 0.004 2.9 ± 0.2 
S-(-)-mephedrone 0.8 ± 0.3 1.1 ± 0.2 ND   ND   1.9 ± 0.2 0.5 ± 0.1 2.6 ± 0.7 
Precursors                      
1S,2R-(+)-ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-ephedrine/1R,2R-(-)-pseudoephedrine 30.7 ± 1.9 32.3 ± 1.2 22.5 ± 0.2 29.8 ± 1.2 31.4 ± 0.1 30.7 ± 0.4 32.7 ± 1.8 
1S,2S-(+)-pseudoephedrine 54.5 ± 3.1 60.3 ± 0.6 35.3 ± 0.7 41.1 ± 2.8 52.8 ± 2.3 42.9 ± 0.3 52.7 ± 0.4 
E1-norephedrine 2.1 ± 0.2 2.3 ± 0.4 0.5 ± 0.03 2.2 ± 1.2 1.5 ± 0.01 1.2 ± 0.3 1.6 ± 0.1 
E2-norephedrine 3.4 ± 0.04 4.0 ± 0.1 1.6 ± 0.1 2.4 ± 0.2 3.7 ± 0.1 2.9 ± 0.02 3.3 ± 0.1 
Hallucinogens                      
R-(-)-MDMA 2.8 ± 0.01 1.1 ± 0.01 1.1 ± 0.1 0.6 ± 0.01 0.8 ± 0.1 2.1 ± 0.03 4.1 ± 0.1 
S-(+)-MDMA 1.1 ± 0.01 0.4 ± 0.1 0.5 ± 0.04 0.3 ± 0.02 0.5 ± 0.1 1.4 ± 0.04 2.4 ± 0.002 
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA 0.9 ± 0.04 0.6 ± 0.1 ND   ND   ND   0.8 ± 0.03 1.1 ± 0.1 
S-(+)-HMMA 1.0 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.7 ± 0.1 0.7 ± 0.01 ND   1.4 ± 0.1 
Opioids                      
Codeine 945.2 ± 97.1 827.9 ± 53.1 855.0 ± 20.1 1686.5 ± 17.5 873.8 ± 7.3 147.1 ± 7.4 118.1 ± 6.3 
Dihydrocodeine 4.9 ± 0.1 2.6 ± 0.3 2.8 ± 0.2 2.0 ± 0.2 1.5 ± 0.04 0.8 ± 0.4 0.7 ± 0.2 
Hydrocodone ND   ND   ND   ND   ND   ND   ND   
Oxycodone ND   ND   ND   ND   ND   0.4 ± 0.1 0.5 ± 0.1 
Morphine 769.1 ± 88.4 301.2 ± 35.5 328.2 ± 10.1 371.3 ± 0.3 315.6 ± 7.0 68.6 ± 14.3 54.0 ± 0.7 
Normorphine ND   14.6 ± 3.3 ND   10.8 ± 0.3 11.7 ± 2.1 ND   10.8 ± 1.9 
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   2.5 ± 0.4 2.8 ± 0.7 5.5 ± 0.3 2.1 ± 0.005 2.1 ± 0.2 
E1-tramadol 62.0 ± 3.2 61.5 ± 0.6 62.6 ± 0.4 57.0 ± 2.1 57.4 ± 2.3 56.9 ± 5.3 67.5 ± 1.1 
E2-tramadol 57.0 ± 1.6 61.5 ± 2.1 52.9 ± 3.1 55.7 ± 2.3 54.8 ± 0.03 58.4 ± 2.4 61.8 ± 0.5 
O-desmethyltramadol 174.6 ± 14.8 179.4 ± 17.2 176.1 ± 18.8 195.4 ± 0.5 169.0 ± 2.4 140.7 ± 4.3 147.2 ± 5.5 
Methadone ND   ND   ND   ND   ND   ND   ND   
EDDP 0.2 ± 0.1 ND   0.4 ± 0.1 0.05 ± 0.03 0.2 ± 0.01 0.2 ± 0.03 0.2 ± 0.01 
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Antidepressants                      
E1-venlafaxine 10.4 ± 0.1 8.6 ± 0.1 8.6 ± 0.2 6.8 ± 0.3 6.5 ± 0.3 6.5 ± 0.5 8.1 ± 0.2 
E2-venlafaxine 10.9 ± 0.7 9.2 ± 0.1 8.6 ± 0.2 7.0 ± 0.1 7.0 ± 0.5 7.1 ± 0.3 8.1 ± 0.2 
E1-desmethylvenlafaxine 31.6 ± 1.5 32.0 ± 0.1 33.9 ± 5.9 31.5 ± 0.8 23.1 ± 1.8 24.4 ± 1.6 30.2 ± 0.1 
E2-desmethylvenlafaxine 17.3 ± 0.4 18.4 ± 0.2 18.5 ± 0.2 16.4 ± 0.7 13.7 ± 0.7 16.5 ± 2.0 17.8 ± 1.3 
Anaesthetics                      
Ketamine 0.4 ± 0.05 1.4 ± 0.2 ND   0.5 ± 0.1 0.5 ± 0.03 ND   ND   
Human biomarkers                      
Caffeine 8591.7 ± 586.3 7547.7 ± 118.4 7148.1 ± 512.8 7424.6 ± 2.8 7876.7 ± 312.3 4946.0 ± 150.1 3874.1 ± 60.1 
1,7-dimethylxanthine 25925.1 ± 3114.2 22781.6 ± 332.7 16707.6 ± 1756.9 14612.9 ± 2164.5 21499.4 ± 28.3 18944.4 ± 18.3 15417.5 ± 744.8 
Nicotine 7422.1 ± 381.3 5610.1 ± 21.1 7408.3 ± 255.7 5288.8 ± 169.9 6226.5 ± 158.8 6114.2 ± 681.7 4727.0 ± 201.1 
Cotinine 452.9 ± 24.5 400.0 ± 0.2 369.3 ± 7.4 331.2 ± 6.8 428.2 ± 11.7 419.3 ± 8.0 401.5 ± 0.1 
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Table C5: Concentrations (ng.L-1) calculated from Effluent wastewater at WWTW1 over a 7-day period. 
Compound 
Concentration (ng.L-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 0.6 ± 0.03 ND   ND   ND   ND   ND   ND   
Benzoylecgonine 9.0 ± 0.01 12.9 ± 0.5 14.3 ± 3.0 ND   14.4 ± 0.5 11.0 ± 0.8 52.6 ± 1.9 
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine ND   ND   ND   ND   ND   ND   ND   
R-(-)-methamphetamine 34.1 ± 3.3 26.4 ± 0.02 29.3 ± 5.0 44.8 ± 0.4 52.9 ± 4.9 35.6 ± 0.5 49.1 ± 4.0 
S-(+)-methamphetamine 20.5 ± 5.1 3.3 ± 0.8 3.7 ± 1.0 2.3 ± 0.3 7.6 ± 0.1 7.0 ± 0.4 148.4 ± 16.9 
R-(+)-mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-ephedrine/1R,2R-(-)-pseudoephedrine 26.8 ± 0.7 38.9 ± 0.004 41.6 ± 1.6 49.1 ± 3.6 32.2 ± 0.8 31.3 ± 0.5 217.5 ± 17.9 
1S,2S-(+)-pseudoephedrine ND   ND   ND   ND   ND   ND   73.3 ± 2.7 
E1-norephedrine 0.6 ± 0.7 ND   ND   5.0 ± 1.7 2.6 ± 0.4 0.7 ± 0.4 ND   
E2-norephedrine ND   ND   ND   ND   ND   ND   10.4 ± 0.7 
Hallucinogens                      
R-(-)-MDMA ND   0.3 ± 0.03 ND   ND   ND   ND   ND   
S-(+)-MDMA ND   ND   ND   ND   ND   ND   ND   
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA ND   ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   ND   ND   ND   
Opioids                      
Codeine 71.9 ± 5.6 51.8 ± 0.2 57.5 ± 2.2 11.8 ± 3.1 76.4 ± 3.9 10.9 ± 3.6 149.4 ± 1.7 
Dihydrocodeine ND   ND   ND   ND   4.2 ± 0.2 ND   ND   
Hydrocodone ND   ND   31.6 ± 3.2 21.1 ± 0.5 40.4 ± 3.3 ND   ND   
Oxycodone ND   ND   ND   ND   ND   ND   ND   
Morphine ND   ND   ND   ND   ND   ND   ND   
Normorphine ND   ND   ND   ND   ND   ND   ND   
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   ND   ND   ND   ND   ND   
E1-tramadol 284.4 ± 6.1 253.4 ± 12.4 339.6 ± 10.3 302.1 ± 6.6 402.1 ± 30.3 193.7 ± 1.5 252.1 ± 19.8 
E2-tramadol 239.4 ± 5.0 182.3 ± 0.7 242.2 ± 10.4 246.0 ± 11.0 285.4 ± 8.2 153.3 ± 9.1 205.5 ± 10.9 
O-desmethyltramadol 490.5 ± 39.9 681.6 ± 21.2 767.3 ± 28.4 638.7 ± 39.1 905.1 ± 85.3 264.4 ± 48.6 157.1 ± 3.0 
Methadone ND   ND   ND   ND   ND   ND   ND   
EDDP ND   ND   ND   ND   ND   ND   ND   
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Antidepressants                      
E1-venlafaxine 62.5 ± 1.6 49.4 ± 4.4 70.9 ± 6.8 71.6 ± 0.4 85.7 ± 5.5 43.6 ± 3.8 43.6 ± 6.2 
E2-venlafaxine 47.7 ± 2.2 38.3 ± 1.7 54.6 ± 10.2 53.2 ± 5.1 63.2 ± 1.0 34.6 ± 0.3 37.8 ± 4.5 
E1-desmethylvenlafaxine 302.9 ± 8.9 263.7 ± 1.4 340.2 ± 19.1 258.8 ± 4.4 444.4 ± 14.2 138.6 ± 0.5 111.1 ± 8.9 
E2-desmethylvenlafaxine 174.4 ± 3.6 148.9 ± 28.8 194.6 ± 33.4 152.3 ± 0.7 246.6 ± 11.0 72.8 ± 12.5 56.3 ± 23.3 
Anaesthetics                      
Ketamine 26.1 ± 3.7 9.8 ± 0.02 6.6 ± 0.8 6.8 ± 0.3 28.4 ± 0.6 61.4 ± 3.0 28.1 ± 7.1 
Human biomarkers                      
Caffeine 1556.5 ± 301.4 548.9 ± 17.7 658.1 ± 55.8 96.0 ± 41.2 107.1 ± 21.0 161.4 ± 17.5 23732.5 ± 864.0 
1,7-dimethylxanthine 913.6 ± 464.8 927.5 ± 16.5 1913.2 ± 117.9 252.3 ± 0.9 303.9 ± 7.1 337.1 ± 43.0 27964.2 ± 1107.0 
Nicotine 186.7 ± 160.4 394.9 ± 5.5 558.4 ± 117.9 200.6 ± 55.0 637.7 ± 109.7 195.6 ± 75.5 206.8 ± 36.1 
Cotinine 33.9 ± 19.7 77.5 ± 0.9 88.7 ± 1.0 27.6 ± 0.1 57.1 ± 0.6 31.6 ± 3.3 331.0 ± 5.8 
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Table C6: Concentrations (ng.L-1) calculated from Effluent wastewater at WWTW2 over a 7-day period. 
Compound 
Concentration (ng.L-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 1.1 ± 0.3 1.0 ± 0.05 1.7 ± 1.5 0.7 ± 0.2 0.8 ± 0.2 1.1 ± 0.4 ND   
Benzoylecgonine 39.8 ± 12.7 34.2 ± 1.4 52.9 ± 6.9 32.9 ± 3.3 28.0 ± 0.4 39.9 ± 2.8 52.6 ± 4.4 
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine ND   ND   ND   ND   ND   ND   ND   
R-(-)-methamphetamine 27.1 ± 2.4 29.1 ± 0.2 29.7 ± 3.2 26.8 ± 1.6 27.3 ± 1.3 30.5 ± 2.5 30.7 ± 5.3 
S-(+)-methamphetamine 135.3 ± 2.2 151.9 ± 1.8 105.0 ± 16.9 104.3 ± 4.7 96.6 ± 6.6 102.8 ± 5.8 108.7 ± 19.1 
R-(+)-mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-ephedrine/1R,2R-(-)-pseudoephedrine 58.0 ± 2.3 57.9 ± 1.6 62.6 ± 0.1 63.8 ± 1.4 48.2 ± 4.5 46.2 ± 5.0 46.3 ± 1.9 
1S,2S-(+)-pseudoephedrine 16.7 ± 2.9 20.2 ± 2.1 ND   ND   ND   11.1 ± 0.8 12.5 ± 1.1 
E1-norephedrine 4.5 ± 2.3 4.8 ± 0.3 6.1 ± 1.0 4.0 ± 0.7 5.7 ± 2.1 5.3 ± 1.3 5.1 ± 1.3 
E2-norephedrine ND   ND   ND   ND   ND   ND   ND   
Hallucinogens                      
R-(-)-MDMA 9.3 ± 2.3 8.7 ± 0.4 6.2 ± 0.9 4.0 ± 0.2 2.9 ± 0.04 3.1 ± 0.3 5.3 ± 1.0 
S-(+)-MDMA ND   ND   ND   ND   ND   ND   1.1 ± 0.06 
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA ND   ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   ND   ND   ND   
Opioids                      
Codeine ND   88.6 ± 0.8 22.6 ± 1.5 42.8 ± 3.8 93.5 ± 4.0 26.4 ± 4.2 ND   
Dihydrocodeine ND   4.6 ± 0.2 ND   ND   ND   ND   ND   
Hydrocodone 59.9 ± 21.0 68.3 ± 4.6 ND   ND   167.1 ± 2.3 148.5 ± 18.9 81.3 ± 7.0 
Oxycodone ND   ND   ND   ND   ND   ND   ND   
Morphine ND   ND   ND   ND   62.1 ± 3.2 ND   ND   
Normorphine ND   ND   ND   ND   ND   ND   ND   
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   ND   ND   ND   ND   ND   
E1-tramadol 656.0 ± 0.9 682.9 ± 1.1 821.3 ± 97.9 716.2 ± 25.5 768.2 ± 10.4 802.2 ± 16.2 731.1 ± 74.3 
E2-tramadol 499.5 ± 8.5 554.5 ± 11.8 692.7 ± 89.4 574.2 ± 3.8 577.9 ± 5.1 586.5 ± 34.4 498.8 ± 48.8 
O-desmethyltramadol 1141.0 ± 272.4 1228.8 ± 90.4 1949.5 ± 41.4 1336.1 ± 25.8 1683.2 ± 63.9 1654.4 ± 138.2 1225.1 ± 106.2 
Methadone ND   ND   ND   ND   ND   ND   ND   
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EDDP ND   ND   ND   ND   ND   ND   ND   
Antidepressants                      
E1-venlafaxine 90.9 ± 1.1 102.2 ± 2.0 112.5 ± 1.8 108.9 ± 18.0 106.6 ± 3.5 111.3 ± 3.1 105.1 ± 16.9 
E2-venlafaxine 68.1 ± 2.8 81.2 ± 0.7 90.3 ± 3.7 98.0 ± 5.1 81.1 ± 1.9 83.1 ± 1.9 81.1 ± 15.7 
E1-desmethylvenlafaxine 324.4 ± 23.8 398.9 ± 17.3 572.8 ± 22.0 460.4 ± 58.5 469.8 ± 8.2 452.5 ± 26.8 312.6 ± 51.0 
E2-desmethylvenlafaxine 188.7 ± 6.3 235.0 ± 31.1 382.4 ± 42.1 294.5 ± 36.4 307.5 ± 13.5 268.4 ± 36.6 216.7 ± 20.9 
Anaesthetics                      
Ketamine ND   2.8 ± 0.4 5.4 ± 0.9 4.2 ± 0.3 3.3 ± 1.1 ND   2.8 ± 1.0 
Human biomarkers                      
Caffeine 409.1 ± 115.4 591.1 ± 15.7 864.4 ± 71.7 273.3 ± 24.4 145.8 ± 33.6 171.0 ± 25.7 298.9 ± 76.3 
1,7-dimethylxanthine 2789.5 ± 1670.4 4250.9 ± 180.3 2905.7 ± 397.3 2103.4 ± 128.4 1441.4 ± 41.2 1232.6 ± 118.3 1505.7 ± 277.7 
Nicotine 1053.6 ± 765.2 1751.9 ± 10.8 1301.1 ± 327.5 331.0 ± 119.4 282.2 ± 9.1 481.9 ± 26.8 1325.8 ± 371.7 
Cotinine 66.4 ± 38.4 104.3 ± 5.1 73.1 ± 11.2 34.6 ± 1.8 27.5 ± 2.5 34.2 ± 7.3 55.1 ± 11.6 
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Table C7: Mass loads (g.day-1) calculated from Effluent wastewater at WWTW1 over a 7-day period. 
Compound 
Mass Load (g.day-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 0.03 ± 0.002 ND   ND   ND   ND   ND   ND   
Benzoylecgonine 0.4 ± 0.001 0.6 ± 0.02 0.7 ± 0.2 ND   0.6 ± 0.02 0.5 ± 0.04 2.6 ± 0.1 
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine ND   ND   ND   ND   ND   ND   0.1 ± 0.01 
R-(-)-methamphetamine 1.5 ± 0.1 1.1 ± 0.001 1.3 ± 0.2 2.1 ± 0.02 2.0 ± 0.2 1.5 ± 0.02 2.2 ± 0.2 
S-(+)-methamphetamine 1.0 ± 0.2 0.2 ± 0.04 0.2 ± 0.05 0.1 ± 0.02 0.3 ± 0.01 0.3 ± 0.02 7.3 ± 0.8 
R-(+)-mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-ephedrine/1R,2R-(-)-pseudoephedrine 1.3 ± 0.03 1.9 ± 0.0002 2.1 ± 0.1 2.5 ± 0.2 1.3 ± 0.03 1.5 ± 0.02 10.7 ± 0.9 
1S,2S-(+)-pseudoephedrine ND   ND   ND   ND   ND   ND   3.6 ± 0.1 
E1-norephedrine 0.03 ± 0.04 ND   ND   0.3 ± 0.09 0.1 ± 0.02 0.03 ± 0.02 ND   
E2-norephedrine ND   ND   ND   ND   ND   ND   0.5 ± 0.03 
Hallucinogens                      
R-(-)-MDMA ND   0.01 ± 0.001 ND   ND   ND   ND   ND   
S-(+)-MDMA ND   ND   ND   ND   ND   ND   ND   
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA ND   ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   ND   ND   ND   
Opioids                      
Codeine 3.5 ± 0.3 2.5 ± 0.01 2.8 ± 0.1 0.6 ± 0.2 3.1 ± 0.2 0.5 ± 0.2 7.3 ± 0.1 
Dihydrocodeine ND   ND   ND   ND   0.2 ± 0.01 ND   ND   
Hydrocodone ND   ND   1.6 ± 0.2 1.1 ± 0.03 1.7 ± 0.1 ND   ND   
Oxycodone ND   ND   ND   ND   ND   ND   ND   
Morphine ND   ND   ND   ND   ND   ND   ND   
Normorphine ND   ND   ND   ND   ND   ND   ND   
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   ND   ND   ND   ND   ND   
E1-tramadol 13.9 ± 0.3 12.1 ± 0.6 16.8 ± 0.5 15.6 ± 0.3 16.4 ± 1.2 9.2 ± 0.1 12.4 ± 1.0 
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E2-tramadol 11.7 ± 0.2 8.7 ± 0.03 12.0 ± 0.5 12.7 ± 0.6 11.7 ± 0.3 7.3 ± 0.4 10.1 ± 0.5 
O-desmethyltramadol 23.9 ± 1.9 32.5 ± 1.0 37.9 ± 1.4 33.0 ± 2.0 37.0 ± 3.5 12.5 ± 2.3 7.7 ± 0.1 
Methadone ND   ND   ND   ND   ND   ND   ND   
EDDP ND   ND   ND   ND   ND   ND   ND   
Antidepressants                      
E1-venlafaxine 3.0 ± 0.1 2.4 ± 0.2 3.5 ± 0.3 3.7 ± 0.02 3.5 ± 0.2 2.1 ± 0.2 2.1 ± 0.3 
E2-venlafaxine 2.3 ± 0.1 1.8 ± 0.1 2.7 ± 0.5 2.7 ± 0.3 2.6 ± 0.04 1.6 ± 0.02 1.9 ± 0.2 
E1-desmethylvenlafaxine 14.8 ± 0.4 12.6 ± 0.1 16.8 ± 0.9 13.4 ± 0.2 18.2 ± 0.6 6.6 ± 0.2 5.5 ± 0.4 
E2-desmethylvenlafaxine 8.5 ± 0.2 7.1 ± 1.4 9.6 ± 1.7 7.9 ± 0.04 10.1 ± 0.5 3.4 ± 0.6 2.8 ± 1.1 
Anaesthetics                      
Ketamine 1.3 ± 0.2 0.5 ± 0.001 0.3 ± 0.04 0.3 ± 0.02 1.2 ± 0.02 2.9 ± 0.1 1.4 ± 0.3 
Human biomarkers                      
Caffeine 76.0 ± 14.7 26.2 ± 0.8 32.5 ± 2.8 5.0 ± 2.1 4.4 ± 0.9 7.6 ± 0.8 1165.5 ± 42.4 
1,7-dimethylxanthine 44.6 ± 22.7 44.2 ± 0.8 94.5 ± 5.8 13.0 ± 0.05 12.4 ± 0.3 15.9 ± 0.2 1373.3 ± 54.4 
Nicotine 9.1 ± 7.8 18.8 ± 0.3 27.6 ± 5.8 10.4 ± 2.8 26.1 ± 4.5 9.3 ± 3.6 10.2 ± 1.8 
Cotinine 1.7 ± 1.0 3.7 ± 0.04 4.4 ± 0.05 1.4 ± 0.005 2.3 ± 0.02 1.5 ± 0.2 16.3 ± 0.3 
 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 203 
 
Table C8: Mass loads (g.day-1) calculated from Effluent wastewater at WWTW2 over a 7-day period. 
Compound 
Mass loads (g.day-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 0.1 ± 0.02 0.1 ± 0.005 0.1 ± 0.1 0.1 ± 0.02 0.1 ± 0.02 0.1 ± 0.04 ND   
Benzoylecgonine 3.2 ± 1.0 2.7 ± 0.1 4.1 ± 0.5 2.7 ± 0.3 2.2 ± 0.03 2.8 ± 0.2 3.3 ± 0.4 
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine ND   ND   ND   ND   ND   ND   ND   
R-(-)-methamphetamine 2.0 ± 0.2 2.1 ± 0.02 2.1 ± 0.1 2.0 ± 0.1 2.0 ± 0.1 1.9 ± 0.3 1.7 ± 0.3 
S-(+)-methamphetamine 11.0 ± 0.2 11.8 ± 0.1 8.1 ± 0.7 8.6 ± 0.4 7.6 ± 0.5 7.1 ± 0.4 6.8 ± 1.2 
R-(+)-mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-ephedrine/1R,2R-(-)-pseudoephedrine 4.7 ± 0.2 4.5 ± 0.1 4.8 ± 0.01 5.3 ± 0.1 3.8 ± 0.4 3.2 ± 0.3 2.9 ± 0.1 
1S,2S-(+)-pseudoephedrine 1.8 ± 0.3 2.0 ± 0.2 ND   ND   ND   1.0 ± 0.1 1.0 ± 0.1 
E1-norephedrine 0.4 ± 0.2 0.4 ± 0.03 0.5 ± 0.04 0.3 ± 0.1 0.5 ± 0.2 0.4 ± 0.1 0.3 ± 0.1 
E2-norephedrine ND   0.1 ± 0.1 ND   ND   ND   ND   ND   
Hallucinogens                      
R-(-)-MDMA 0.8 ± 0.2 0.8 ± 0.04 0.3 ± 0.04 0.3 ± 0.02 0.3 ± 0.005 0.3 ± 0.04 0.5 ± 0.1 
S-(+)-MDMA ND   ND   ND   ND   ND   ND   0.1 ± 0.01 
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA ND   ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   ND   ND   ND   
Opioids                      
Codeine ND   6.9 ± 0.1 1.7 ± 0.1 3.5 ± 0.3 7.4 ± 0.5 1.8 ± 0.5 ND   
Dihydrocodeine ND   0.4 ± 0.02 ND   ND   ND   ND   ND   
Hydrocodone 4.9 ± 1.6 5.3 ± 0.4 ND   ND   13.1 ± 0.3 10.3 ± 2.0 5.1 ± 0.7 
Oxycodone ND   ND   ND   ND   ND   ND   ND   
Morphine ND   ND   ND   ND   2.2 ± 0.4 ND   ND   
Normorphine ND   ND   ND   ND   ND   ND   ND   
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   ND   ND   ND   ND   ND   
E1-tramadol 53.5 ± 0.1 53.0 ± 0.1 63.1 ± 4.0 59.2 ± 2.1 60.5 ± 1.2 55.4 ± 1.7 45.5 ± 7.3 
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E2-tramadol 40.7 ± 0.6 43.0 ± 1.1 53.2 ± 3.6 47.4 ± 0.3 45.5 ± 0.6 40.5 ± 3.7 31.0 ± 4.8 
O-desmethyltramadol 93.0 ± 20.6 95.4 ± 8.6 149.7 ± 1.7 110.4 ± 2.1 132.5 ± 5.0 114.35 ± 9.5 76.2 ± 6.6 
Methadone ND   ND   ND   ND   ND   ND   ND   
EDDP 0.06 ± 0.01 ND   ND   ND   ND   ND   0.2 ± 0.003 
Antidepressants                      
E1-venlafaxine 7.4 ± 0.1 7.9 ± 0.2 8.6 ± 0.1 9.0 ± 1.5 8.4 ± 0.4 7.7 ± 0.3 6.5 ± 1.7 
E2-venlafaxine 5.6 ± 0.2 6.3 ± 0.1 6.9 ± 0.2 8.1 ± 0.4 6.4 ± 0.2 5.7 ± 0.2 5.0 ± 1.5 
E1-desmethylvenlafaxine 26.4 ± 1.9 31.0 ± 1.3 44.0 ± 1.7 38.0 ± 4.8 37.0 ± 0.6 31.3 ± 1.9 19.4 ± 3.2 
E2-desmethylvenlafaxine 15.4 ± 0.5 18.2 ± 2.4 29.4 ± 3.2 24.3 ± 3.0 24.2 ± 1.1 18.5 ± 2.5 13.5 ± 1.3 
Anaesthetics                      
Ketamine ND   0.2 ± 0.04 0.4 ± 0.04 0.4 ± 0.02 0.3 ± 0.1 ND   0.2 ± 0.1 
Human biomarkers                      
Caffeine 33.3 ± 8.7 45.9 ± 1.5 66.4 ± 2.9 22.6 ± 2.0 11.5 ± 3.8 11.8 ± 2.8 18.6 ± 7.5 
1,7-dimethylxanthine 227.3 ± 126.1 329.9 ± 17.1 223.9 ± 16.2 173.7 ± 10.4 113.4 ± 4.7 85.2 ± 12.7 93.7 ± 27.4 
Nicotine 85.9 ± 57.8 135.9 ± 1.0 99.9 ± 13.3 27.3 ± 9.6 22.2 ± 1.0 33.3 ± 2.9 82.5 ± 36.6 
Cotinine 5.4 ± 2.9 8.1 ± 0.5 5.6 ± 0.5 2.9 ± 0.1 2.2 ± 0.3 2.4 ± 0.8 3.4 ± 1.1 
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Table C9: Concentrations (ng.L-1) calculated from RASliquid samples at WWTW1 over a 7-day period. 
Compound 
Concentration (ng.L-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine ND   ND   ND   0.3 ± 0.004 ND   ND   0.4 ± 0.001 
Benzoylecgonine ND   ND   ND   ND   ND   ND   ND   
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine ND   ND   ND   ND   ND   ND   ND   
R-(-)-methamphetamine ND   32.9 ± 0.3 45.2 ± 4.1 35.3 ± 1.0 54.3 ± 9.0 ND   84.1 ± 1.5 
S-(+)-methamphetamine ND   2.5 ± 0.7 5.1 ± 1.2 9.4 ± 1.0 6.1 ± 0.7 ND   264.4 ± 6.9 
R-(+)-mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-ephedrine ND   ND   5.6 ± 0.6 8.5 ± 0.7 8.3 ± 0.2 ND   8.8 ± 1.0 
1R,2S-(-)-ephedrine/1R,2R-(-)-
pseudoephedrine 
ND   ND   23.5 ± 1.6 60.5 ± 1.9 55.6 ± 1.5 ND   218.0 ± 11.3 
1S,2S-(+)-pseudoephedrine ND   ND   ND   9.1 ± 0.7 ND   ND   45.2 ± 0.3 
E1-norephedrine ND   ND   ND   ND   ND   ND   ND   
E2-norephedrine ND   ND   ND   ND   ND   ND   ND   
Hallucinogens                      
R-(-)-MDMA ND   ND   ND   ND   0.5 ± 0.01 ND   0.9 ± 0.04 
S-(+)-MDMA ND   ND   ND   ND   ND   ND   ND   
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA ND   ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   ND   ND   ND   
Opioids                      
Codeine ND   5.3 ± 0.3 8.9 ± 2.0 15.1 ± 2.7 4.8 ± 0.01 ND   274.6 ± 29.9 
Dihydrocodeine ND   ND   ND   ND   ND   ND   ND   
Hydrocodone ND   40.8 ± 3.9 58.3 ± 6.2 57.6 ± 3.7 47.6 ± 1.3 ND   60.2 ± 4.7 
Oxycodone ND   ND   ND   ND   ND   ND   ND   
Morphine ND   4.9 ± 1.4 2.7 ± 0.4 5.3 ± 2.1 3.1 ± 0.01 ND   47.7 ± 5.8 
Normorphine ND   ND   ND   ND   ND   ND   ND   
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   ND   ND   ND   ND   ND   
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E1-tramadol ND   474.4 ± 20.4 444.6 ± 71.6 298.7 ± 3.8 442.8 ± 72.2 ND   423.7 ± 0.6 
E2-tramadol ND   355.2 ± 23.9 322.1 ± 21.6 220.4 ± 11.7 327.0 ± 60.3 ND   353.1 ± 7.4 
O-desmethyltramadol ND   625.2 ± 36.2 660.1 ± 4.0 430.9 ± 8.2 620.5 ± 46.6 ND   791.2 ± 104.9 
Methadone ND                     
EDDP ND                     
Antidepressants                      
E1-venlafaxine ND   106.1 ± 0.3 97.3 ± 21.2 66.1 ± 2.1 97.5 ± 14.4 ND   90.8 ± 0.4 
E2-venlafaxine ND   79.8 ± 3.2 75.5 ± 2.0 58.1 ± 1.0 73.4 ± 16.8 ND   74.4 ± 1.6 
E1-desmethylvenlafaxine ND   418.1 ± 15.7 434.2 ± 36.5 247.7 ± 12.2 412.3 ± 79.2 ND   439.3 ± 7.6 
E2-desmethylvenlafaxine ND   410.8 ± 51.0 275.6 ± 14.0 149.3 ± 6.5 240.8 ± 42.9 ND   238.7 ± 0.8 
Anaesthetics                      
Ketamine ND   13.1 ± 1.5 11.5 ± 1.8 14.0 ± 0.01 197.7 ± 37.3 ND   62.6 ± 3.5 
Human biomarkers                      
Caffeine ND   234.8 ± 4.6 194.8 ± 34.3 202.9 ± 14.3 452.2 ± 35.8 ND   316.5 ± 16.2 
1,7-dimethylxanthine ND   566.0 ± 21.2 551.9 ± 157.9 640.9 ± 33.4 1545.4 ± 4.3 ND   3282.9 ± 84.9 
Nicotine ND   381.9 ± 41.5 423.8 ± 8.5 788.4 ± 27.6 825.2 ± 15.0 ND   259.0 ± 86.3 
Cotinine ND   ND   ND   ND   ND   ND   ND   
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Table C10: Concentrations (ng.L-1) calculated from RASliquid samples at WWTW2 over a 7-day period. 
Compound 
Concentration (ng.L-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 0.4 ± 0.001 ND   1.0 ± 0.1 ND   ND   ND   0.3 ± 0.004 
Benzoylecgonine ND   ND   ND   ND   ND   ND   ND   
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine ND   ND   ND   ND   ND   ND   ND   
R-(-)-methamphetamine 32.0 ± 0.1 31.8 ± 2.1 31.1 ± 4.6 25.2 ± 4.4 30.6 ± 1.8 ND   32.3 ± 3.3 
S-(+)-methamphetamine 108.1 ± 6.6 130.8 ± 16.3 79.2 ± 4.2 90.7 ± 6.6 84.3 ± 13.1 ND   76.4 ± 13.0 
R-(+)-mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-ephedrine/1R,2R-(-)-
pseudoephedrine 
ND   ND   ND   ND   ND   ND   ND   
1S,2S-(+)-pseudoephedrine 9.8 ± 0.7 9.2 ± 0.1 ND   ND   7.2 ± 0.8 ND   ND   
E1-norephedrine ND   ND   ND   ND   ND   ND   ND   
E2-norephedrine ND   ND   ND   ND   ND   ND   ND   
Hallucinogens                      
R-(-)-MDMA 6.4 ± 0.1 8.1 ± 0.7 6.4 ± 1.3 4.1 ± 0.6 2.6 ± 0.04 ND   3.4 ± 0.7 
S-(+)-MDMA ND   1.1 ± 0.1 ND   0.4 ± 0.01 ND   ND   ND   
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA ND   ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   ND   ND   ND   
Opioids                      
Codeine 7.1 ± 1.2 8.0 ± 0.4 6.6 ± 0.3 15.1 ± 1.0 15.3 ± 0.6 ND   8.8 ± 0.8 
Dihydrocodeine ND   ND   ND   ND   ND   ND   ND   
Hydrocodone 180.2 ± 14.3 184.7 ± 18.7 89.7 ± 5.2 213.5 ± 1.9 318.2 ± 12.7 ND   269.0 ± 16.5 
Oxycodone ND   ND   ND   ND   ND   ND   ND   
Morphine 4.9 ± 0.5 8.2 ± 4.5 15.4 ± 1.0 14.4 ± 1.5 21.7 ± 3.4  ±  8.2 ± 0.4 
Normorphine ND   ND   ND   ND   ND   ND   ND   
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   ND   ND   ND   ND   ND   
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E1-tramadol 1005.6 ± 56.9 936.1 ± 37.1 1047.9 ± 102.5 989.3 ± 8.0 940.0 ± 34.8 ND   926.6 ± 154.7 
E2-tramadol 701.3 ± 14.1 726.9 ± 37.7 806.1 ± 51.4 755.6 ± 35.6 683.4 ± 33.4 ND   679.1 ± 106.1 
O-desmethyltramadol 1910.2 ± 107.8 1980.3 ± 332.8 2194.4 ± 214.3 1829.4 ± 64.0 1773.0 ± 224.9 ND   1701.8 ± 35.5 
Methadone ND   ND   ND   ND   ND   ND   ND   
EDDP ND   ND   ND   ND   ND   ND   ND   
Antidepressants                      
E1-venlafaxine 122.0 ± 0.7 148.2 ± 6.6 156.7 ± 17.7 136.3 ± 5.9 123.2 ± 4.7 ND   119.1 ± 22.6 
E2-venlafaxine 104.3 ± 10.7 127.8 ± 7.0 134.6 ± 10.1 118.8 ± 1.5 112.1 ± 3.8 ND   108.1 ± 11.3 
E1-desmethylvenlafaxine 713.8 ± 9.3 625.2 ± 51.3 547.0 ± 164.6 725.7 ± 49.8 676.4 ± 77.0 ND   594.3 ± 59.5 
E2-desmethylvenlafaxine 382.6 ± 0.2 380.1 ± 5.8 393.9 ± 10.1 416.6 ± 1.8 401.8 ± 23.5 ND   378.9 ± 5.8 
Anaesthetics                      
Ketamine ND   3.1 ± 0.04 3.5 ± 1.3 3.9 ± 0.7 3.8 ± 0.6 ND   4.3 ± 1.0 
Human biomarkers                      
Caffeine 349.1 ± 48.2 289.1 ± 280.8 362.5 ± 22.1 457.6 ± 100.6 196.9 ± 27.5 ND   1656.1 ± 458.1 
1,7-dimethylxanthine 1376.8 ± 121.7 864.2 ± 111.5 684.0 ± 36.8 ND   575.7 ± 65.8 ND   5159.4 ± 352.4 
Nicotine 740.8 ± 1.1 125.1 ± 54.4 418.9 ± 169.6 688.7 ± 22.4 337.6 ± 29.3 ND   4523.4 ± 4.0 
Cotinine ND   ND   ND   ND   ND   ND   ND   
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Table C11: Concentrations (ng.L-1) calculated from Upstream river water at WWTW1 over the 7-day sampling period. 
Compound 
Concentration (ng.L-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine ND   ND   ND   ND   ND   ND   ND   
Benzoylecgonine 4.7 ± 0.03 3.7 ± 0.1 2.8 ± 1.2 ND   ND   2.7 ± 0.4 2.8 ± 0.8 
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine ND   ND   ND   ND   ND   ND   ND   
R-(-)-methamphetamine 5.8 ± 0.3 5.8 ± 1.0 3.2 ± 0.05 3.7 ± 0.3 4.4 ± 0.3 5.3 ± 0.7 5.2 ± 0.4 
S-(+)-methamphetamine 1.3 ± 0.1 5.0 ± 1.0 1.0 ± 0.2 1.0 ± 0.03 0.9 ± 0.2 0.8 ± 0.2 1.0 ± 0.05 
R-(+)-mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-ephedrine 0.5 ± 0.3 0.6 ± 0.2 0.2 ± 0.02 0.5 ± 0.03 1.1 ± 0.1 0.9 ± 0.1 0.7 ± 0.1 
1R,2S-(-)-ephedrine/1R,2R-(-)-
pseudoephedrine 
18.8 ± 0.1 22.9 ± 0.8 16.9 ± 0.3 18.2 ± 0.4 20.3 ± 0.3 20.0 ± 0.2 18.6 ± 0.4 
1S,2S-(+)-pseudoephedrine 3.6 ± 0.03 5.6 ± 0.1 3.1 ± 0.3 3.7 ± 0.1 4.1 ± 0.1 3.8 ± 0.04 3.5 ± 0.1 
E1-norephedrine ND   ND   ND   ND   ND   ND   ND   
E2-norephedrine ND   ND   ND   ND   ND   ND   ND   
Hallucinogens                      
R-(-)-MDMA ND   ND   ND   ND   ND   ND   ND   
S-(+)-MDMA ND   ND   ND   ND   ND   ND   ND   
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA ND   ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   ND   ND   ND   
Opioids                      
Codeine 5.5 ± 1.4 9.4 ± 1.3 ND   4.1 ± 0.3 ND   4.2 ± 1.5 5.0 ± 0.3 
Dihydrocodeine ND   ND   ND   ND   ND   ND   ND   
Hydrocodone ND   4.3 ± 0.03 ND   ND   ND   4.5 ± 0.3 5.2 ± 0.3 
Oxycodone ND   ND   ND   ND   ND   ND   ND   
Morphine ND   ND   ND   ND   ND   ND   ND   
Normorphine ND   ND   ND   ND   ND   ND   ND   
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   ND   ND   ND   ND   ND   
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E1-tramadol 48.5 ± 0.4 40.9 ± 2.9 21.3 ± 1.7 21.5 ± 1.5 33.5 ± 3.1 43.0 ± 2.2 54.3 ± 1.9 
E2-tramadol 41.6 ± 0.5 32.5 ± 2.4 15.3 ± 1.6 19.5 ± 0.3 29.4 ± 0.2 32.9 ± 2.2 44.6 ± 1.4 
O-desmethyltramadol 73.2 ± 2.3 56.8 ± 1.1 53.3 ± 2.6 53.4 ± 1.7 51.9 ± 1.1 66.9 ± 0.4 72.1 ± 1.1 
Methadone ND   ND   ND   ND   ND   ND   ND   
EDDP ND   ND   ND   ND   ND   ND   ND   
Antidepressants                      
E1-venlafaxine 8.8 ± 0.5 6.5 ± 0.3 2.5 ± 0.02 3.6 ± 0.2 5.1 ± 0.2 8.1 ± 0.4 8.9 ± 0.4 
E2-venlafaxine 7.3 ± 0.7 5.8 ± 0.6 2.5 ± 0.3 3.6 ± 0.2 5.3 ± 0.6 7.0 ± 0.8 7.8 ± 0.9 
E1-desmethylvenlafaxine 52.2 ± 3.4 43.2 ± 0.2 12.1 ± 0.1 16.6 ± 0.2 35.9 ± 5.0 44.2 ± 7.3 51.3 ± 3.6 
E2-desmethylvenlafaxine 31.0 ± 0.2 28.3 ± 0.3 9.0 ± 0.9 12.6 ± 0.2 22.4 ± 1.4 32.0 ± 1.6 34.4 ± 4.0 
Anaesthetics                      
Ketamine 2.9 ± 0.8 2.8 ± 0.03 1.6 ± 0.3 1.8 ± 0.2 1.7 ± 0.5 2.7 ± 0.2 2.3 ± 0.1 
Human biomarkers                      
Caffeine 1100.0 ± 16.1 779.1 ± 18.3 461.4 ± 40.9 405.3 ± 0.6 104.4 ± 7.7 358.5 ± 19.6 579.8 ± 12.9 
1,7-dimethylxanthine 634.9 ± 32.8 1298.5 ± 31.8 505.7 ± 305.1 660.8 ± 39.0 165.1 ± 7.3 537.3 ± 6.9 345.2 ± 1.2 
Nicotine 83.5 ± 0.8 108.1 ± 8.8 312.4 ± 139.7 243.1 ± 5.2 16.6 ± 2.2 69.9 ± 6.9 140.1 ± 0.3 
Cotinine 22.6 ± 0.5 48.5 ± 1.3 22.8 ± 5.0 32.8 ± 1.1 14.8 ± 0.8 34.8 ± 0.9 23.7 ± 1.1 
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Table C12: Concentrations (ng.L-1) calculated from Downstream river water at WWTW1 over the 7-day sampling period. 
Compound 
Concentration (ng.L-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 5.2 ± 0.1 ND   ND   ND   ND   ND   ND   
Benzoylecgonine 34.9 ± 3.2 8.7 ± 0.6 5.4 ± 0.4 6.3 ± 0.6 6.1 ± 0.4 5.8 ± 0.3 7.4 ± 0.2 
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine ND   ND   ND   ND   ND   ND   ND   
R-(-)-methamphetamine 31.7 ± 2.9 33.1 ± 0.2 14.0 ± 1.7 15.5 ± 2.5 24.4 ± 7.9 10.8 ± 2.0 10.7 ± 0.7 
S-(+)-methamphetamine 178.8 ± 0.9 10.5 ± 0.7 2.1 ± 0.1 3.0 ± 0.7 4.8 ± 0.9 1.9 ± 0.9 1.7 ± 0.03 
R-(+)-mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-ephedrine ND   1.7 ± 0.1 ND   1.4 ± 0.2 3.1 ± 0.03 1.6 ± 0.1 1.2 ± 0.002 
1R,2S-(-)-ephedrine/1R,2R-(-)-
pseudoephedrine 
142.6 ± 14.7 30.8 ± 1.4 20.1 ± 0.3 22.4 ± 1.6 36.9 ± 0.5 23.8 ± 1.7 21.3 ± 0.1 
1S,2S-(+)-pseudoephedrine 46.2 ± 6.0 5.3 ± 0.4 ND   ND   6.0 ± 0.02 ND   ND   
E1-norephedrine 5.4 ± 0.2 2.0 ± 0.03 ND   ND   1.9 ± 0.1 ND   ND   
E2-norephedrine ND   ND   ND   ND   ND   ND   ND   
Hallucinogens                      
R-(-)-MDMA ND   ND   ND   ND   ND   ND   ND   
S-(+)-MDMA ND   ND   ND   ND   ND   ND   ND   
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA ND   ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   ND   ND   ND   
Opioids                      
Codeine 217.5 ± 4.1 29.7 ± 0.2 11.3 ± 2.6 12.5 ± 1.0 26.5 ± 0.3 ND   4.3 ± 1.2 
Dihydrocodeine ND   ND   ND   ND   ND   ND   ND   
Hydrocodone ND   ND   ND   ND   ND   ND   ND   
Oxycodone ND   ND   ND   ND   ND   ND   ND   
Morphine ND   ND   ND   ND   ND   ND   ND   
Normorphine ND   ND   ND   ND   ND   ND   ND   
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   ND   ND   ND   ND   ND   
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E1-tramadol 157.0 ± 0.6 196.2 ± 0.1 122.6 ± 4.9 119.5 ± 5.4 185.5 ± 40.8 60.3 ± 0.03 55.6 ± 0.4 
E2-tramadol 121.2 ± 21.0 149.3 ± 10.9 94.9 ± 10.3 96.5 ± 4.7 141.6 ± 46.8 48.4 ± 1.4 38.6 ± 0.7 
O-desmethyltramadol 392.5 ± 1.4 421.3 ± 10.7 251.2 ± 2.4 198.9 ± 1.9 410.1 ± 24.4 62.9 ± 1.0 64.2 ± 0.5 
Methadone ND   ND   ND   ND   ND   ND   ND   
EDDP ND   ND   ND   ND   ND   ND   ND   
Antidepressants                      
E1-venlafaxine 28.2 ± 1.4 47.9 ± 0.1 25.0 ± 0.9 24.9 ± 0.1 39.2 ± 8.2 16.0 ± 0.5 14.4 ± 1.7 
E2-venlafaxine 22.9 ± 0.2 37.2 ± 0.4 19.3 ± 1.3 19.9 ± 0.1 28.9 ± 9.4 12.5 ± 0.5 10.9 ± 0.3 
E1-desmethylvenlafaxine 144.3 ± 4.5 187.3 ± 5.3 119.1 ± 0.9 101.7 ± 4.5 149.7 ± 6.6 25.9 ± 2.3 24.0 ± 0.6 
E2-desmethylvenlafaxine 76.7 ± 4.0 106.2 ± 8.0 75.4 ± 2.2 59.1 ± 2.4 101.1 ± 25.5 14.8 ± 0.4 15.5 ± 0.8 
Anaesthetics                      
Ketamine 22.6 ± 0.8 12.9 ± 0.04 5.6 ± 0.2 3.8 ± 0.4 4.1 ± 1.3 17.2 ± 0.5 28.3 ± 1.2 
Human biomarkers                      
Caffeine 21130.9 ± 1148.1 603.9 ± 0.2 652.4 ± 27.2 233.4 ± 11.9 113.0 ± 25.6 127.4 ± 30.1 161.9 ± 1.8 
1,7-dimethylxanthine 21464.9 ± 2015.5 1326.7 ± 21.0 1244.3 ± 35.2 530.3 ± 54.8 216.5 ± 18.3 388.8 ± 24.3 254.9 ± 6.2 
Nicotine 438.2 ± 13.9 255.2 ± 0.2 382.1 ± 0.5 349.8 ± 45.8 60.1 ± 36.8 113.6 ± 17.2 90.5 ± 8.4 
Cotinine 268.4 ± 4.8 56.7 ± 2.2 55.3 ± 0.7 35.8 ± 0.01 24.0 ± 0.03 35.0 ± 0.5 25.8 ± 0.9 
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Table C13: Concentrations (ng.L-1) calculated from Upstream river water at WWTW2 over the 7-day sampling period. 
Compound 
Concentration (ng.L-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 1.6 ± 0.3 1.1 ± 0.3 0.7 ± 0.2 0.6 ± 0.2 1.1 ± 0.9 0.6 ± 0.04 1.0 ± 0.1 
Benzoylecgonine 28.7 ± 2.2 21.0 ± 0.001 18.2 ± 0.3 21.8 ± 1.9 14.2 ± 0.2 14.2 ± 1.0 26.4 ± 0.5 
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine ND   ND   ND   ND   ND   ND   ND   
R-(-)-methamphetamine 25.9 ± 7.4 10.2 ± 1.6 13.6 ± 4.0 15.5 ± 1.0 6.1 ± 1.8 6.3 ± 0.7 20.8 ± 2.2 
S-(+)-methamphetamine 465.2 ± 9.5 180.6 ± 10.4 170.3 ± 20.0 190.7 ± 4.2 139.0 ± 44.8 137.9 ± 14.4 246.9 ± 8.2 
R-(+)-mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-ephedrine/1R,2R-(-)-pseudoephedrine 35.9 ± 1.1 30.6 ± 0.5 27.2 ± 0.7 29.3 ± 1.9 26.2 ± 1.5 26.4 ± 1.2 26.3 ± 1.0 
1S,2S-(+)-pseudoephedrine 12.3 ± 0.05 12.1 ± 0.1 9.2 ± 0.8 20.1 ± 1.5 11.8 ± 0.6 11.9 ± 0.1 10.1 ± 1.2 
E1-norephedrine ND   ND   ND   ND   ND   ND   ND   
E2-norephedrine ND   ND   ND   ND   ND   ND   ND   
Hallucinogens                      
R-(-)-MDMA 1.1 ± 0.1 1.2 ± 0.1 0.8 ± 0.2 0.6 ± 0.02 0.5 ± 0.1 0.5 ± 0.1 0.4 ± 0.04 
S-(+)-MDMA 0.4 ± 0.04 - ±  0.3 ± 0.01 0.2 ± 0.01 0.2 ± 0.1 0.2 ± 0.02 0.2 ± 0.01 
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA ND   ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   ND   ND   ND   
Opioids                      
Codeine 51.1 ± 0.7 42.1 ± 0.03 29.4 ± 0.4 51.4 ± 0.7 48.3 ± 1.8 32.7 ± 0.6 39.4 ± 3.2 
Dihydrocodeine ND   ND   ND   ND   ND   ND   ND   
Hydrocodone 17.2 ± 0.1 13.7 ± 1.0 18.6 ± 2.0 17.4 ± 0.9 15.0 ± 0.1 ND   17.4 ± 1.2 
Oxycodone ND   ND   ND   ND   ND   ND   ND   
Morphine 80.0 ± 10.3 66.2 ± 1.0 56.2 ± 1.6 73.6 ± 5.5 62.1 ± 3.2 54.8 ± 3.2 55.7 ± 8.2 
Normorphine ND   ND   ND   ND   ND   ND   ND   
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   11.7 ± 0.4 ND   ND   17.5 ± 0.03 ND   ND   
E1-tramadol 1458.9 ± 52.8 1408.9 ± 83.3 881.4 ± 49.6 936.3 ± 39.8 1070.4 ± 412.6 933.9 ± 43.4 1270.3 ± 9.4 
E2-tramadol 1076.7 ± 0.2 1059.3 ± 45.4 594.0 ± 50.5 674.8 ± 16.7 734.9 ± 234.0 712.3 ± 47.6 956.8 ± 1.9 
O-desmethyltramadol 2698.9 ± 124.5 2824.7 ± 102.1 2483.7 ± 52.7 2564.8 ± 37.5 2443.4 ± 67.1 2221.5 ± 44.8 2777.8 ± 16.8 
Methadone ND   ND   ND   ND   ND   ND   ND   
EDDP ND   ND   ND   ND   ND   ND   ND   
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Antidepressants                      
E1-venlafaxine 46.8 ± 1.9 41.6 ± 1.2 30.1 ± 3.0 24.7 ± 1.9 29.0 ± 6.8 30.9 ± 1.5 41.8 ± 0.6 
E2-venlafaxine 54.6 ± 2.6 51.4 ± 1.9 32.1 ± 1.7 31.4 ± 4.0 36.3 ± 11.4 31.8 ± 1.4 50.3 ± 0.6 
E1-desmethylvenlafaxine 253.3 ± 133.6 347.8 ± 36.0 110.9 ± 34.8 185.5 ± 5.4 218.3 ± 87.5 185.7 ± 6.4 290.8 ± 4.0 
E2-desmethylvenlafaxine 173.0 ± 1.0 159.1 ± 0.6 48.3 ± 38.1 102.8 ± 0.2 100.5 ± 29.4 67.2 ± 35.9 109.8 ± 38.6 
Anaesthetics                      
Ketamine 6.8 ± 0.1 6.6 ± 1.1 7.6 ± 0.3 7.8 ± 0.7 9.1 ± 4.9 8.8 ± 0.3 7.9 ± 1.2 
Human biomarkers                      
Caffeine 2276.2 ± 5.4 1529.0 ± 29.5 2449.4 ± 30.8 4316.1 ± 241.1 2480.8 ± 29.5 1313.4 ± 40.2 1691.3 ± 79.3 
1,7-dimethylxanthine 12597.6 ± 172.7 8264.5 ± 17.2 6170.2 ± 59.5 15026.7 ± 1862.1 11605.7 ± 613.6 4196.1 ± 98.1 9723.8 ± 785.0 
Nicotine 1359.3 ± 59.1 1184.2 ± 342.3 1121.8 ± 30.8 4332.2 ± 182.6 1966.3 ± 73.6 553.3 ± 30.9 1004.2 ± 114.1 
Cotinine 399.2 ± 6.8 201.1 ± 7.8 260.4 ± 4.4 473.4 ± 8.7 280.8 ± 11.3 169.6 ± 1.1 267.7 ± 5.9 
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 Table C14: Concentrations (ng.L-1) calculated from Downstream river water at WWTW2 over the 7-day sampling period. 
Compound 
Concentration (ng.L-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 2.1 ± 0.2 0.9 ± 0.04 0.9 ± 0.2 0.4 ± 0.1 0.5 ± 0.2 0.4 ± 0.04 0.6 ± 0.3 
Benzoylecgonine 31.0 ± 0.8 26.7 ± 1.3 21.3 ± 0.1 20.6 ± 0.2 13.2 ± 0.02 14.5 ± 0.4 13.5 ± 0.5 
R-(-)-amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-amphetamine ND   ND   ND   ND   ND   ND   ND   
R-(-)-methamphetamine 28.3 ± 1.1 22.5 ± 1.6 21.5 ± 0.3 20.2 ± 1.9 9.6 ± 0.7 15.6 ± 0.9 11.8 ± 0.05 
S-(+)-methamphetamine 206.1 ± 3.1 73.5 ± 5.3 119.5 ± 8.8 146.9 ± 20.3 90.8 ± 20.3 86.5 ± 0.1 69.5 ± 2.2 
R-(+)-mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-ephedrine/1R,2R-(-)-pseudoephedrine 33.5 ± 0.7 35.1 ± 0.3 34.2 ± 0.8 33.2 ± 1.0 25.8 ± 2.5 30.0 ± 0.3 24.3 ± 0.2 
1S,2S-(+)-pseudoephedrine 12.1 ± 0.2 14.4 ± 0.3 11.6 ± 0.1 14.4 ± 0.2 ND   ND   ND   
E1-norephedrine 1.8 ± 0.2 2.4 ± 0.02 2.0 ± 0.3 2.2 ± 0.2 1.0 ± 0.3 1.9 ± 0.4 0.7 ± 0.4 
E2-norephedrine ND   ND   ND   ND   ND   ND   ND   
Hallucinogens                      
R-(-)-MDMA 4.6 ± 0.01 2.3 ± 0.2 3.2 ± 0.1 2.0 ± 0.1 0.9 ± 0.2 1.0 ± 0.1 0.7 ± 0.03 
S-(+)-MDMA ND   ND   ND   ND   ND   ND   ND   
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA ND   ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   ND   ND   ND   
Opioids                      
Codeine 25.3 ± 0.1 31.4 ± 1.7 16.3 ± 0.1 35.8 ± 4.2 33.6 ± 0.4 29.2 ± 1.1 21.8 ± 1.3 
Dihydrocodeine ND   ND   ND   ND   ND   ND   ND   
Hydrocodone ND   ND   ND   ND   ND   ND   ND   
Oxycodone ND   ND   ND   ND   ND   ND   ND   
Morphine 27.7 ± 0.5 22.1 ± 0.1 19.5 ± 1.8 35.6 ± 3.8 55.1 ± 2.8 29.9 ± 1.3 21.2 ± 4.5 
Normorphine ND   ND   ND   ND   ND   ND   ND   
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-monoacetylmorphine ND   ND   ND   ND   ND   ND   ND   
E1-tramadol 974.8 ± 18.0 711.0 ± 42.2 652.1 ± 22.7 785.0 ± 16.4 618.4 ± 33.1 703.6 ± 58.6 494.7 ± 8.0 
E2-tramadol 647.5 ± 30.5 503.9 ± 7.5 470.1 ± 12.4 606.0 ± 12.0 429.2 ± 43.2 510.2 ± 3.2 368.5 ± 21.7 
O-desmethyltramadol 1691.3 ± 38.1 1892.6 ± 146.6 1394.4 ± 42.1 1960.2 ± 91.5 1758.5 ± 105.5 2100.6 ± 4.9 1478.2 ± 4.7 
Methadone ND   ND   ND   ND   ND   ND   ND   
EDDP ND   ND   ND   ND   ND   ND   ND   
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 216 
 
Antidepressants                      
E1-venlafaxine 81.4 ± 0.3 104.5 ± 5.7 60.2 ± 4.5 62.3 ± 10.7 37.2 ± 1.8 44.6 ± 5.3 37.7 ± 1.2 
E2-venlafaxine 68.7 ± 0.6 83.4 ± 2.8 47.2 ± 2.0 51.9 ± 10.7 26.9 ± 1.1 36.3 ± 2.7 31.6 ± 1.6 
E1-desmethylvenlafaxine 297.1 ± 7.4 423.4 ± 49.5 231.7 ± 11.4 308.4 ± 12.1 163.0 ± 7.4 215.7 ± 30.3 153.8 ± 3.9 
E2-desmethylvenlafaxine 142.9 ± 6.2 241.0 ± 17.2 122.1 ± 5.0 159.2 ± 2.8 84.9 ± 6.5 111.7 ± 15.1 84.3 ± 4.5 
Anaesthetics                      
Ketamine 6.7 ± 0.1 5.0 ± 0.6 6.2 ± 0.04 5.6 ± 0.4 5.9 ± 0.4 7.9 ± 0.99 3.9 ± 0.3 
Human biomarkers                      
Caffeine 792.6 ± 13.6 187.3 ± 7.9 806.8 ± 122.1 1605.1 ± 36.3 1894.4 ± 31.6 697.4 ± 36.5 1755.4 ± 65.7 
1,7-dimethylxanthine 4620.0 ± 168.4 1308.5 ± 41.2 2192.1 ± 63.5 6130.5 ± 395.5 5417.6 ± 710.1 3049.1 ± 366.8 5910.9 ± 156.9 
Nicotine 635.8 ± 2.5 574.2 ± 3.6 492.6 ± 21.4 2176.7 ± 122.7 2527.5 ± 147.2 280.6 ± 2.3 7007.5 ± 84.6 
Cotinine 154.9 ± 4.2 46.3 ± 0.5 95.5 ± 2.0 212.0 ± 0.2 189.1 ± 0.6 97.6 ± 4.7 297.9 ± 4.9 
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APPENDIX D: SUPPLEMENTARY INFORMATION FOR CHAPTER 6  
Wastewater-Based Epidemiology and Enantiomeric Profiling for Drugs of Abuse in 
South African Wastewater 
Table D1: Plant information of the two WWTWs during the study. 
 Capacity 
(ML.day-1) 
Domestic: 
Industrial 
HRTa 
(hours) 
Population Estimateb 
Flowinf
c 
(ML.day-1) 
WWTW1 63.0 60:40 24 200 000 42.6 
WWTW2 105.0 80:20 24 470 000 79.9 
a Hydraulic retention time (in hours) of wastewater within the treatment process. 
b de facto population estimate based on projected census data for 2017 from the last formal census done in 2011. 
c Average flow rate (in megalitres per day) of wastewater influent during the sampling period. 
 
 
 
Figure D1: Summarised method for the LC-MS protocol used during the study. More in-depth method 
validation can be found in Castignanò et al., 2016. 
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Table D2: Correction factors for the excretion profiles of the DTRs in faeces/urine as well as their 
molecular mass ratios used for mass load and population-normalised mass load estimates. 
Drug DTR Excretion (%) Mw (parent/DTR) CF  
Cocaine Benzoylecgonine 29.0a  1.05 3.6 
Methamphetamine Methamphetamine 43.0a 1.0 2.3 
 S-(+)-methamphetamine 40.9b  1.0 2.4 
 R-(-)-methamphetamine 44.2b  1.0 2.3 
 Amphetamine 4.0-7.0c 1.1 20.1 
 Norephedrine 5.0c 0.99 19.7 
MDMA MDMA 22.5d 1.0 4.4g 
 R-(-)-MDMA 35.5e 1.0 2.8 
 S-(+)-MDMA 9.8e 1.0 10.2 
 HMMA 18.2d 0.99 5.0c 
Mephedrone Mephedrone 15.4f 1.0 6.5c 
a Castiglioni et al., 2016 
b Stereoselective excretion after oral administration of racemic methamphetamine (Gracia-lor et al., 2016) 
c Castrignanò et al.,2017a 
d Gracia-lor et al., 2016 
e Stereoselective excretion of an oral racemic MDMA administration (Lanz et al., 1997) 
f Bade et al., 2017 
g González-Mariño et al., 2017 
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Table D3: Concentrations (ng.L-1) calculated from raw wastewater at WWTW1 over a 7-day period. 
Compound 
Concentration (ng.L-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 52.4 ± 3.1 60.8 ± 7.7 40.9 ± 6.1 91.3 ± 3.9 52.4 ± 0.1 145.1 ± 14.8 58.6 ± 2.5 
Benzoylecgonine 169.1 ± 5.5 197.6 ± 8.3 197.5 ± 8.5 162.3 ± 8.2 129.8 ± 4.5 346.3 ± 32.0 233.1 ± 3.5 
Cocaethylene 1.0 ± 0.2 1.0 ± 0.5 ND   ND   ND   1.9 ± 0.1 2.2 ± 0.3 
R-(-)-Amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-Amphetamine 20.2 ± 1.3 15.6 ± 5.8 15.5 ± 9.0 13.1 ± 3.5 18.8 ± 5.4 20.7 ± 5.4 17.0 ± 2.7 
R-(-)-Methamphetamine 96.1 ± 11.0 69.1 ± 11.1 55.7 ± 8.8 83.0 ± 5.3 78.5 ± 1.3 102.7 ± 2.4 121.8 ± 9.2 
S-(+)-Methamphetamine 444.2 ± 53.4 429.3 ± 54.2 248.5 ± 43.6 609.4 ± 12.2 417.0 ± 16.7 394.0 ± 35.1 773.9 ± 38.9 
R-(+)-Mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-Mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-Ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-Ephedrine/1R,2R-(-)-pseudoephedrine 1208.1 ± 28.1 965.8 ± 0.7 1472.6 ± 23.6 1749.9 ± 34.3 964.6 ± 12.1 1134.6 ± 97.3 1252.1 ± 106.4 
1S,2S-(+)-Pseudoephedrine 1299.7 ± 4.7 822.1 ± 9.6 864.9 ± 0.2 1264.5 ± 3.8 943.5 ± 47.1 961.6 ± 79.4 893.7 ± 15.5 
E1-Norephedrine 61.4 ± 3.4 47.4 ± 1.0 44.2 ± 4.0 55.2 ± 1.6 58.1 ± 0.6 55.5 ± 9.6 59.1 ± 0.2 
E2-Norephedrine 100.8 ± 3.6 78.6 ± 1.5 69.1 ± 1.0 79.6 ± 1.5 81.8 ± 0.3 82.4 ± 2.7 94.5 ± 3.4 
Hallucinogens                      
R-(-)-MDMA 1.9 ± 0.1 1.7 ± 0.3 ND   ND   ND   ND   2.5 ± 0.2 
S-(+)-MDMA ND   0.7 ± 0.1 ND   ND   ND   ND   1.9 ± 0.4 
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA 4.9 ± 1.1 ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   7.2 ± 0.4 ND   8.0 ± 0.2 
Opioids                      
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-MAM ND   ND   ND   ND   ND   ND   ND   
Morphine 407.2 ± 6.7 355.4 ± 41.1 328.9 ± 6.3 326.6 ± 10.3 291.8 ± 31.8 380.0 ± 6.9 400.8 ± 30.8 
Normorphine 150.2 ± 24.2 157.2 ± 5.7 88.9 ± 0.02 103.3 ± 8.0 105.8 ± 12.6 143.6 ± 21.4 127.3 ± 10.6 
MDMA - 3,4-methylenedioxymethamphetamine; HMA - 4-hydroxy-3-methoxyamphetamine; HMMA - 4-hydroxy-3-methoxymethamphetamine; O-6-MAM - O-6-monoacetylmorphine. 
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Table D4: Concentrations (ng.L-1) calculated from raw wastewater at WWTW2 over a 7-day period. 
Compound 
Concentration (ng.L-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 308.3 ± 7.6 217.3 ± 5.2 195.2 ± 12.4 107.8 ± 3.6 323.1 ± 1.3 349.7 ± 26.3 563.0 ± 3.3 
Benzoylecgonine 693.5 ± 86.5 517.7 ± 10.4 485.8 ± 21.3 409.6 ± 0.9 588.5 ± 0.1 840.2 ± 28.0 1084.2 ± 50.5 
Cocaethylene 9.9 ± 0.7 4.8 ± 0.3 6.2 ± 0.9 1.1 ± 0.03 8.4 ± 1.7 18.8 ± 0.7 19.4 ± 2.6 
R-(-)-Amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-Amphetamine 97.3 ± 0.6 90.5 ± 2.1 50.9 ± 6.6 62.1 ± 3.8 79.2 ± 0.1 100.6 ± 6.3 128.9 ± 11.1 
R-(-)-Methamphetamine 112.1 ± 6.8 135.2 ± 3.8 119.3 ± 1.4 94.7 ± 4.5 118.7 ± 3.9 161.3 ± 19.1 183.5 ± 2.3 
S-(+)-Methamphetamine 2317.6 ± 6.6 2171.9 ± 106.6 1828.3 ± 133.2 1587.4 ± 46.6 1889.8 ± 51.2 2877.1 ± 238.7 3226.4 ± 36.5 
R-(+)-Mephedrone ND   2.0 ± 1.0 1.6 ± 0.1 ND   3.5 ± 0.1 1.6 ± 0.01 6.4 ± 0.4 
S-(-)-Mephedrone 1.4 ± 0.5 2.0 ± 0.3 ND   ND   3.4 ± 0.3 1.1 ± 0.2 5.7 ± 1.5 
Precursors                      
1S,2R-(+)-Ephedrine ND   ND   ND   ND   ND   ND   ND ND  
1R,2S-(-)-Ephedrine/1R,2R-(-)-pseudoephedrine 374.1 ± 22.8 384.3 ± 14.7 274.1 ± 2.4 362.9 ± 14.1 373.6 ± 1.8 415.2 ± 4.9 461.1 ± 25.0 
1S,2S-(+)-Pseudoephedrine 664.5 ± 38.0 718.1 ± 7.0 430.4 ± 8.8 501.0 ± 33.7 628.0 ± 27.9 580.0 ± 3.6 742.2 ± 5.1 
E1-Norephedrine 25.1 ± 1.7 27.7 ± 4.3 5.7 ± 0.4 26.6 ± 14.6 18.0 ± 0.1 16.7 ± 3.7 22.2 ± 1.2 
E2-Norephedrine 41.5 ± 0.5 48.1 ± 1.5 19.1 ± 0.6 29.7 ± 2.2 44.6 ± 1.3 39.7 ± 0.3 46.9 ± 1.1 
Hallucinogens                      
R-(-)-MDMA 34.5 ± 0.1 13.8 ± 0.2 13.5 ± 1.0 7.6 ± 0.1 10.0 ± 1.4 28.0 ± 0.4 57.5 ± 1.1 
S-(+)-MDMA 12.8 ± 0.1 5.4 ± 0.6 6.2 ± 0.4 3.9 ± 0.2 6.4 ± 0.6 19.3 ± 0.6 34.4 ± 0.02 
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA 10.7 ± 0.5 7.3 ± 1.8 ND   ND   ND   10.8 ± 0.4 16.0 ± 0.9 
S-(+)-HMMA 12.1 ± 0.9 9.5 ± 0.8 9.5 ± 1.0 9.1 ± 0.7 8.6 ± 0.1 ND   19.2 ± 0.9 
Opioids                      
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-MAM ND   ND   29.9 ± 4.5 34.1 ± 8.8 66.0 ± 3.7 28.2 ± 0.1 29.3 ± 3.2 
Morphine 9379.7 ± 1078.0 3585.8 ± 422.8 4002.8 ± 123.0 4528.2 ± 3.8 3757.4 ± 83.2 927.5 ± 193.0 761.0 ± 10.1 
Normorphine ND   173.8 ± 39.5 ND   131.8 ± 3.4 139.4 ± 25.5 ND   152.3 ± 26.3 
MDMA - 3,4-methylenedioxymethamphetamine; HMA - 4-hydroxy-3-methoxyamphetamine; HMMA - 4-hydroxy-3-methoxymethamphetamine; O-6-MAM - O-6-monoacetylmorphine. 
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Table D5: Drug loads (g.day-1) calculated from raw wastewater at WWTW1. 
Compound 
Mass Load (g.day-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 2.69 ± 0.2 3.05 ± 0.4 2.12 ± 0.3 4.97 ± 0.2 2.25 ± 0.01 7.23 ± 0.7 3.03 ± 0.1 
Benzoylecgonine 8.69 ± 0.3 9.91 ± 0.4 10.27 ± 0.4 8.83 ± 0.4 5.59 ± 0.2 17.26 ± 1.6 12.05 ± 0.2 
Cocaethylene 0.05 ± 0.01 0.05 ± 0.02 0.004 ± 0.01 ND   ND   0.10 ± 0.01 0.11 ± 0.01 
R-(-)-Amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-Amphetamine 1.04 ± 0.1 0.78 ± 0.3 0.81 ± 0.5 0.71 ± 0.2 0.81 ± 0.2 1.03 ± 0.3 0.88 ± 0.1 
R-(-)-Methamphetamine 4.94 ± 0.6 3.47 ± 0.6 2.90 ± 0.5 4.51 ± 0.3 3.38 ± 0.1 5.12 ± 0.1 6.30 ± 0.5 
S-(+)-Methamphetamine 22.83 ± 2.7 21.53 ± 2.7 12.92 ± 2.3 33.15 ± 0.7 17.95 ± 0.7 19.64 ± 1.7 40.01 ± 2.0 
R-(+)-Mephedrone ND   ND   ND   ND   ND   ND   ND   
S-(-)-Mephedrone ND   ND   ND   ND   ND   ND   ND   
Precursors                      
1S,2R-(+)-Ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-Ephedrine/1R,2R-(-)-pseudoephedrine 62.09 ± 1.4 48.45 ± 0.03 76.57 ± 1.2 95.18 ± 1.9 41.52 ± 0.5 56.55 ± 4.9 64.74 ± 5.5 
1S,2S-(+)-Pseudoephedrine 66.80 ± 0.2 41.24 ± 0.5 44.98 ± 0.01 68.78 ± 0.2 40.61 ± 2.0 47.93 ± 4.0 46.21 ± 0.8 
E1-Norephedrine 3.16 ± 0.2 2.38 ± 0.05 2.30 ± 0.2 3.00 ± 0.1 2.50 ± 0.03 2.77 ± 0.5 3.06 ± 0.01 
E2-Norephedrine 5.18 ± 0.2 3.94 ± 0.1 3.59 ± 0.1 4.33 ± 0.1 3.52 ± 0.01 4.10 ± 0.1 4.89 ± 0.2 
Hallucinogens                      
R-(-)-MDMA 0.10 ± 0.01 0.08 ± 0.01 ND   ND   ND   ND   0.13 ± 0.01 
S-(+)-MDMA ND   0.04 ± 0.005 ND   ND   ND   ND   0.10 ± 0.02 
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA 0.25 ± 0.1 ND   ND   ND   ND   ND   ND   
S-(+)-HMMA ND   ND   ND   ND   0.31 ± 0.02 ND   0.42 ± 0.01 
Opioids                      
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-MAM ND   ND   ND   ND   ND   ND   ND   
Morphine 20.93 ± 0.3 17.83 ± 2.1 17.10 ± 0.3 17.76 ± 0.6 12.56 ± 1.4 18.94 ± 0.3 20.72 ± 1.6 
Normorphine 7.72 ± 1.2 7.89 ± 0.3 4.62 ± 0.001 5.62 ± 0.4 4.55 ± 0.5 7.16 ± 1.1 6.58 ± 0.5 
MDMA - 3,4-methylenedioxymethamphetamine; HMA - 4-hydroxy-3-methoxyamphetamine; HMMA - 4-hydroxy-3-methoxymethamphetamine; O-6-MAM - O-6-monoacetylmorphine. 
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Table D6: Drug loads (g.day-1) calculated from raw wastewater at WWTW2. 
Compound 
Mass Load (g.day-1) 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Stimulants                      
Cocaine 25.28 ± 0.6 18.25 ± 0.4 16.00 ± 1.0 8.84 ± 0.3 27.14 ± 0.1 25.88 ± 1.9 39.97 ± 0.2 
Benzoylecgonine 56.86 ± 7.1 43.49 ± 0.9 39.84 ± 1.7 33.59 ± 0.1 49.44 ± 0.01 62.18 ± 2.1 76.98 ± 3.6 
Cocaethylene 0.81 ± 0.1 0.40 ± 0.03 0.51 ± 0.1 0.09 ± 0.002 0.71 ± 0.1 1.39 ± 0.1 1.38 ± 0.2 
R-(-)-Amphetamine ND   ND   ND   ND   ND   ND   ND   
S-(+)-Amphetamine 7.98 ± 0.05 7.60 ± 0.2 4.17 ± 0.5 5.09 ± 0.3 6.66 ± 0.01 7.44 ± 0.5 9.15 ± 0.8 
R-(-)-Methamphetamine 9.19 ± 0.6 11.36 ± 0.3 9.78 ± 0.1 7.77 ± 0.4 9.97 ± 0.3 11.94 ± 1.4 13.03 ± 0.2 
S-(+)-Methamphetamine 190.05 ± 0.5 182.44 ± 9.0 149.92 ± 10.9 130.17 ± 3.8 158.75 ± 4.3 212.90 ± 17.7 229.07 ± 2.6 
R-(+)-Mephedrone ND   1.07 ± 0.5 0.87 ± 0.04 ND   1.93 ± 0.03 0.75 ± 0.004 2.95 ± 0.2 
S-(-)-Mephedrone 0.75 ± 0.3 1.11 ± 0.2 ND   ND   1.87 ± 0.2 0.54 ± 0.1 2.63 ± 0.7 
Precursors                      
1S,2R-(+)-Ephedrine ND   ND   ND   ND   ND   ND   ND   
1R,2S-(-)-Ephedrine/1R,2R-(-)-pseudoephedrine 30.68 ± 1.9 32.28 ± 1.2 22.47 ± 0.2 29.76 ± 1.2 31.38 ± 0.1 30.73 ± 0.4 32.74 ± 1.8 
1S,2S-(+)-Pseudoephedrine 54.49 ± 3.1 60.32 ± 0.6 35.29 ± 0.7 41.08 ± 2.8 52.75 ± 2.3 42.92 ± 0.3 52.69 ± 0.4 
E1-Norephedrine 2.06 ± 0.2 2.33 ± 0.4 0.47 ± 0.03 2.18 ± 1.2 1.51 ± 0.01 1.23 ± 0.3 1.58 ± 0.1 
E2-Norephedrine 3.40 ± 0.04 4.04 ± 0.1 1.56 ± 0.1 2.44 ± 0.2 3.74 ± 0.1 2.94 ± 0.02 3.33 ± 0.1 
Hallucinogens                      
R-(-)-MDMA 2.83 ± 0.01 1.16 ± 0.01 1.11 ± 0.1 0.62 ± 0.01 0.84 ± 0.1 2.08 ± 0.03 4.08 ± 0.1 
S-(+)-MDMA 1.05 ± 0.01 0.45 ± 0.1 0.51 ± 0.04 0.32 ± 0.02 0.54 ± 0.1 1.43 ± 0.04 2.44 ± 0.002 
E1-HMA ND   ND   ND   ND   ND   ND   ND   
E2-HMA ND   ND   ND   ND   ND   ND   ND   
R-(-)-HMMA 0.88 ± 0.04 0.61 ± 0.1 ND   ND   ND   0.80 ± 0.03 1.13 ± 0.1 
S-(+)-HMMA 0.99 ± 0.1 0.80 ± 0.1 0.78 ± 0.1 0.75 ± 0.1 0.72 ± 0.01 ND   1.36 ± 0.1 
Opioids                      
Heroin ND   ND   ND   ND   ND   ND   ND   
O-6-MAM ND   ND   2.45 ± 0.4 2.80 ± 0.7 5.54 ± 0.3 2.09 ± 0.005 2.08 ± 0.2 
Morphine 769.13 ± 88.4 301.21 ± 35.5 328.23 ± 10.1 371.31 ± 0.3 315.62 ± 7.0 68.63 ± 14.3 54.03 ± 0.7 
Normorphine ND   14.60 ± 3.3 ND   10.81 ± 0.3 11.71 ± 2.1 ND   10.82 ± 1.9 
MDMA - 3,4-methylenedioxymethamphetamine; HMA - 4-hydroxy-3-methoxyamphetamine; HMMA - 4-hydroxy-3-methoxymethamphetamine; O-6-MAM - O-6-monoacetylmorphine. 
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Table D7: Population-normalised mass load estimates (mg.day-1.1000inh-1) for several countries using the WBE approach.  
Drug Sampling locations Country 
Year 
Sampled 
Load 
(mg.day-1.1000inh-1) 
Reference 
Cocaine 2 WWTWs South Africa 2017 100.6 – 589.6 Current study 
 49 cities Europe 2016 0.9 – 914.8 EMCDDA, 2016 
 Medellin Colombia 2015 2747.0 – 3465.0 Bijlsma et al., 2016 
 Bogotá Colombia 2015 703.0 – 871.0 Bijlsma et al., 2016 
 Auckland Australia 2014 24.3 – 37.1 Lai et al., 2017 
 Liberia Costa Rica 2014 1880.0 – 2550.0 Causanilles et al., 2017 
 El Roble Costa Rica 2014 2390.0 Causanilles et al., 2017 
 1 WWTW Canada 2014 12.0 Palardy et al., 2015 
 1 WWTW UK 2011 1023.0 – 1767.0 Baker et al., 2014 
 1 WWTW Czech Republic 2011 115.9 – 329.2 Baker et al., 2012 
 2 WWTWs Canada 2010 390.0 – 3750.0 Yargeau et al., 2014 
Methamphetamine 2 WWTWs South Africa 2017 181.9 – 1184.8 Current study 
 44 cities Europe  2016 0.4 – 671.8 EMCDDA, 2016 
 Oslo Norway 2015 172.4 Castrignanò et al., 2017b 
 Zurich Switzerland 2015 20.2 Castrignanò et al., 2017b 
 14 cities China 2014 - 2015 208.6 – 1789.9 Xu et al., 2017 
 1 WWTW Canada 2014 9.0 Palardy et al., 2015 
 Auckland Australia 2014 144.0 – 1130.0 Lai et al., 2017 
 5 cities South-Korea 2012 - 2013 <2.6 – 67.9 Kim et al., 2015 
 1 WWTW Czech Republic 2011 293.3 – 626.7 Baker et al., 2012 
 2 WWTWs Canada 2010 54.0 Yargeau et al., 2014 
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Mephedrone 2 WWTWs South Africa 2017 1.6 – 10.4 Current study 
 - UK 2015 14.9 – 47.7 Castrignanò et al., 2017a 
MDMA 2 WWTWs South Africa 2017 2.2 – 69.3 Current study 
53 cities Europe  2016 1.5 – 125.7 EMCDDA, 2016 
Milan Italy 2015 5.0 – 53.2 González-Mariño et al., 2017 
Lugano Switzerland 2015 0.6 – 4.3 González-Mariño et al., 2017 
Porto Portugal 2015 1.2 – 10.5 González-Mariño et al., 2017 
Castellon Spain 2015 3.2 Castrignanò et al., 2017b 
Utrecht Netherlands 2015 62.0 Castrignanò et al., 2017b 
Auckland Australia 2014 45.9 – 88.5 Lai et al., 2017 
1 WWTW Czech Republic 2011 21.2 – 173.3 Baker et al., 2012 
Brussels Belgium 2010 13.0 van Nuijs et al., 2011 
2 WWTWs Canada 2010 140.0 Yargeau et al., 2014 
Zagreb Croatia 2009 3.6 Terzic et al., 2010 
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